drop database if exists mytrial;
create database mytrial;
use mytrial;

-- CREATE Database Objects

--  organization is a reserved word
CREATE TABLE org (
    org_name varchar(300) not null,
    primary key (org_name)
);

-- NOTE: I see NCT_no link to specific CT title
CREATE TABLE trial (
	trial_id varchar(9) not null,
    trial_status varchar(25) not null,
    target_enrollment integer,
    NCT_no char(11),
    phase varchar(10) not null,
    title varchar(300) not null,
    org_name varchar(300),
    primary key (trial_id),
    foreign key (org_name) references org (org_name)
);

CREATE TABLE researcher (
    researcher_id varchar(9) not null,
    r_name varchar(50) not null,
    r_username varchar(30) not null,
    r_password varchar(20) not null,
    primary key (researcher_id)
);

CREATE TABLE patient (
    patient_id varchar(300) not null,
    disease varchar(300) not null,
    phase varchar(20) not null,
    p_status varchar(30) not null,
    trial_id varchar(9) not null,
    p_username varchar(30) not null,
    p_password varchar(20) not null,
    researcher_id varchar(9) not null,
    primary key (patient_id),
    foreign key (trial_id) references trial (trial_id),
    foreign key (researcher_id) references researcher (researcher_id)
);

CREATE TABLE donor (
    patient_id varchar(9) not null,
    name varchar(50) not null,
    email varchar(50),
    primary key (patient_id, name),
    foreign key (patient_id) references patient (patient_id)
);

CREATE TABLE p_watchlist (
    name varchar(50) not null,
    patient_id varchar(9) not null,
    disease_area varchar(300) not null,
    primary key (patient_id, name),
    foreign key (patient_id) references patient (patient_id)
);

CREATE TABLE discussion_forum (
    df_id varchar(9) not null,
    df_name varchar(60) not null,
    df_timestamp TIMESTAMP DEFAULT CURRENT_TIMESTAMP,
    details varchar(600) not null,
    researcher_id varchar(9) not null,
    primary key (df_id),
    foreign key (researcher_id) references researcher (researcher_id)
);

CREATE TABLE investigates (
    researcher_id varchar(9) not null,
    trial_id varchar(9) not null,
    primary key (researcher_id, trial_id),
    foreign key (researcher_id) references researcher (researcher_id),
    foreign key (trial_id) references trial (trial_id)
);

-- CREATE TABLE awards (
--     grant_no varchar(11) not null,
--     researcher_id varchar(9) not null,
--     primary key (researcher_id, grant_no),
--     foreign key (researcher_id) references researcher (researcher_id),
--     foreign key (grant_no) references ct_grant (grant_no)
-- );

CREATE TABLE r_disease_area (
    researcher_id varchar(9) not null,
    disease_name varchar(300) not null,
    primary key (researcher_id, disease_name),
    foreign key (researcher_id) references researcher (researcher_id)
);

CREATE TABLE reply (
    reply_id      INT NOT NULL AUTO_INCREMENT,
    r_timestamp   TIMESTAMP DEFAULT CURRENT_TIMESTAMP,
    content       VARCHAR(300),
    df_id         VARCHAR(9),
    researcher_id VARCHAR(9) NOT NULL,
    PRIMARY KEY (reply_id),
    FOREIGN KEY (df_id) REFERENCES discussion_forum(df_id),
    FOREIGN KEY (researcher_id) REFERENCES researcher(researcher_id)
);



CREATE TABLE works_for (
    researcher_id varchar(9) not null,
    org_name varchar(300) not null,
    primary key (researcher_id, org_name),
    foreign key (researcher_id) references researcher (researcher_id),
    foreign key (org_name) references org (org_name)
);

CREATE TABLE t_disease_area (
    trial_id varchar(9) not null,
    disease_name varchar(300) not null,
    primary key (trial_id, disease_name),
    foreign key (trial_id) references trial (trial_id)
);

CREATE TABLE ct_grant (
    grant_number	varchar(20), 
	grant_title		varchar(255), 
    trial_id		varchar(10) default null, 
	disease_focus	varchar(150),
    start_date		varchar(15) default null,
    end_date		varchar(15) default null,
    type			varchar(100), 
    award_status	varchar(20),
    institution		varchar(120),
    stem_cell_use	varchar(80),
    amount			decimal(15,2) check (amount > 0),		
    primary key (grant_number),
	foreign key (trial_id) references trial(trial_id)
    on delete set default
);

-- added disease_area to primary key since a researcher can watch multiple disease areas
CREATE TABLE r_watchlist (
    name			    varchar(20), 
	researcher_id		varchar(9) default -1, 
	disease_area		varchar(300),
	primary key (name, researcher_id, disease_area),
	foreign key (researcher_id) references researcher(researcher_id)
	on delete set default
);

-- INSERT into Database TABLES
INSERT org VALUES 
       ('Aspen Neuroscience'),
       ('Semma Therapeutics'),
       ('Cal State Univ, Sacramento'),
       ('Lineage Cell Therapeutics Inc.'),
       ('BioTime, Inc.'),
       ('Ankasa Regenerative Therapeutics'),
       ('University of California, San Diego'),
       ('International Society for Stem Cell Research'),
       ('Mosaic Event Management, Inc.'),
       ('Cedars-Sinai Medical Center'),
       ('City College Of San Francisco'),
       ('Human Organ Project'),
       ('Caladrius Biosciences'),
       ('TriFoil Imaging, Inc.'),
       ('Cal State Univ, Long Beach'),
       ('Pasadena City College'),
       ('Humacyte, Inc.'),
       ('Fluidigm Corporation'),
       ('Cellular Dynamics International'),
       ('Capricor, Inc'),
       ('Parkinson\'s Institute'),
       ('GMR Epigenetics'),
       ('Scripps Research Institute'),
       ('Immune-Onc Therapeutics'),
       ('X-Therma Inc.'),
       ('La Jolla Institute for Allergy and Immunology'),
       ('University of California, Riverside'),
       ('International Society for Experimental Hematology'),
       ('International Symposium on Neural Regeneration, Inc.'),
       ('Tippi C. Mackenzie'),
       ('University of California, San Francisco'),
       ('Children\'s Neurobiological Solutions (CNS) Foundation'),
       ('Neurona Therapeutics'),
       ('Keystone Symposia on Molecular and Cellular Biology'),
       ('Numerate, Inc.'),
       ('Palo Alto Veterans Institute for Research'),
       ('Gordon Research Conferences'),
       ('Zenobia Therapeutics'),
       ('SanBio, Inc.'),
       ('Poseida Therapeutics, Inc.'),
       ('University of California, Irvine'),
       ('Benjamin D. Yu'),
       ('The University Corporation at California State University, Northridge'),
       ('University of California, Los Angeles'),
       ('Sanford Burnham Prebys Medical Discovery Institute'),
       ('Stanford University'),
       ('OncoMed Pharmaceuticals, Inc.'),
       ('ImmunoCellular Therapeutics'),
       ('Western University of Health Sciences'),
       ('University of Southern California'),
       ('Cal State Univ, San Bernadino'),
       ('Rumi Scientific CA'),
       ('St. Jude Children\'s Research Hospital'),
       ('Alliance Forum Foundation'),
       ('University of California, Merced'),
       ('Vala Sciences, Inc.'),
       ('Gladstone Institutes, J. David'),
       ('San Diego State University Foundation'),
       ('Loma Linda University'),
       ('Calimmune, Inc.'),
       ('Scaled Biolabs Inc.'),
       ('Lundquist Institute for Biomedical Innovation'),
       ('Biocom Institute'),
       ('Angiocrine Bioscience, Inc.'),
       ('Pathways to Stem Cell Science'),
       ('jCyte, Inc'),
       ('Nohla Therapeutics Inc'),
       ('California Institute of Technology'),
       ('Research for Cure'),
       ('RUNX1 Research Program'),
       ('Buck Institute for Age Research'),
       ('Escape Therapeutics, Inc'),
       ('Children\'s Hospital of Orange County'),
       ('StemCells, Inc.'),
       ('MAX BioPharma, Inc.'),
       ('Sangamo BioSciences, Inc.'),
       ('Cal Poly Pomona'),
       ('ExCellThera Inc.'),
       ('Celularity Inc'),
       ('Scripps Health'),
       ('Gamma Medica-Ideas, Inc.'),
       ('ViaCyte, Inc.'),
       ('Cal Poly Corporation, an Auxiliary of California Polytechnic State University, San Luis Obispo'),
       ('University of California, Santa Barbara'),
       ('International Alliance for Biological Standardization'),
       ('Jasper Therapeutics, Inc.'),
       ('Sanford Consortium for Regenerative Medicine'),
       ('Orchard Therapeutics plc'),
       ('FUJIFILM Cellular Dynamics'),
       ('Samumed, LLC'),
       ('Berkeley City College'),
       ('Humboldt State University Sponsored Programs Foundation'),
       ('Lundquist Institute for Biomedical Innovation at Harbor - UCLA Medical Center'),
       ('Cellular Biomedicine Group, Inc.'),
       ('Ocular Research Symposia Foundation, Inc.'),
       ('Human BioMolecular Research Institute'),
       ('VistaGen Therapeutics, Inc.'),
       ('University of California, Berkeley'),
       ('Children\'s Hospital of Los Angeles'),
       ('San Francisco State University'),
       ('Mohammad Pashmforoush'),
       ('Ali Nsair'),
       ('Medeor Therapeutics, Inc.'),
       ('Boston Children\'s Hospital'),
       ('JDRF International'),
       ('OCTANe Foundation for Innovation'),
       ('UCSF Benioff Children’s Hospital Oakland'),
       ('Calibr'),
       ('BrainStorm Cell Therapeutics'),
       ('Cellerant Therapeutics, Inc.'),
       ('Midwinter Conference of Immunologists'),
       ('Fate Therapeutics, Inc.'),
       ('SJSU Research Foundation'),
       ('University of California, Santa Cruz'),
       ('Vitalant Research Institute'),
       ('Brain Neurotherapy Bio'),
       ('Brain Mapping Foundation'),
       ('The Scintillon Institute'),
       ('Cal State Univ, San Marcos'),
       ('iPierian, Inc.'),
       ('Jackson Labs'),
       ('Reza Ardehali'),
       ('California State University, Channel Islands'),
       ('University of California, Davis'),
       ('City of Hope, Beckman Research Institute'),
       ('American Association of Blood Banks'),
       ('Vitabolus, Inc.'),
       ('Salk Institute for Biological Studies'),
       ('Cal State Univ, Fullerton'),
       ('Rocket Pharmaceuticals, Inc.'),
       ('IQVIA, Inc.'),
       ('Ludwig Institute for Cancer Research'),
       ('Forty Seven Inc.'),
       ('Geron Corporation'),
       ('Childrens Hospital of Oakland Research Institute'),
       ('Cal State Univ, Northridge'),
       ('Humboldt State University'),
       ('Cal State Univ, Channel Island'),
       ('San Jose State University');

       
INSERT trial VALUES
('000000001','Active, not recruiting',16,'NCT02590692','Phase 1','Phase 1 Safety Assessment of CPCB-RPE1, hESC-derived RPE Cell Coated Parylene Membrane Implants, in Patients with Advanced Dry Age Related Macular Degeneration','University of Southern California'),													
('000000002','Recruiting',10,'NCT02986698','Phase 1','In Utero Hematopoietic Stem Cell Transplantation For The Treatment Of Fetuses With Alpha Thalassemia Major','University of California, San Francisco'),													
('000000003','Completed',261,'NCT03280056','Phase 3','A Phase 3, Randomized, Placebo-controlled Multicenter Study to Evaluate Efficacy & Safety of Repeated Administrations of NurOwn® in Patients with ALS','BrainStorm Cell Therapeutics'),													
('000000004','Completed',18,'NCT02943850','Phase 1/2','Progenitor Cells Secreting GDNF for the Treatment of ALS','Cedars-Sinai Medical Center'),													
('000000005','Recruiting',57,'NCT03233854','Phase 1','Phase 1 Study of CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells in Adults with Recurrent or Refractory B Cell Malignancies','Stanford University'),													
('000000006','Recruiting',156,'NCT03088878','Phase 1/2','A Phase 1b/2a Study of the ROR1-Targeting Monoclonal Antibody, Cirmtuzumab, and the Bruton Tyrosine Kinase Inhibitor, Ibrutinib, in B-Cell Cancers','University of California, San Diego'),													
('000000007','Active, not recruiting',6,'NCT03432364','Phase 1/2','A Phase 1/2 Study to Assess the Safety, Tolerability, and Efficacy of ST-400 Autologous HSPC Transplant in Transfusion-dependent β-Thalassemia','Sangamo BioSciences, Inc.'),													
('000000008','Active, not recruiting',10,'NCT03483324','Phase 1','AB-110-001 Phase 1b Trial and Related Activities to Support Clinical Development of AB-110','Angiocrine Bioscience, Inc.'),													
('000000009','Active, not recruiting',42,'NCT03925935','Phase 1','Trial of AB-205 in Adults With Lymphoma Undergoing High-Dose Therapy and Autologous Stem Cell Transplantation','Angiocrine Bioscience, Inc.'),													
('000000010','Active, not recruiting',60,'NCT03475212','Phase 1/2','Antiviral Cellular Therapy for Enhancing T-cell Reconstitution Before or After Hematopoietic Stem Cell Transplantation (ACES)','Children''s Hospital of Los Angeles'),													
('000000011','Completed',88,'NCT02216409','Phase 1','Clinical Investigation of a Humanized Anti-CD47 Antibody in Targeting Cancer Stem Cells in Hematologic Malignancies and Solid Tumors','Stanford University'),													
('000000012','Completed',26,'NCT02222688','Phase 1','Therapeutic Eradication of Cancer Stem Cells with UC-961 (Cirmtuzumab)','University of California, San Diego'),													
('000000013','Recruiting',2,'NCT04525352','Phase 1','A Phase I Clinical Trial for a Lentiviral Gene Therapy Targeting the TCIRG1 Gene for Infantile Malignant Osteopetrosis (IMO)','Rocket Pharmaceuticals, Inc.'),													
('000000014','Recruiting',92,'NCT02208362','Phase 1','Phase I Study of Chimeric Antigen Receptor Engineered Central Memory T cells for the Treatment of Malignant Glioma','City of Hope, Beckman Research Institute'),													
('000000015','Recruiting',39,'NCT03696030','Phase 1','A Phase I Study of Chimeric Antigen Receptor Engineered Stem/Memory T Cells for the Treatment of HER2-Positive Brain Metastases','City of Hope, Beckman Research Institute'),													
('000000016','Recruiting',18,'NCT04510051','Phase 1','Phase I Study of IL13Rα2-Targeting CAR T Cells After Lymphodepletion for Children with Refractory or Recurrent Malignant Brain Tumors','City of Hope, Beckman Research Institute'),													
('000000017','Suspended',414,'NCT02546102','Phase 3','A Phase III randomized double-blind, controlled study of ICT 107 with maintenance temozolomide (TMZ) in newly diagnosed glioblastoma following resection and concomitant TMZ chemoradiotherapy','ImmunoCellular Therapeutics'),													
('000000018','Completed',78,'NCT02953782','Phase 1/2','A Phase 1b/2 Trial of the Anti-CD47 Antibody Hu5F9-G4 in Combination with Cetuximab in Patients with Solid Tumors and Advanced Colorectal Cancer','Forty Seven Inc.'),													
('000000019','Recruiting',20,'NCT03957954','Phase 1','Safety and Feasibility of Cultivated Autologous Limbal Stem Cells for Limbal Stem Cell Deficiency','University of California, Los Angeles'),													
('000000020','Active, not recruiting',86,'NCT04365101','Phase 1/2','A phase I/II study of human placental hematopoietic stem cell derived natural killer cells (CYNK-001) for the treatment of adults with COVID-19','Celularity Inc'),													
('000000021','Launching',null,'','Phase 1','Evaluation and Characterization of SARS-CoV-2 Antibody in Convalescent Volunteer Plasma Donors for Potential Therapeutic Use','City of Hope, Beckman Research Institute'),													
('000000022','Recruiting',120,'NCT03818854','Phase 2','Mesenchymal Stromal Cells for ARDS (COVID positive and COVID negative)','University of California, San Francisco'),													
('000000023','Completed',25,'NCT02485938','Phase 2','Allogeneic Cardiosphere-Derived Cells for Duchenne Muscular Dystrophy Cardiomyopathy','Capricor, Inc'),													
('000000024','Closed',156,'NCT01458405','Phase 2','Allogeneic Cardiac-Derived Stem Cells for Patients Following a Myocardial Infarction','Capricor, Inc'),													
('000000025','Recruiting',18,'NCT02797470','Phase 1/2','Stem Cell Gene Therapy for HIV Mediated by Lentivector Transduced, Pre-selected CD34+ Cells in AIDS lymphoma patients','University of California, Davis'),													
('000000026','Completed',13,'NCT01734850','Phase 1/2','GENE-MODIFIED HEMATOPOIETIC STEM/PROGENITOR CELL BASED THERAPY FOR HIV DISEASE','Calimmune, Inc.'),													
('000000027','Active, not recruiting',12,'NCT02500849','Phase 1','A Phase I, Open-Label Study To Assess The Safety, Feasibility and Engraftment of Zinc Finger Nucleases (ZFN) CCR5 Modified Autologous CD34+ Hematopoietic Stem/Progenitor Cells (SB-728MR-HSPC) with Escalating Doses of Busulfan In HIV-1 (R5) Infected Subjec','City of Hope, Beckman Research Institute'),													
('000000028','Launching',null,'NCT04648046','Phase 1/2','Anti-HIV duoCAR-T cell therapy for HIV infection','University of California, San Francisco'),													
('000000029','Completed',29,'NCT01937923','Phase 1/2','MSC engineered to produce BDNF for the treatment of Huntington''s disease','University of California, Davis'),													
('000000030','Active, not recruiting',355,'NCT02644941','Phase 3','A Human Acellular Vessel in Patients Needing Renal Replacement Therapy: A Comparison with ePTFE Grafts as Conduits for Hemodialysis (HUMANITY)','Humacyte, Inc.'),													
('000000031','Recruiting',240,'NCT03183245','Phase 3','A Phase 3 Study Comparing the Utility of Human Acellular Vessels  to Arteriovenous Fistula in Subjects with End-Stage Renal Disease (California Sites)','Humacyte, Inc.'),													
('000000032','Active, not recruiting',30,'NCT03363945','Phase 3','Cellular Immunotherapy for Induction of Immune Tolerance in HLA Matched Living Donor Kidney Transplant Recipients','Medeor Therapeutics, Inc.'),													
('000000033','Recruiting',22,'NCT03943238','Phase 1','Induction of Tolerance by Combinatorial Therapy w/ Donor Stem Cells and Expanded Recipient Treg cells in HLA-mismatched Kidney Transplant Recipients','Stanford University'),													
('000000034','Active, not recruiting',15,'NCT00319657','Phase 1','Induction of Tolerance to Combined Kidney and Hematopoietic Progenitor Cell Transplants from HLA Haplotype Matched Living Donors','Stanford University'),													
('000000035','Recruiting',6,'NCT03897361','Phase 1/2','Phase 1/2 study for autologous human CD34+ hematopoietic stem cells ex vivo transduced with pCCL-CTNS lentiviral vector for treatment of Cystinosis.','University of California, San Diego'),													
('000000036','Recruiting',287,'NCT03248479','Phase 1','A Phase 1b Trial of Hu5F9-G4 Monotherapy or Hu5F9-G4 in Combination with Azacitidine in Patients with Acute Myeloid Leukemia','Forty Seven Inc.'),													
('000000037','Recruiting',44,'NCT04372433','Phase 1','Phase 1 Clinical Development of IO-202, A First-in-Class Antibody Targeting LILRB4, for the Treatment of AML with Monocytic Differentiation and CMML','Immune-Onc Therapeutics'),													
('000000038','Closed',146,'NCT03301597','Phase 2','A Phase 2 Open-Label, Multi-Center, Randomized, Controlled, Optimal Dose-Finding Study of DCC-UCB in Adults Receiving High Dose Chemotherapy for AML','Nohla Therapeutics Inc'),													
('000000039','Recruiting',9,'NCT03812263','Phase 1/2','A Clinical Trial to Evaluate the Safety and Efficacy of RP-L201 in Subjects With Leukocyte Adhesion Deficiency-I','Rocket Pharmaceuticals, Inc.'),													
('000000040','Recruiting',24,'NCT03546361','Phase 1','A phase I trial of intratumoral administration of CCL21-gene modified dendritic cell (DC) combined with intravenous pembrolizumab for advanced NSCLC','University of California, Los Angeles'),													
('000000041','Closed',4,'NCT01875653','Phase 3','Tumor stem cell-targeted immunotherapy for metastatic melanoma –a randomized phase 3 clinical trial.','Caladrius Biosciences'),													
('000000042','Recruiting',12,'NCT03240861','Phase 1','Genetic Re-programming of Stem Cells to Fight Cancer','University of California, Los Angeles'),													
('000000043','Recruiting',220,'NCT03288493','Phase 1','Clinical Study of T stem cell memory (Tscm)-based CAR-T cells in Patients with Multiple Myeloma','Poseida Therapeutics, Inc.'),													
('000000044','Completed',60,'NCT03133676','Phase 1','Evaluation of the Safety and Tolerability of KA34 in a Phase 1, Double-Blind, Dose Escalation Trial in Patients with Knee Osteoarthritis','Calibr'),													
('000000045','Active, not recruiting',59,'NCT03197623','Phase 1/2','Treatment of non-traumatic osteonecrosis with endogenous Mesenchymal stem cells','University of California, Davis'),													
('000000046','Recruiting',12,'NCT04167540','Phase 1','A Phase 1b Safety Study for MRI guided delivery of AAV2-GDNF for the treatment of Parkinson’s disease','Brain Neurotherapy Bio'),													
('000000047','Recruiting',26,'NCT03145298','Phase 1/2','Pulmonary Arterial Hypertension Treated with Cardiosphere-Derived Allogeneic Stem Cells','Cedars-Sinai Medical Center'),													
('000000048','Recruiting',16,'NCT04284293','Phase 1','Clinical Study to Assess Safety and Efficacy of Subretinal Injection of Human Neural Progenitor Cells for Treatment of Retinitis Pigmentosa','Cedars-Sinai Medical Center'),													
('000000049','Completed',84,'NCT03073733','Phase 2','A Phase 2 Study of the Safety of Repeat Intravitreal Injection of Human Retinal Progenitor Cells (jCell) in Adult Subjects with Retinitis Pigmentosa','jCyte, Inc'),													
('000000050','Completed',84,'NCT03073733','Phase 2','Phase 2b Clinical Study of Safety and Efficacy of Intravitreal Injection of Retinal Progenitor Cells (jCell)  for Treatment of Retinitis Pigmentosa','jCyte, Inc'),													
('000000051','Completed',28,'NCT02320812','Phase 1/2','Retinal progenitor cells for treatment of retinitis pigmentosa','University of California, Irvine'),																									
('000000053','Completed',10,'NCT02999984','Phase 2','Efficacy and safety of cryopreserved autologous CD34+ HSC transduced with EFS lentiviral vector encoding for human ADA gene in ADA-SCID subjects','University of California, Los Angeles'),													
('000000054','Recruiting',15,'NCT03538899','Phase 1','Gene Transfer for Artemis-Deficient Severe Combined Immunodeficiency Using a Lentiviral Vector to Transduce Autologous CD34 Hematopoietic Stem Cells','University of California, San Francisco'),													
('000000055','Recruiting',28,'NCT01512888','Phase 1/2','Lentiviral Gene Therapy for Infants with X-linked Severe Combined Immunodeficiency using Autologous Bone Marrow Stem Cells and Busulfan Conditioning','St. Jude Children''s Research Hospital'),													
('000000056','Recruiting',40,'NCT02963064','Phase 1/2','A monoclonal antibody that depletes blood stem cells and enables chemotherapy free transplants','Stanford University'),													
('000000057','Suspended',15,'NCT03282656','Phase 2','Phase 2 Study of Hematopoietic Stem Cell Gene Transfer Inducing Fetal Hemoglobin in Sickle Cell Disease','Boston Children''s Hospital'),													
('000000058','Recruiting',6,'NCT03249831','Phase 1','Treatment of sickle cell disease by induction of  mixed chimerism and immune tolerance using CD4+ T-depleted haploidentical blood stem cell transplant','City of Hope, Beckman Research Institute'),													
('000000059','Not yet recruiting',12,'NCT04594031','Phase 1','A Phase 1 Study of ECT-001 Expanded Cord Blood and Myeloablative Regimen with Reduced Toxicity in Patients with Severe Sickle Cell Disease','ExCellThera Inc.'),													
('000000060','Active, not recruiting',6,'NCT02247843','Phase 1','Clinical Trial of Stem Cell Gene Therapy for Sickle Cell Disease','University of California, Los Angeles'),													
('000000061','Active, not recruiting',48,'NCT01954316','Phase 1','A Phase I dose escalation and expansion clinical trial of the novel first-in-class Polo-like Kinase 4 (PLK4) inhibitor, CFI-400945 in patients with advanced solid tumors','University of California, Los Angeles'),													
('000000062','Recruiting',35,'NCT04652908','Phase 1','The CuRe Trial: Cellular Therapy for In Utero Myelomeningocele Repair','University of California, Davis'),													
('000000063','Completed',5,'NCT01217008','Phase 1','Evaluation of Safety and Preliminary Efficacy of Escalating Doses of GRNOPC1 in Subacute Spinal Cord Injury','Geron Corporation'),													
('000000064','Completed',25,'NCT02302157','Phase 1/2','A Phase I/IIa Dose Escalation Safety Study of AST-OPC1 in Patients with Cervical Sensorimotor Complete Spinal Cord Injury','Lineage Cell Therapeutics Inc.'),													
('000000065','Completed',163,'NCT02448641','Phase 2','A Double-Blind, Controlled Ph 2b Study of the Safety and Efficacy of Modified Stem Cells in Patients with Chronic Motor Deficit from Ischemic Stroke','SanBio, Inc.'),													
('000000066','Completed',113,'NCT02691247','Phase 2','Phase 2 Safety and Efficacy Study of CLBS03 Autologous T-Regulatory Cells in Adolescents with Recent Onset Type 1 Diabetes Mellitus','Caladrius Biosciences'),													
('000000067','Recruiting',8,'NCT03977662','Phase 1/2','Pancreatic Islet and PARAthyroid Co-Transplantation for Treatment of Diabetes in IntraMuscular Site: PARADIGM','University of California, San Francisco'),													
('000000068','Active, not recruiting',69,'NCT02239354','Phase 1/2','Preclinical and clinical testing of a stem cell-based combination product for insulin-dependent diabetes','ViaCyte, Inc.'),													
('000000069','Recruiting',75,'NCT03163511','Phase 1/2','Clinical trial of directly vascularized islet cell replacement therapy for high-risk type 1 diabetes','ViaCyte, Inc.'),													
('000000070','Active, not recruiting',10,'NCT02234934','Phase 1/2','A Phase I/II, Non Randomized, Multicenter, Open-Label Study of G1XCGD (Lentiviral Vector Transduced CD34+ Cells) in Patients With X-Linked Chronic Granulomatous Disease','University of California, Los Angeles');												


INSERT researcher VALUES
('000000001','Hideho Okada','HidehoOkada','MDAwMTIz'),				
('000000002','Lili Yang','LiliYang','MDAwMTIz'),				
('000000003','Cristina Puig Saus','CristinaPuigSaus','MDAwMTIz'),				
('000000004','Leo Wang','LeoWang','MDAwMTIz'),				
('000000005','Joseph Woodard','JosephWoodard','MDAwMTIz'),				
('000000006','Diana Farmer','DianaFarmer','MDAwMTIz'),				
('000000007','Dan Kaufman','DanKaufman','MDAwMTIz'),				
('000000008','Donald Kohn','DonaldKohn','MDAwMTIz'),				
('000000009','Eiji Yoshihara','EijiYoshihara','MDAwMTIz'),				
('000000010','Aline Betancourt','AlineBetancourt','MDAwMTIz'),				
('000000011','Mathew Blurton-Jones','MathewBlurton-Jones','MDAwMTIz'),				
('000000012','Justin Ichida','JustinIchida','MDAwMTIz'),				
('000000013','Robert Hunt','RobertHunt','MDAwMTIz'),				
('000000014','Stanley Carmichael','StanleyCarmichael','MDAwMTIz'),				
('000000015','Tariq Rana','TariqRana','MDAwMTIz'),				
('000000016','Yanhong Shi','YanhongShi','MDAwMTIz'),				
('000000017','David  Williams','DavidWilliams','MDAwMTIz'),				
('000000018','Steven Deeks','StevenDeeks','MDAwMTIz'),				
('000000019','Gayatri Rao','GayatriRao','MDAwMTIz'),				
('000000020','Mark  Tuszynski','MarkTuszynski','MDAwMTIz'),				
('000000021','Helen Blau','HelenBlau','MDAwMTIz'),				
('000000022','Kevin Healy','KevinHealy','MDAwMTIz'),				
('000000023','Brian Cummings','BrianCummings','MDAwMTIz'),				
('000000024','Karen Christman','KarenChristman','MDAwMTIz'),				
('000000025','Cory Nicholas','CoryNicholas','MDAwMTIz'),				
('000000026','Daniela Bota','DanielaBota','MDAwMTIz'),				
('000000027','Evan Snyder','EvanSnyder','MDAwMTIz'),				
('000000028','Steve Dowdy','SteveDowdy','MDAwMTIz'),				
('000000029','Xiaokui Zhang','XiaokuiZhang','MDAwMTIz'),				
('000000030','PREET Chaudhary','PREETChaudhary','MDAwMTIz'),				
('000000031','Song  Li','SongLi','MDAwMTIz'),				
('000000032','Vaithilingaraja Arumugaswami','VaithilingarajaArumugaswami','MDAwMTIz'),				
('000000033','Jianhua Yu','JianhuaYu','MDAwMTIz'),				
('000000034','Albert Wong','AlbertWong','MDAwMTIz'),				
('000000035','Caroline Kuo','CarolineKuo','MDAwMTIz'),				
('000000036','Stuart Lipton','StuartLipton','MDAwMTIz'),				
('000000037','Michael Matthay','MichaelMatthay','MDAwMTIz'),				
('000000038','Pierre Caudrelier','PierreCaudrelier','MDAwMTIz'),				
('000000039','Brigitte Gomperts','BrigitteGomperts','MDAwMTIz'),				
('000000040','Gay Crooks','GayCrooks','MDAwMTIz'),				
('000000041','John Zaia','JohnZaia','MDAwMTIz'),				
('000000042','Hiromitsu Nakauchi','HiromitsuNakauchi','MDAwMTIz'),				
('000000043','Gerhard Bauer','GerhardBauer','MDAwMTIz'),				
('000000044','Yvonne Chen','YvonneChen','MDAwMTIz'),				
('000000045','Rosa Bacchetta','RosaBacchetta','MDAwMTIz'),				
('000000046','Henry Klassen','HenryKlassen','MDAwMTIz'),				
('000000047','Clive Svendsen','CliveSvendsen','MDAwMTIz'),				
('000000048','Sophie Deng','SophieDeng','MDAwMTIz'),				
('000000049','Krystof Bankiewicz','KrystofBankiewicz','MDAwMTIz'),				
('000000050','Karen Aboody','KarenAboody','MDAwMTIz'),				
('000000051','Saul Priceman','SaulPriceman','MDAwMTIz'),				
('000000052','Mark Humayun','MarkHumayun','MDAwMTIz'),				
('000000053','Mehrdad Abedi','MehrdadAbedi','MDAwMTIz'),				
('000000054','Stephanie Cherqui','StephanieCherqui','MDAwMTIz'),				
('000000055','Peter Stock','PeterStock','MDAwMTIz'),				
('000000056','Andres Bratt-Leal','AndresBratt-Leal','MDAwMTIz'),				
('000000057','Mark Walters','MarkWalters','MDAwMTIz'),				
('000000058','Theodore  Nowicki','TheodoreNowicki','MDAwMTIz'),				
('000000059','Kinnari Patel','KinnariPatel','MDAwMTIz'),				
('000000060','Bianca Mothe','BiancaMothe','MDAwMTIz'),				
('000000061','Ying Zhu','YingZhu','MDAwMTIz'),				
('000000062','Judith  Shizuru','JudithShizuru','MDAwMTIz'),				
('000000063','Wendy Pang','WendyPang','MDAwMTIz'),				
('000000064','Leslie Thompson','LeslieThompson','MDAwMTIz'),				
('000000065','Everett Meyer','EverettMeyer','MDAwMTIz'),				
('000000066','Edward Kavalerchik','EdwardKavalerchik','MDAwMTIz'),				
('000000067','Victoria Fox','VictoriaFox','MDAwMTIz'),				
('000000068','Karin Gaensler','KarinGaensler','MDAwMTIz'),				
('000000069','Steven Schwartz','StevenSchwartz','MDAwMTIz'),				
('000000070','Theodore Leng','TheodoreLeng','MDAwMTIz'),				
('000000071','Jonathan Lin','JonathanLin','MDAwMTIz'),				
('000000072','Tracy  Grikscheit','TracyGrikscheit','MDAwMTIz'),				
('000000073','Philip Beachy','PhilipBeachy','MDAwMTIz'),				
('000000074','Neil Segil','NeilSegil','MDAwMTIz'),				
('000000075','Alan Cheng','AlanCheng','MDAwMTIz'),				
('000000076','Xiuli  Wang','XiuliWang','MDAwMTIz'),				
('000000077','Devon Shedlock','DevonShedlock','MDAwMTIz'),				
('000000078','Katja Weinacht','KatjaWeinacht','MDAwMTIz'),				
('000000079','Eric Adler','EricAdler','MDAwMTIz'),				
('000000080','Li Gan','LiGan','MDAwMTIz'),				
('000000081','Ronald Evans','RonaldEvans','MDAwMTIz'),				
('000000082','Steven Dubinett','StevenDubinett','MDAwMTIz'),				
('000000083','Farhad Parhami','FarhadParhami','MDAwMTIz'),				
('000000084','Bertha Chen','BerthaChen','MDAwMTIz'),				
('000000085','Magdalene Seiler','MagdaleneSeiler','MDAwMTIz'),				
('000000086','Henry Erlich','HenryErlich','MDAwMTIz'),				
('000000087','Steven Mack','StevenMack','MDAwMTIz'),				
('000000088','Morton Cowan','MortonCowan','MDAwMTIz'),				
('000000089','Crystal Mackall','CrystalMackall','MDAwMTIz'),				
('000000090','Bettina Cockroft','BettinaCockroft','MDAwMTIz'),				
('000000091','Bob Valamehr','BobValamehr','MDAwMTIz'),				
('000000092','Joseph Rosenthal','JosephRosenthal','MDAwMTIz'),				
('000000093','Daniel Brennan','DanielBrennan','MDAwMTIz'),				
('000000094','Thale Jarvis','ThaleJarvis','MDAwMTIz'),				
('000000095','David Rowitch','DavidRowitch','MDAwMTIz'),				
('000000096','Glori Rosenson','GloriRosenson','MDAwMTIz'),				
('000000097','Cathy Vijeh','CathyVijeh','MDAwMTIz'),				
('000000098','Joseph Wu','JosephWu','MDAwMTIz'),				
('000000099','Xiaoping Hu','XiaopingHu','MDAwMTIz'),				
('000000100','John Adams','JohnAdams','MDAwMTIz'),				
('000000101','Tannishtha Reya','TannishthaReya','MDAwMTIz'),				
('000000102','Scott Kitchen','ScottKitchen','MDAwMTIz'),				
('000000103','Shuvo Roy','ShuvoRoy','MDAwMTIz'),				
('000000104','Aileen Anderson','AileenAnderson','MDAwMTIz'),				
('000000105','Saswati Chatterjee','SaswatiChatterjee','MDAwMTIz'),				
('000000106','Yang Xu','YangXu','MDAwMTIz'),				
('000000107','Alan Agulnick','AlanAgulnick','MDAwMTIz'),				
('000000108','Kyle Loh','KyleLoh','MDAwMTIz'),				
('000000109','April Pyle','AprilPyle','MDAwMTIz'),				
('000000110','Julia Unternaehrer-Hamm','JuliaUnternaehrer-Hamm','MDAwMTIz'),				
('000000111','Alice Tarantal','AliceTarantal','MDAwMTIz'),				
('000000112','Ngan Huang','NganHuang','MDAwMTIz'),				
('000000113','David Baylink','DavidBaylink','MDAwMTIz'),				
('000000114','Dmitriy Sheyn','DmitriySheyn','MDAwMTIz'),				
('000000115','Vicki Nienaber','VickiNienaber','MDAwMTIz'),				
('000000116','Alireza Moshaverinia','AlirezaMoshaverinia','MDAwMTIz'),				
('000000117','Anthony Oro','AnthonyOro','MDAwMTIz'),				
('000000118','Karl Wahlin','KarlWahlin','MDAwMTIz'),				
('000000119','Catriona Jamieson','CatrionaJamieson','MDAwMTIz'),				
('000000120','Semil Choksi','SemilChoksi','MDAwMTIz'),				
('000000121','Guillem Pratx','GuillemPratx','MDAwMTIz'),				
('000000122','Alyssa Panitch','AlyssaPanitch','MDAwMTIz'),				
('000000123','Gerald Morris','GeraldMorris','MDAwMTIz'),				
('000000124','John Cashman','JohnCashman','MDAwMTIz'),				
('000000125','Kristen Johnson','KristenJohnson','MDAwMTIz'),				
('000000126','Michael Pulsipher','MichaelPulsipher','MDAwMTIz'),				
('000000127','Matthew Spear','MatthewSpear','MDAwMTIz'),				
('000000128','Timothy Babich','TimothyBabich','MDAwMTIz'),				
('000000129','George Hara','GeorgeHara','MDAwMTIz'),				
('000000130','Matthew Porteus','MatthewPorteus','MDAwMTIz'),				
('000000131','Colleen Delaney','ColleenDelaney','MDAwMTIz'),				
('000000132','Howard Foyt','HowardFoyt','MDAwMTIz'),				
('000000133','Jeffrey Lawson','JeffreyLawson','MDAwMTIz'),				
('000000134','Christine Brown','ChristineBrown','MDAwMTIz'),				
('000000135','Thomas  Kipps','ThomasKipps','MDAwMTIz'),				
('000000136','Anthony Lubiniecki','AnthonyLubiniecki','MDAwMTIz'),				
('000000137','Ezra Cohen','EzraCohen','MDAwMTIz'),				
('000000138','Ralph Kern','RalphKern','MDAwMTIz'),				
('000000139','Esther Latres','EstherLatres','MDAwMTIz'),				
('000000140','Holger Willenbring','HolgerWillenbring','MDAwMTIz'),				
('000000141','Bijan Nejadnik','BijanNejadnik','MDAwMTIz'),				
('000000142','Tippi MacKenzie','TippiMacKenzie','MDAwMTIz'),				
('000000143','Yuan Chen','YuanChen','MDAwMTIz'),				
('000000144','Mark Mercola','MarkMercola','MDAwMTIz'),				
('000000145','Deborah Lieu','DeborahLieu','MDAwMTIz'),				
('000000146','Xiaoxi Wei','XiaoxiWei','MDAwMTIz'),				
('000000147','Ali Brivanlou','AliBrivanlou','MDAwMTIz'),				
('000000148','Markus Müschen','MarkusMüschen','MDAwMTIz'),				
('000000149','Gary  Steinberg','GarySteinberg','MDAwMTIz'),				
('000000150','Justin Cooper-White','JustinCooper-White','MDAwMTIz'),				
('000000151','Swapna Panuganti','SwapnaPanuganti','MDAwMTIz'),				
('000000152','Biju Thomas','BijuThomas','MDAwMTIz'),				
('000000153','Sonja Schrepfer','SonjaSchrepfer','MDAwMTIz'),				
('000000154','Alessandra Sacco','AlessandraSacco','MDAwMTIz'),				
('000000155','Janet Baulch','JanetBaulch','MDAwMTIz'),				
('000000156','Naynesh Kamani','NayneshKamani','MDAwMTIz'),				
('000000157','Samuel Strober','SamuelStrober','MDAwMTIz'),				
('000000158','Song Li','SongLi','MDAwMTIz'),				
('000000159','Jack Wang','JackWang','MDAwMTIz'),				
('000000160','William Sietsema','WilliamSietsema','MDAwMTIz'),				
('000000161','Stephen Gottschalk','StephenGottschalk','MDAwMTIz'),				
('000000162','Tejal Desai','TejalDesai','MDAwMTIz'),				
('000000163','Roel Nusse','RoelNusse','MDAwMTIz'),				
('000000164','Deepak Srivastava','DeepakSrivastava','MDAwMTIz'),				
('000000165','Birgitt Schuele','BirgittSchuele','MDAwMTIz'),				
('000000166','John Chute','JohnChute','MDAwMTIz'),				
('000000167','Julie Sneddon','JulieSneddon','MDAwMTIz'),				
('000000168','Alysson Muotri','AlyssonMuotri','MDAwMTIz'),				
('000000169','Denis Evseenko','DenisEvseenko','MDAwMTIz'),				
('000000170','Yadong Huang','YadongHuang','MDAwMTIz'),				
('000000171','Paul Salvaterra','PaulSalvaterra','MDAwMTIz'),				
('000000172','Michael Lewis','MichaelLewis','MDAwMTIz'),				
('000000173','Leslie Meltzer','LeslieMeltzer','MDAwMTIz'),				
('000000174','Ralph Feuer','RalphFeuer','MDAwMTIz'),				
('000000175','Eugene Brandon','EugeneBrandon','MDAwMTIz'),				
('000000176','Christel Uittenbogaart','ChristelUittenbogaart','MDAwMTIz'),				
('000000177','Robert Sah','RobertSah','MDAwMTIz'),				
('000000178','Shibani Pati','ShibaniPati','MDAwMTIz'),				
('000000179','David Schaffer','DavidSchaffer','MDAwMTIz'),				
('000000180','David Segal','DavidSegal','MDAwMTIz'),				
('000000181','Jeanne Loring','JeanneLoring','MDAwMTIz'),				
('000000182','David Baltimore','DavidBaltimore','MDAwMTIz'),				
('000000183','Kevin D''Amour','KevinD''Amour','MDAwMTIz'),				
('000000184','Peter Robinson','PeterRobinson','MDAwMTIz'),				
('000000185','Jacob Corn','JacobCorn','MDAwMTIz'),				
('000000186','Arjun Deb','ArjunDeb','MDAwMTIz'),				
('000000187','Linda Cambier','LindaCambier','MDAwMTIz'),				
('000000188','Phillip Yang','PhillipYang','MDAwMTIz'),				
('000000189','Bennett Novitch','BennettNovitch','MDAwMTIz'),				
('000000190','Andrew Brack','AndrewBrack','MDAwMTIz'),				
('000000191','Owen Witte','OwenWitte','MDAwMTIz'),				
('000000192','Jeffrey Goldberg','JeffreyGoldberg','MDAwMTIz'),				
('000000193','Marcus Muench','MarcusMuench','MDAwMTIz'),				
('000000194','Senta Georgia','SentaGeorgia','MDAwMTIz'),				
('000000195','Dionicio Siegel','DionicioSiegel','MDAwMTIz'),				
('000000196','David Traver','DavidTraver','MDAwMTIz'),				
('000000197','Peter  Butler','PeterButler','MDAwMTIz'),				
('000000198','Joseph Anderson','JosephAnderson','MDAwMTIz'),				
('000000199','Linda Marban','LindaMarban','MDAwMTIz'),				
('000000200','Lawrence Goldstein','LawrenceGoldstein','MDAwMTIz'),				
('000000201','Felicia Pagliuca','FeliciaPagliuca','MDAwMTIz'),				
('000000202','Jennifer Puck','JenniferPuck','MDAwMTIz'),				
('000000203','Ron Johnson','RonJohnson','MDAwMTIz'),				
('000000204','Paul Finnegan','PaulFinnegan','MDAwMTIz'),				
('000000205','Nitika Parmar','NitikaParmar','MDAwMTIz'),				
('000000206','Katherine Nielsen','KatherineNielsen','MDAwMTIz'),				
('000000207','Nilay Patel','NilayPatel','MDAwMTIz'),				
('000000208','Paul Utz','PaulUtz','MDAwMTIz'),				
('000000209','Henry Lester','HenryLester','MDAwMTIz'),				
('000000210','Lisa Klig','LisaKlig','MDAwMTIz'),				
('000000211','Trevor Cardinal','TrevorCardinal','MDAwMTIz'),				
('000000212','Lisa Hammersley','LisaHammersley','MDAwMTIz'),				
('000000213','Lily Chen','LilyChen','MDAwMTIz'),				
('000000214','Tzvia Abramson','TzviaAbramson','MDAwMTIz'),				
('000000215','Jacob Varkey','JacobVarkey','MDAwMTIz'),				
('000000216','Pamela Eversole-Cire','PamelaEversole-Cire','MDAwMTIz'),				
('000000217','Carin Zimmerman','CarinZimmerman','MDAwMTIz'),				
('000000218','Cindy Malone','CindyMalone','MDAwMTIz'),				
('000000219','Nicole Bournias-Vardiabasis','NicoleBournias-Vardiabasis','MDAwMTIz'),				
('000000220','Ellen Fung','EllenFung','MDAwMTIz'),				
('000000221','Wafa Tawackoli','WafaTawackoli','MDAwMTIz'),				
('000000222','John Ravits','JohnRavits','MDAwMTIz'),				
('000000223','Fouad  Kandeel','FouadKandeel','MDAwMTIz'),				
('000000224','Ophir Klein','OphirKlein','MDAwMTIz'),				
('000000225','Anthony Gringeri','AnthonyGringeri','MDAwMTIz'),				
('000000226','Edward Holmes','EdwardHolmes','MDAwMTIz'),				
('000000227','Sidney Golub','SidneyGolub','MDAwMTIz'),				
('000000228','Peter Schultz','PeterSchultz','MDAwMTIz'),				
('000000229','Shaomei Wang','ShaomeiWang','MDAwMTIz'),				
('000000230','Robert  Dillman','RobertDillman','MDAwMTIz'),				
('000000231','David Schubert','DavidSchubert','MDAwMTIz'),				
('000000232','Roslyn Isseroff','RoslynIsseroff','MDAwMTIz'),				
('000000233','Darryl D''Lima','DarrylD''Lima','MDAwMTIz'),				
('000000234','Qing Liu-Michael','QingLiu-Michael','MDAwMTIz'),				
('000000235','Gerald Chader','GeraldChader','MDAwMTIz'),				
('000000236','Randi Hagerman','RandiHagerman','MDAwMTIz'),				
('000000237','James Dunn','JamesDunn','MDAwMTIz'),				
('000000238','Joseph Gold','JosephGold','MDAwMTIz'),				
('000000239','Toshio Miki','ToshioMiki','MDAwMTIz'),				
('000000240','Hanna Mikkola','HannaMikkola','MDAwMTIz'),				
('000000241','Shaochen Chen','ShaochenChen','MDAwMTIz'),				
('000000242','Sarah Heilshorn','SarahHeilshorn','MDAwMTIz'),				
('000000243','Shyni Varghese','ShyniVarghese','MDAwMTIz'),				
('000000244','Irving Weissman','IrvingWeissman','MDAwMTIz'),				
('000000245','Paula Cannon','PaulaCannon','MDAwMTIz'),				
('000000246','J.  Leach','J.Leach','MDAwMTIz'),				
('000000247','Qilong Ying','QilongYing','MDAwMTIz'),				
('000000248','Laura Marcu','LauraMarcu','MDAwMTIz'),				
('000000249','Andrew Leavitt','AndrewLeavitt','MDAwMTIz'),				
('000000250','Fan Yang','FanYang','MDAwMTIz'),				
('000000251','Carla Koehler','CarlaKoehler','MDAwMTIz'),				
('000000252','Leif Havton','LeifHavton','MDAwMTIz'),				
('000000253','Leonard Zon','LeonardZon','MDAwMTIz'),				
('000000254','Steven Finkbeiner','StevenFinkbeiner','MDAwMTIz'),				
('000000255','Susan Fisher','SusanFisher','MDAwMTIz'),				
('000000256','Diana Laird','DianaLaird','MDAwMTIz'),				
('000000257','Xavier Darzacq','XavierDarzacq','MDAwMTIz'),				
('000000258','Todd McDevitt','ToddMcDevitt','MDAwMTIz'),				
('000000259','Francois Binette','FrancoisBinette','MDAwMTIz'),				
('000000260','Michelle Khine','MichelleKhine','MDAwMTIz'),				
('000000261','Jennifer Landress','JenniferLandress','MDAwMTIz'),				
('000000262','Kara McCloskey','KaraMcCloskey','MDAwMTIz'),				
('000000263','Sheng Ding','ShengDing','MDAwMTIz'),				
('000000264','Valerie Weaver','ValerieWeaver','MDAwMTIz'),				
('000000265','Dianne McKay','DianneMcKay','MDAwMTIz'),				
('000000266','Michael Snyder','MichaelSnyder','MDAwMTIz'),				
('000000267','David Cheresh','DavidCheresh','MDAwMTIz'),				
('000000268','Peter Donovan','PeterDonovan','MDAwMTIz'),				
('000000269','Joseph Ecker','JosephEcker','MDAwMTIz'),				
('000000270','Andrew Dillin','AndrewDillin','MDAwMTIz'),				
('000000271','Joshua Stuart','JoshuaStuart','MDAwMTIz'),				
('000000272','Miles  Wilkinson','MilesWilkinson','MDAwMTIz'),				
('000000273','Maike Sander','MaikeSander','MDAwMTIz'),				
('000000274','Wei Wang','WeiWang','MDAwMTIz'),				
('000000275','Marius Wernig','MariusWernig','MDAwMTIz'),				
('000000276','Xinnan Wang','XinnanWang','MDAwMTIz'),				
('000000277','David Tirrell','DavidTirrell','MDAwMTIz'),				
('000000278','Lisa Flanagan','LisaFlanagan','MDAwMTIz'),				
('000000279','Christian Metallo','ChristianMetallo','MDAwMTIz'),				
('000000280','Paul Noble','PaulNoble','MDAwMTIz'),				
('000000281','Samantha Butler','SamanthaButler','MDAwMTIz'),				
('000000282','Cornelis Murre','CornelisMurre','MDAwMTIz'),				
('000000283','Mark Anderson','MarkAnderson','MDAwMTIz'),				
('000000284','Thomas Rando','ThomasRando','MDAwMTIz'),				
('000000285','Jason Rock','JasonRock','MDAwMTIz'),				
('000000286','Anita Caufield','AnitaCaufield','MDAwMTIz'),				
('000000287','Peter Belafsky','PeterBelafsky','MDAwMTIz'),				
('000000288','Dennis Slamon','DennisSlamon','MDAwMTIz'),				
('000000289','Mark Yarborough','MarkYarborough','MDAwMTIz'),				
('000000290','Jeffrey Rosenfeld','JeffreyRosenfeld','MDAwMTIz'),				
('000000291','Dana Jones','DanaJones','MDAwMTIz'),				
('000000292','Regis Kelly','RegisKelly','MDAwMTIz'),				
('000000293','Stuart  Lipton','StuartLipton','MDAwMTIz'),				
('000000294','Michele Calos','MicheleCalos','MDAwMTIz'),				
('000000295','Robert Reiter','RobertReiter','MDAwMTIz'),				
('000000296','Zack Jerome','ZackJerome','MDAwMTIz'),				
('000000297','Inder  Verma','InderVerma','MDAwMTIz'),				
('000000298','Gerald Lipshutz','GeraldLipshutz','MDAwMTIz'),				
('000000299','Dan Gazit','DanGazit','MDAwMTIz'),				
('000000300','John Griffin','JohnGriffin','MDAwMTIz'),				
('000000301','Julien Sage','JulienSage','MDAwMTIz'),				
('000000302','Matthew Jenusaitis','MatthewJenusaitis','MDAwMTIz'),				
('000000303','Joan  Heller Brown','JoanHellerBrown','MDAwMTIz'),				
('000000304','Barry Stripp','BarryStripp','MDAwMTIz'),				
('000000305','Eric Ahrens','EricAhrens','MDAwMTIz'),				
('000000306','Fyodor Urnov','FyodorUrnov','MDAwMTIz'),				
('000000307','Camilla Forsberg','CamillaForsberg','MDAwMTIz'),				
('000000308','Shu  Chien','ShuChien','MDAwMTIz'),				
('000000309','Joachim Hallmayer','JoachimHallmayer','MDAwMTIz'),				
('000000310','Kang Zhang','KangZhang','MDAwMTIz'),				
('000000311','Joseph Gleeson','JosephGleeson','MDAwMTIz'),				
('000000312','Jacquelyn Maher','JacquelynMaher','MDAwMTIz'),				
('000000313','James Brewer','JamesBrewer','MDAwMTIz'),				
('000000314','Thomas Novak','ThomasNovak','MDAwMTIz'),				
('000000315','Deborah Requesens','DeborahRequesens','MDAwMTIz'),				
('000000316','Tatiana Segura','TatianaSegura','MDAwMTIz'),				
('000000317','Fouad Kandeel','FouadKandeel','MDAwMTIz'),				
('000000318','Michelle Monje','MichelleMonje','MDAwMTIz'),				
('000000319','Robert Baloh','RobertBaloh','MDAwMTIz'),				
('000000320','Reza Ardehali','RezaArdehali','MDAwMTIz'),				
('000000321','Emanual Maverakis','EmanualMaverakis','MDAwMTIz'),				
('000000322','Ali Nsair','AliNsair','MDAwMTIz'),				
('000000323','Mana Parast','ManaParast','MDAwMTIz'),				
('000000324','Jason Pomerantz','JasonPomerantz','MDAwMTIz'),				
('000000325','Ann Zovein','AnnZovein','MDAwMTIz'),				
('000000326','Alex Richmond','AlexRichmond','MDAwMTIz'),				
('000000327','Marilyn Smith','MarilynSmith','MDAwMTIz'),				
('000000328','Anne Brunet','AnneBrunet','MDAwMTIz'),				
('000000329','Michael Cleary','MichaelCleary','MDAwMTIz'),				
('000000330','Miguel Ramalho-Santos','MiguelRamalho-Santos','MDAwMTIz'),				
('000000331','Deepak Lamba','DeepakLamba','MDAwMTIz'),				
('000000332','Jeremy Reiter','JeremyReiter','MDAwMTIz'),				
('000000333','Huei-sheng Chen','Huei-shengChen','MDAwMTIz'),				
('000000334','Alexander Dunn','AlexanderDunn','MDAwMTIz'),				
('000000335','Howard Chang','HowardChang','MDAwMTIz'),				
('000000336','George Sen','GeorgeSen','MDAwMTIz'),				
('000000337','Kathrin Plath','KathrinPlath','MDAwMTIz'),				
('000000338','Benoit Bruneau','BenoitBruneau','MDAwMTIz'),				
('000000339','Gerald Crabtree','GeraldCrabtree','MDAwMTIz'),				
('000000340','Ananda Goldrath','AnandaGoldrath','MDAwMTIz'),				
('000000341','Eugene Yeo','EugeneYeo','MDAwMTIz'),				
('000000342','Eduardo Marbán','EduardoMarbán','MDAwMTIz'),				
('000000343','Barbara Panning','BarbaraPanning','MDAwMTIz'),				
('000000344','Robert Tjian','RobertTjian','MDAwMTIz'),				
('000000345','Antoni Ribas','AntoniRibas','MDAwMTIz'),				
('000000346','John Laird','JohnLaird','MDAwMTIz'),				
('000000347','Nancy Lane','NancyLane','MDAwMTIz'),				
('000000348','Vicki Wheelock','VickiWheelock','MDAwMTIz'),				
('000000349','Andrew McMahon','AndrewMcMahon','MDAwMTIz'),				
('000000350','Stanley Nelson','StanleyNelson','MDAwMTIz'),				
('000000351','Alexandra Capela','AlexandraCapela','MDAwMTIz'),				
('000000352','Rachel Smith','RachelSmith','MDAwMTIz'),				
('000000353','Kyriacos Athanasiou','KyriacosAthanasiou','MDAwMTIz'),				
('000000354','Stephen Forman','StephenForman','MDAwMTIz'),				
('000000355','Juan Carlos Izpisua Belmonte','JuanCarlosIzpisuaBelmonte','MDAwMTIz'),				
('000000356','Craig Walsh','CraigWalsh','MDAwMTIz'),				
('000000357','Walter Boyd','WalterBoyd','MDAwMTIz'),				
('000000358','Arnold Kriegstein','ArnoldKriegstein','MDAwMTIz'),				
('000000359','Philip Schwartz','PhilipSchwartz','MDAwMTIz'),				
('000000360','Kathy Rich','KathyRich','MDAwMTIz'),				
('000000361','Vasanthy Narayanaswami','VasanthyNarayanaswami','MDAwMTIz'),				
('000000362','James Williamson','JamesWilliamson','MDAwMTIz'),				
('000000363','Shannon  Noonan','ShannonNoonan','MDAwMTIz'),				
('000000364','Roberta Brinton','RobertaBrinton','MDAwMTIz'),				
('000000365','Lina Kim','LinaKim','MDAwMTIz'),				
('000000366','Victoria Lunyak','VictoriaLunyak','MDAwMTIz'),				
('000000367','Roger Madison','RogerMadison','MDAwMTIz'),				
('000000368','Richard Jove','RichardJove','MDAwMTIz'),				
('000000369','Paul Patterson','PaulPatterson','MDAwMTIz'),				
('000000370','Martin Birchall','MartinBirchall','MDAwMTIz'),				
('000000371','Timothy Hoey','TimothyHoey','MDAwMTIz'),				
('000000372','Marcel Daadi','MarcelDaadi','MDAwMTIz'),				
('000000373','John Hood','JohnHood','MDAwMTIz'),				
('000000374','Robert Robbins','RobertRobbins','MDAwMTIz'),				
('000000375','Martina Wiedau-Pazos','MartinaWiedau-Pazos','MDAwMTIz'),				
('000000376','Dong-Er Zhang','Dong-ErZhang','MDAwMTIz'),				
('000000377','David McGee','DavidMcGee','MDAwMTIz'),				
('000000378','Karin Immergluck','KarinImmergluck','MDAwMTIz'),				
('000000379','Bernadette McCafferty','BernadetteMcCafferty','MDAwMTIz'),				
('000000380','Rubén Flores','RubénFlores','MDAwMTIz'),				
('000000381','Katharine Ku','KatharineKu','MDAwMTIz'),				
('000000382','Adele Rennie','AdeleRennie','MDAwMTIz'),				
('000000383','Ronnie Hanecak','RonnieHanecak','MDAwMTIz'),				
('000000384','Babak Kateb','BabakKateb','MDAwMTIz'),				
('000000385','Anirvan Ghosh','AnirvanGhosh','MDAwMTIz'),				
('000000386','Aaron Hsueh','AaronHsueh','MDAwMTIz'),				
('000000387','Joanna Wysocka','JoannaWysocka','MDAwMTIz'),				
('000000388','Farah Sheikh','FarahSheikh','MDAwMTIz'),				
('000000389','Charles King','CharlesKing','MDAwMTIz'),				
('000000390','Sean Wu','SeanWu','MDAwMTIz'),				
('000000391','Joel Gottesfeld','JoelGottesfeld','MDAwMTIz'),				
('000000392','William Lowry','WilliamLowry','MDAwMTIz'),				
('000000393','Yi  Sun','YiSun','MDAwMTIz'),				
('000000394','Shuo Lin','ShuoLin','MDAwMTIz'),				
('000000395','Binhai Zheng','BinhaiZheng','MDAwMTIz'),				
('000000396','Michael Clarke','MichaelClarke','MDAwMTIz'),				
('000000397','Kristin Baldwin','KristinBaldwin','MDAwMTIz'),				
('000000398','Deborah Spector','DeborahSpector','MDAwMTIz'),				
('000000399','John Murnane','JohnMurnane','MDAwMTIz'),				
('000000400','Kun Zhang','KunZhang','MDAwMTIz'),				
('000000401','Michael Rape','MichaelRape','MDAwMTIz'),				
('000000402','Jiing-Kuan Yee','Jiing-KuanYee','MDAwMTIz'),				
('000000403','R. Jeremy Nichols','R.JeremyNichols','MDAwMTIz'),				
('000000404','Francis Doyle','FrancisDoyle','MDAwMTIz'),				
('000000405','John Yu','JohnYu','MDAwMTIz'),				
('000000406','Joann Zhang','JoannZhang','MDAwMTIz'),				
('000000407','Steven Conolly','StevenConolly','MDAwMTIz'),				
('000000408','Karl Willert','KarlWillert','MDAwMTIz'),				
('000000409','Theo Palmer','TheoPalmer','MDAwMTIz'),				
('000000410','Richard Gatti','RichardGatti','MDAwMTIz'),				
('000000411','Jifan Hu','JifanHu','MDAwMTIz'),				
('000000412','Daniel Lim','DanielLim','MDAwMTIz'),				
('000000413','Martin Martin','MartinMartin','MDAwMTIz'),				
('000000414','Brian Rutt','BrianRutt','MDAwMTIz'),				
('000000415','Marc Unger','MarcUnger','MDAwMTIz'),				
('000000416','Irvin Chen','IrvinChen','MDAwMTIz'),				
('000000417','John Dimos','JohnDimos','MDAwMTIz'),				
('000000418','Markus Muschen','MarkusMuschen','MDAwMTIz'),				
('000000419','Arturo Alvarez-Buylla','ArturoAlvarez-Buylla','MDAwMTIz'),				
('000000420','Bruno  Peault','BrunoPeault','MDAwMTIz'),				
('000000421','Peter Coffey','PeterCoffey','MDAwMTIz'),				
('000000422','Xianmin Zeng','XianminZeng','MDAwMTIz'),				
('000000423','Mark Zern','MarkZern','MDAwMTIz'),				
('000000424','Fred Gage','FredGage','MDAwMTIz'),				
('000000425','Noriyuki Kasahara','NoriyukiKasahara','MDAwMTIz'),				
('000000426','David DiGiusto','DavidDiGiusto','MDAwMTIz'),				
('000000427','Elizabeth Read','ElizabethRead','MDAwMTIz'),				
('000000428','Emmanuelle Passegue','EmmanuellePassegue','MDAwMTIz'),				
('000000429','Robert Wechsler-Reya','RobertWechsler-Reya','MDAwMTIz'),				
('000000430','William Murphy','WilliamMurphy','MDAwMTIz'),				
('000000431','Irene Griswold-Prenner','IreneGriswold-Prenner','MDAwMTIz'),				
('000000432','Robert Negrin','RobertNegrin','MDAwMTIz'),				
('000000433','Eric Kurzrock','EricKurzrock','MDAwMTIz'),				
('000000434','Anjana Rao','AnjanaRao','MDAwMTIz'),				
('000000435','David Raulet','DavidRaulet','MDAwMTIz'),				
('000000436','Tony Wyss-Coray','TonyWyss-Coray','MDAwMTIz'),				
('000000437','Ellen Robey','EllenRobey','MDAwMTIz'),				
('000000438','Douglas Black','DouglasBlack','MDAwMTIz'),				
('000000439','Yong Kim','YongKim','MDAwMTIz'),				
('000000440','Terrence Town','TerrenceTown','MDAwMTIz'),				
('000000441','Steven Artandi','StevenArtandi','MDAwMTIz'),				
('000000442','Jeffrey Bluestone','JeffreyBluestone','MDAwMTIz'),				
('000000443','Kenneth Weinberg','KennethWeinberg','MDAwMTIz'),				
('000000444','Christopher Contag','ChristopherContag','MDAwMTIz'),				
('000000445','John Rubenstein','JohnRubenstein','MDAwMTIz'),				
('000000446','Garry Nolan','GarryNolan','MDAwMTIz'),				
('000000447','Nicholas Gascoigne','NicholasGascoigne','MDAwMTIz'),				
('000000448','Husein Hadeiba','HuseinHadeiba','MDAwMTIz'),				
('000000449','Marian Waterman','MarianWaterman','MDAwMTIz'),				
('000000450','Basil Hantash','BasilHantash','MDAwMTIz'),				
('000000451','Kun-Liang Guan','Kun-LiangGuan','MDAwMTIz'),				
('000000452','Benhur Lee','BenhurLee','MDAwMTIz'),				
('000000453','Martin Marsala','MartinMarsala','MDAwMTIz'),				
('000000454','Mitchel Berger','MitchelBerger','MDAwMTIz'),				
('000000455','Dennis Carson','DennisCarson','MDAwMTIz'),				
('000000456','Alfred Lane','AlfredLane','MDAwMTIz'),				
('000000457','Geoff Symonds','GeoffSymonds','MDAwMTIz'),				
('000000458','Allan Robins','AllanRobins','MDAwMTIz'),				
('000000459','Robb Maclellan','RobbMaclellan','MDAwMTIz'),				
('000000460','Min Zhao','MinZhao','MDAwMTIz'),				
('000000461','Wange Lu','WangeLu','MDAwMTIz'),				
('000000462','Luisa  Iruela-Arispe','LuisaIruela-Arispe','MDAwMTIz'),				
('000000463','Martin  Pera','MartinPera','MDAwMTIz'),				
('000000464','Michael Teitell','MichaelTeitell','MDAwMTIz'),				
('000000465','Susan  McConnell','SusanMcConnell','MDAwMTIz'),				
('000000466','Hank Greely','HankGreely','MDAwMTIz'),				
('000000467','Olivia Kelly','OliviaKelly','MDAwMTIz'),				
('000000468','Martin Friedlander','MartinFriedlander','MDAwMTIz'),				
('000000469','Warner Greene','WarnerGreene','MDAwMTIz'),				
('000000470','Pali Kaur','PaliKaur','MDAwMTIz'),				
('000000471','J. William Langston','J.WilliamLangston','MDAwMTIz'),				
('000000472','Jill Helms','JillHelms','MDAwMTIz'),				
('000000473','Gabriel Travis','GabrielTravis','MDAwMTIz'),				
('000000474','Michael West','MichaelWest','MDAwMTIz'),				
('000000475','Jan Nolta','JanNolta','MDAwMTIz'),				
('000000476','Frank LaFerla','FrankLaFerla','MDAwMTIz'),				
('000000477','Brian Black','BrianBlack','MDAwMTIz'),				
('000000478','Barbara Des Rochers','BarbaraDesRochers','MDAwMTIz'),				
('000000479','Michael Barish','MichaelBarish','MDAwMTIz'),				
('000000480','Kenneth Dorshkind','KennethDorshkind','MDAwMTIz'),				
('000000481','Dennis Clegg','DennisClegg','MDAwMTIz'),				
('000000482','Jill Adler-Moore','JillAdler-Moore','MDAwMTIz'),				
('000000483','Sylvia Evans','SylviaEvans','MDAwMTIz'),				
('000000484','David Haussler','DavidHaussler','MDAwMTIz'),				
('000000485','Robert Mahley','RobertMahley','MDAwMTIz'),				
('000000486','Robert Maxson','RobertMaxson','MDAwMTIz'),				
('000000487','Frederick Meyers','FrederickMeyers','MDAwMTIz'),				
('000000488','Carmen Domingo','CarmenDomingo','MDAwMTIz'),				
('000000489','Ulrich Mueller','UlrichMueller','MDAwMTIz'),				
('000000490','David  Warburton','DavidWarburton','MDAwMTIz'),				
('000000491','Kristina Bonham','KristinaBonham','MDAwMTIz'),				
('000000492','Carlos Barbas','CarlosBarbas','MDAwMTIz'),				
('000000493','Ying Liu','YingLiu','MDAwMTIz'),				
('000000494','Hsian-Rong Tseng','Hsian-RongTseng','MDAwMTIz'),				
('000000495','Orhan NALCIOGLU','OrhanNALCIOGLU','MDAwMTIz'),				
('000000496','Michael Phelps','MichaelPhelps','MDAwMTIz'),				
('000000497','Douglas Wagenaar','DouglasWagenaar','MDAwMTIz'),				
('000000498','Patrick McDonough','PatrickMcDonough','MDAwMTIz'),				
('000000499','Pin Wang','PinWang','MDAwMTIz'),				
('000000500','Larry Couture','LarryCouture','MDAwMTIz'),				
('000000501','Evert Kroon','EvertKroon','MDAwMTIz'),				
('000000502','Joel Kubby','JoelKubby','MDAwMTIz'),				
('000000503','Kit Lam','KitLam','MDAwMTIz'),				
('000000504','Bing Ren','BingRen','MDAwMTIz'),				
('000000505','Robert Blelloch','RobertBlelloch','MDAwMTIz'),				
('000000506','Edwin Monuki','EdwinMonuki','MDAwMTIz'),				
('000000507','Gage DeKoeyer Crump','GageDeKoeyerCrump','MDAwMTIz'),				
('000000508','Benjamin  Yu','BenjaminYu','MDAwMTIz'),				
('000000509','Ching-Pin  Chang','Ching-PinChang','MDAwMTIz'),				
('000000510','Paul Knoepfler','PaulKnoepfler','MDAwMTIz'),				
('000000511','Lin He','LinHe','MDAwMTIz'),				
('000000512','Ricardo Zayas','RicardoZayas','MDAwMTIz'),				
('000000513','David Woodley','DavidWoodley','MDAwMTIz'),				
('000000514','Long-cheng Li','Long-chengLi','MDAwMTIz'),				
('000000515','Jeffrey Lotz','JeffreyLotz','MDAwMTIz'),				
('000000516','Michael Longaker','MichaelLongaker','MDAwMTIz'),				
('000000517','Samuel Pfaff','SamuelPfaff','MDAwMTIz'),				
('000000518','Renee Reijo Pera','ReneeReijoPera','MDAwMTIz'),				
('000000519','Emmanuel Baetge','EmmanuelBaetge','MDAwMTIz'),				
('000000520','Zhuohua Zhang','ZhuohuaZhang','MDAwMTIz'),				
('000000521','Julie Baker','JulieBaker','MDAwMTIz'),				
('000000522','Webster Cavenee','WebsterCavenee','MDAwMTIz'),				
('000000523','Amander Clark','AmanderClark','MDAwMTIz'),				
('000000524','Bruce Conklin','BruceConklin','MDAwMTIz'),				
('000000525','Robert  Farese','RobertFarese','MDAwMTIz'),				
('000000526','Mary McEachron','MaryMcEachron','MDAwMTIz'),				
('000000527','John Hennessy','JohnHennessy','MDAwMTIz'),				
('000000528','George Breslauer','GeorgeBreslauer','MDAwMTIz'),				
('000000529','Larry Vanderhoef','LarryVanderhoef','MDAwMTIz'),				
('000000530','Michael Drake','MichaelDrake','MDAwMTIz'),				
('000000531','Gene Block','GeneBlock','MDAwMTIz'),				
('000000532','John White','JohnWhite','MDAwMTIz'),				
('000000533','Glenn Lucas','GlennLucas','MDAwMTIz'),				
('000000534','Margaret Delaney','MargaretDelaney','MDAwMTIz'),				
('000000535','A. Washington','A.Washington','MDAwMTIz'),				
('000000536','Chrysostomos Nikias','ChrysostomosNikias','MDAwMTIz'),				
('000000537','Mohammad Pashmforoush','MohammadPashmforoush','MDAwMTIz'),				
('000000538','Douglas Ethell','DouglasEthell','MDAwMTIz'),				
('000000539','Siavash Kurdistani','SiavashKurdistani','MDAwMTIz'),				
('000000540','Jennifer Manilay','JenniferManilay','MDAwMTIz'),				
('000000541','Chong-Xian Pan','Chong-XianPan','MDAwMTIz'),				
('000000542','Andrew Putnam','AndrewPutnam','MDAwMTIz'),				
('000000543','Tiziano Barberi','TizianoBarberi','MDAwMTIz'),				
('000000544','Songtao Shi','SongtaoShi','MDAwMTIz'),				
('000000545','Lei Wang','LeiWang','MDAwMTIz'),				
('000000546','Bin Chen','BinChen','MDAwMTIz'),				
('000000547','Irina Conboy','IrinaConboy','MDAwMTIz'),				
('000000548','Karl Deisseroth','KarlDeisseroth','MDAwMTIz'),				
('000000549','Lindsay Hinck','LindsayHinck','MDAwMTIz'),				
('000000550','Prudence Talbot','PrudenceTalbot','MDAwMTIz'),				
('000000551','Linda Giudice','LindaGiudice','MDAwMTIz'),				
('000000552','Vittorio Sebastiano','VittorioSebastiano','MDAwMTIz'),				
('000000553','Garry Van Gerpen','GarryVanGerpen','MDAwMTIz'),				
('000000554','Scott Waugh','ScottWaugh','MDAwMTIz'),				
('000000555','Carolyn Lutzko','CarolynLutzko','MDAwMTIz'),				
('000000556','Christopher Zarins','ChristopherZarins','MDAwMTIz'),				
('000000557','Hans Keirstead','HansKeirstead','MDAwMTIz'),				
('000000558','Douglas Wallace','DouglasWallace','MDAwMTIz'),				
('000000559','Guoping Fan','GuopingFan','MDAwMTIz'),				
('000000560','Stefan Heller','StefanHeller','MDAwMTIz'),				
('000000561','Randall Lee','RandallLee','MDAwMTIz'),				
('000000562','Harold Bernstein','HaroldBernstein','MDAwMTIz'),				
('000000563','Samuel Pleasure','SamuelPleasure','MDAwMTIz'),				
('000000564','Senyon Choe','SenyonChoe','MDAwMTIz'),				
('000000565','Michael Pirrung','MichaelPirrung','MDAwMTIz'),				
('000000566','Heike Daldrup-Link','HeikeDaldrup-Link','MDAwMTIz'),				
('000000567','Thomas Wandless','ThomasWandless','MDAwMTIz'),				
('000000568','Gregg Duester','GreggDuester','MDAwMTIz'),				
('000000569','Zoran Galic','ZoranGalic','MDAwMTIz'),				
('000000570','Timothy O''Connor','TimothyO''Connor','MDAwMTIz'),				
('000000571','Elizabeth Lawlor','ElizabethLawlor','MDAwMTIz'),				
('000000572','John Cooke','JohnCooke','MDAwMTIz'),				
('000000573','David Feldheim','DavidFeldheim','MDAwMTIz'),				
('000000574','Eric Verdin','EricVerdin','MDAwMTIz'),				
('000000575','Thea Tlsty','TheaTlsty','MDAwMTIz'),				
('000000576','Su Guo','SuGuo','MDAwMTIz'),				
('000000577','Ziwei Huang','ZiweiHuang','MDAwMTIz'),				
('000000578','David Hinton','DavidHinton','MDAwMTIz'),				
('000000579','Alexey Terskikh','AlexeyTerskikh','MDAwMTIz'),				
('000000580','Mark Kay','MarkKay','MDAwMTIz'),				
('000000581','Carolyn Bertozzi','CarolynBertozzi','MDAwMTIz'),				
('000000582','Beverly Emerson','BeverlyEmerson','MDAwMTIz'),				
('000000583','Hudson Freeze','HudsonFreeze','MDAwMTIz'),				
('000000584','Krishna Shenoy','KrishnaShenoy','MDAwMTIz'),				
('000000585','Frank Sauer','FrankSauer','MDAwMTIz'),				
('000000586','Calvin Kuo','CalvinKuo','MDAwMTIz'),				
('000000587','Peter Laird','PeterLaird','MDAwMTIz'),				
('000000588','Vincent Procaccio','VincentProcaccio','MDAwMTIz'),				
('000000589','Didier Stainier','DidierStainier','MDAwMTIz'),				
('000000590','Thomas  Lane','ThomasLane','MDAwMTIz'),				
('000000591','Charles Limoli','CharlesLimoli','MDAwMTIz'),				
('000000592','A.  Reddi','A.Reddi','MDAwMTIz'),				
('000000593','Ebenezer Yamoah','EbenezerYamoah','MDAwMTIz'),				
('000000594','Dale Bredesen','DaleBredesen','MDAwMTIz'),				
('000000595','Kyoko Yokomori','KyokoYokomori','MDAwMTIz'),				
('000000596','Robert Oshima','RobertOshima','MDAwMTIz'),				
('000000597','Grant MacGregor','GrantMacGregor','MDAwMTIz'),				
('000000598','Fen-Biao Gao','Fen-BiaoGao','MDAwMTIz'),				
('000000599','Randy Schekman','RandySchekman','MDAwMTIz'),				
('000000600','Peter Bryant','PeterBryant','MDAwMTIz'),				
('000000601','Mark Chao','MarkChao','MDAwMTIz'),				
('000000602','Jane Lebkowski','JaneLebkowski','MDAwMTIz');	

INSERT investigates VALUES
('000000052','000000001'),													
('000000142','000000002'),													
('000000138','000000003'),													
('000000047','000000004'),													
('000000089','000000005'),													
('000000135','000000006'),													
('000000090','000000007'),													
('000000066','000000008'),													
('000000066','000000009'),													
('000000126','000000010'),													
('000000244','000000011'),													
('000000135','000000012'),													
('000000019','000000013'),													
('000000134','000000014'),													
('000000051','000000015'),													
('000000004','000000016'),													
('000000225','000000017'),													
('000000601','000000018'),													
('000000048','000000019'),													
('000000029','000000020'),													
('000000041','000000021'),													
('000000037','000000022'),													
('000000199','000000023'),													
('000000352','000000024'),													
('000000053','000000025'),													
('000000457','000000026'),													
('000000041','000000027'),													
('000000018','000000028'),													
('000000348','000000029'),													
('000000133','000000030'),													
('000000133','000000031'),													
('000000093','000000032'),													
('000000065','000000033'),													
('000000157','000000034'),													
('000000054','000000035'),													
('000000601','000000036'),													
('000000005','000000037'),													
('000000131','000000038'),													
('000000059','000000039'),													
('000000082','000000040'),													
('000000230','000000041'),													
('000000345','000000042'),													
('000000127','000000043'),													
('000000125','000000044'),													
('000000347','000000045'),													
('000000049','000000046'),													
('000000172','000000047'),													
('000000047','000000048'),													
('000000046','000000049'),													
('000000046','000000050'),													
('000000046','000000051'),													
('000000058','000000042'),													
('000000008','000000053'),													
('000000088','000000054'),													
('000000161','000000055'),													
('000000062','000000056'),													
('000000017','000000057'),													
('000000092','000000058'),													
('000000038','000000059'),													
('000000008','000000060'),													
('000000288','000000061'),													
('000000006','000000062'),													
('000000602','000000063'),													
('000000259','000000064'),													
('000000141','000000065'),													
('000000160','000000066'),													
('000000055','000000067'),													
('000000132','000000068'),													
('000000132','000000069'),													
('000000008','000000070');																			


       
INSERT r_disease_area VALUES
('000000001','Brain Cancer'),
('000000001','Cancer'),
('000000001','Solid Tumors'),
('000000002','Acute Myeloid Leukemia'),
('000000002','Blood Cancer'),
('000000002','Blood Disorders'),
('000000002','Cancer'),
('000000002','COVID-19'),
('000000002','Infectious Disease'),
('000000002','Multiple Myeloma'),
('000000003','Cancer'),
('000000003','Melanoma'),
('000000003','Solid Tumors'),
('000000004','Brain Cancer'),
('000000004','Cancer'),
('000000004','Solid Tumors'),
('000000005','Acute Myeloid Leukemia'),
('000000005','Blood Cancer'),
('000000005','Cancer'),
('000000006','Neurological Disorders'),
('000000006','Pediatrics'),
('000000006','Spina Bifida'),
('000000007','Acute Myeloid Leukemia'),
('000000007','Blood Cancer'),
('000000007','Cancer'),
('000000007','Ovarian Cancer'),
('000000007','Solid Tumors'),
('000000008','Adenosine deaminase-deficient (ADA-SCID)'),
('000000008','Blood Disorders'),
('000000008','Genetic Disorder'),
('000000008','Immune Disease'),
('000000008','Pediatrics'),
('000000008','Severe Combined Immunodeficiency'),
('000000008','Sickle Cell Disease'),
('000000008','X-linked Chronic Granulomatous Disease'),
('000000009','Diabetes'),
('000000009','Metabolic Disorders'),
('000000009','Type 1 diabetes'),
('000000010','Inflammatory bowel disease'),
('000000010','Intestinal Disease'),
('000000010','Metabolic Disorders'),
('000000011','Alzheimer\'s Disease'),
('000000011','Neurological Disorders'),
('000000012','Amyotrophic Lateral Sclerosis'),
('000000012','COVID-19'),
('000000012','Infectious Disease'),
('000000012','Neurological Disorders'),
('000000013','Neurological Disorders'),
('000000013','Traumatic Brain Injury'),
('000000014','Neurological Disorders'),
('000000014','Stroke'),
('000000015','COVID-19'),
('000000015','Infectious Disease'),
('000000016','Canavan Disease'),
('000000016','COVID-19'),
('000000016','Genetic Disorder'),
('000000016','Infectious Disease'),
('000000016','Neurological Disorders'),
('000000016','Pediatrics'),
('000000017','Blood Disorders'),
('000000017','Sickle Cell Disease'),
('000000018','HIV/AIDS'),
('000000018','Immune Disease'),
('000000018','Infectious Disease'),
('000000019','Bone or Cartilage Disease'),
('000000020','Neurological Disorders'),
('000000020','Spinal Cord Injury'),
('000000021','Aging'),
('000000021','COVID-19'),
('000000021','Infectious Disease'),
('000000021','Skeletal/Smooth Muscle disorders'),
('000000022','COVID-19'),
('000000022','Heart Disease'),
('000000022','Infectious Disease'),
('000000022','Toxicity'),
('000000023','Neurological Disorders'),
('000000023','Spinal Cord Injury'),
('000000023','Trauma'),
('000000023','Traumatic Brain Injury'),
('000000024','COVID-19'),
('000000024','Infectious Disease'),
('000000024','Respiratory Disorders'),
('000000024','Vascular Disease'),
('000000025','Epilepsy'),
('000000025','Neurological Disorders'),
('000000027','Brain Injury'),
('000000027','COVID-19'),
('000000027','hypoxic'),
('000000027','Infectious Disease'),
('000000027','ischemic'),
('000000027','Neurological Disorders'),
('000000027','Parkinson\'s Disease'),
('000000027','Pediatrics'),
('000000027','Respiratory Disorders'),
('000000028','COVID-19'),
('000000028','Infectious Disease'),
('000000029','COVID-19'),
('000000029','Infectious Disease'),
('000000029','Respiratory Disorders'),
('000000030','COVID-19'),
('000000030','Infectious Disease'),
('000000030','Respiratory Disorders'),
('000000031','COVID-19'),
('000000031','Infectious Disease'),
('000000032','COVID-19'),
('000000032','Infectious Disease'),
('000000032','Neurological Disorders'),
('000000033','COVID-19'),
('000000033','Infectious Disease'),
('000000034','Brain Cancer'),
('000000034','Cancer'),
('000000034','COVID-19'),
('000000034','Infectious Disease'),
('000000035','Blood Disorders'),
('000000035','Hyper IgM Syndrome'),
('000000035','Immune Disease'),
('000000036','Autism'),
('000000036','COVID-19'),
('000000036','Infectious Disease'),
('000000036','Neurological Disorders'),
('000000036','Stroke'),
('000000037','COVID-19'),
('000000037','Infectious Disease'),
('000000038','Blood Disorders'),
('000000038','Sickle Cell Disease'),
('000000039','Cancer'),
('000000039','COVID-19'),
('000000039','Infectious Disease'),
('000000039','Lung Cancer'),
('000000039','Respiratory Disorders'),
('000000039','Solid Tumors'),
('000000040','Blood Disorders'),
('000000040','Cancer'),
('000000040','COVID-19'),
('000000040','Immune Disease'),
('000000040','Infectious Disease'),
('000000040','Respiratory Disorders'),
('000000041','Brain Cancer'),
('000000041','Cancer'),
('000000041','COVID-19'),
('000000041','HIV/AIDS'),
('000000041','Immune Disease'),
('000000041','Infectious Disease'),
('000000041','Multiple Indications (Alpha Clinics)'),
('000000041','Respiratory Disorders'),
('000000042','Blood Disorders'),
('000000042','Cancer'),
('000000042','Lung Cancer'),
('000000044','Blood Cancer'),
('000000044','Cancer'),
('000000044','Multiple Myeloma'),
('000000045','Blood Disorders'),
('000000045','Immune Disease'),
('000000045','IPEX Syndrome'),
('000000046','Retinitis Pigmentosa'),
('000000046','Vision Loss'),
('000000047','Amyotrophic Lateral Sclerosis'),
('000000047','Huntington\'s Disease'),
('000000047','Neurological Disorders'),
('000000047','Pediatrics'),
('000000047','Retinitis Pigmentosa'),
('000000047','Vision Loss'),
('000000048','Corneal Damage'),
('000000048','Vision Loss'),
('000000049','Neurological Disorders'),
('000000049','Parkinson\'s Disease'),
('000000050','Brain Cancer'),
('000000050','Cancer'),
('000000050','Ovarian Cancer'),
('000000050','Solid Tumors'),
('000000051','Brain Cancer'),
('000000051','Breast Cancer'),
('000000051','Cancer'),
('000000051','Ovarian Cancer'),
('000000052','Age-related macular degeneration'),
('000000052','Vision Loss'),
('000000053','Blood Cancer'),
('000000053','Cancer'),
('000000053','HIV-related Lymphoma'),
('000000053','HIV/AIDS'),
('000000053','Infectious Disease'),
('000000053','Multiple Indications (Alpha Clinics)'),
('000000054','Cystinosis'),
('000000054','Genetic Disorder'),
('000000054','Kidney Disease'),
('000000054','Kidney Failure'),
('000000054','Metabolic Disorders'),
('000000054','Pediatrics'),
('000000055','Diabetes'),
('000000055','Metabolic Disorders'),
('000000056','Neurological Disorders'),
('000000056','Parkinson\'s Disease'),
('000000057','Blood Disorders'),
('000000057','Multiple Indications (Alpha Clinics)'),
('000000057','Sickle Cell Disease'),
('000000058','Cancer'),
('000000058','Sarcoma'),
('000000059','Blood Disorders'),
('000000059','Immune Disease'),
('000000061','Bone or Cartilage Disease'),
('000000061','Intervertebral disc degeneration'),
('000000061','Osteonecrosis'),
('000000062','Blood Disorders'),
('000000062','Immune Disease'),
('000000062','Muscular Dystrophy'),
('000000062','Pediatrics'),
('000000062','Severe Combined Immunodeficiency'),
('000000062','Skeletal/Smooth Muscle disorders'),
('000000062','X-linked (X-SCID)'),
('000000063','Blood Disorders'),
('000000063','Severe Combined Immunodeficiency'),
('000000064','Huntington\'s Disease'),
('000000064','Neurological Disorders'),
('000000065','Kidney Disease'),
('000000065','Kidney Failure'),
('000000066','Blood Cancer'),
('000000066','Cancer'),
('000000068','Acute Myeloid Leukemia'),
('000000068','Blood Cancer'),
('000000069','Age-related macular degeneration'),
('000000069','Vision Loss'),
('000000070','Age-related macular degeneration'),
('000000070','Vision Loss'),
('000000071','Vision Loss'),
('000000072','Intestinal Disease'),
('000000072','Liver Disease'),
('000000072','Metabolic Disorders'),
('000000072','Neurological Disorders'),
('000000072','Pediatrics'),
('000000073','Bladder or Urinary Tract Disorder'),
('000000073','Cancer'),
('000000073','Skeletal/Smooth Muscle disorders'),
('000000073','Solid Tumors'),
('000000074','Hearing Loss'),
('000000075','Hearing Loss'),
('000000076','HIV/AIDS'),
('000000076','Infectious Disease'),
('000000077','Cancer'),
('000000077','Prostate Cancer'),
('000000078','Immune Disease'),
('000000078','Thymic Disorder'),
('000000079','Danon Disease'),
('000000079','Heart Disease'),
('000000079','Pediatrics'),
('000000080','Dementia'),
('000000080','Neurological Disorders'),
('000000081','Diabetes'),
('000000081','Metabolic Disorders'),
('000000082','Cancer'),
('000000082','Lung Cancer'),
('000000083','Bone or Cartilage Disease'),
('000000084','Bladder or Urinary Tract Disorder'),
('000000084','Incontinence'),
('000000084','Skeletal/Smooth Muscle disorders'),
('000000085','Retinitis Pigmentosa'),
('000000085','Vision Loss'),
('000000086','Beta Thalassemia'),
('000000086','Blood Disorders'),
('000000087','Beta Thalassemia'),
('000000087','Blood Disorders'),
('000000088','Blood Disorders'),
('000000088','Immune Disease'),
('000000088','Pediatrics'),
('000000088','Severe Combined Immunodeficiency'),
('000000089','B cell cancers'),
('000000089','Blood Cancer'),
('000000089','Cancer'),
('000000089','Leukemia'),
('000000090','Beta Thalassemia'),
('000000090','Blood Disorders'),
('000000091','Cancer'),
('000000091','Solid Tumors'),
('000000092','Blood Disorders'),
('000000092','Sickle Cell Disease'),
('000000093','Kidney Disease'),
('000000093','Kidney Failure'),
('000000095','Neurological Disorders'),
('000000098','Blood Disorders'),
('000000098','Heart Disease'),
('000000098','Toxicity'),
('000000100','Multiple Indications (Alpha Clinics)'),
('000000101','Acute Myeloid Leukemia'),
('000000101','Blood Cancer'),
('000000101','Blood Disorders'),
('000000102','HIV/AIDS'),
('000000102','Infectious Disease'),
('000000103','Diabetes'),
('000000103','Metabolic Disorders'),
('000000104','Neurological Disorders'),
('000000104','Spinal Cord Injury'),
('000000105','Blood Disorders'),
('000000105','Hemophilia A'),
('000000106','Cancer'),
('000000106','Diabetes'),
('000000106','Genetic Disorder'),
('000000106','Heart Disease'),
('000000106','Immune Disease'),
('000000106','Metabolic Disorders'),
('000000107','Diabetes'),
('000000107','Metabolic Disorders'),
('000000108','Liver Disease'),
('000000108','Metabolic Disorders'),
('000000109','Muscular Dystrophy'),
('000000109','Skeletal/Smooth Muscle disorders'),
('000000110','Cancer'),
('000000110','Ovarian Cancer'),
('000000111','Blood Disorders'),
('000000111','Heart Disease'),
('000000111','Kidney Disease'),
('000000112','Vascular Disease'),
('000000113','Acute Myeloid Leukemia'),
('000000113','Blood Cancer'),
('000000114','Bone or Cartilage Disease'),
('000000115','Neurological Disorders'),
('000000115','Parkinson\'s Disease'),
('000000116','Bone or Cartilage Disease'),
('000000117','Epidermolysis Bullosa'),
('000000117','Skin Disease'),
('000000118','Age-related macular degeneration'),
('000000118','Vision Loss'),
('000000119','Acute Myeloid Leukemia'),
('000000119','Blood Cancer'),
('000000119','Cancer'),
('000000119','Multiple Indications (Alpha Clinics)'),
('000000120','Respiratory Disorders'),
('000000121','Other'),
('000000122','Vascular Disease'),
('000000123','Other'),
('000000124','Cancer'),
('000000124','Heart Disease'),
('000000124','Pancreatic Cancer'),
('000000125','Arthritis'),
('000000125','Bone or Cartilage Disease'),
('000000126','Blood Cancer'),
('000000126','Blood Disorders'),
('000000126','Bone Marrow Transplant and Viral Infection'),
('000000126','Cancer'),
('000000127','Blood Cancer'),
('000000127','Cancer'),
('000000130','Blood Disorders'),
('000000130','Cystic Fibrosis'),
('000000130','Genetic Disorder'),
('000000130','Immune Disease'),
('000000130','Pediatrics'),
('000000130','Respiratory Disorders'),
('000000130','Severe Combined Immunodeficiency'),
('000000130','Sickle Cell Disease'),
('000000130','X-linked (X-SCID)'),
('000000131','Acute Myeloid Leukemia'),
('000000131','Blood Cancer'),
('000000132','Diabetes'),
('000000132','Metabolic Disorders'),
('000000133','Kidney Disease'),
('000000133','Kidney Failure'),
('000000134','Brain Cancer'),
('000000134','Cancer'),
('000000135','B cell cancers'),
('000000135','Blood Cancer'),
('000000135','Cancer'),
('000000135','Leukemia'),
('000000137','Blood Cancer'),
('000000137','Cancer'),
('000000138','Amyotrophic Lateral Sclerosis'),
('000000138','Neurological Disorders'),
('000000139','Diabetes'),
('000000139','Metabolic Disorders'),
('000000140','Liver Disease'),
('000000140','Metabolic Disorders'),
('000000141','Neurological Disorders'),
('000000141','Stroke'),
('000000142','Alpha Thalassemia Major'),
('000000142','Blood Disorders'),
('000000142','Immune Disease'),
('000000142','Pediatrics'),
('000000143','Cancer'),
('000000143','Colon Cancer'),
('000000144','Heart Disease'),
('000000144','Heart failure'),
('000000145','Heart Disease'),
('000000146','Other'),
('000000147','Huntington\'s Disease'),
('000000147','Neurological Disorders'),
('000000148','B cell cancers'),
('000000148','Blood Cancer'),
('000000148','Cancer'),
('000000148','Leukemia'),
('000000149','Neurological Disorders'),
('000000149','Stroke'),
('000000150','Neurological Disorders'),
('000000150','Parkinson\'s Disease'),
('000000151','Acute Myeloid Leukemia'),
('000000151','Blood Cancer'),
('000000152','Vision Loss'),
('000000153','Heart Disease'),
('000000154','Muscular Dystrophy'),
('000000154','Skeletal/Smooth Muscle disorders'),
('000000155','Alzheimer\'s Disease'),
('000000155','Neurological Disorders'),
('000000156','Blood Disorders'),
('000000157','Kidney Disease'),
('000000157','Kidney Failure'),
('000000158','Neurological Disorders'),
('000000158','Neuropathy'),
('000000159','Bone or Cartilage Disease'),
('000000159','Osteoarthritis'),
('000000160','Diabetes'),
('000000160','Metabolic Disorders'),
('000000161','Blood Disorders'),
('000000161','Immune Disease'),
('000000161','Severe Combined Immunodeficiency'),
('000000161','X-linked (X-SCID)'),
('000000162','Diabetes'),
('000000162','Metabolic Disorders'),
('000000163','Liver Disease'),
('000000163','Metabolic Disorders'),
('000000164','Heart Disease'),
('000000164','Vascular Disease'),
('000000165','Neurological Disorders'),
('000000165','Parkinson\'s Disease'),
('000000166','Blood Cancer'),
('000000166','Blood Disorders'),
('000000166','Cancer'),
('000000166','Leukemia'),
('000000167','Diabetes'),
('000000167','Metabolic Disorders'),
('000000168','Autism'),
('000000168','Infectious Disease'),
('000000168','Neurological Disorders'),
('000000168','Pediatrics'),
('000000168','Rett\'s Syndrome'),
('000000169','Arthritis'),
('000000169','Bone or Cartilage Disease'),
('000000170','Alzheimer\'s Disease'),
('000000170','Neurological Disorders'),
('000000172','Heart Disease'),
('000000172','Pulmonary Hypertension'),
('000000173','Adenosine deaminase-deficient (ADA-SCID)'),
('000000173','Blood Disorders'),
('000000173','Genetic Disorder'),
('000000173','Immune Disease'),
('000000173','Pediatrics'),
('000000173','Severe Combined Immunodeficiency'),
('000000175','Multiple Indications (Alpha Clinics)'),
('000000178','Trauma'),
('000000179','Neurological Disorders'),
('000000179','Parkinson\'s Disease'),
('000000179','Spinal Cord Injury'),
('000000180','Autism'),
('000000180','Neurological Disorders'),
('000000181','Immune Disease'),
('000000181','Neurological Disorders'),
('000000181','Parkinson\'s Disease'),
('000000182','HIV/AIDS'),
('000000182','Infectious Disease'),
('000000183','Diabetes'),
('000000183','Metabolic Disorders'),
('000000184','Multiple Indications (Alpha Clinics)'),
('000000185','Blood Cancer'),
('000000185','Cancer'),
('000000186','Heart Disease'),
('000000187','Heart Disease'),
('000000188','Heart Disease'),
('000000189','Amyotrophic Lateral Sclerosis'),
('000000189','Genetic Disorder'),
('000000189','Neurological Disorders'),
('000000189','Pediatrics'),
('000000189','Spinal Cord Injury'),
('000000189','Spinal Muscular Atrophy'),
('000000190','Aging'),
('000000190','Skeletal/Smooth Muscle disorders'),
('000000191','Cancer'),
('000000191','Prostate Cancer'),
('000000192','Vision Loss'),
('000000193','Blood Disorders'),
('000000193','Hemophilia A'),
('000000194','Diabetes'),
('000000194','Metabolic Disorders'),
('000000195','Blood Disorders'),
('000000196','Blood Disorders'),
('000000197','Diabetes'),
('000000197','Metabolic Disorders'),
('000000198','Metabolic Disorders'),
('000000198','Neurological Disorders'),
('000000199','Heart disease associated with Duchenne muscular dystrophy'),
('000000199','Heart Disease'),
('000000200','Aging'),
('000000200','Alzheimer\'s Disease'),
('000000200','Amyotrophic Lateral Sclerosis'),
('000000200','Genetic Disorder'),
('000000200','Neurological Disorders'),
('000000201','Diabetes'),
('000000201','Metabolic Disorders'),
('000000202','Artemis deficient (ART-SCID)'),
('000000202','Blood Disorders'),
('000000202','Immune Disease'),
('000000202','Severe Combined Immunodeficiency'),
('000000204','Blood Cancer'),
('000000204','Cancer'),
('000000222','Amyotrophic Lateral Sclerosis'),
('000000222','Neurological Disorders'),
('000000224','Developmental Disorders'),
('000000224','Intestinal Disease'),
('000000224','Metabolic Disorders'),
('000000225','Brain Cancer'),
('000000225','Cancer'),
('000000228','Arthritis'),
('000000228','Bone or Cartilage Disease'),
('000000228','Multiple Sclerosis'),
('000000228','Neurological Disorders'),
('000000229','Vision Loss'),
('000000230','Cancer'),
('000000230','Melanoma'),
('000000231','Alzheimer\'s Disease'),
('000000231','Neurological Disorders'),
('000000232','Diabetes'),
('000000232','Diabetic Wounds'),
('000000232','Metabolic Disorders'),
('000000232','Skin Disease'),
('000000233','Arthritis'),
('000000233','Bone or Cartilage Disease'),
('000000237','Intestinal Disease'),
('000000237','Metabolic Disorders'),
('000000237','Neurological Disorders'),
('000000237','Pediatrics'),
('000000238','Heart Disease'),
('000000239','Liver Disease'),
('000000239','Metabolic Disorders'),
('000000240','Anemia'),
('000000240','Blood Cancer'),
('000000240','Blood Disorders'),
('000000240','Cancer'),
('000000241','Heart Disease'),
('000000242','Neurological Disorders'),
('000000242','Spinal Cord Injury'),
('000000243','Muscular Dystrophy'),
('000000243','Skeletal/Smooth Muscle disorders'),
('000000244','Blood Cancer'),
('000000244','Blood Disorders'),
('000000244','Cancer'),
('000000244','Heart Disease'),
('000000244','Liver Disease'),
('000000244','Metabolic Disorders'),
('000000245','HIV/AIDS'),
('000000245','Infectious Disease'),
('000000246','Bone or Cartilage Disease'),
('000000247','Other'),
('000000248','Vascular Disease'),
('000000249','Blood Disorders'),
('000000250','Bone or Cartilage Disease'),
('000000251','Other'),
('000000252','Amyotrophic Lateral Sclerosis'),
('000000252','Neurological Disorders'),
('000000252','Spinal Cord Injury'),
('000000252','Spinal Muscular Atrophy'),
('000000254','Amyotrophic Lateral Sclerosis'),
('000000254','Huntington\'s Disease'),
('000000254','Neurological Disorders'),
('000000257','Other'),
('000000258','Heart Disease'),
('000000258','Neurological Disorders'),
('000000259','Neurological Disorders'),
('000000259','Spinal Cord Injury'),
('000000260','Heart Disease'),
('000000262','Heart Disease'),
('000000262','Vascular Disease'),
('000000263','Heart Disease'),
('000000264','Other'),
('000000265','Blood Disorders'),
('000000266','Multiple Indications (Alpha Clinics)'),
('000000267','Cancer'),
('000000267','Solid Tumors'),
('000000269','Multiple Indications (Alpha Clinics)'),
('000000271','Multiple Indications (Alpha Clinics)'),
('000000272','Neurological Disorders'),
('000000273','Diabetes'),
('000000273','Metabolic Disorders'),
('000000275','Autism'),
('000000275','Neurological Disorders'),
('000000275','Pediatrics'),
('000000275','Rett\'s Syndrome'),
('000000276','Neurological Disorders'),
('000000276','Parkinson\'s Disease'),
('000000277','Diabetes'),
('000000277','Metabolic Disorders'),
('000000278','Neurological Disorders'),
('000000279','Heart Disease'),
('000000281','Neurological Disorders'),
('000000281','Spinal Cord Injury'),
('000000282','Blood Disorders'),
('000000283','Diabetes'),
('000000283','HIV/AIDS'),
('000000283','Immune Disease'),
('000000283','Infectious Disease'),
('000000283','Metabolic Disorders'),
('000000283','Pediatrics'),
('000000284','Aging'),
('000000284','Skeletal/Smooth Muscle disorders'),
('000000287','Respiratory Disorders'),
('000000288','Cancer'),
('000000288','Solid Tumors'),
('000000293','Neurological Disorders'),
('000000293','Parkinson\'s Disease'),
('000000293','Stroke'),
('000000294','Immune Disease'),
('000000294','Muscular Dystrophy'),
('000000294','Neurological Disorders'),
('000000294','Parkinson\'s Disease'),
('000000294','Pediatrics'),
('000000295','Cancer'),
('000000295','Prostate Cancer'),
('000000296','Amyotrophic Lateral Sclerosis'),
('000000296','Cancer'),
('000000296','HIV/AIDS'),
('000000296','Immune Disease'),
('000000296','Infectious Disease'),
('000000296','Melanoma'),
('000000296','Muscular Dystrophy'),
('000000296','Neurological Disorders'),
('000000296','Skeletal/Smooth Muscle disorders'),
('000000297','Blood Disorders'),
('000000297','Immune Disease'),
('000000297','Liver Disease'),
('000000297','Metabolic Disorders'),
('000000297','Pediatrics'),
('000000298','Genetic Disorder'),
('000000298','Liver Disease'),
('000000298','Metabolic Disorders'),
('000000298','Pediatrics'),
('000000299','Arthritis'),
('000000299','Bone or Cartilage Disease'),
('000000300','Huntington\'s Disease'),
('000000300','Neurological Disorders'),
('000000301','Cancer'),
('000000304','Respiratory Disorders'),
('000000305','Amyotrophic Lateral Sclerosis'),
('000000305','Neurological Disorders'),
('000000306','Blood Disorders'),
('000000306','Pediatrics'),
('000000307','Aging'),
('000000309','Autism'),
('000000309','Neurological Disorders'),
('000000310','Vision Loss'),
('000000311','Neurological Disorders'),
('000000311','Pediatrics'),
('000000312','Infectious Disease'),
('000000312','Liver Disease'),
('000000313','Alzheimer\'s Disease'),
('000000313','Neurological Disorders'),
('000000314','Multiple Indications (Alpha Clinics)'),
('000000315','Multiple Indications (Alpha Clinics)'),
('000000317','Diabetes'),
('000000317','Metabolic Disorders'),
('000000318','Brain Cancer'),
('000000318','Cancer'),
('000000318','Neurological Disorders'),
('000000318','Pediatrics'),
('000000318','Solid Tumors'),
('000000319','Neurological Disorders'),
('000000319','Neuropathy'),
('000000320','Heart Disease'),
('000000321','Skin Disease'),
('000000322','Heart Disease'),
('000000323','Fertility'),
('000000324','Muscular Dystrophy'),
('000000324','Skeletal/Smooth Muscle disorders'),
('000000325','Blood Cancer'),
('000000325','Blood Disorders'),
('000000326','Neurological Disorders'),
('000000326','Pediatrics'),
('000000328','Aging'),
('000000328','Neurological Disorders'),
('000000329','Blood Cancer'),
('000000329','Cancer'),
('000000331','Vision Loss'),
('000000332','Amyotrophic Lateral Sclerosis'),
('000000332','Neurological Disorders'),
('000000332','Neuropathy'),
('000000333','Heart Disease'),
('000000333','Pediatrics'),
('000000336','Skin Disease'),
('000000337','Neurological Disorders'),
('000000337','Rett\'s Syndrome'),
('000000338','Heart Disease'),
('000000339','Neurological Disorders'),
('000000341','Amyotrophic Lateral Sclerosis'),
('000000341','Dementia'),
('000000341','Neurological Disorders'),
('000000342','Heart Disease'),
('000000345','Cancer'),
('000000345','Melanoma'),
('000000345','Skin cancer'),
('000000345','Solid Tumors'),
('000000346','Heart Disease'),
('000000346','Vascular Disease'),
('000000347','Bone or Cartilage Disease'),
('000000347','Osteonecrosis'),
('000000348','Huntington\'s Disease'),
('000000348','Neurological Disorders'),
('000000349','Kidney Disease'),
('000000350','Muscular Dystrophy'),
('000000350','Pediatrics'),
('000000350','Skeletal/Smooth Muscle disorders'),
('000000351','Alzheimer\'s Disease'),
('000000351','Neurological Disorders'),
('000000352','Heart Disease'),
('000000352','Heart failure'),
('000000353','Bone or Cartilage Disease'),
('000000354','Brain Cancer'),
('000000354','Cancer'),
('000000355','Vascular Disease'),
('000000356','Multiple Sclerosis'),
('000000356','Neurological Disorders'),
('000000357','Heart Disease'),
('000000358','Epilepsy'),
('000000358','Neurological Disorders'),
('000000358','Spinal Cord Injury'),
('000000359','Neurological Disorders'),
('000000359','Pediatrics'),
('000000364','Alzheimer\'s Disease'),
('000000364','Neurological Disorders'),
('000000366','Aging'),
('000000367','Neurological Disorders'),
('000000368','Diabetes'),
('000000368','Metabolic Disorders'),
('000000370','Respiratory Disorders'),
('000000371','Cancer'),
('000000372','Neurological Disorders'),
('000000372','Parkinson\'s Disease'),
('000000373','Bone or Cartilage Disease'),
('000000374','Heart Disease'),
('000000375','Amyotrophic Lateral Sclerosis'),
('000000375','Neurological Disorders'),
('000000384','Neurological Disorders'),
('000000385','Aging'),
('000000385','Alzheimer\'s Disease'),
('000000385','Autism'),
('000000385','Neurological Disorders'),
('000000386','Fertility'),
('000000388','Heart Disease'),
('000000388','Pediatrics'),
('000000389','Diabetes'),
('000000389','Metabolic Disorders'),
('000000390','Heart Disease'),
('000000391','Huntington\'s Disease'),
('000000391','Neurological Disorders'),
('000000393','Autism'),
('000000393','Neurological Disorders'),
('000000393','Pediatrics'),
('000000393','Rett\'s Syndrome'),
('000000395','Amyotrophic Lateral Sclerosis'),
('000000395','Neurological Disorders'),
('000000396','Genetic Disorder'),
('000000398','Infectious Disease'),
('000000398','Neurological Disorders'),
('000000402','Neurological Disorders'),
('000000402','Pediatrics'),
('000000403','Neurological Disorders'),
('000000403','Parkinson\'s Disease'),
('000000405','Neurological Disorders'),
('000000409','Autism'),
('000000409','Neurological Disorders'),
('000000409','Trauma'),
('000000410','Neurological Disorders'),
('000000410','Pediatrics'),
('000000412','Neurological Disorders'),
('000000412','Parkinson\'s Disease'),
('000000413','Genetic Disorder'),
('000000413','Intestinal Disease'),
('000000413','Metabolic Disorders'),
('000000413','Pediatrics'),
('000000414','Neurological Disorders'),
('000000414','Stroke'),
('000000416','HIV/AIDS'),
('000000416','Immune Disease'),
('000000416','Infectious Disease'),
('000000417','Neurological Disorders'),
('000000417','Pediatrics'),
('000000418','Blood Cancer'),
('000000418','Cancer'),
('000000419','Epilepsy'),
('000000419','Neurological Disorders'),
('000000420','Bone or Cartilage Disease'),
('000000421','Vision Loss'),
('000000422','Neurological Disorders'),
('000000422','Parkinson\'s Disease'),
('000000423','Liver Disease'),
('000000423','Metabolic Disorders'),
('000000424','Amyotrophic Lateral Sclerosis'),
('000000424','Autism'),
('000000424','Blood Disorders'),
('000000424','Genetic Disorder'),
('000000424','Neurological Disorders'),
('000000424','Parkinson\'s Disease'),
('000000424','Pediatrics'),
('000000424','Rett\'s Syndrome'),
('000000425','Brain Cancer'),
('000000425','Cancer'),
('000000426','HIV/AIDS'),
('000000426','Immune Disease'),
('000000428','Blood Cancer'),
('000000428','Cancer'),
('000000429','Brain Cancer'),
('000000429','Cancer'),
('000000431','Neurological Disorders'),
('000000433','Pediatrics'),
('000000434','Immune Disease'),
('000000435','Blood Disorders'),
('000000436','Alzheimer\'s Disease'),
('000000436','Neurological Disorders'),
('000000437','Immune Disease'),
('000000440','Neurological Disorders'),
('000000441','Blood Disorders'),
('000000441','Pediatrics'),
('000000442','Diabetes'),
('000000442','Immune Disease'),
('000000442','Metabolic Disorders'),
('000000443','Immune Disease'),
('000000443','Pediatrics'),
('000000445','Epilepsy'),
('000000445','Neurological Disorders'),
('000000447','Blood Disorders'),
('000000447','Immune Disease'),
('000000448','Immune Disease'),
('000000453','Neurological Disorders'),
('000000453','Spinal Cord Injury'),
('000000454','Brain Cancer'),
('000000454','Cancer'),
('000000455','Blood Cancer'),
('000000455','Cancer'),
('000000456','Epidermolysis Bullosa'),
('000000456','Pediatrics'),
('000000457','HIV/AIDS'),
('000000457','Infectious Disease'),
('000000458','Diabetes'),
('000000458','Metabolic Disorders'),
('000000459','Heart Disease'),
('000000462','Blood Disorders'),
('000000465','Neurological Disorders'),
('000000465','Parkinson\'s Disease'),
('000000467','Diabetes'),
('000000467','Metabolic Disorders'),
('000000468','Aging'),
('000000468','Vision Loss'),
('000000469','Cancer'),
('000000471','Neurological Disorders'),
('000000471','Parkinson\'s Disease'),
('000000472','Bone or Cartilage Disease'),
('000000473','Vision Loss'),
('000000475','Huntington\'s Disease'),
('000000475','Neurological Disorders'),
('000000476','Aging'),
('000000476','Alzheimer\'s Disease'),
('000000476','Neurological Disorders'),
('000000477','Blood Disorders'),
('000000477','Heart Disease'),
('000000479','Brain Cancer'),
('000000479','Cancer'),
('000000483','Heart Disease'),
('000000491','Liver Disease'),
('000000491','Metabolic Disorders'),
('000000493','Amyotrophic Lateral Sclerosis'),
('000000493','Neurological Disorders'),
('000000498','Heart Disease'),
('000000501','Diabetes'),
('000000501','Metabolic Disorders'),
('000000506','Neurological Disorders'),
('000000507','Bone or Cartilage Disease'),
('000000507','Trauma'),
('000000509','Heart Disease'),
('000000516','Heart Disease'),
('000000517','Amyotrophic Lateral Sclerosis'),
('000000517','Neurological Disorders'),
('000000518','Fertility'),
('000000520','Neurological Disorders'),
('000000520','Parkinson\'s Disease'),
('000000521','Genetic Disorder'),
('000000521','Muscular Dystrophy'),
('000000521','Pediatrics'),
('000000521','Skeletal/Smooth Muscle disorders'),
('000000523','Genetic Disorder'),
('000000523','Pediatrics'),
('000000524','Heart Disease'),
('000000524','Toxicity'),
('000000525','Dementia'),
('000000525','Neurological Disorders'),
('000000537','Heart Disease'),
('000000538','Aging'),
('000000538','Alzheimer\'s Disease'),
('000000539','Cancer'),
('000000539','Solid Tumors'),
('000000541','Blood Cancer'),
('000000541','Cancer'),
('000000542','Heart Disease'),
('000000543','Muscular Dystrophy'),
('000000543','Skeletal/Smooth Muscle disorders'),
('000000544','Bone or Cartilage Disease'),
('000000545','Neurological Disorders'),
('000000545','Parkinson\'s Disease'),
('000000546','Amyotrophic Lateral Sclerosis'),
('000000546','Neurological Disorders'),
('000000547','Aging'),
('000000547','Muscular Dystrophy'),
('000000547','Pediatrics'),
('000000547','Skeletal/Smooth Muscle disorders'),
('000000547','Trauma'),
('000000551','Fertility'),
('000000556','Heart Disease'),
('000000557','Amyotrophic Lateral Sclerosis'),
('000000557','Neurological Disorders'),
('000000557','Spinal Cord Injury'),
('000000557','Spinal Muscular Atrophy'),
('000000559','Neurological Disorders'),
('000000559','Stroke'),
('000000560','Hearing Loss'),
('000000561','Heart Disease'),
('000000562','Heart Disease'),
('000000563','Immune Disease'),
('000000563','Multiple Sclerosis'),
('000000563','Neurological Disorders'),
('000000563','Stroke'),
('000000569','Cancer'),
('000000569','Melanoma'),
('000000570','Cancer'),
('000000571','Cancer'),
('000000571','Pediatrics'),
('000000572','Vascular Disease'),
('000000575','Cancer'),
('000000576','Neurological Disorders'),
('000000576','Parkinson\'s Disease'),
('000000577','Neurological Disorders'),
('000000577','Spinal Cord Injury'),
('000000577','Stroke'),
('000000577','Trauma'),
('000000578','Aging'),
('000000578','Vision Loss'),
('000000584','Heart Disease'),
('000000586','Intestinal Disease'),
('000000586','Metabolic Disorders'),
('000000586','Pediatrics'),
('000000586','Trauma'),
('000000587','Cancer'),
('000000589','Diabetes'),
('000000589','Metabolic Disorders'),
('000000590','Immune Disease'),
('000000590','Multiple Sclerosis'),
('000000591','Cancer'),
('000000591','Neurological Disorders'),
('000000592','Bone or Cartilage Disease'),
('000000593','Hearing Loss'),
('000000595','Genetic Disorder'),
('000000595','Muscular Dystrophy'),
('000000596','Fertility'),
('000000598','Autism'),
('000000598','Developmental Disorders');

INSERT works_for VALUES
('000000592','University of California, Davis'),
('000000535','University of California, San Francisco'),
('000000386','Stanford University'),
('000000382','University of California, Los Angeles'),
('000000104','University of California, Irvine'),
('000000107','ViaCyte, Inc.'),
('000000075','Stanford University'),
('000000034','Stanford University'),
('000000154','Sanford Burnham Prebys Medical Discovery Institute'),
('000000326','Children\'s Neurobiological Solutions (CNS) Foundation'),
('000000334','Stanford University'),
('000000351','StemCells, Inc.'),
('000000579','Sanford Burnham Prebys Medical Discovery Institute'),
('000000456','Stanford University'),
('000000147','Rumi Scientific CA'),
('000000322','University of California, Los Angeles'),
('000000111','University of California, Davis'),
('000000010','Vitabolus, Inc.'),
('000000116','University of California, Los Angeles'),
('000000458','ViaCyte, Inc.'),
('000000122','University of California, Davis'),
('000000168','University of California, San Diego'),
('000000523','University of California, Los Angeles'),
('000000340','University of California, San Diego'),
('000000056','Aspen Neuroscience'),
('000000190','University of California, San Francisco'),
('000000270','University of California, Berkeley'),
('000000249','University of California, San Francisco'),
('000000349','University of Southern California'),
('000000542','University of California, Irvine'),
('000000385','University of California, San Diego'),
('000000286','Human Organ Project'),
('000000434','La Jolla Institute for Allergy and Immunology'),
('000000325','University of California, San Francisco'),
('000000328','Stanford University'),
('000000225','ImmunoCellular Therapeutics'),
('000000136','International Alliance for Biological Standardization'),
('000000117','Stanford University'),
('000000345','University of California, Los Angeles'),
('000000109','University of California, Los Angeles'),
('000000186','University of California, Los Angeles'),
('000000358','University of California, San Francisco'),
('000000419','University of California, San Francisco'),
('000000384','Brain Mapping Foundation'),
('000000478','Berkeley City College'),
('000000343','University of California, San Francisco'),
('000000304','Cedars-Sinai Medical Center'),
('000000450','Escape Therapeutics, Inc'),
('000000452','University of California, Los Angeles'),
('000000508','University of California, San Diego'),
('000000189','University of California, Los Angeles'),
('000000338','Gladstone Institutes, J. David'),
('000000379','University of California, Santa Barbara'),
('000000084','Stanford University'),
('000000090','Sangamo BioSciences, Inc.'),
('000000582','Salk Institute for Biological Studies'),
('000000060','Cal State Univ, San Marcos'),
('000000141','SanBio, Inc.'),
('000000152','University of Southern California'),
('000000546','University of California, Santa Cruz'),
('000000504','Ludwig Institute for Cancer Research'),
('000000395','University of California, San Diego'),
('000000165','Parkinson\'s Institute'),
('000000091','Fate Therapeutics, Inc.'),
('000000477','University of California, San Francisco'),
('000000023','University of California, Irvine'),
('000000414','Stanford University'),
('000000039','University of California, Los Angeles'),
('000000524','Gladstone Institutes, J. David'),
('000000420','University of California, Los Angeles'),
('000000586','Stanford University'),
('000000307','University of California, Santa Cruz'),
('000000217','City College Of San Francisco'),
('000000251','University of California, Los Angeles'),
('000000492','Scripps Research Institute'),
('000000488','San Francisco State University'),
('000000035','University of California, Los Angeles'),
('000000581','University of California, Berkeley'),
('000000555','Children\'s Hospital of Los Angeles'),
('000000097','International Society for Stem Cell Research'),
('000000119','University of California, San Diego'),
('000000389','University of California, San Diego'),
('000000591','University of California, Irvine'),
('000000509','Stanford University'),
('000000541','University of California, Davis'),
('000000176','Midwinter Conference of Immunologists'),
('000000279','University of California, San Diego'),
('000000134','City of Hope, Beckman Research Institute'),
('000000444','Stanford University'),
('000000556','Stanford University'),
('000000536','University of Southern California'),
('000000218','Cal State Univ, Northridge'),
('000000047','Cedars-Sinai Medical Center'),
('000000131','Nohla Therapeutics Inc'),
('000000282','University of California, San Diego'),
('000000025','Neurona Therapeutics'),
('000000356','University of California, Irvine'),
('000000003','University of California, Los Angeles'),
('000000089','Stanford University'),
('000000594','Buck Institute for Age Research'),
('000000299','Cedars-Sinai Medical Center'),
('000000007','University of California, San Diego'),
('000000291','University of California, Los Angeles'),
('000000093','Medeor Therapeutics, Inc.'),
('000000412','University of California, San Francisco'),
('000000026','University of California, Irvine'),
('000000233','Scripps Health'),
('000000490','Children\'s Hospital of Los Angeles'),
('000000017','Boston Children\'s Hospital'),
('000000182','California Institute of Technology'),
('000000113','Loma Linda University'),
('000000267','University of California, San Diego'),
('000000426','City of Hope, Beckman Research Institute'),
('000000573','University of California, Santa Cruz'),
('000000484','University of California, Santa Cruz'),
('000000578','University of Southern California'),
('000000377','University of California, Davis'),
('000000435','University of California, Berkeley'),
('000000095','University of California, San Francisco'),
('000000179','University of California, Berkeley'),
('000000231','Salk Institute for Biological Studies'),
('000000180','University of California, Davis'),
('000000277','California Institute of Technology'),
('000000196','International Society for Experimental Hematology'),
('000000513','University of Southern California'),
('000000145','University of California, Davis'),
('000000315','FUJIFILM Cellular Dynamics'),
('000000398','University of California, San Diego'),
('000000331','Buck Institute for Age Research'),
('000000164','Gladstone Institutes, J. David'),
('000000169','University of Southern California'),
('000000455','University of California, San Diego'),
('000000481','University of California, Santa Barbara'),
('000000288','University of California, Los Angeles'),
('000000077','Poseida Therapeutics, Inc.'),
('000000006','University of California, Davis'),
('000000256','University of California, San Francisco'),
('000000265','University of California, San Diego'),
('000000589','University of California, San Francisco'),
('000000195','University of California, San Diego'),
('000000114','Cedars-Sinai Medical Center'),
('000000008','University of California, Los Angeles'),
('000000376','University of California, San Diego'),
('000000438','University of California, Los Angeles'),
('000000538','Western University of Health Sciences'),
('000000497','Gamma Medica-Ideas, Inc.'),
('000000558','University of California, Irvine'),
('000000593','University of California, Davis'),
('000000342','Cedars-Sinai Medical Center'),
('000000226','Sanford Consortium for Regenerative Medicine'),
('000000066','Angiocrine Bioscience, Inc.'),
('000000506','University of California, Irvine'),
('000000009','Lundquist Institute for Biomedical Innovation at Harbor - UCLA Medical Center'),
('000000571','Children\'s Hospital of Los Angeles'),
('000000427','Vitalant Research Institute'),
('000000220','Childrens Hospital of Oakland Research Institute'),
('000000437','University of California, Berkeley'),
('000000321','University of California, Davis'),
('000000519','ViaCyte, Inc.'),
('000000428','University of California, San Francisco'),
('000000079','University of California, San Diego'),
('000000305','University of California, San Diego'),
('000000433','University of California, Davis'),
('000000574','Gladstone Institutes, J. David'),
('000000139','JDRF International'),
('000000175','IQVIA, Inc.'),
('000000341','University of California, San Diego'),
('000000027','Sanford Burnham Prebys Medical Discovery Institute'),
('000000065','Stanford University'),
('000000501','ViaCyte, Inc.'),
('000000137','University of California, San Diego'),
('000000250','Stanford University'),
('000000388','University of California, San Diego'),
('000000083','MAX BioPharma, Inc.'),
('000000201','Semma Therapeutics'),
('000000598','Gladstone Institutes, J. David'),
('000000223','City of Hope, Beckman Research Institute'),
('000000317','City of Hope, Beckman Research Institute'),
('000000404','University of California, Santa Barbara'),
('000000259','Lineage Cell Therapeutics Inc.'),
('000000476','University of California, Irvine'),
('000000585','University of California, Riverside'),
('000000424','Salk Institute for Biological Studies'),
('000000487','University of California, Davis'),
('000000306','Sangamo BioSciences, Inc.'),
('000000473','University of California, Los Angeles'),
('000000507','University of Southern California'),
('000000446','Stanford University'),
('000000553','Salk Institute for Biological Studies'),
('000000149','Stanford University'),
('000000040','University of California, Los Angeles'),
('000000019','Rocket Pharmaceuticals, Inc.'),
('000000531','University of California, Los Angeles'),
('000000457','Calimmune, Inc.'),
('000000528','University of California, Berkeley'),
('000000129','Alliance Forum Foundation'),
('000000336','University of California, San Diego'),
('000000235','Ocular Research Symposia Foundation, Inc.'),
('000000339','Stanford University'),
('000000298','University of California, Los Angeles'),
('000000123','University of California, San Diego'),
('000000043','University of California, Davis'),
('000000533','University of California, Santa Barbara'),
('000000096','International Society for Stem Cell Research'),
('000000597','University of California, Irvine'),
('000000568','Sanford Burnham Prebys Medical Discovery Institute'),
('000000121','Stanford University'),
('000000559','University of California, Los Angeles'),
('000000466','Stanford University'),
('000000240','University of California, Los Angeles'),
('000000557','University of California, Irvine'),
('000000562','University of California, San Francisco'),
('000000566','University of California, San Francisco'),
('000000021','Stanford University'),
('000000086','Childrens Hospital of Oakland Research Institute'),
('000000046','jCyte, Inc'),
('000000209','California Institute of Technology'),
('000000001','University of California, San Francisco'),
('000000042','Stanford University'),
('000000140','University of California, San Francisco'),
('000000335','Stanford University'),
('000000132','ViaCyte, Inc.'),
('000000494','University of California, Los Angeles'),
('000000583','Sanford Burnham Prebys Medical Discovery Institute'),
('000000333','Sanford Burnham Prebys Medical Discovery Institute'),
('000000448','Palo Alto Veterans Institute for Research'),
('000000297','Salk Institute for Biological Studies'),
('000000431','iPierian, Inc.'),
('000000547','University of California, Berkeley'),
('000000416','University of California, Los Angeles'),
('000000244','Stanford University'),
('000000246','University of California, Davis'),
('000000471','Parkinson\'s Institute'),
('000000159','Cellular Biomedicine Group, Inc.'),
('000000185','University of California, Berkeley'),
('000000215','Humboldt State University'),
('000000312','University of California, San Francisco'),
('000000313','University of California, San Diego'),
('000000237','Stanford University'),
('000000362','Scripps Research Institute'),
('000000475','University of California, Davis'),
('000000602','Geron Corporation'),
('000000155','University of California, Irvine'),
('000000324','University of California, San Francisco'),
('000000285','University of California, San Francisco'),
('000000181','Scripps Research Institute'),
('000000442','University of California, San Francisco'),
('000000192','Stanford University'),
('000000133','Humacyte, Inc.'),
('000000515','University of California, San Francisco'),
('000000290','University of California, San Francisco'),
('000000261','Biocom Institute'),
('000000540','University of California, Merced'),
('000000202','University of California, San Francisco'),
('000000332','University of California, San Francisco'),
('000000033','City of Hope, Beckman Research Institute'),
('000000411','GMR Epigenetics'),
('000000402','City of Hope, Beckman Research Institute'),
('000000482','Cal Poly Pomona'),
('000000472','Stanford University'),
('000000309','Stanford University'),
('000000303','University of California, San Diego'),
('000000406','TriFoil Imaging, Inc.'),
('000000387','Stanford University'),
('000000391','Scripps Research Institute'),
('000000502','University of California, Santa Cruz'),
('000000100','University of California, Los Angeles'),
('000000124','Human BioMolecular Research Institute'),
('000000166','University of California, Los Angeles'),
('000000572','Stanford University'),
('000000417','iPierian, Inc.'),
('000000300','Numerate, Inc.'),
('000000527','Stanford University'),
('000000373','Samumed, LLC'),
('000000346','University of California, Davis'),
('000000399','University of California, San Francisco'),
('000000222','University of California, San Diego'),
('000000445','University of California, San Francisco'),
('000000532','University of California, Merced'),
('000000405','Cedars-Sinai Medical Center'),
('000000041','City of Hope, Beckman Research Institute'),
('000000071','University of California, San Diego'),
('000000198','University of California, Davis'),
('000000269','Salk Institute for Biological Studies'),
('000000311','University of California, San Diego'),
('000000238','City of Hope, Beckman Research Institute'),
('000000092','City of Hope, Beckman Research Institute'),
('000000005','Immune-Onc Therapeutics'),
('000000098','Stanford University'),
('000000271','University of California, Santa Cruz'),
('000000355','Salk Institute for Biological Studies'),
('000000062','Stanford University'),
('000000110','Loma Linda University'),
('000000521','Stanford University'),
('000000167','University of California, San Francisco'),
('000000301','Stanford University'),
('000000150','Scaled Biolabs Inc.'),
('000000012','University of Southern California'),
('000000310','University of California, San Diego'),
('000000262','University of California, Merced'),
('000000050','City of Hope, Beckman Research Institute'),
('000000024','University of California, San Diego'),
('000000068','University of California, San Francisco'),
('000000378','University of California, San Francisco'),
('000000548','Stanford University'),
('000000118','University of California, San Diego'),
('000000408','University of California, San Diego'),
('000000381','Stanford University'),
('000000206','University of California, San Francisco'),
('000000337','University of California, Los Angeles'),
('000000360','University of Southern California'),
('000000078','Stanford University'),
('000000480','University of California, Los Angeles'),
('000000443','Stanford University'),
('000000183','ViaCyte, Inc.'),
('000000022','University of California, Berkeley'),
('000000059','Rocket Pharmaceuticals, Inc.'),
('000000503','University of California, Davis'),
('000000584','Stanford University'),
('000000125','Calibr'),
('000000397','Scripps Research Institute'),
('000000491','VistaGen Therapeutics, Inc.'),
('000000049','Brain Neurotherapy Bio'),
('000000400','University of California, San Diego'),
('000000451','University of California, San Diego'),
('000000108','Stanford University'),
('000000595','University of California, Irvine'),
('000000353','University of California, Davis'),
('000000500','City of Hope, Beckman Research Institute'),
('000000529','University of California, Davis'),
('000000248','University of California, Davis'),
('000000200','University of California, San Diego'),
('000000545','Salk Institute for Biological Studies'),
('000000252','University of California, Los Angeles'),
('000000004','City of Hope, Beckman Research Institute'),
('000000253','Gordon Research Conferences'),
('000000173','Orchard Therapeutics plc'),
('000000064','University of California, Irvine'),
('000000080','Gladstone Institutes, J. David'),
('000000002','University of California, Los Angeles'),
('000000213','San Francisco State University'),
('000000511','University of California, Berkeley'),
('000000365','University of California, Santa Barbara'),
('000000187','Cedars-Sinai Medical Center'),
('000000551','University of California, San Francisco'),
('000000199','Capricor, Inc'),
('000000549','University of California, Santa Cruz'),
('000000278','University of California, Irvine'),
('000000212','Cal State Univ, Sacramento'),
('000000210','Cal State Univ, Long Beach'),
('000000514','University of California, San Francisco'),
('000000462','University of California, Los Angeles'),
('000000085','University of California, Irvine'),
('000000273','University of California, San Diego'),
('000000323','University of California, San Diego'),
('000000415','Fluidigm Corporation'),
('000000372','Sanford Burnham Prebys Medical Discovery Institute'),
('000000193','Vitalant Research Institute'),
('000000534','University of California, Santa Cruz'),
('000000449','University of California, Irvine'),
('000000327','Research for Cure'),
('000000275','Stanford University'),
('000000020','University of California, San Diego'),
('000000283','University of California, San Francisco'),
('000000601','Forty Seven Inc.'),
('000000052','University of Southern California'),
('000000580','Stanford University'),
('000000144','Stanford University'),
('000000057','University of California, San Francisco'),
('000000289','University of California, Davis'),
('000000423','University of California, Davis'),
('000000148','Children\'s Hospital of Los Angeles'),
('000000418','City of Hope, Beckman Research Institute'),
('000000463','University of Southern California'),
('000000370','University of California, Davis'),
('000000468','Scripps Research Institute'),
('000000453','University of California, San Diego'),
('000000413','University of California, Los Angeles'),
('000000375','University of California, Los Angeles'),
('000000526','Buck Institute for Age Research'),
('000000011','University of California, Irvine'),
('000000302','OCTANe Foundation for Innovation'),
('000000130','Stanford University'),
('000000127','Poseida Therapeutics, Inc.'),
('000000053','University of California, Davis'),
('000000479','City of Hope, Beckman Research Institute'),
('000000396','Stanford University'),
('000000329','Stanford University'),
('000000530','University of California, Irvine'),
('000000172','Cedars-Sinai Medical Center'),
('000000516','Stanford University'),
('000000037','University of California, San Francisco'),
('000000496','University of California, Los Angeles'),
('000000565','University of California, Riverside'),
('000000126','Children\'s Hospital of Los Angeles'),
('000000401','University of California, Berkeley'),
('000000266','Stanford University'),
('000000464','University of California, Los Angeles'),
('000000474','BioTime, Inc.'),
('000000294','Stanford University'),
('000000260','University of California, Irvine'),
('000000318','Stanford University'),
('000000330','University of California, San Francisco'),
('000000272','University of California, San Diego'),
('000000460','University of California, Davis'),
('000000454','University of California, San Francisco'),
('000000537','Mohammad Pashmforoush'),
('000000088','University of California, San Francisco'),
('000000347','University of California, Davis'),
('000000156','American Association of Blood Banks'),
('000000074','University of Southern California'),
('000000112','Palo Alto Veterans Institute for Research'),
('000000447','Scripps Research Institute'),
('000000219','Cal State Univ, San Bernadino'),
('000000207','Cal State Univ, Fullerton'),
('000000205','Cal State Univ, Channel Island'),
('000000425','University of California, Los Angeles'),
('000000467','ViaCyte, Inc.'),
('000000224','Gordon Research Conferences'),
('000000495','University of California, Irvine'),
('000000191','University of California, Los Angeles'),
('000000470','Jackson Labs'),
('000000216','Pasadena City College'),
('000000498','Vala Sciences, Inc.'),
('000000204','Angiocrine Bioscience, Inc.'),
('000000510','University of California, Davis'),
('000000280','Cedars-Sinai Medical Center'),
('000000369','California Institute of Technology'),
('000000171','City of Hope, Beckman Research Institute'),
('000000208','Stanford University'),
('000000245','University of Southern California'),
('000000197','University of California, Los Angeles'),
('000000287','University of California, Davis'),
('000000600','University of California, Irvine'),
('000000421','University of California, Santa Barbara'),
('000000268','University of California, Irvine'),
('000000587','University of Southern California'),
('000000184','IQVIA, Inc.'),
('000000228','Calibr'),
('000000055','University of California, San Francisco'),
('000000073','Stanford University'),
('000000359','Children\'s Hospital of Orange County'),
('000000188','Stanford University'),
('000000038','ExCellThera Inc.'),
('000000499','University of Southern California'),
('000000030','University of Southern California'),
('000000550','University of California, Riverside'),
('000000247','University of Southern California'),
('000000234','University of Southern California'),
('000000403','Parkinson\'s Institute'),
('000000352','Capricor, Inc'),
('000000174','San Diego State University Foundation'),
('000000138','BrainStorm Cell Therapeutics'),
('000000561','University of California, San Francisco'),
('000000236','University of California, Davis'),
('000000599','University of California, Berkeley'),
('000000292','University of California, San Francisco'),
('000000518','Stanford University'),
('000000320','University of California, Los Angeles'),
('000000512','San Diego State University Foundation'),
('000000410','University of California, Los Angeles'),
('000000368','City of Hope, Beckman Research Institute'),
('000000459','University of California, Los Angeles'),
('000000230','Caladrius Biosciences'),
('000000525','Gladstone Institutes, J. David'),
('000000319','Cedars-Sinai Medical Center'),
('000000505','University of California, San Francisco'),
('000000013','University of California, Irvine'),
('000000485','Gladstone Institutes, J. David'),
('000000486','University of Southern California'),
('000000432','Stanford University'),
('000000596','Sanford Burnham Prebys Medical Discovery Institute'),
('000000295','University of California, Los Angeles'),
('000000374','Stanford University'),
('000000177','University of California, San Diego'),
('000000344','University of California, Berkeley'),
('000000429','Sanford Burnham Prebys Medical Discovery Institute'),
('000000364','University of Southern California'),
('000000163','Stanford University'),
('000000367','International Symposium on Neural Regeneration, Inc.'),
('000000203','Mosaic Event Management, Inc.'),
('000000081','Salk Institute for Biological Studies'),
('000000383','University of California, Irvine'),
('000000045','Stanford University'),
('000000232','University of California, Davis'),
('000000380','University of California, San Diego'),
('000000281','University of California, Los Angeles'),
('000000517','Salk Institute for Biological Studies'),
('000000563','University of California, San Francisco'),
('000000157','Stanford University'),
('000000242','Stanford University'),
('000000105','City of Hope, Beckman Research Institute'),
('000000051','City of Hope, Beckman Research Institute'),
('000000102','University of California, Los Angeles'),
('000000554','University of California, Los Angeles'),
('000000390','Stanford University'),
('000000120','University of California, San Francisco'),
('000000194','Children\'s Hospital of Los Angeles'),
('000000564','Salk Institute for Biological Studies'),
('000000363','Gladstone Institutes, J. David'),
('000000241','University of California, San Diego'),
('000000229','Cedars-Sinai Medical Center'),
('000000263','Gladstone Institutes, J. David'),
('000000178','Vitalant Research Institute'),
('000000308','University of California, San Diego'),
('000000394','University of California, Los Angeles'),
('000000103','University of California, San Francisco'),
('000000243','University of California, San Diego'),
('000000539','University of California, Los Angeles'),
('000000227','University of California, Irvine'),
('000000031','University of California, Los Angeles'),
('000000158','University of California, Los Angeles'),
('000000544','University of Southern California'),
('000000153','University of California, San Francisco'),
('000000048','University of California, Los Angeles'),
('000000014','University of California, Los Angeles'),
('000000350','University of California, Los Angeles'),
('000000560','Stanford University'),
('000000054','University of California, San Diego'),
('000000354','City of Hope, Beckman Research Institute'),
('000000161','St. Jude Children\'s Research Hospital'),
('000000028','University of California, San Diego'),
('000000441','Stanford University'),
('000000407','University of California, Berkeley'),
('000000018','University of California, San Francisco'),
('000000082','University of California, Los Angeles'),
('000000254','Gladstone Institutes, J. David'),
('000000087','University of California, San Francisco'),
('000000069','University of California, Los Angeles'),
('000000293','Sanford Burnham Prebys Medical Discovery Institute'),
('000000036','Scripps Research Institute'),
('000000576','University of California, San Francisco'),
('000000465','Stanford University'),
('000000255','University of California, San Francisco'),
('000000151','Cellerant Therapeutics, Inc.'),
('000000483','University of California, San Diego'),
('000000101','University of California, San Diego'),
('000000015','University of California, San Diego'),
('000000316','University of California, Los Angeles'),
('000000162','University of California, San Francisco'),
('000000440','Cedars-Sinai Medical Center'),
('000000094','Keystone Symposia on Molecular and Cellular Biology'),
('000000575','University of California, San Francisco'),
('000000409','Stanford University'),
('000000058','University of California, Los Angeles'),
('000000070','Stanford University'),
('000000135','University of California, San Diego'),
('000000590','University of California, Irvine'),
('000000314','Cellular Dynamics International'),
('000000284','Palo Alto Veterans Institute for Research'),
('000000567','Stanford University'),
('000000128','RUNX1 Research Program'),
('000000371','OncoMed Pharmaceuticals, Inc.'),
('000000570','City of Hope, Beckman Research Institute'),
('000000142','University of California, San Francisco'),
('000000543','City of Hope, Beckman Research Institute'),
('000000258','Gladstone Institutes, J. David'),
('000000436','Palo Alto Veterans Institute for Research'),
('000000239','University of Southern California'),
('000000072','Children\'s Hospital of Los Angeles'),
('000000211','Cal Poly Corporation, an Auxiliary of California Polytechnic State University, San Luis Obispo'),
('000000214','San Jose State University'),
('000000489','Scripps Research Institute'),
('000000032','University of California, Los Angeles'),
('000000264','University of California, San Francisco'),
('000000361','Childrens Hospital of Oakland Research Institute'),
('000000115','Zenobia Therapeutics'),
('000000348','University of California, Davis'),
('000000067','Pathways to Stem Cell Science'),
('000000366','Buck Institute for Age Research'),
('000000588','University of California, Irvine'),
('000000552','Stanford University'),
('000000221','Cedars-Sinai Medical Center'),
('000000357','University of California, Davis'),
('000000461','University of Southern California'),
('000000469','Gladstone Institutes, J. David'),
('000000522','Ludwig Institute for Cancer Research'),
('000000274','University of California, San Diego'),
('000000063','Jasper Therapeutics, Inc.'),
('000000392','University of California, Los Angeles'),
('000000430','University of California, Davis'),
('000000160','Caladrius Biosciences'),
('000000257','University of California, Berkeley'),
('000000422','Buck Institute for Age Research'),
('000000029','Celularity Inc'),
('000000099','University of California, Riverside'),
('000000146','X-Therma Inc.'),
('000000276','Stanford University'),
('000000076','City of Hope, Beckman Research Institute'),
('000000170','Gladstone Institutes, J. David'),
('000000106','University of California, San Diego'),
('000000016','City of Hope, Beckman Research Institute'),
('000000393','University of California, Los Angeles'),
('000000493','University of California, San Diego'),
('000000061','Ankasa Regenerative Therapeutics'),
('000000439','University of California, Los Angeles'),
('000000143','City of Hope, Beckman Research Institute'),
('000000044','University of California, Los Angeles'),
('000000296','University of California, Los Angeles'),
('000000520','Sanford Burnham Prebys Medical Discovery Institute'),
('000000577','Sanford Burnham Prebys Medical Discovery Institute'),
('000000569','University of California, Los Angeles');

INSERT t_disease_area VALUES
('000000001','Age-related macular degeneration'),
('000000002','Alpha Thalassemia Major'),
('000000003','Amyotrophic Lateral Sclerosis'),
('000000004','Amyotrophic Lateral Sclerosis'),
('000000005','B cell cancers'),
('000000005','Leukemia'),
('000000006','B cell cancers'),
('000000006','Leukemia'),
('000000007','Beta Thalassemia'),
('000000008','Blood Cancer'),
('000000009','Blood Cancer'),
('000000010','Blood Cancer'),
('000000010','Bone Marrow Transplant'),
('000000010','Viral Infection'),
('000000011','Blood Cancer'),
('000000011','Solid Tumors'),
('000000012','Blood Cancer'),
('000000013','Bone or Cartilage Disease'),
('000000014','Brain Cancer'),
('000000015','Brain Cancer'),
('000000015','Breast Cancer'),
('000000016','Brain Cancer'),
('000000017','Brain Cancer'),
('000000018','Colon Cancer'),
('000000019','Corneal Damage'),
('000000020','COVID-19'),
('000000021','COVID-19'),
('000000022','COVID-19'),
('000000023','Heart disease associated with Duchenne muscular dystrophy'),
('000000024','Heart failure'),
('000000025','HIV-related Lymphoma'),
('000000025','HIV/AIDS'),
('000000026','HIV/AIDS'),
('000000027','HIV/AIDS'),
('000000028','HIV/AIDS'),
('000000029','Huntington\'s Disease'),
('000000030','Kidney Failure'),
('000000031','Kidney Failure'),
('000000032','Kidney Failure'),
('000000033','Kidney Failure'),
('000000034','Kidney Failure'),
('000000035','Kidney Failure'),
('000000036','Leukemia, Acute Myeloid (AML),'),
('000000037','Leukemia, Acute Myeloid (AML),'),
('000000038','Leukemia, Acute Myeloid (AML),'),
('000000039','Leukocyte Adhesion Deficiency'),
('000000040','Lung Cancer'),
('000000041','Melanoma'),
('000000042','Melanoma'),
('000000042','Skin cancer'),
('000000042','Sarcoma'),
('000000043','Multiple Myeloma'),
('000000044','Osteoarthritis'),
('000000045','Osteonecrosis'),
('000000046','Parkinson\'s Disease'),
('000000047','Pulmonary Hypertension'),
('000000048','Retinitis Pigmentosa'),
('000000049','Retinitis Pigmentosa'),
('000000050','Retinitis Pigmentosa'),
('000000051','Retinitis Pigmentosa'),
('000000053','Severe Combined Immunodeficiency'),
('000000053','Adenosine deaminase-deficient (ADA-SCID),'),
('000000054','Severe Combined Immunodeficiency'),
('000000054','Artemis deficient (ART-SCID),'),
('000000055','Severe Combined Immunodeficiency'),
('000000055','X-linked (X-SCID),'),
('000000056','Severe Combined Immunodeficiency'),
('000000056','X-linked (X-SCID),'),
('000000057','Sickle Cell Disease'),
('000000058','Sickle Cell Disease'),
('000000059','Sickle Cell Disease'),
('000000060','Sickle Cell Disease'),
('000000061','Solid Tumors'),
('000000062','Spina Bifida'),
('000000063','Spinal Cord Injury'),
('000000064','Spinal Cord Injury'),
('000000065','Stroke'),
('000000066','Type 1 diabetes'),
('000000067','Type 1 diabetes'),
('000000068','Type 1 diabetes'),
('000000069','Type 1 diabetes'),
('000000070','X-linked Chronic Granulomatous Disease');

INSERT INTO r_watchlist VALUES
('Mark Humayun','000000052','Age-related macular degeneration'),
('Tippi MacKenzie','000000142','Alpha Thalassemia Major'),
('Ralph Kern','000000138','Amyotrophic Lateral Sclerosis'),
('Clive Svendsen','000000047','Amyotrophic Lateral Sclerosis'),
('Crystal Mackall','000000089','B cell cancers, Leukemia'),
('Thomas  Kipps','000000135','B cell cancers, Leukemia'),
('Bettina Cockroft','000000090','Beta Thalassemia'),
('Edward Kavalerchik','000000066','Blood Cancer'),
('Michael Pulsipher','000000126','Blood Cancer, Bone Marrow Transplant and Viral Infection'),
('Irving Weissman','000000244','Blood Cancer, Solid Tumors'),
('Thomas  Kipps','000000135','Blood Cancer'),
('Gayatri Rao','000000019','Bone or Cartilage Disease'),
('Christine Brown','000000134','Brain Cancer'),
('Saul Priceman','000000051','Brain Cancer, Breast Cancer'),
('Leo Wang','000000004','Brain Cancer'),
('Anthony Gringeri','000000225','Brain Cancer'),
('Mark Chao','000000601','Colon Cancer'),
('Sophie Deng','000000048','Corneal Damage'),
('Xiaokui Zhang','000000029','COVID-19'),
('John Zaia','000000041','COVID-19'),
('Michael Matthay','000000037','COVID-19'),
('Linda Marban','000000199','Heart disease associated with Duchenne muscular dystrophy'),
('Rachel Smith','000000352','Heart failure'),
('Mehrdad Abedi','000000053','HIV-related Lymphoma, HIV/AIDS'),
('Geoff Symonds','000000457','HIV/AIDS'),
('John Zaia','000000041','HIV/AIDS'),
('Steven Deeks','000000018','HIV/AIDS'),
('Vicki Wheelock','000000348','Huntington\'s Disease'),
('Jeffrey Lawson','000000133','Kidney Failure'),
('Daniel Brennan','000000093','Kidney Failure'),
('Everett Meyer','000000065','Kidney Failure'),
('Samuel Strober','000000157','Kidney Failure'),
('Stephanie Cherqui','000000054','Kidney Failure'),
('Mark Chao','000000601','Leukemia, Acute Myeloid (AML)'),
('Joseph Woodard','000000005','Leukemia, Acute Myeloid (AML)'),
('Colleen Delaney','000000131','Leukemia, Acute Myeloid (AML)'),
('Kinnari Patel','000000059','Leukocyte Adhesion Deficiency'),
('Steven Dubinett','000000082','Lung Cancer'),
('Robert  Dillman','000000230','Melanoma'),
('Antoni Ribas','000000345','Melanoma, Skin cancer'),
('Matthew Spear','000000127','Multiple Myeloma'),
('Kristen Johnson','000000125','Osteoarthritis'),
('Nancy Lane','000000347','Osteonecrosis'),
('Krystof Bankiewicz','000000049','Parkinson\'s Disease'),
('Michael Lewis','000000172','Pulmonary Hypertension'),
('Clive Svendsen','000000047','Retinitis Pigmentosa'),
('Henry Klassen','000000046','Retinitis Pigmentosa'),
('Theodore  Nowicki','000000058','Sarcoma'),
('Donald Kohn','000000008','Severe Combined Immunodeficiency, Adenosine deaminase-deficient (ADA-SCID)'),
('Morton Cowan','000000088','Severe Combined Immunodeficiency, Artemis deficient (ART-SCID)'),
('Stephen Gottschalk','000000161','Severe Combined Immunodeficiency, X-linked (X-SCID)'),
('Judith  Shizuru','000000062','Severe Combined Immunodeficiency, X-linked (X-SCID)'),
('David  Williams','000000017','Sickle Cell Disease'),
('Joseph Rosenthal','000000092','Sickle Cell Disease'),
('Pierre Caudrelier','000000038','Sickle Cell Disease'),
('Donald Kohn','000000008','Sickle Cell Disease'),
('Dennis Slamon','000000288','Solid Tumors'),
('Diana Farmer','000000006','Spina Bifida'),
('Jane Lebkowski','000000602','Spinal Cord Injury'),
('Francois Binette','000000259','Spinal Cord Injury'),
('Bijan Nejadnik','000000141','Stroke'),
('William Sietsema','000000160','Type 1 diabetes'),
('Peter Stock','000000055','Type 1 diabetes'),
('Howard Foyt','000000132','Type 1 diabetes'),
('Donald Kohn','000000008','X-linked Chronic Granulomatous Disease');

INSERT ct_grant VALUES
('TRAN1-12245','Development of novel synNotch CART cell therapy in patients with recurrent EGFRvIII+ glioblastoma',NULL,'Brain Cancer, Cancer, Solid Tumors',NULL,NULL,'Therapeutic Translational Research Projects','Pre-Active','University of California, San Francisco','Somatic Cell','2663144'),
('TRAN1-12250','HSC-Engineered Off-The-Shelf CAR-iNKT Cell Therapy for Multiple Myeloma',NULL,'Blood Cancer, Cancer, Multiple Myeloma',NULL,NULL,'Therapeutic Translational Research Projects','Pre-Active','University of California, Los Angeles','Adult Stem Cell','5949651'),
('TRAN1-12258','CAR-Tnm cell therapy for melanoma targeting TYRP-1',NULL,'Cancer, Melanoma, Solid Tumors',NULL,NULL,'Therapeutic Translational Research Projects','Pre-Active','University of California, Los Angeles','Adult Stem Cell','5904462'),
('CLIN2-12153','Phase I Study of IL13Rα2-Targeting CAR T Cells After Lymphodepletion for Children with Refractory or Recurrent Malignant Brain Tumors','000000016','Brain Cancer, Cancer, Solid Tumors','Jun 1, 2021','Dec 31, 2023','Clinical Trial Stage Projects','Active','City of Hope, Beckman Research Institute','Adult Stem Cell','8401309'),
('CLIN2-12149','Phase 1 Clinical Development of IO-202, A First-in-Class Antibody Targeting LILRB4, for the Treatment of AML with Monocytic Differentiation and CMML','000000037','Acute Myeloid Leukemia, Blood Cancer, Cancer','Jun 1, 2021','Jul 31, 2023','Clinical Trial Stage Projects','Active','Immune-Onc Therapeutics','Cancer Stem Cell','6000000'),
('CLIN2-12129','The CuRe Trial: Cellular Therapy for In Utero Myelomeningocele Repair','000000062','Neurological Disorders, Spina Bifida','Jan 1, 2021','Dec 31, 2023','Clinical Trial Stage Projects','Active','University of California, Davis','Adult Stem Cell','8996474'),
('DISC2-12105','Human iPSC-derived chimeric antigen receptor-expressing macrophages for cancer treatment',NULL,'Cancer, Ovarian Cancer, Solid Tumors','Jan 1, 2021','Dec 31, 2021','Quest - Discovery Stage Research Projects','Active','University of California, San Diego','iPS Cell','222200'),
('DISC2-12111','Hematopoietic Stem Cell Gene Therapy for X-linked Agammaglobulinemia',NULL,'Blood Disorders','Jan 1, 2021','Dec 31, 2021','Quest - Discovery Stage Research Projects','Active','University of California, Los Angeles','Adult Stem Cell','219230'),
('DISC2-12124','Dual angiogenic and immunomodulating nanotechnology for subcutaneous stem cell derived islet transplantation for the treatment of diabetes',NULL,'Diabetes, Metabolic Disorders, Type 1 diabetes','Jan 1, 2021','Dec 31, 2021','Quest - Discovery Stage Research Projects','Active','Lundquist Institute for Biomedical Innovation at Harbor - UCLA Medical Center','Embryonic Stem Cell','250000'),
('DISC2-12126','The First Orally Delivered Cell Therapy for the Treatment of Inflammatory Bowel Disease',NULL,'Inflammatory bowel disease, Intestinal Disease, Metabolic Disorders','Jan 1, 2021','Dec 31, 2021','Quest - Discovery Stage Research Projects','Active','Vitabolus, Inc.','Adult Stem Cell','249000'),
('DISC2-12130','Transplantation of Pluripotent Stem Cell Derived Microglia for the Treatment of Adult-onset Leukoencephalopathy (HDLS/ALSP)',NULL,'Neurological Disorders','Jan 1, 2021','Dec 31, 2021','Quest - Discovery Stage Research Projects','Active','University of California, Irvine','Embryonic Stem Cell','214668'),
('DISC2-12158','Development of a SYF2 antisense oligonucleotide (ASO) treatment for ALS',NULL,'Amyotrophic Lateral Sclerosis, Neurological Disorders','Jan 1, 2021','Dec 31, 2021','Quest - Discovery Stage Research Projects','Active','University of Southern California','iPS Cell','222300'),
('DISC2-12164','Optimization of a human interneuron cell therapy for traumatic brain injury',NULL,'Neurological Disorders, Traumatic Brain Injury','Jan 1, 2021','Dec 31, 2021','Quest - Discovery Stage Research Projects','Active','University of California, Irvine','iPS Cell','250000'),
('DISC2-12169','Human-induced pluripotent stem cell-derived glial enriched progenitors to treat white matter stroke and vascular dementia.',NULL,'Neurological Disorders, Stroke','Jan 1, 2021','Dec 31, 2021','Quest - Discovery Stage Research Projects','Active','University of California, Los Angeles','iPS Cell','250000'),
('DISC2-12170','Development of COVID-19 Antiviral Therapy Using Human iPSC-Derived Lung Organoids',NULL,'COVID-19, Infectious Disease','Jan 1, 2021','Dec 31, 2021','Quest - Discovery Stage Research Projects','Active','University of California, San Diego','iPS Cell','250000'),
('DISC2-12172','Combating COVID-19 using human PSC-derived NK cells',NULL,'COVID-19, Infectious Disease','Jan 1, 2021','Dec 31, 2021','Quest - Discovery Stage Research Projects','Active','City of Hope, Beckman Research Institute','Embryonic Stem Cell, iPS Cell','249998'),
('CLIN2SCD-12031','Phase 2 Study of Hematopoietic Stem Cell Gene Transfer Inducing Fetal Hemoglobin in Sickle Cell Disease','000000057','Blood Disorders, Sickle Cell Disease','Jan 1, 2021','Dec 31, 2024','Cure Sickle Cell Initiative Clinical Trial Stage Projects','Active','Boston Children\'s Hospital','Adult Stem Cell','8333581'),
('CLIN2-12090','Anti-HIV duoCAR-T cell therapy for HIV infection','000000028','HIV/AIDS, Immune Disease, Infectious Disease','Jan 1, 2021','Dec 31, 2023','Clinical Trial Stage Projects','Active','University of California, San Francisco','Adult Stem Cell','8970732'),
('CLIN2-12095','A Phase I Clinical Trial for a Lentiviral Gene Therapy Targeting the TCIRG1 Gene for Infantile Malignant Osteopetrosis (IMO)','000000013','Bone or Cartilage Disease','Dec 1, 2020','Jan 31, 2024','Clinical Trial Stage Projects','Active','Rocket Pharmaceuticals, Inc.','Adult Stem Cell','3728485'),
('DISC2P-12212','Simplification of Excipient Solution for Implanting Candidate Human H9-scNSC Cell Line for Spinal Cord Injury',NULL,'Neurological Disorders, Spinal Cord Injury','Jan 1, 2021','Dec 31, 2021','Progression Award - Discovery Stage Research Projects','Active','University of California, San Diego','Embryonic Stem Cell','180000'),
('DISC2P-12191','Stimulating endogenous muscle stem cells to counter muscle wasting',NULL,'Skeletal/Smooth Muscle disorders','Dec 1, 2020','Nov 30, 2021','Progression Award - Discovery Stage Research Projects','Active','Stanford University','Adult Stem Cell','237060'),
('DISC2P-11946','Safety “Clinical Trial” of the Cardiac Liability of COVID19 Polytherapy',NULL,'COVID-19, Infectious Disease','Dec 1, 2020','Nov 30, 2021','Progression Award - Discovery Stage Research Projects','Active','University of California, Berkeley','iPS Cell','224500'),
('DISC2P-12150','Human neural stem cell (hNSC) derived exosomes vs CSC14 hNSCs for the treatment of traumatic brain injury (TBI)',NULL,'Neurological Disorders, Traumatic Brain Injury','Jun 1, 2021','Dec 31, 2022','Progression Award - Discovery Stage Research Projects','Active','University of California, Irvine','Embryonic Stem Cell','202667'),
('DISC2COVID19-12007','Pro-healing biomaterial for treating lung inflammation associated with COVID-19',NULL,'COVID-19, Infectious Disease, Respiratory Disorders','Sep 1, 2020','Aug 31, 2021','Discovery Research Projects','Active','University of California, San Diego','Adult Stem Cell','221758'),
('DISC2COVID19-12020','Battling COVID-19 Using Off-The-Shelf HSC-Engineered iNKT Cells',NULL,'COVID-19, Infectious Disease','Sep 1, 2020','Aug 31, 2021','Discovery Research Projects','Active','University of California, Los Angeles','Adult Stem Cell','250000'),
('DISC2P-11700','Global gene expression profiling of single inhibitory neurons derived from human stem cells',NULL,'Epilepsy, Neurological Disorders','Aug 1, 2020','Jul 31, 2021','Progression Award - Discovery Stage Research Projects','Active','Neurona Therapeutics','Embryonic Stem Cell','202500'),
('EDUC1.11-11718','2020 CIRM Grantee Meeting',NULL,'','Aug 1, 2020','Jan 31, 2021','Conference – The 2020 Grantee Meeting','Active','University of California, Irvine','','176762'),
('DISC2COVID19-12022','Using hiPSC-derived lung organoids, a clinically-relevant system, to validate & winnow a list of approved drugs that inhibit SARS-CoV-2 cytopathy',NULL,'COVID-19, Infectious Disease, Respiratory Disorders','Aug 1, 2020','Jul 31, 2021','Discovery Research Projects','Active','Sanford Burnham Prebys Medical Discovery Institute','iPS Cell','228229'),
('DISC1COVID19-12047','Development of Anti-COVID RNAi Therapeutics Using Human iPSC-Derived Alveolar Epithelial Cells',NULL,'COVID-19, Infectious Disease','Aug 1, 2020','Jul 31, 2021','Discovery Research Projects','Active','University of California, San Diego','iPS Cell','150000'),
('CLIN2COVID19-11857','A phase I/II study of human placental hematopoietic stem cell derived natural killer cells (CYNK-001) for the treatment of adults with COVID-19','000000020','COVID-19, Infectious Disease, Respiratory Disorders','Aug 1, 2020','Jul 31, 2022','Clinical Trial Stage Projects','Active','Celularity Inc','Adult Stem Cell','750000'),
('DISC2COVID19-12016','Chimeric Antigen Receptor Targeting Spike Glycoprotein of SARS-cov2',NULL,'COVID-19, Infectious Disease, Respiratory Disorders','Aug 1, 2020','Jul 31, 2021','Discovery Research Projects','Active','University of Southern California','iPS Cell','249996'),
('DISC2COVID19-11838','Biomaterial vaccine to enhance the formation of SARS-CoV-2-specific T memory stem cells',NULL,'COVID-19, Infectious Disease','Jul 1, 2020','Jun 30, 2021','Discovery Research Projects','Active','University of California, Los Angeles','Adult Stem Cell','149916'),
('TRAN1COVID19-11975','COVID-19 Antiviral Therapy to Block Direct Cell Injury and Associated Tissue Damage',NULL,'COVID-19, Infectious Disease','Jul 1, 2020','Jun 30, 2021','Therapeutic Translational Research Projects','Active','University of California, Los Angeles','Adult Stem Cell','349999'),
('DISC2COVID19-11947','Persistent Off-the-Shelf meACE2-CAR-IL-15 NK Cells Derived from CD34(+) Cord Blood Stem Cells to Prevent and Treat COVID-19',NULL,'COVID-19, Infectious Disease','Jul 1, 2020','Jun 30, 2021','Discovery Research Projects','Active','City of Hope, Beckman Research Institute','Adult Stem Cell','150000'),
('DISC2COVID19-11920','Application of PGE2/BPV, a muscle stem cell targeting therapeutic, to the treatment of COVID-19 associated diaphragm atrophy',NULL,'COVID-19, Infectious Disease','Jul 1, 2020','Jun 30, 2021','Discovery Research Projects','Active','Stanford University','Adult Stem Cell','149996'),
('DISC2COVID19-11941','Identifying HLA Class I Restricted Peptides That Induce CD8+ T Cells Against SARS-CoV-2',NULL,'COVID-19, Infectious Disease','Jul 1, 2020','Jun 30, 2021','Discovery Research Projects','Active','Stanford University','Adult Stem Cell','249999'),
('DISC2P-11791','Evaluation of Gene Therapy Approaches for Autosomal Recessive Hyper IgE Syndrome Due to Mutations in DOCK8',NULL,'Blood Disorders, Immune Disease','Jul 1, 2020','Dec 31, 2021','Progression Award - Discovery Stage Research Projects','Active','University of California, Los Angeles','Adult Stem Cell','234000'),
('DISC2COVID19-11811','Repurposing Aminoadamantane Nitrate Compounds to Inhibit SARS-CoV-2 Viral Activity and to Protect the Brain from Viral-Related Damage',NULL,'COVID-19, Infectious Disease','Jun 1, 2020','May 31, 2021','Discovery Research Projects','Active','Scripps Research Institute','iPS Cell','150000'),
('DISC2COVID19-11901','Development of a novel PIKFYVE kinase inhibitor for the treatment of COVID-19',NULL,'COVID-19, Infectious Disease','Jun 1, 2020','May 31, 2021','Discovery Research Projects','Active','University of Southern California','iPS Cell','150000'),
('CLIN2COVID19-11823','Mesenchymal Stromal Cells for ARDS (COVID positive and COVID negative)','000000022','COVID-19, Infectious Disease','Jul 1, 2020','Jun 30, 2022','Clinical Trial Stage Projects','Active','University of California, San Francisco','Adult Stem Cell','701049'),
('CLIN2SCD-11674','A Phase 1 Study of ECT-001 Expanded Cord Blood and Myeloablative Regimen with Reduced Toxicity in Patients with Severe Sickle Cell Disease.','000000059','Blood Disorders, Sickle Cell Disease','Jun 1, 2020','Oct 31, 2023','Cure Sickle Cell Initiative Clinical Trial Stage Projects','Active','ExCellThera Inc.','Adult Stem Cell','2000000'),
('DISC2COVID19-11764','Identifying a lead compound for COVID19 using high throughput screening with lung stem cell organoids',NULL,'COVID-19, Infectious Disease, Respiratory Disorders','Jun 1, 2020','May 31, 2021','Discovery Research Projects','Active','University of California, Los Angeles','iPS Cell','149998'),
('DISC2COVID19-11817','Stem cell-based rapid identification of SARS-CoV-2 T cell epitopes and T cell receptors for therapeutic use',NULL,'COVID-19, Infectious Disease, Respiratory Disorders','Jun 1, 2020','May 31, 2021','Discovery Research Projects','Active','University of California, Los Angeles','Adult Stem Cell','126692'),
('CLIN2COVID19-11775','Evaluation and Characterization of SARS-CoV-2 Antibody in Convalescent Volunteer Plasma Donors for Potential Therapeutic Use','000000021','COVID-19, Infectious Disease, Respiratory Disorders','May 1, 2020','Oct 31, 2021','Clinical Trial Stage Projects','Active','City of Hope, Beckman Research Institute','Other, Vital Research Opportunity','999999'),
('DISC2P-11662','Using metabolic pausing for maintaining stable and high-quality pluripotent stem cells',NULL,'','Jun 1, 2020','May 31, 2021','Progression Award - Discovery Stage Research Projects','Active','Stanford University','Embryonic Stem Cell','208422'),
('EDUC1.5-11705','The 2020 SPARK Annual Meeting',NULL,'','Feb 1, 2020','Sep 30, 2021','Conference - Manage The SPARK Annual Meeting','Active','University of California, Davis','','50000'),
('TRAN1-11555','BCMA/CS1 Bispecific CAR-T Cell Therapy to Prevent Antigen Escape in Multiple Myeloma',NULL,'Blood Cancer, Cancer, Multiple Myeloma','Feb 1, 2020','Jan 31, 2022','Therapeutic Translational Research Projects','Active','University of California, Los Angeles','Adult Stem Cell','3176805'),
('TRAN1-11611','Development of a human stem cell-derived inhibitory neuron therapeutic for the treatment of chronic focal epilepsy',NULL,'Epilepsy, Neurological Disorders','Feb 1, 2020','Jul 31, 2021','Therapeutic Translational Research Projects','Active','Neurona Therapeutics','Embryonic Stem Cell','4848505'),
('CLIN1-11591','IND-enabling activities for a Phase 1 Study of Autologous CD4LVFOXP3 T Cells in Subjects with IPEX Syndrome',NULL,'Blood Disorders, Immune Disease, IPEX Syndrome','Dec 1, 2019','Sep 30, 2021','Late Stage Preclinical Projects','Active','Stanford University','Vital Research Opportunity','5002496'),
('CLIN2-11472','A Phase 2 Study of the Safety of Repeat Intravitreal Injection of Human Retinal Progenitor Cells (jCell) in Adult Subjects with Retinitis Pigmentosa','000000049','Retinitis Pigmentosa, Vision Loss','Dec 1, 2019','Nov 30, 2021','Clinical Trial Stage Projects','Active','jCyte, Inc','','6608592'),
('CLIN2-11620','Clinical Study to Assess Safety and Efficacy of Subretinal Injection of Human Neural Progenitor Cells for Treatment of Retinitis Pigmentosa','000000048','Retinitis Pigmentosa, Vision Loss','Dec 1, 2019','Nov 30, 2023','Clinical Trial Stage Projects','Active','Cedars-Sinai Medical Center','Adult Stem Cell','10444063'),
('CLIN2-11650','Safety and Feasibility of Cultivated Autologous Limbal Stem Cells for Limbal Stem Cell Deficiency','000000019','Corneal Damage, Vision Loss','Dec 1, 2019','Nov 30, 2023','Clinical Trial Stage Projects','Active','University of California, Los Angeles','Adult Stem Cell','10301486'),
('CLIN2-11661','A Phase 1b Safety Study for MRI guided delivery of AAV2-GDNF for the treatment of Parkinson’s disease','000000046','Neurological Disorders, Parkinson\'s Disease','Dec 1, 2019','Nov 30, 2023','Clinical Trial Stage Projects','Active','Brain Neurotherapy Bio','Vital Research Opportunity','5510462'),
('TRAN1-11536','Ex Vivo Gene Editing of Human Hematopoietic Stem Cells for the Treatment of X-Linked Hyper-IgM Syndrome',NULL,'Blood Disorders, Hyper IgM Syndrome, Immune Disease','Feb 1, 2020','Jul 31, 2022','Therapeutic Translational Research Projects','Active','University of California, Los Angeles','Adult Stem Cell','4896628'),
('TRAN1-11544','Neural Stem cell-mediated oncolytic immunotherapy for ovarian cancer',NULL,'Cancer, Ovarian Cancer, Solid Tumors','Feb 1, 2020','Jul 31, 2022','Therapeutic Translational Research Projects','Active','City of Hope, Beckman Research Institute','Adult Stem Cell','2873262'),
('CLIN2-11574','A Phase I Study of Chimeric Antigen Receptor Engineered Stem/Memory T Cells for the Treatment of HER2-Positive Brain Metastases','000000015','Brain Cancer, Breast Cancer, Cancer, Solid Tumors','Sep 1, 2019','Aug 31, 2022','Clinical Trial Stage Projects','Active','City of Hope, Beckman Research Institute','Adult Stem Cell','9015149'),
('TRAN1-11532','PRPE-SF,  polarized hESC-derived RPE Soluble Factors,  as a Therapy for Early Stage Dry Age-related Macular Degeneration',NULL,'Age-related macular degeneration, Vision Loss','Sep 1, 2019','Aug 31, 2022','Therapeutic Translational Research Projects','Active','`','Embryonic Stem Cell','3733556'),
('TRAN1-11548','An optimized human neural stem cell line (hNSC) for the treatment of traumatic brain injury (TBI)',NULL,'Neurological Disorders, Traumatic Brain Injury','Nov 1, 2019','Apr 30, 2022','Therapeutic Translational Research Projects','Active','University of California, Irvine','Embryonic Stem Cell','4804737'),
('TRAN1-11579','Human Embryonic Stem Cell-Derived Neural Stem Cells for Severe Spinal Cord Injury (SCI)',NULL,'Neurological Disorders, Spinal Cord Injury','Nov 1, 2019','Apr 30, 2022','Therapeutic Translational Research Projects','Active','University of California, San Diego','Embryonic Stem Cell','6235897'),
('TRAN1-11628','Human Neural Stem Cells (hNSCs) for neuroprotection in perinatal hypoxic-ischemic brain injury (HII)-Pre-IND-enabling Studies',NULL,'Brain Injury, hypoxic, ischemic, Neurological Disorders, Pediatrics','Nov 1, 2019','Apr 30, 2022','Therapeutic Translational Research Projects','Active','Sanford Burnham Prebys Medical Discovery Institute','Adult Stem Cell','4963684'),
('EDUC1.10-11681','CIRM - Leading the New Era of Living Medicines',NULL,'','Jul 1, 2019','Dec 31, 2020','Conference - The 2020 Alpha Stem Cell Clinic Annual Symposium','Active','University of California, Davis','','60000'),
('CLIN2-11478','Phase 1/2 study for autologous human CD34+ hematopoietic stem cells ex vivo transduced with pCCL-CTNS lentiviral vector for treatment of Cystinosis.','000000035','Cystinosis, Kidney Disease, Kidney Failure, Metabolic Disorders','Aug 1, 2019','Jul 31, 2023','Clinical Trial Stage Projects','Active','University of California, San Diego','Adult Stem Cell','11999944'),
('CLIN2-11437','Pancreatic Islets and Parathyroid Gland Co-transplantation for Treatment of Diabetes in the Intra-Muscular Site: PARADIGM','000000067','Diabetes, Metabolic Disorders, Type 1 diabetes','Jul 1, 2019','Jan 31, 2025','Clinical Trial Stage Projects','Active','University of California, San Francisco','Adult Stem Cell','11083012'),
('DISC2P-11595','Autologous therapy for Parkinson\'s disease: single cell RNAseq for in depth characterization of transplanted cells',NULL,'Neurological Disorders, Parkinson\'s Disease','Jul 1, 2019','Jun 30, 2020','Progression Award - Discovery Stage Research Projects','Closed','Aspen Neuroscience','iPS Cell','177579'),
('CLIN1-11497','Curing Sickle cell Disease with CRISPR-Cas9 genome editing',NULL,'Blood Disorders, Sickle Cell Disease','Jun 1, 2019','Nov 30, 2020','Late Stage Preclinical Projects','Active','University of California, San Francisco','Adult Stem Cell','2242805'),
('CLIN2-11480','LADICell','000000039','Blood Disorders, Immune Disease, Leukocyte Adhesion Deficiency','Jun 1, 2019','Jul 31, 2023','Clinical Trial Stage Projects','Active','Rocket Pharmaceuticals, Inc.','Adult Stem Cell','6567085'),
('EDUC1.4-11552','2020 and 2021 Bridges Annual Meeting',NULL,'','Dec 1, 2019','Nov 30, 2021','Conference - Manage The Bridges Annual Meeting','Active','Cal State Univ, San Marcos','','320000'),
('CLIN1-11256','IND-enabling development of ART352-L, an endogenous stem cell reactivation therapy to enhance bone healing in the elderly',NULL,'Bone or Cartilage Disease, Intervertebral disc degeneration','May 1, 2019','Jun 30, 2020','Late Stage Preclinical Projects','Closed','Ankasa Regenerative Therapeutics','Adult Stem Cell','3987693'),
('CLIN2-11431-A','A monoclonal antibody that depletes blood stem cells and enables chemotherapy free transplants','000000056','Blood Disorders, Severe Combined Immunodeficiency, X-linked (X-SCID)','Feb 1, 2020','Aug 31, 2020','Clinical Trial Stage Projects','Closed','Stanford University','Adult Stem Cell','1113487'),
('CLIN2-11431-B','A monoclonal antibody that depletes blood stem cells and enables chemotherapy free transplants',NULL,'Blood Disorders, Severe Combined Immunodeficiency, X-linked (X-SCID)','Sep 1, 2020','Mar 31, 2023','Clinical Trial Stage Projects','Active','Jasper Therapeutics, Inc.','Adult Stem Cell','2313398'),
('CLIN1-10953','An hESC-derived hNSC Therapeutic for Huntington’s Disease',NULL,'Huntington\'s Disease, Neurological Disorders','Mar 1, 2019','Feb 28, 2022','Late Stage Preclinical Projects','Active','University of California, Irvine','Embryonic Stem Cell','5635393'),
('CLIN2-11400','Induction of Tolerance by Combinatorial Therapy w/ Donor Stem Cells and Expanded Recipient Treg cells in HLA-mismatched Kidney Transplant Recipients','000000033','Kidney Disease, Kidney Failure','Mar 1, 2019','Nov 30, 2023','Clinical Trial Stage Projects','Active','Stanford University','Adult Stem Cell','11955585'),
('CLIN2-11371','AB-205-001 Phase 1b Trial and Related Activities to Support Clinical Development of AB-205','000000009','Blood Cancer, Cancer','Feb 1, 2019','Jan 31, 2023','Clinical Trial Stage Projects','Active','Angiocrine Bioscience, Inc.','Adult Stem Cell','6192579'),
('CLIN1-11404','Placental Mesenchymal Stem Cell Augmentation of Fetal Myelomeningocele Repair',NULL,'Neurological Disorders, Spina Bifida','Jan 1, 2019','Jan 31, 2021','Late Stage Preclinical Projects','Closed','University of California, Davis','Adult Stem Cell','5619643'),
('EDUC1.5-11452','2019 SPARK Annual Meeting',NULL,'','Jan 1, 2019','Sep 30, 2019','Conference - Manage The SPARK Annual Meeting','Closed','Pathways to Stem Cell Science','','49915'),
('TRAN1-11259','Developing engineered autologous leukemia vaccines to target residual leukemic stem cells',NULL,'Acute Myeloid Leukemia, Blood Cancer, Cancer','Feb 1, 2019','Aug 31, 2021','Therapeutic Translational Research Projects','Active','University of California, San Francisco','Cancer Stem Cell','4171728'),
('TRAN1-11265','Clinical Translation of Autologous Regenerative Cell Therapy for Blindness',NULL,'Age-related macular degeneration, Vision Loss','Jan 1, 2019','May 30, 2021','Therapeutic Translational Research Projects','Active','University of California, Los Angeles','iPS Cell','5068026'),
('TRAN1-11300','NeuBright, a purified allogeneic cell therapy product for treatment of Dry Age-related Macular Degeneration',NULL,'Age-related macular degeneration, Vision Loss','Feb 1, 2019','Jul 31, 2021','Therapeutic Translational Research Projects','Active','Stanford University','Adult Stem Cell','4235758'),
('DISC2-10973','Small Molecule Proteostasis Regulators to Treat Photoreceptor Diseases',NULL,'Vision Loss','Feb 1, 2019','Jan 31, 2022','Quest - Discovery Stage Research Projects','Active','University of California, San Diego','iPS Cell','1160648'),
('DISC2-10979','Universal Pluripotent Liver Failure Therapy (UPLiFT)',NULL,'Liver Disease, Metabolic Disorders','Mar 1, 2019','Feb 28, 2022','Quest - Discovery Stage Research Projects','Active','Children\'s Hospital of Los Angeles','iPS Cell','1297512'),
('DISC2-11070','Drug Development for Autism Spectrum Disorder Using Human Patient iPSCs',NULL,'Autism, Neurological Disorders','Feb 1, 2019','Jul 31, 2021','Quest - Discovery Stage Research Projects','Active','Scripps Research Institute','iPS Cell','1827576'),
('DISC2-11105','Pluripotent stem cell-derived bladder epithelial progenitors for definitive cell replacement therapy of bladder cancer',NULL,'Bladder or Urinary Tract Disorder, Cancer, Skeletal/Smooth Muscle disorders, Solid Tumors','Feb 1, 2019','Jan 31, 2021','Quest - Discovery Stage Research Projects','Closed','Stanford University','Embryonic Stem Cell','1265436'),
('DISC2-11183','A screen for drugs to protect against chemotherapy-induced hearing loss, using sensory hair cells derived by direct lineage reprogramming from hiPSCs',NULL,'Hearing Loss','Feb 1, 2019','Jan 31, 2021','Quest - Discovery Stage Research Projects','Closed','University of Southern California','iPS Cell','741574'),
('DISC2-11199','Modulation of the Wnt pathway to restore inner ear function',NULL,'Hearing Loss','Feb 1, 2019','Jul 31, 2021','Quest - Discovery Stage Research Projects','Active','Stanford University','Adult Stem Cell','1394870'),
('CLIN1-11223','CMV-specific T cells expressing anti-HIV CAR and CMV vaccine boost as immunotherapy for HIV/AIDS',NULL,'HIV/AIDS, Infectious Disease','Dec 1, 2018','Jul 31, 2021','Late Stage Preclinical Projects','Active','City of Hope, Beckman Research Institute','','3812797'),
('EDUC1.9-11423','2019 Alpha Stem Cell Clinic Symposium - Mending Stem Cells: The Past, Present & Future Regenerative Medicine',NULL,'','Jan 1, 2019','Jun 30, 2019','Conference - The 2019 Alpha Stem Cell Clinic Annual Symposium','Closed','University of California, San Francisco','','60000'),
('CLIN1-10999','Late-Stage Preclinical Study of CAR-T Memory Stem Cells Targeting PSMA (P-PSMA-101) for the Treatment of Castrate-Resistant Metastatic Prostate Cancer',NULL,'Cancer, Prostate Cancer, Solid Tumors','Sep 1, 2018','Dec 23, 2019','Late Stage Preclinical Projects','Closed','Poseida Therapeutics, Inc.','Adult Stem Cell','3992090'),
('DISC2-11036','Non-viral reprogramming of the endogenous TCRα locus to direct stem memory T cells against shared neoantigens in malignant gliomas',NULL,'Brain Cancer, Cancer, Solid Tumors','Dec 1, 2018','Sep 30, 2021','Quest - Discovery Stage Research Projects','Active','University of California, San Francisco','Adult Stem Cell','900000'),
('DISC2-11107','Chimeric Antigen Receptor-Engineered Stem/Memory T Cells for the Treatment of Recurrent Ovarian Cancer',NULL,'Cancer, Ovarian Cancer, Solid Tumors','Oct 1, 2018','Mar 31, 2021','Quest - Discovery Stage Research Projects','Active','City of Hope, Beckman Research Institute','Adult Stem Cell','1351174'),
('DISC2-11109','Regenerative Thymic Tissues as Curative Cell Therapy for Patients with 22q11 Deletion Syndrome',NULL,'Immune Disease, Thymic Disorder, 22q11 Deletion/DiGeorge','Jan 1, 2019','Jul 31, 2021','Quest - Discovery Stage Research Projects','Active','Stanford University','Embryonic Stem Cell, iPS Cell','1251720'),
('DISC2-11131','Genetically Modified Hematopoietic Stem Cells for the Treatment of Danon Disease',NULL,'Danon Disease, Heart Disease, Metabolic Disorders','Nov 1, 2018','Oct 31, 2021','Quest - Discovery Stage Research Projects','Active','University of California, San Diego','Adult Stem Cell','1393200'),
('DISC2-11157','Preclinical Development of An HSC-Engineered Off-The-Shelf iNKT Cell Therapy for Cancer',NULL,'Cancer','Dec 1, 2018','Feb 28, 2021','Quest - Discovery Stage Research Projects','Closed','University of California, Los Angeles','Adult Stem Cell','1404000'),
('DISC2-11165','Develop iPSC-derived microglia to treat progranulin-deficient Frontotemporal Dementia',NULL,'Dementia, Neurological Disorders','Nov 1, 2018','Aug 31, 2021','Quest - Discovery Stage Research Projects','Active','Gladstone Institutes, J. David','iPS Cell','1547157'),
('DISC2-11175','Therapeutic immune tolerant human islet-like organoids (HILOs) for Type 1 Diabetes',NULL,'Diabetes, Metabolic Disorders, Type 1 diabetes','Nov 1, 2018','Oct 31, 2020','Quest - Discovery Stage Research Projects','Closed','Salk Institute for Biological Studies','Embryonic Stem Cell','1637209'),
('CLIN1-10967','Ex Vivo Gene Engineering of Blood Stem Cells for Enhanced Chemotherapy Efficacy in Glioblastoma Patients',NULL,'Brain Cancer, Cancer, Solid Tumors','Aug 1, 2018','Aug 31, 2021','Late Stage Preclinical Projects','Active','City of Hope, Beckman Research Institute','Adult Stem Cell','3684259'),
('CLIN1-11059','MRI Guided Delivery of Neural Progenitor Cells Secreting GDNF for the Treatment of Parkinson\'s disease',NULL,'Neurological Disorders, Parkinson\'s Disease','Aug 1, 2018','Feb 28, 2022','Late Stage Preclinical Projects','Active','University of California, San Francisco','Adult Stem Cell','5811340'),
('CLIN2-10784','A phase I trial of intratumoral administration of CCL21-gene modified dendritic cell (DC) combined with intravenous pembrolizumab for advanced NSCLC','000000040','Cancer, Lung Cancer, Solid Tumors','Jul 1, 2018','Jun 30, 2022','Clinical Trial Stage Projects','Active','University of California, Los Angeles','Adult Stem Cell','10955315'),
('TRAN1-10937','Therapeutic development of Oxy200, an oxysterol with bone anabolic and anti-resorptive properties for intervention in osteoporosis',NULL,'Bone or Cartilage Disease','Aug 1, 2018','Jun 30, 2020','Therapeutic Translational Research Projects','Closed','MAX BioPharma, Inc.','Adult Stem Cell','1400000'),
('TRAN1-10958','Autologous iPSC-derived smooth muscle cell therapy for treatment of urinary incontinence',NULL,'Bladder or Urinary Tract Disorder, Incontinence, Skeletal/Smooth Muscle disorders','Sep 1, 2018','Aug 31, 2022','Therapeutic Translational Research Projects','Active','Stanford University','iPS Cell','5977155'),
('TRAN1-10995','Morphological and functional integration of stem cell derived retina organoid sheets into degenerating retina models',NULL,'Retinitis Pigmentosa, Vision Loss','Sep 1, 2018','Nov 30, 2021','Therapeutic Translational Research Projects','Active','University of California, Irvine','Embryonic Stem Cell','4769039'),
('TRAN2-10990-A','Development of a Noninvasive Prenatal Test for Beta-Hemoglobinopathies for Earlier Stem Cell Therapeutic Interventions',NULL,'Beta Thalassemia, Blood Disorders, Sickle Cell Disease','Sep 1, 2018','Dec 31, 2020','Diagnostic Translational Research Projects','Closed','Children\'s Hospital of Oakland Research Institute','Adult Stem Cell','1088592'),
('TRAN2-10990-B','Development of a Noninvasive Prenatal Test for Beta-Hemoglobinopathies for Earlier Stem Cell Therapeutic Interventions',NULL,'Beta Thalassemia, Blood Disorders, Sickle Cell Disease','Jan 1, 2021','Mar 31, 2022','Diagnostic Translational Research Projects','Active','University of California, San Francisco','Adult Stem Cell','633014'),
('CLIN2-10830','Gene Transfer for Artemis-Deficient Severe Combined Immunodeficiency Using a Lentiviral Vector to Transduce Autologous CD34 Hematopoietic Stem Cells','000000054','Blood Disorders, Severe Combined Immunodeficiency, Artemis deficient (ART-SCID)','Jun 1, 2018','Jun 30, 2023','Clinical Trial Stage Projects','Active','University of California, San Francisco','Adult Stem Cell','12000000'),
('CLIN2-10846','Phase 1 Study of CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells in Adults with Recurrent or Refractory B Cell Malignancies','000000005','B cell cancers, Blood Cancer, Cancer, Leukemia','Jun 1, 2018','May 31, 2022','Clinical Trial Stage Projects','Active','Stanford University','Adult Stem Cell','11034982'),
('CLIN2-11031','A Phase 1/2 Study to Assess the Safety, Tolerability, and Efficacy of ST-400 Autologous HSPC Transplant in Transfusion-dependent β-Thalassemia','000000007','Beta Thalassemia, Blood Disorders','Jun 1, 2018','Dec 31, 2022','Clinical Trial Stage Projects','Active','Sangamo BioSciences, Inc.','Adult Stem Cell','8000000'),
('CLIN1-10893','IND enabling development of FT516: A Natural Killer Cell Immunotherapy for Cancer Derived from a Human Inducible Pluripotent Stem Cell',NULL,'Cancer, Solid Tumors','Apr 1, 2018','Aug 24, 2020','Late Stage Preclinical Projects','Closed','Fate Therapeutics, Inc.','iPS Cell','4000000'),
('CLIN2-10847','Treatment of sickle cell disease by induction of  mixed chimerism and immune tolerance using CD4+ T-depleted haploidentical blood stem cell transplant','000000058','Blood Disorders, Sickle Cell Disease','Apr 1, 2018','Apr 30, 2022','Clinical Trial Stage Projects','Active','City of Hope, Beckman Research Institute','Adult Stem Cell','5742180'),
('CLIN2-10411','Cellular Immunotherapy for Induction of Immune Tolerance in HLA Matched Living Donor Kidney Transplant Recipients','000000032','Kidney Disease, Kidney Failure','Mar 1, 2018','Dec 31, 2022','Clinical Trial Stage Projects','Active','Medeor Therapeutics, Inc.','Adult Stem Cell','11217155'),
('EDUC1-10779','Stem Cells for Huntington’s Disease (HD) International (SC4HDI) Conference',NULL,'','Feb 1, 2018','Dec 31, 2018','Conference II','Closed','University of California, Irvine','','31727'),
('EDUC1-10842','iPSCs: A Decade of Progress and Beyond',NULL,'','Feb 1, 2018','Apr 30, 2018','Conference II','Closed','Keystone Symposia on Molecular and Cellular Biology','','35000'),
('EDUC1-10860','“Myelin Through the Ages: Evolution, Development, Degeneration and Disease” - 2018 Gordon Research Conference (GRC) and Gordon Research Seminar (GRS)',NULL,'Neurological Disorders','Feb 1, 2018','Apr 30, 2018','Conference II','Closed','University of California, San Francisco','','10000'),
('EDUC1-10873','ISSCR 2019 Nucleus Forum',NULL,'','Oct 1, 2018','Mar 31, 2019','Conference II','Closed','International Society for Stem Cell Research','','24000'),
('EDUC1-10883','ISSCR 2019',NULL,'','Oct 1, 2018','Aug 31, 2019','Conference II','Closed','International Society for Stem Cell Research','','50000'),
('EDUC1-10884','2018 Stanford Drug Discovery and Stem Cell Technology Conference',NULL,'','Feb 1, 2018','May 31, 2018','Conference II','Closed','Stanford University','','15000'),
('EDUC1-10903','19th Annual UC System-wide Bioengineering Symposium',NULL,'','Jun 1, 2018','Aug 31, 2018','Conference II','Closed','University of California, Riverside','','14536'),
('EDUC1.8-10913','Delivery of Stem Cell Therapeutics to Patients',NULL,'','Feb 1, 2018','Jun 30, 2018','Conference - The 2018 Alpha Stem Cell Clinic Annual Symposium','Closed','University of California, Los Angeles','','60000'),
('DISC2-10714','iPS Glial Therapy for White Matter Stroke and Vascular Dementia',NULL,'Neurological Disorders, Stroke','Apr 1, 2018','Mar 31, 2020','Quest - Discovery Stage Research Projects','Closed','University of California, Los Angeles','iPS Cell','2096095'),
('DISC2-10747','Targeting Cancer Stem Cells in Hematologic Malignancies',NULL,'Acute Myeloid Leukemia, Blood Cancer, Cancer','Apr 1, 2018','Sep 30, 2020','Quest - Discovery Stage Research Projects','Closed','University of California, San Diego','Cancer Stem Cell','1960560'),
('DISC2-10748','Engineering Lifelong Cellular Immunity to HIV',NULL,'HIV/AIDS, Infectious Disease','Apr 1, 2018','Sep 30, 2020','Quest - Discovery Stage Research Projects','Closed','University of California, Los Angeles','Adult Stem Cell','1701178'),
('DISC2-10751','Silicon Nanopore Membrane encapsulated enriched-Beta Clusters for Type 1 Diabetes treatment',NULL,'Diabetes, Metabolic Disorders, Type 1 diabetes','Apr 1, 2018','Mar 31, 2020','Quest - Discovery Stage Research Projects','Closed','University of California, San Francisco','Embryonic Stem Cell','1113000'),
('DISC2-10753','Generation and in vitro profiling of neural stem cell lines to predict in vivo efficacy for chronic cervical spinal cord injury.',NULL,'Neurological Disorders, Spinal Cord Injury','Apr 1, 2018','Sep 30, 2020','Quest - Discovery Stage Research Projects','Closed','University of California, Irvine','Adult Stem Cell','1575613'),
('DISC2-10524','Genome Editing of Sinusoidal Endothelial Stem Cells for Permanent Correction of Hemophilia A',NULL,'Blood Disorders, Hemophilia A','Apr 1, 2018','Sep 30, 2021','Quest - Discovery Stage Research Projects','Active','City of Hope, Beckman Research Institute','Adult Stem Cell','2182193'),
('DISC2-10525','Development of a Cellular Therapeutic for Treatment of Epilepsy',NULL,'Epilepsy, Neurological Disorders','Mar 1, 2018','Jun 30, 2019','Quest - Discovery Stage Research Projects','Closed','Neurona Therapeutics','Embryonic Stem Cell','1616536'),
('DISC2-10559','Development of immune invisible beta cells as a cell therapy for type 1 diabetes through genetic modification of hESCs',NULL,'Diabetes, Metabolic Disorders, Type 1 diabetes','Apr 1, 2018','Sep 30, 2020','Quest - Discovery Stage Research Projects','Closed','University of California, San Diego','Embryonic Stem Cell','1924791'),
('DISC2-10591','Preclinical development of an immune evasive islet cell replacement therapy for type 1 diabetes',NULL,'Diabetes, Metabolic Disorders, Type 1 diabetes','Apr 1, 2018','Mar 31, 2020','Quest - Discovery Stage Research Projects','Closed','ViaCyte, Inc.','Embryonic Stem Cell','1470987'),
('DISC2-10604','Stimulating endogenous muscle stem cells to counter muscle atrophy',NULL,'Skeletal/Smooth Muscle disorders','Mar 1, 2018','Aug 31, 2020','Quest - Discovery Stage Research Projects','Closed','Stanford University','Adult Stem Cell','2198687'),
('DISC2-10665','Neural Stem Cell Relays for Severe Spinal Cord Injury',NULL,'Neurological Disorders, Spinal Cord Injury','Apr 1, 2018','Oct 31, 2019','Quest - Discovery Stage Research Projects','Closed','University of California, San Diego','Embryonic Stem Cell','1638900'),
('DISC2-10679','Towards hepatocyte cell replacement therapy: developing a renewable source of human hepatocytes from pluripotent stem cells',NULL,'Liver Disease, Metabolic Disorders','Apr 1, 2018','Sep 30, 2020','Quest - Discovery Stage Research Projects','Closed','Stanford University','Embryonic Stem Cell','1968456'),
('DISC2-10695','Identification and Generation of Long Term Repopulating Human Muscle Stem Cells from Human Pluripotent Stem Cells',NULL,'Muscular Dystrophy, Skeletal/Smooth Muscle disorders','Apr 1, 2018','Sep 30, 2020','Quest - Discovery Stage Research Projects','Closed','University of California, Los Angeles','Embryonic Stem Cell, iPS Cell','2148519'),
('DISC1-10588','Targeting cancer stem cells with nanoparticle RNAi delivery to prevent recurrence and metastasis of ovarian cancer',NULL,'Cancer, Ovarian Cancer, Solid Tumors','Mar 1, 2018','Feb 29, 2020','Inception - Discovery Stage Research Projects','Closed','Loma Linda University','Cancer Stem Cell','172870'),
('DISC1-10598','Enhanced Branching Morphogenesis and Pluripotent Cell Lineage Differentiation for Pediatric Regenerative Therapies',NULL,'Kidney Disease','Feb 1, 2018','Jan 31, 2019','Inception - Discovery Stage Research Projects','Closed','University of California, Davis','iPS Cell','235800'),
('DISC1-10603','iPSC-Derived Smooth Muscle Progenitors for Treatment of Abdominal Aortic Aneurysm',NULL,'Vascular Disease','Apr 1, 2018','Dec 31, 2020','Inception - Discovery Stage Research Projects','Closed','Palo Alto Veterans Institute for Research','iPS Cell','172621'),
('DISC1-10620','Bone Marrow Targeting of Hematopoietic Stem Cells Engineered to Overexpress 25-OH-VD3 1-α-hydroxylase for Acute Myeloid Leukemia Therapy',NULL,'Acute Myeloid Leukemia, Blood Cancer, Cancer','Apr 1, 2018','Mar 31, 2019','Inception - Discovery Stage Research Projects','Closed','Loma Linda University','Adult Stem Cell','178967'),
('DISC1-10643','IVD rejuvenation using iPSC-derived notochordal cells',NULL,'Bone or Cartilage Disease','Feb 1, 2018','Oct 31, 2019','Inception - Discovery Stage Research Projects','Closed','Cedars-Sinai Medical Center','iPS Cell','241992'),
('DISC1-10674','A new phenotypic screening platform that identifies biologically-relevant targets and lead compounds for the treatment of Parkinson’s disease',NULL,'Neurological Disorders, Parkinson\'s Disease','Feb 1, 2018','Jan 31, 2019','Inception - Discovery Stage Research Projects','Closed','Zenobia Therapeutics','iPS Cell','112500'),
('DISC1-10718','Gingival mesenchymal stem cells as a novel treatment modality for periodontal tissue regeneration',NULL,'Bone or Cartilage Disease','Apr 1, 2018','Mar 31, 2020','Inception - Discovery Stage Research Projects','Closed','University of California, Los Angeles','Adult Stem Cell','194483'),
('TRAN1-10416','DEBCT: Genetically Corrected, Induced Pluripotent Cell-Derived Epithelial Sheets for Definitive Treatment of Dystrophic Epidermolysis Bullosa',NULL,'Epidermolysis Bullosa, Skin Disease','Mar 1, 2018','Aug 31, 2021','Therapeutic Translational Research Projects','Active','Stanford University','iPS Cell','5107353'),
('DISC1-10721','An IPSC cell based model of macular degeneration for drug discovery.',NULL,'Age-related macular degeneration, Vision Loss','Apr 1, 2018','Mar 31, 2020','Inception - Discovery Stage Research Projects','Closed','University of California, San Diego','iPS Cell','232200'),
('TRAN1-10540','A Splicing Modulator Targeting Cancer Stem Cells in Acute Myeloid Leukemia',NULL,'Acute Myeloid Leukemia, Blood Cancer, Cancer','Mar 1, 2018','Nov 30, 2020','Therapeutic Translational Research Projects','Active','University of California, San Diego','Cancer Stem Cell','2511767'),
('TRAN1-10587','Human Embryonic Stem Cell-Derived Natural Killer Cells for Cancer Treatment',NULL,'Acute Myeloid Leukemia, Blood Cancer, Cancer','Mar 1, 2018','Aug 31, 2021','Therapeutic Translational Research Projects','Active','University of California, San Diego','Embryonic Stem Cell','4698821'),
('DISC1-10475','Generation of human airway stem cells by direct transcriptional reprogramming for disease modeling and regeneration',NULL,'Respiratory Disorders','Apr 1, 2018','Mar 31, 2020','Inception - Discovery Stage Research Projects','Closed','University of California, San Francisco','Directly Reprogrammed Cell','238408'),
('DISC1-10513','Novel metabolic labeling method for tracking stem cells to irradiated salivary glands using PET',NULL,'Other','Apr 1, 2018','Mar 31, 2019','Inception - Discovery Stage Research Projects','Closed','Stanford University','Adult Stem Cell','229227'),
('DISC1-10516','Development of treatments to improve healing of ischemic wounds',NULL,'Vascular Disease','Apr 1, 2018','Mar 31, 2019','Inception - Discovery Stage Research Projects','Closed','University of California, Davis','Adult Stem Cell','235099'),
('DISC1-10522','Identification of antigenic neo-epitopes from in vitro reprogrammed human tissue precursors for regenerative therapy',NULL,'Other','Apr 1, 2018','Mar 31, 2019','Inception - Discovery Stage Research Projects','Closed','University of California, San Diego','Embryonic Stem Cell, iPS Cell','193500'),
('DISC1-10555','Optimizing self-renewal signaling kinetics to stabilize ex vivo hematopoietic stem cell expansion',NULL,'Blood Disorders','Apr 1, 2018','Jun 30, 2019','Inception - Discovery Stage Research Projects','Closed','Stanford University','Adult Stem Cell','210906'),
('DISC1-10583','Human Pancreatic Cancer Stem Cells: Developing a Novel Drug for Cancer Eradication',NULL,'Cancer, Pancreatic Cancer, Solid Tumors','Mar 1, 2018','Feb 28, 2019','Inception - Discovery Stage Research Projects','Closed','Human BioMolecular Research Institute','Cancer Stem Cell','303785'),
('CLIN2-10388','Evaluation of the Safety and Tolerability of KA34 in a Phase 1, Double-Blind, Dose Escalation Trial in Patients with Knee Osteoarthritis','000000044','Arthritis, Bone or Cartilage Disease, Osteoarthritis','Dec 1, 2017','Nov 25, 2020','Clinical Trial Stage Projects','Closed','Calibr','Adult Stem Cell','8447523'),
('CLIN2-10392','Antiviral Cellular Therapy for Enhancing T-cell Reconstitution Before or After Hematopoietic Stem Cell Transplantation (ACES)','000000010','Blood Cancer, Blood Disorders, Bone Marrow Transplant and Viral Infection, Cancer','Dec 1, 2017','Nov 30, 2022','Clinical Trial Stage Projects','Active','Children\'s Hospital of Los Angeles','Adult Stem Cell','4825587'),
('CLIN2-10395','Clinical Study of T stem cell memory (Tscm)-based CAR-T cells in Patients with Multiple Myeloma','000000043','Blood Cancer, Cancer, Multiple Myeloma','Dec 1, 2017','Dec 31, 2021','Clinical Trial Stage Projects','Active','Poseida Therapeutics, Inc.','Adult Stem Cell','19813407'),
('EDUC1.5-10834','The 2018 SPARK Annual Meeting',NULL,'','Jan 1, 2018','Sep 30, 2018','Conference - Manage The SPARK Annual Meeting','Closed','University of California, Davis','','39559'),
('EDUC1.4-10812','2018 and 2019 Bridges Annual Meeting',NULL,'','Dec 1, 2017','Nov 30, 2019','Conference - Manage The Bridges Annual Meeting','Closed','Cal State Univ, San Marcos','','291622'),
('EDUC1-10771','Living with and Curing RUNX1 FPD/AML Forum',NULL,'','Sep 1, 2018','Nov 30, 2018','Conference II','Closed','RUNX1 Research Program','','9500'),
('EDUC1-10795','2017 World Alliance Forum in San Francisco (WAFSF) \"Healthcare Game Changers\"',NULL,'','Nov 1, 2017','Jan 31, 2018','Conference II','Closed','Alliance Forum Foundation','','5000'),
('INFR4-10361-B','University of California, San Francisco (UCSF) CIRM Alpha Stem Cell Clinic',NULL,'Multiple Indications (Alpha Clinics)','Oct 1, 2019','Nov 30, 2021','Alpha Stem Cell Clinics Network Expansion','Active','University of California, San Francisco','','5707388'),
('CLIN1-10084','Genome Editing of Autologous Hematopoietic Stem Cells to Treat Sickle Cell Disease',NULL,'Blood Disorders, Sickle Cell Disease','Nov 1, 2017','Sep 30, 2020','Late Stage Preclinical Projects','Closed','Stanford University','Adult Stem Cell','4849363'),
('CLIN2-09574','A Phase 2 Open-Label, Multi-Center, Randomized, Controlled, Optimal Dose-Finding Study of DCC-UCB in Adults Receiving High Dose Chemotherapy for AML','000000038','Acute Myeloid Leukemia, Blood Cancer, Cancer','Nov 1, 2017','Apr 1, 2019','Clinical Trial Stage Projects','Closed','Nohla Therapeutics Inc','Adult Stem Cell','4310000'),
('CLIN2-09672','Clinical trial of directly vascularized islet cell replacement therapy for high-risk type 1 diabetes','000000069','Diabetes, Metabolic Disorders, Type 1 diabetes','Dec 1, 2017','Nov 30, 2023','Clinical Trial Stage Projects','Active','ViaCyte, Inc.','Embryonic Stem Cell','19752463'),
('CLIN2-09688','A Phase 3 Study Comparing the Utility of Human Acellular Vessels  to Arteriovenous Fistula in Subjects with End-Stage Renal Disease (California Sites)','000000031','Kidney Disease, Kidney Failure','Nov 1, 2017','Jul 13, 2020','Clinical Trial Stage Projects','Closed','Humacyte, Inc.','Adult Stem Cell','3525000'),
('CLIN2-10248','Phase I Study of Chimeric Antigen Receptor Engineered Central Memory T cells for the Treatment of Malignant Glioma','000000014','Brain Cancer, Cancer, Solid Tumors','Nov 1, 2017','Nov 30, 2021','Clinical Trial Stage Projects','Active','City of Hope, Beckman Research Institute','Adult Stem Cell','12753854'),
('INFR4-10314','Alpha Stem Cell Clinic for Northern and Central California',NULL,'Multiple Indications (Alpha Clinics)','Dec 1, 2017','Nov 30, 2021','Alpha Stem Cell Clinics Network Expansion','Active','University of California, Davis','','7905671'),
('INFR4-10361-A','University of California, San Francisco (UCSF) CIRM Alpha Stem Cell Clinic',NULL,'Multiple Indications (Alpha Clinics)','Dec 1, 2017','Sep 30, 2019','Alpha Stem Cell Clinics Network Expansion','Closed','Children\'s Hospital of Oakland Research Institute','','2292611'),
('CLIN2-10386','AB-110-001 Phase 1b Trial and Related Activities to Support Clinical Development of AB-110','000000008','Blood Cancer, Cancer','Oct 1, 2017','Dec 31, 2021','Clinical Trial Stage Projects','Active','Angiocrine Bioscience, Inc.','Adult Stem Cell','5000000'),
('CLIN2-10192','A Phase 1b/2a Study of the ROR1-Targeting Monoclonal Antibody, Cirmtuzumab, and the Bruton Tyrosine Kinase Inhibitor, Ibrutinib, in B-Cell Cancers','000000006','B cell cancers, Blood Cancer, Cancer, Leukemia','Oct 1, 2017','Mar 31, 2022','Clinical Trial Stage Projects','Active','University of California, San Diego','Cancer Stem Cell','18292674'),
('EDUC1.7-10742','Basis of Standardization for Cell Therapies',NULL,'','Oct 1, 2017','Jun 30, 2018','Conference - Manage a Symposium on Pluripotent Stem Cell Manufacturing','Closed','International Alliance for Biological Standardization','','100000'),
('TRAN1-10258','Development of ROR1 CAR-T cells to target cancer stem cells in advanced malignancies',NULL,'Blood Cancer, Cancer, Leukemia','Oct 1, 2017','Feb 2, 2021','Therapeutic Translational Research Projects','Active','University of California, San Diego','Cancer Stem Cell','5751079'),
('CLIN2-09894','A Phase 3, Randomized, Placebo-controlled Multicenter Study to Evaluate Efficacy & Safety of Repeated Administrations of NurOwn® in Patients with ALS','000000003','Amyotrophic Lateral Sclerosis, Neurological Disorders','Aug 1, 2017','Jul 31, 2021','Clinical Trial Stage Projects','Active','BrainStorm Cell Therapeutics','Adult Stem Cell','15912390'),
('EDUC1-10227','JDRF Encapsulation Consortium Fall 2017 Meeting',NULL,'Diabetes, Metabolic Disorders, Type 1 diabetes','Sep 1, 2017','Nov 30, 2017','Conference II','Closed','JDRF International','','42425'),
('DISC2-10088','Preclinical development of AAV vector-mediated in vivo hepatic reprogramming of myofibroblasts as a therapy for liver fibrosis',NULL,'Liver Disease, Metabolic Disorders','Nov 1, 2017','Apr 30, 2020','Quest - Discovery Stage Research Projects','Closed','University of California, San Francisco','Directly Reprogrammed Cell','1638389'),
('CLIN2-10344','A Double-Blind, Controlled Ph 2b Study of the Safety and Efficacy of Modified Stem Cells in Patients with Chronic Motor Deficit from Ischemic Stroke','000000065','Neurological Disorders, Stroke','Aug 1, 2017','Oct 31, 2020','Clinical Trial Stage Projects','Closed','SanBio, Inc.','Adult Stem Cell','18970000'),
('DISC2-10090','Human Cardiac Chip for Assessment of Proarrhythmic Risk',NULL,'Heart Disease, Toxicity','Nov 1, 2017','Apr 30, 2020','Quest - Discovery Stage Research Projects','Closed','University of California, Berkeley','iPS Cell','899581'),
('CLIN2-09183','In Utero Hematopoietic Stem Cell Transplantation For The Treatment Of Fetuses With Alpha Thalassemia Major','000000002','Alpha Thalassemia Major, Blood Disorders','Aug 1, 2017','Jul 31, 2022','Clinical Trial Stage Projects','Active','University of California, San Francisco','Adult Stem Cell','10906978'),
('DISC2-10107-A','A Novel Approach to Eradicate Cancer Stem Cells',NULL,'Cancer, Colon Cancer, Solid Tumors','Nov 1, 2017','Dec 31, 2019','Quest - Discovery Stage Research Projects','Closed','City of Hope, Beckman Research Institute','Cancer Stem Cell','1539935'),
('DISC2-10107-B','A Novel Approach to Eradicate Cancer Stem Cells',NULL,'Cancer, Colon Cancer, Solid Tumors','Jan 1, 2020','Jan 31, 2021','Quest - Discovery Stage Research Projects','Active','University of California, San Diego','Cancer Stem Cell','279977'),
('DISC2-10110','Multipotent Cardiovascular Progenitor Regeneration of the Myocardium after MI',NULL,'Heart Disease','Oct 1, 2017','Jun 30, 2020','Quest - Discovery Stage Research Projects','Closed','Stanford University','iPS Cell','1809234'),
('DISC2-10120','Microenvironment for hiPSC-derived pacemaking cardiomyocytes',NULL,'Heart Disease','Nov 1, 2017','Oct 31, 2020','Quest - Discovery Stage Research Projects','Closed','University of California, Davis','iPS Cell','2042438'),
('DISC2-10124','Targeted Gene Editing in the Treatment of X-Linked Hyper-IgM Syndrome',NULL,'Blood Disorders, Hyper IgM Syndrome','Oct 1, 2017','Mar 31, 2020','Quest - Discovery Stage Research Projects','Closed','University of California, Los Angeles','Adult Stem Cell','1512333'),
('DISC2-10129','Non-Toxic, Highly-Effective Bioinspired Cryoprotectants for On-Demand Stem Cell Therapies',NULL,'Other','Nov 1, 2017','Apr 30, 2020','Quest - Discovery Stage Research Projects','Closed','X-Therma Inc.','Embryonic Stem Cell, iPS Cell','887883'),
('DISC2-10134','Platform Technology for Pluripotent Stem Cell-Derived T cell Immunotherapy',NULL,'Cancer','Oct 1, 2017','Sep 30, 2019','Quest - Discovery Stage Research Projects','Closed','University of California, Los Angeles','Embryonic Stem Cell','965636'),
('DISC2-10182','Discovery of therapeutics for Huntington’s Disease',NULL,'Huntington\'s Disease, Neurological Disorders','Nov 1, 2017','Oct 31, 2019','Quest - Discovery Stage Research Projects','Closed','Rumi Scientific CA','Embryonic Stem Cell','1399800'),
('DISC2-10188','Immunization strategies to prevent Zika viral congenital eye and brain disease',NULL,'Infectious Disease, Neurological Disorders, Zika virus','Nov 1, 2017','Jul 31, 2020','Quest - Discovery Stage Research Projects','Closed','University of California, Los Angeles','Adult Stem Cell, iPS Cell','2128867'),
('DISC2-10195','Identification and characterization of the optimal human neural stem cell line (hNSC) for the treatment of traumatic brain injury (TBI) 2.0.',NULL,'Neurological Disorders, Traumatic Brain Injury','Oct 1, 2017','Mar 31, 2020','Quest - Discovery Stage Research Projects','Closed','University of California, Irvine','Embryonic Stem Cell','1671213'),
('DISC2-10061','Lgr5-mediated self-renewal in B cell selection and leukemia-initiation',NULL,'B cell cancers, Blood Cancer, Cancer, Leukemia','Nov 1, 2017','Oct 31, 2019','Quest - Discovery Stage Research Projects','Closed','City of Hope, Beckman Research Institute','Cancer Stem Cell','2186520'),
('CLIN1-09433','Intraparenchymal NR1 Stem Cell Therapy for Chronic Subcortical Ischemic Stroke',NULL,'Neurological Disorders, Stroke','Aug 1, 2017','Jan 26, 2021','Late Stage Preclinical Projects','Closed','Stanford University','Embryonic Stem Cell','5300000'),
('DISC2-10067','A tool for rapid development of clinical-grade protocols for dopaminergic neuronal differentiation of Parkinson’s Disease patient-derived iPSCs',NULL,'Neurological Disorders, Parkinson\'s Disease','Sep 1, 2017','May 31, 2019','Quest - Discovery Stage Research Projects','Closed','Scaled Biolabs Inc.','iPS Cell','657528'),
('CLIN1-09776','Development of CLT030-ADC, a Leukemic Stem Cell Targeting Antibody-Drug-Conjugate, for Treatment of Acute Myeloid Leukemia',NULL,'Acute Myeloid Leukemia, Blood Cancer, Cancer','Aug 1, 2017','Dec 31, 2019','Late Stage Preclinical Projects','Closed','Cellerant Therapeutics, Inc.','Cancer Stem Cell','6863755'),
('DISC1-09912','A Novel Tissue Engineering Technique to Repair Degenerated Retina',NULL,'Vision Loss','Sep 1, 2017','Aug 31, 2018','Inception - Discovery Stage Research Projects','Closed','University of Southern California','Embryonic Stem Cell','215133'),
('DISC1-09984','Hypo-immunogenic cardiac patches for myocardial regeneration',NULL,'Heart Disease','Oct 1, 2017','Sep 30, 2018','Inception - Discovery Stage Research Projects','Closed','University of California, San Francisco','iPS Cell','235818'),
('DISC1-09999','Generation of expandable, self-renewing muscle stem cells for Duchenne Muscular Dystrophy',NULL,'Muscular Dystrophy, Skeletal/Smooth Muscle disorders','Jul 1, 2017','Jun 30, 2019','Inception - Discovery Stage Research Projects','Closed','Sanford Burnham Prebys Medical Discovery Institute','Embryonic Stem Cell, iPS Cell','252000'),
('DISC1-10036','Prodrug innovation to target muscle stem cells and enhance muscle regeneration',NULL,'Skeletal/Smooth Muscle disorders','Oct 1, 2017','Sep 30, 2019','Inception - Discovery Stage Research Projects','Closed','Stanford University','Adult Stem Cell','235834'),
('DISC1-10074','Reprogramming human stem cells for blood cell generation',NULL,'Blood Disorders','Jul 1, 2017','Jun 30, 2018','Inception - Discovery Stage Research Projects','Closed','University of California, San Diego','Adult Stem Cell','210060'),
('DISC1-10079','An exosome-based translational strategy to mitigate Alzheimer’s disease neuropathology',NULL,'Alzheimer\'s Disease, Neurological Disorders','Oct 1, 2017','Sep 30, 2018','Inception - Discovery Stage Research Projects','Closed','University of California, Irvine','Embryonic Stem Cell','157650'),
('EDUC1-10141','15th International Cord Blood Sympsium',NULL,'Blood Disorders','May 1, 2017','Jul 31, 2017','Conference II','Closed','American Association of Blood Banks','','30000'),
('EDUC1-10224','Third International Workshop on Clinical Tolerance',NULL,'','Aug 1, 2017','Oct 31, 2017','Conference II','Closed','Stanford University','','29500'),
('EDUC1-10240','The 18th Annual UC System-Wide Bioengineering Symposium',NULL,'','Jun 1, 2017','Aug 31, 2017','Conference II','Closed','University of California, Los Angeles','','25000'),
('TRAN1-09814','Injectable pro-regenerative scaffold for treating symptomatic peripheral artery disease',NULL,'Vascular Disease','Jul 1, 2017','Oct 31, 2021','Therapeutic Translational Research Projects','Active','University of California, San Diego','Adult Stem Cell','2839317'),
('TRAN4-09884','A Novel, Robust and Comprehensive Predictive Tool Using Human Disease-Specific Induced Pluripotent Stem Cells for Preclinical Drug Screening',NULL,'Heart Disease, Toxicity','Jul 1, 2017','Aug 31, 2019','Tool Translational Research Projects','Closed','Stanford University','iPS Cell','975000'),
('CLIN1-09472','Allogenic human adipose-derived mesenchymal stem cells for the treatment of knee osteoarthritis',NULL,'Bone or Cartilage Disease, Osteoarthritis','Mar 1, 2017','Mar 14, 2018','Late Stage Preclinical Projects','Closed','Cellular Biomedicine Group, Inc.','Adult Stem Cell','1200000'),
('CLIN2-09730','Phase 2 Safety and Efficacy Study of CLBS03 Autologous T-Regulatory Cells in Adolescents with Recent Onset Type 1 Diabetes Mellitus','000000066','Diabetes, Metabolic Disorders, Type 1 diabetes','Apr 1, 2017','Jun 19, 2020','Clinical Trial Stage Projects','Closed','Caladrius Biosciences','Adult Stem Cell','8175946'),
('CLIN2-09284','Human Neural Progenitors Secreting Glial Cell Line-Derived Neurotrophic Factor (CNS10-NPC-GDNF) for the Treatment of Amyotrophic Lateral Sclerosis','000000004','Amyotrophic Lateral Sclerosis, Neurological Disorders','Apr 1, 2017','Jul 31, 2021','Clinical Trial Stage Projects','Active','Cedars-Sinai Medical Center','Adult Stem Cell','6154067'),
('CLIN2-09504','Lentiviral Gene Therapy for Infants with X-linked Severe Combined Immunodeficiency using Autologous Bone Marrow Stem Cells and Busulfan Conditioning','000000055','Blood Disorders, Immune Disease, Severe Combined Immunodeficiency, X-linked (X-SCID)','Apr 1, 2017','Mar 31, 2022','Clinical Trial Stage Projects','Active','St. Jude Children\'s Research Hospital','Adult Stem Cell','11924780'),
('EDUC1-09947','2017 Stanford Drug Discovery and Stem Cell Technology Conference',NULL,'','Apr 1, 2017','Jun 30, 2017','Conference II','Closed','Stanford University','','2359'),
('EDUC1.6-09695','2nd Annual Symposium of the CIRM Alpha Stem Cell Clinics Network \"Alpha Clinics - Making the Future a Reality for Stem Cell-Based Therapies\"',NULL,'','Feb 1, 2017','Apr 30, 2017','Conference - The 2017 Alpha Stem Cell Clinic Annual Symposium','Closed','City of Hope, Beckman Research Institute','','79287'),
('DISC2-09526','GENE EDITING FOR FOXP3 IN HUMAN HSC',NULL,'Blood Disorders, Immune Disease, IPEX Syndrome','May 1, 2017','Oct 31, 2019','Quest - Discovery Stage Research Projects','Closed','Stanford University','Adult Stem Cell','984228'),
('DISC2-09559','Thin Film Encapsulation Devices for Human Stem Cell derived Insulin Producing Cells',NULL,'Diabetes, Metabolic Disorders, Type 1 diabetes','Jun 1, 2017','May 31, 2019','Quest - Discovery Stage Research Projects','Closed','University of California, San Francisco','Embryonic Stem Cell','1092063'),
('DISC2-09565','Preclinical development of human hepatocyte progenitor cells for cell therapy',NULL,'Liver Disease, Metabolic Disorders','Jun 1, 2017','May 31, 2019','Quest - Discovery Stage Research Projects','Closed','Stanford University','Adult Stem Cell','1651211'),
('DISC2-09569','hNSC-mediated delivery of ApiCCT1 as a candidate therapeutic for Huntington’s disease',NULL,'Huntington\'s Disease, Neurological Disorders','Jun 1, 2017','Nov 30, 2019','Quest - Discovery Stage Research Projects','Closed','University of California, Irvine','Embryonic Stem Cell','1650263'),
('DISC2-09596','Direct Cardiac Reprogramming for Regenerative Medicine',NULL,'Heart Disease','Jun 1, 2017','May 31, 2019','Quest - Discovery Stage Research Projects','Closed','Gladstone Institutes, J. David','Directly Reprogrammed Cell','2392157'),
('DISC2-09610','CRISPR/dCas9 mutant targeting SNCA promoter for downregulation of alpha-synuclein expression as a novel therapeutic approach for Parkinson’s disease',NULL,'Neurological Disorders, Parkinson\'s Disease','Jun 1, 2017','Dec 12, 2018','Quest - Discovery Stage Research Projects','Closed','Parkinson\'s Institute','iPS Cell','1288415'),
('DISC2-09615','Targeted off-the-shelf immunotherapy to treat refractory cancers',NULL,'Blood Cancer, Cancer, Ovarian Cancer, Solid Tumors','May 1, 2017','Oct 31, 2019','Quest - Discovery Stage Research Projects','Closed','University of California, San Diego','Embryonic Stem Cell, iPS Cell','1936936'),
('DISC2-09624','Protein tyrosine phosphatase - sigma inhibitors for hematopoietic regeneration',NULL,'Blood Cancer, Blood Disorders, Cancer','Jun 1, 2017','May 31, 2019','Quest - Discovery Stage Research Projects','Closed','University of California, Los Angeles','Adult Stem Cell','2116708'),
('DISC2-09635','Designing a cellular niche for transplantation of human embryonic stem cell-derived beta cells',NULL,'Diabetes, Metabolic Disorders','May 1, 2017','Aug 31, 2019','Quest - Discovery Stage Research Projects','Closed','University of California, San Francisco','Embryonic Stem Cell','2006076'),
('DISC2-09637','Genome Editing to Correct Cystic Fibrosis Mutations in Airway Stem Cells',NULL,'Cystic Fibrosis, Respiratory Disorders','May 1, 2017','Oct 31, 2019','Quest - Discovery Stage Research Projects','Closed','Stanford University','Adult Stem Cell','1968456'),
('DISC2-09649','A treatment for Zika virus infection and neuroprotection efficacy',NULL,'Infectious Disease, Neurological Disorders, Zika virus','Apr 1, 2017','Sep 30, 2019','Quest - Discovery Stage Research Projects','Closed','University of California, San Diego','iPS Cell','1924524'),
('CLIN2-09698','Phase 2b Clinical Study of Safety and Efficacy of Intravitreal Injection of Retinal Progenitor Cells (jCell)  for Treatment of Retinitis Pigmentosa','000000050','Retinitis Pigmentosa, Vision Loss','Feb 1, 2017','Jul 31, 2021','Clinical Trial Stage Projects','Active','jCyte, Inc','Other','8295750'),
('CLIN2-09439','Induction of Tolerance to Combined Kidney and Hematopoietic Progenitor Cell Transplants from HLA Haplotype Matched Living Donors','000000034','Kidney Disease, Kidney Failure','Feb 1, 2017','Dec 31, 2021','Clinical Trial Stage Projects','Active','Stanford University','Adult Stem Cell','6653266'),
('TRAN1-09292-B','Curing Sickle cell Disease with CRISPR-Cas9 genome editing',NULL,'Blood Disorders, Sickle Cell Disease','Jan 1, 2020','Dec 31, 2020','Therapeutic Translational Research Projects','Closed','University of California, San Francisco','Adult Stem Cell','60635'),
('TRAN1-09270','An autologous somatic stem cell therapy for the treatment of osteonecrosis',NULL,'Bone or Cartilage Disease, Osteonecrosis','Mar 1, 2017','Nov 30, 2018','Therapeutic Translational Research Projects','Closed','Ankasa Regenerative Therapeutics','Adult Stem Cell','2088780'),
('TRAN1-09288','Pluripotent stem cell-derived chondrocytes for articular cartilage repair',NULL,'Bone or Cartilage Disease','Mar 1, 2017','Dec 31, 2019','Therapeutic Translational Research Projects','Closed','University of Southern California','Embryonic Stem Cell','2503104'),
('TRAN1-09292-A','Curing Sickle cell Disease with CRISPR-Cas9 genome editing',NULL,'Blood Disorders, Sickle Cell Disease','Feb 1, 2017','Sep 15, 2019','Therapeutic Translational Research Projects','Closed','Children\'s Hospital of Oakland Research Institute','Adult Stem Cell','4394276'),
('TRAN1-09394','Human iPSC-derived GABAergic Progenitors for Alzheimer’s Disease Treatment',NULL,'Alzheimer\'s Disease, Neurological Disorders','Mar 1, 2017','Sep 30, 2018','Therapeutic Translational Research Projects','Closed','Gladstone Institutes, J. David','iPS Cell','1900000'),
('EDUC1.5-09742','Manage the 2017 SPARK Annual Meeting',NULL,'','Jan 1, 2017','Oct 31, 2017','Conference - Manage The SPARK Annual Meeting','Closed','City of Hope, Beckman Research Institute','','22555'),
('EDUC1-09707','The 7th Annual California ALS research network and PAC10 meeting',NULL,'Amyotrophic Lateral Sclerosis, Neurological Disorders','Dec 1, 2016','Feb 28, 2017','Conference II','Closed','University of Southern California','','10830'),
('CLIN2-09444','Pulmonary Arterial Hypertension Treated with Cardiosphere-Derived Allogeneic Stem Cells','000000047','Heart Disease, Pulmonary Hypertension, Vascular Disease','Jan 1, 2017','May 31, 2022','Clinical Trial Stage Projects','Active','Cedars-Sinai Medical Center','Adult Stem Cell','7354772'),
('CLIN2-09339-B','Efficacy and safety of cryopreserved autologous CD34+ HSC transduced with EFS lentiviral vector encoding for human ADA gene in ADA-SCID subjects',NULL,'Blood Disorders, Genetic Disorder, Immune Disease, Pediatrics, Severe Combined Immunodeficiency, Adenosine deaminase-deficient (ADA-SCID)','Jun 1, 2018','Dec 31, 2022','Clinical Trial Stage Projects','Active','Orchard Therapeutics plc','Adult Stem Cell','8465745'),
('CLIN2-09339-A','Efficacy and safety of cryopreserved autologous CD34+ HSC transduced with EFS lentiviral vector encoding for human ADA gene in ADA-SCID subjects','000000053','Blood Disorders, Genetic Disorder, Immune Disease, Pediatrics, Severe Combined Immunodeficiency, Adenosine deaminase-deficient (ADA-SCID)','Jan 1, 2017','Jun 30, 2018','Clinical Trial Stage Projects','Closed','University of California, Los Angeles','Adult Stem Cell','10156925'),
('EDUC1.4-09623','2017 Bridges Annual Meeting',NULL,'','Dec 1, 2016','Sep 30, 2017','Conference - Manage The Bridges Annual Meeting','Closed','San Diego State University Foundation','','153449'),
('INFR2-09298','A Translating Center designed to expedite the development and delivery of high quality stem cell therapies to patients',NULL,'Multiple Indications (Alpha Clinics)','Dec 1, 2016','Nov 30, 2021','Translating Center','Active','IQVIA, Inc.','','15000000'),
('CLIN1-09230','Ex vivo transduced autologous human CD34+ hematopoietic stem cells for treatment of cystinosis',NULL,'Cystinosis, Genetic Disorder, Metabolic Disorders, Pediatrics','Nov 1, 2016','Nov 15, 2019','Late Stage Preclinical Projects','Closed','University of California, San Diego','Adult Stem Cell','5273189'),
('EDUC1-09545','The 2017 Midwinter Conference of Immunologists at Asilomar',NULL,'','Oct 1, 2016','Feb 28, 2017','Conference II','Closed','Midwinter Conference of Immunologists','','5000'),
('EDUC1-09580','2016 Tissue Engineering and Regenerative Medicine International Society - Americas (TERMIS-AM) Conference in San Diego, CA on December 11-14, 2016',NULL,'','Dec 1, 2016','Feb 28, 2017','Conference II','Closed','University of California, San Diego','','40000'),
('EDUC1-09588','Cellular Therapies and Transfusion Medicine in Trauma and Critical Care - Looking Towards the Future',NULL,'','May 1, 2017','Jul 31, 2017','Conference II','Closed','Vitalant Research Institute','','30000'),
('EDUC1-09475','2016 World Alliance Forum in San Francisco (WAFSF) “US-Japan Innovative Healthcare Technologies Conference”',NULL,'','Nov 1, 2016','Jan 31, 2017','Conference II','Closed','Alliance Forum Foundation','','20000'),
('DISC2-08982','Scalable, Defined Production of Oligodendrocyte Precursor Cells to Treat Neural Disease and Injury',NULL,'Neurological Disorders, Spinal Cord Injury','Nov 1, 2016','Apr 30, 2019','Quest - Discovery Stage Research Projects','Closed','University of California, Berkeley','Embryonic Stem Cell, iPS Cell','1627099'),
('DISC2-09032','MSC delivery of an artificial transcription factor to the brain as a treatment for Angelman Syndrome',NULL,'Autism, Neurological Disorders','Dec 1, 2016','May 31, 2019','Quest - Discovery Stage Research Projects','Closed','University of California, Davis','Adult Stem Cell','1055319'),
('DISC2-09073','Autologous cell therapy for Parkinson’s disease using iPSC-derived DA neurons',NULL,'Neurological Disorders, Parkinson\'s Disease','Dec 1, 2016','Mar 31, 2018','Quest - Discovery Stage Research Projects','Closed','Scripps Research Institute','iPS Cell','2299786'),
('DISC2-09098','Use of Human iPSC-derived Endothelial Cells for Calcific Aortic Valve Disease Therapeutics',NULL,'Heart Disease, Vascular Disease','Dec 1, 2016','Nov 30, 2018','Quest - Discovery Stage Research Projects','Closed','Gladstone Institutes, J. David','iPS Cell','2400048'),
('DISC2-09123','Immunotherapy for HIV infection using engineered hematopoietic stem/progenitor cells',NULL,'HIV/AIDS, Infectious Disease','Oct 1, 2016','Mar 31, 2019','Quest - Discovery Stage Research Projects','Closed','California Institute of Technology','Adult Stem Cell','1569193'),
('CLIN1-08671','Stem cell-derived islet cell replacement therapy with immunosuppression for high-risk type 1 diabetes',NULL,'Diabetes, Metabolic Disorders, Type 1 diabetes','Aug 1, 2016','Sep 30, 2017','Late Stage Preclinical Projects','Closed','ViaCyte, Inc.','Embryonic Stem Cell','3544721'),
('CLIN2-08938','A Human Acellular Vessel in Patients Needing Renal Replacement Therapy: A Comparison with ePTFE Grafts as Conduits for Hemodialysis (HUMANITY)','000000030','Kidney Disease, Kidney Failure','Aug 1, 2016','Jul 13, 2020','Clinical Trial Stage Projects','Closed','Humacyte, Inc.','Adult Stem Cell','7625000'),
('DISC2-08824','CRISPR/Cas9 nanoparticle enabled therapy for Duchenne Muscular Dystrophy in muscle stem cells',NULL,'Muscular Dystrophy, Skeletal/Smooth Muscle disorders','Nov 1, 2016','Apr 30, 2019','Quest - Discovery Stage Research Projects','Closed','University of California, Los Angeles','iPS Cell','2150400'),
('DISC2-08874','Novel Rejuvenated T Cell Immunotherapy for Lung Cancer',NULL,'Cancer, Lung Cancer, Solid Tumors','Nov 1, 2016','Oct 31, 2018','Quest - Discovery Stage Research Projects','Closed','Stanford University','iPS Cell','1968456'),
('INFR1-09166','An Accelerating Center designed to expedite the development and delivery of high quality stem cell therapies to patients',NULL,'Multiple Indications (Alpha Clinics)','Aug 1, 2016','Sep 13, 2019','Accelerating Center','Closed','IQVIA, Inc.','','11772453'),
('CLIN1-08686','Regeneration of a Normal Corneal Surface by Limbal Stem Cell Therapy',NULL,'Corneal Damage, Vision Loss','Aug 1, 2016','Dec 31, 2019','Late Stage Preclinical Projects','Closed','University of California, Los Angeles','Adult Stem Cell','4244211'),
('EDUC1.3-09229','Stem Cells for Lung Diseases - Overcoming Barriers to Find New Therapies',NULL,'Respiratory Disorders','Jun 1, 2016','Nov 30, 2016','Conference - Lung Regenerative Medicine Workshop','Closed','University of California, Los Angeles','','44548'),
('DISC1-08750','Curing bladder cancer by replacing corrupted urothelium with differentiated hES cells',NULL,'Cancer','Sep 1, 2016','Aug 31, 2017','Inception - Discovery Stage Research Projects','Closed','Stanford University','Embryonic Stem Cell','210906'),
('DISC1-08776','Genome editing for causation and reversion of MPN-associated mutations in human hematopoietic stem cells',NULL,'Blood Cancer, Cancer','Sep 1, 2016','Feb 28, 2018','Inception - Discovery Stage Research Projects','Closed','University of California, Berkeley','Adult Stem Cell','235800'),
('DISC1-08790','Targeting progenitors in scar tissue to reduce chronic scar burden',NULL,'Heart Disease','Sep 1, 2016','Aug 31, 2018','Inception - Discovery Stage Research Projects','Closed','University of California, Los Angeles','Adult Stem Cell','230400'),
('DISC1-08792','Generation of bile duct-competent transplantable human liver organoids',NULL,'Liver Disease, Metabolic Disorders','Aug 1, 2016','Jul 31, 2017','Inception - Discovery Stage Research Projects','Closed','University of California, San Francisco','iPS Cell','206460'),
('DISC1-08643','Exosomal Y-RNAs as mediators of bioactivity of cardiac-derived cell therapy',NULL,'Heart Disease','Jul 1, 2016','Jun 30, 2017','Inception - Discovery Stage Research Projects','Closed','Cedars-Sinai Medical Center','Adult Stem Cell','181063'),
('DISC1-08800','Blood Brain Barrier (BBB)-on-Chip: Development and validation of a novel iPS-based microfluidic model of the human BBB',NULL,'Neurological Disorders','Aug 1, 2016','Jul 31, 2017','Inception - Discovery Stage Research Projects','Closed','Cedars-Sinai Medical Center','iPS Cell','241992'),
('DISC1-08650','Activation of patient-specific endogenous myocardial repair through the exosomes generated  from the hypoxic iPSC-derived cardiomyocytes (iCMs).',NULL,'Heart Disease','Aug 1, 2016','Jul 31, 2017','Inception - Discovery Stage Research Projects','Closed','Stanford University','iPS Cell','234619'),
('DISC1-08819','Organoid Modeling of Human Cortical Microcircuits',NULL,'Neurological Disorders','Sep 1, 2016','Aug 31, 2018','Inception - Discovery Stage Research Projects','Closed','University of California, Los Angeles','Embryonic Stem Cell','208916'),
('TRAN1-08522','2nd Generation Vaccine for the Treatment of Glioblastoma',NULL,'Brain Cancer, Cancer, Solid Tumors','Aug 1, 2016','Aug 29, 2019','Therapeutic Translational Research Projects','Closed','Stanford University','Cancer Stem Cell','2929889'),
('DISC1-08652','Examining the efficacy of GDF11 antibody as a rejuvenator of aged human muscle stem cell capacity and muscle repair .',NULL,'Aging, Skeletal/Smooth Muscle disorders','Jul 1, 2016','Jun 30, 2017','Inception - Discovery Stage Research Projects','Closed','University of California, San Francisco','Adult Stem Cell','180000'),
('DISC1-08823','Novel Platforms to Enhance In Vivo Delivery of Skeletal Muscle Progenitor Cells from Human Pluripotent Stem Cells',NULL,'Muscular Dystrophy, Skeletal/Smooth Muscle disorders','Jul 1, 2016','Dec 31, 2017','Inception - Discovery Stage Research Projects','Closed','University of California, Los Angeles','iPS Cell','230400'),
('DISC1-08825','Reverse transcriptase inhibitors as a novel therapeutic approach for neurological autoimmune disorders',NULL,'Neurological Disorders','Jul 1, 2016','Jul 31, 2017','Inception - Discovery Stage Research Projects','Closed','University of California, San Diego','Embryonic Stem Cell, iPS Cell','210060'),
('DISC1-08842','Identification of stem cell surface markers as potential therapeutic targets for advanced prostate cancer',NULL,'Cancer, Prostate Cancer, Solid Tumors','Jul 1, 2016','Jun 30, 2017','Inception - Discovery Stage Research Projects','Closed','University of California, Los Angeles','Adult Stem Cell','209160'),
('DISC1-08848','Embryonic Stem Cells for Corneal Endothelial Degeneration',NULL,'Vision Loss','Jul 1, 2016','Jun 30, 2017','Inception - Discovery Stage Research Projects','Closed','Stanford University','Embryonic Stem Cell, iPS Cell','235836'),
('DISC1-08855','Modulating Liver Sinusoidal Endothelial Cell Permeability to Enhance Engraftment of Endothelial Cell Progenitors for the Treatment of Hemophilia A',NULL,'Blood Disorders, Hemophilia A','Aug 1, 2016','Jan 31, 2018','Inception - Discovery Stage Research Projects','Closed','Vitalant Research Institute','Adult Stem Cell, iPS Cell','180000'),
('DISC1-08868','Developing a personalized approach to beta cell replacement for patients with a genetic form of diabetes',NULL,'Diabetes, Metabolic Disorders','Sep 1, 2016','Feb 28, 2018','Inception - Discovery Stage Research Projects','Closed','Children\'s Hospital of Los Angeles','iPS Cell','179995'),
('DISC1-08683','Microenvironment based optimization of retinal induction using CRISPR-CAS9 reporter pluripotent stem cells as an expandable source of retinal progenitors and photoreceptors.',NULL,'Vision Loss','Oct 1, 2016','Sep 30, 2019','Inception - Discovery Stage Research Projects','Closed','University of California, San Diego','iPS Cell','232200'),
('DISC1-08723','iPS-Interneuron Transplantation for Neural Repair after Stroke',NULL,'Neurological Disorders, Stroke','Sep 1, 2016','Aug 31, 2017','Inception - Discovery Stage Research Projects','Closed','University of California, Los Angeles','iPS Cell','229396'),
('DISC1-08731','Autologous iPSC-based therapy for radiation induced bladder injury',NULL,'Bladder or Urinary Tract Disorder, Skeletal/Smooth Muscle disorders','Oct 1, 2016','Mar 31, 2018','Inception - Discovery Stage Research Projects','Closed','Stanford University','iPS Cell','235836'),
('DISC1-08737','New Methods for the Chemical Expansion of Hematopoietic Stem and Progenitor Cells',NULL,'Blood Disorders','Jul 1, 2016','Jun 30, 2018','Inception - Discovery Stage Research Projects','Closed','University of California, San Diego','Adult Stem Cell','232200'),
('EDUC1-08465','International Society for Experimental Hematology, 45th Annual Scientific Meeting',NULL,'Blood Disorders','May 1, 2016','Sep 30, 2016','Conference II','Closed','International Society for Experimental Hematology','','25000'),
('EDUC1-08866','14th International Cord Blood Symposium: Give Life Twice',NULL,'Blood Disorders','May 1, 2016','Jul 31, 2016','Conference II','Closed','American Association of Blood Banks','','15000'),
('EDUC1-08985','Neurogenesis during Development and in the Adult Brain (joint with Transcriptional and Epigenetic Control in Stem Cells)',NULL,'','Jan 1, 2017','Mar 31, 2017','Conference II','Closed','Keystone Symposia on Molecular and Cellular Biology','','35000'),
('EDUC1-09080','HD-CARE INAUGURAL SYMPOSIUM',NULL,'Huntington\'s Disease, Neurological Disorders','Apr 1, 2016','Jun 30, 2016','Conference II','Closed','University of California, Irvine','','1500'),
('TRAN1-08561-B','Personalized Cell Therapy for Diabetes',NULL,'Diabetes, Metabolic Disorders','Apr 1, 2017','Dec 31, 2018','Therapeutic Translational Research Projects','Closed','University of California, Los Angeles','iPS Cell','1494896'),
('TRAN1-08471','ASCENT- Advanced Stem Cell Enteric Neuropathy Therapy',NULL,'Intestinal Disease, Metabolic Disorders, Neurological Disorders, Pediatrics','Jul 1, 2016','Dec 31, 2021','Therapeutic Translational Research Projects','Active','Children\'s Hospital of Los Angeles','iPS Cell','7077352'),
('TRAN1-08519','Overexpression of HexA/HexB by lentivector expression in blood cells to treat Tay-Sachs and Sandhoff disease',NULL,'Metabolic Disorders, Neurological Disorders','Jun 1, 2016','Sep 30, 2019','Therapeutic Translational Research Projects','Closed','University of California, Davis','Adult Stem Cell','883174'),
('TRAN1-08525','Process development for establishing an iPSC-based therapeutic candidate for Canavan disease',NULL,'Canavan Disease, Neurological Disorders','Jul 1, 2016','Dec 31, 2021','Therapeutic Translational Research Projects','Active','City of Hope, Beckman Research Institute','iPS Cell','7377384'),
('TRAN1-08533','Stem Cell-Based iNKT Cell Therapy for Cancer',NULL,'Acute Myeloid Leukemia, Blood Cancer, Cancer, Multiple Myeloma','Jul 1, 2016','Dec 31, 2020','Therapeutic Translational Research Projects','Closed','University of California, Los Angeles','Adult Stem Cell','6956775'),
('CLIN2-08334','Allogeneic Cardiosphere-Derived Cells for Duchenne Muscular Dystrophy Cardiomyopathy','000000023','Heart Disease, Heart disease associated with Duchenne muscular dystrophy','Apr 1, 2016','May 31, 2019','Clinical Trial Stage Projects','Closed','Capricor, Inc','Adult Stem Cell','3376259'),
('TRAN1-08552','Human Embryonic Stem Cell-Derived Neural Stem Cell Transplants in Amyotrophic Lateral Sclerosis',NULL,'Amyotrophic Lateral Sclerosis, Neurological Disorders','Jun 1, 2016','Mar 31, 2018','Therapeutic Translational Research Projects','Closed','University of California, San Diego','Embryonic Stem Cell','1790000'),
('TRAN1-08561-A','Personalized Cell Therapy for Diabetes',NULL,'Diabetes, Metabolic Disorders','Jul 1, 2016','Mar 31, 2017','Therapeutic Translational Research Projects','Closed','Semma Therapeutics','iPS Cell','597333'),
('CLIN1-08363','Ex Vivo Transduction of the Human Artemis (DCLRE1C) cDNA by Lentiviral Vector AProArt into CD34+ Hematopoietic Cells for Artemis (ART)-Deficient Severe Combined Immunodeficiency (SCID)',NULL,'Blood Disorders, Immune Disease, Severe Combined Immunodeficiency, Artemis deficient (ART-SCID)','May 1, 2016','Apr 30, 2018','Late Stage Preclinical Projects','Closed','University of California, San Francisco','Adult Stem Cell','4268865'),
('EDUC1.1-08976','2016 CIRM Bridges & SPARK Meetings',NULL,'','Mar 1, 2016','Sep 30, 2016','Conference - Manage The 2016 Bridges And SPARK Annual Meetings','Closed','Mosaic Event Management, Inc.','','205388'),
('CLIN1-08342','Development of AB-110: genetically-modified endothelial cells plus expanded cord blood hematopoietic stem cells  as a transplantation therapy',NULL,'Blood Cancer, Cancer','Apr 1, 2016','Aug 31, 2017','Late Stage Preclinical Projects','Closed','Angiocrine Bioscience, Inc.','Adult Stem Cell','3797117'),
('EDUC1.2-08931','UCSD Division of Regenerative Medicine and CIRM Alpha Clinics Network Symposium',NULL,'','Mar 1, 2016','May 31, 2016','Conference - The 2016 Alpha Stem Cell Clinic Annual Symposium','Closed','University of California, San Diego','','37778'),
('EDUC2-08376','Bridges to Stem Cell Research Internship Program',NULL,'','Aug 1, 2016','Sep 30, 2021','Bridges','Active','San Diego State University Foundation','','3045886'),
('EDUC3-08407','Internship at a Cutting Edge CIRM-funded Stem Cell Research Facility',NULL,'','Jun 1, 2016','Dec 31, 2021','SPARK','Active','University of California, Davis','','373324'),
('EDUC2-08381','CIRM Graduate Student Training Grant for the Implementation of a Stem Cell Technology and Lab Management Program: Training in Stem Cell Sciences and Regenerative Medicine',NULL,'','Jun 1, 2016','Sep 30, 2021','Bridges','Active','Cal State Univ, Channel Island','','2970025'),
('EDUC3-08422','Developing High School Students\' Research Practices and Regenerative Medicine Knowledge through a Summer Intern Program',NULL,'','Jun 1, 2016','Dec 31, 2021','SPARK','Active','University of California, San Francisco','','382430'),
('EDUC2-08382','Bridges to Stem Cell Research, Therapy and Careers: A Talent Development Program for Training Diverse Undergraduates for Careers in Regenerative Medicine',NULL,'','Aug 1, 2017','Dec 31, 2022','Bridges','Active','Cal State Univ, Fullerton','','2947898'),
('EDUC3-08425','Stem Cell and Regenerative Medicine- Summer Research Internship',NULL,'','Jun 1, 2016','Dec 31, 2021','SPARK','Active','Stanford University','','380827'),
('EDUC3-08431','CIRM Early Investigators High School Stem Cell Research Program',NULL,'','Jun 1, 2016','Dec 31, 2021','SPARK','Active','California Institute of Technology','','189343'),
('EDUC2-08383','CIRM Stem Cell Biotechnology Training Program',NULL,'','Jul 1, 2016','Sep 30, 2021','Bridges','Active','Cal State Univ, Long Beach','','3055374'),
('EDUC2-08388','Interdisciplinary Master of Science Program in Regenerative Medicine',NULL,'','Jul 1, 2016','Jun 30, 2022','Bridges','Active','Cal Poly Corporation, an Auxiliary of California Polytechnic State University, San Luis Obispo','','2632378'),
('EDUC2-08390','Strengthening the Pipeline of Master\'s-level Scientific and Laboratory Personnel in Stem Cell Research',NULL,'','Jan 1, 2017','Jan 31, 2022','Bridges','Active','Cal State Univ, Sacramento','','2084054'),
('EDUC2-08391','CIRM Bridges 2.0: Training the Next Generation of Stem Cell Scientists',NULL,'','Jun 1, 2016','Nov 30, 2021','Bridges','Active','San Francisco State University','','3041625'),
('EDUC2-08394','SCILL- Stem Cell Internships in Laboratory-based Learning',NULL,'','Jun 1, 2016','May 31, 2022','Bridges','Active','San Jose State University','','3086302'),
('EDUC2-08397','CIRM 2.0 Bridges Training Program',NULL,'','Aug 1, 2016','Sep 30, 2021','Bridges','Active','Humboldt State University','','2702644'),
('EDUC2-08398','Bridges to Stem Cell Research and Therapy at Pasadena City College',NULL,'','Sep 1, 2016','Aug 31, 2021','Bridges','Active','Pasadena City College','','2556959'),
('EDUC2-08400','Stem Cell Training Enhancement Program with a focus on Translational Research',NULL,'','Jul 1, 2017','Jun 30, 2022','Bridges','Active','City College Of San Francisco','','2069835'),
('EDUC2-08411','Stem Cell Scientist Training Program',NULL,'','Jul 1, 2017','Jun 30, 2022','Bridges','Active','Cal State Univ, Northridge','','2760691'),
('EDUC2-08418','Stem Cell Scholars- from Basic Research to Clinical Translation: training a diverse pool of students in the lab, engaging them in patient and healthcare activities, motivating  them to educate their immediate community and enabling them for careers in ...',NULL,'','Sep 1, 2017','Dec 31, 2022','Bridges','Active','Cal State Univ, San Bernadino','','2659136'),
('EDUC3-08387','SPARK Award Program in Stem Cell Biology for California High School Students',NULL,'','Jun 1, 2016','Dec 31, 2021','SPARK','Active','City of Hope, Beckman Research Institute','','276780'),
('EDUC3-08399','Leveraging Investment in hiGHschool Training:  Summer Program to Accelerate Regenerative medicine Knowledge (LIGHT a SPARK)',NULL,'','Jun 1, 2016','Dec 31, 2021','SPARK','Active','Children\'s Hospital of Oakland Research Institute','','228940'),
('EDUC2-08375','CIRM Bridges to Stem Cell Research and Therapy Training Grant',NULL,'','Jul 1, 2016','Sep 30, 2021','Bridges','Active','Cal State Univ, San Marcos','','3041366'),
('EDUC3-08404','Mentored High School Summer Research Program',NULL,'','May 1, 2016','Dec 31, 2021','SPARK','Active','Cedars-Sinai Medical Center','','305281'),
('EDUC1-08714','California ALS Research Summit 2016',NULL,'Amyotrophic Lateral Sclerosis, Neurological Disorders','Jan 1, 2016','Mar 31, 2016','Conference II','Closed','University of California, San Diego','','11400'),
('EDUC1-08433','Primary Immune Deficiency Treatment Consortium (PIDTC) Annual Scientific Workshop',NULL,'Immune Disease','May 1, 2016','Jul 31, 2016','Conference II','Closed','University of California, Los Angeles','','29807'),
('EDUC1-08626','2016 Rachmiel Levine-Arthur Riggs Diabetes Research Symposium',NULL,'','Mar 1, 2016','May 31, 2016','Conference II','Closed','City of Hope, Beckman Research Institute','','10000'),
('EDUC1-08673','2016 Gordon Research Conference on Craniofacial Morphogenesis and Tissue Regeneration',NULL,'Developmental Disorders','Mar 1, 2016','May 31, 2016','Conference II','Closed','Gordon Research Conferences','','5000'),
('EDUC1-08701','Drug Discovery & Stem Cell Models for Cardiovascular Disease Conference',NULL,'Blood Disorders, Heart Disease','Mar 1, 2016','May 31, 2016','Conference II','Closed','Stanford University','','7500'),
('CLIN2-08280','A Phase III randomized double-blind, controlled study of ICT 107 with maintenance temozolomide (TMZ) in newly diagnosed glioblastoma following resection and concomitant TMZ chemoradiotherapy','000000017','Brain Cancer, Cancer, Solid Tumors','Nov 1, 2015','Jun 21, 2017','Clinical Trial Stage Projects','Closed','ImmunoCellular Therapeutics','Cancer Stem Cell','5391016'),
('EDUC1-08380','Stem Cell Meeting on the Mesa',NULL,'','Oct 1, 2015','Dec 31, 2015','Conference II','Closed','Sanford Consortium for Regenerative Medicine','','50000'),
('EDUC1-08410','2015 World Alliance Forum in San Francisco (2015 WAFSF) \"Regenerative Medicine: Let\'s Talk Business!\"',NULL,'','Oct 1, 2015','Dec 31, 2015','Conference II','Closed','Alliance Forum Foundation','','10000'),
('EDUC1-08366','Human Research In Times of Controversy: From Stem Cells To Fetal Tissue',NULL,'','Oct 1, 2015','Dec 31, 2015','Conference II','Closed','University of California, Irvine','','13562'),
('CLIN1-08309','Development of a Chondrogenic Drug Candidate Targeting Resident Mesenchymal Stem Cells for the Treatment of Osteoarthritis',NULL,'Bone or Cartilage Disease','Sep 1, 2015','Apr 30, 2017','Late Stage Preclinical Projects','Closed','Calibr','','1667832'),
('CLIN2-08289','Stem Cell Gene Therapy for HIV Mediated by Lentivector Transduced, Pre-selected CD34+ Cells in AIDS lymphoma patients','000000025','Blood Cancer, Cancer, HIV-related Lymphoma, HIV/AIDS, Infectious Disease','Sep 1, 2015','Aug 31, 2021','Clinical Trial Stage Projects','Active','University of California, Davis','Adult Stem Cell','8414265'),
('CLIN2-08231','A Phase I/II, Non Randomized, Multicenter, Open-Label Study of G1XCGD (Lentiviral Vector Transduced CD34+ Cells) in Patients With X-Linked Chronic Granulomatous Disease','000000070','Blood Disorders, Immune Disease, Pediatrics, X-linked Chronic Granulomatous Disease','Sep 1, 2015','Dec 31, 2022','Clinical Trial Stage Projects','Active','University of California, Los Angeles','Adult Stem Cell','7083364'),
('CLIN1-08235','IND-enabling study of subretinal delivery of human neural progenitor cells for the treatment of retinitis pigmentosa',NULL,'Vision Loss','Aug 1, 2015','Nov 30, 2018','Late Stage Preclinical Projects','Closed','Cedars-Sinai Medical Center','Adult Stem Cell','4954514'),
('CLIN2-08239','Tumor stem cell-targeted immunotherapy for metastatic melanoma –a randomized phase 3 clinical trial.','000000041','Cancer, Melanoma, Solid Tumors','Jul 1, 2015','Feb 18, 2016','Clinical Trial Stage Projects','Closed','Caladrius Biosciences','Cancer Stem Cell','3000000'),
('PC1-08086','Human Stem-Cell Based Development of a Potent Alzheimer’s Drug Candidate',NULL,'Alzheimer\'s Disease, Neurological Disorders','Sep 1, 2015','May 31, 2018','Preclinical Development Awards','Closed','Salk Institute for Biological Studies','Embryonic Stem Cell, iPS Cell','1664885'),
('PC1-08117','A hNSC Development Candidate for Huntington’s Disease',NULL,'Huntington\'s Disease, Neurological Disorders','Jul 1, 2015','Dec 31, 2018','Preclinical Development Awards','Closed','University of California, Irvine','Embryonic Stem Cell','4951623'),
('PC1-08142','Development of a Chondrogenic Drug Candidate Targeting Cartilage-residing Mesenchymal Stem Cells for the Treatment of Osteoarthritis',NULL,'Bone or Cartilage Disease','Jun 1, 2015','Feb 29, 2016','Preclinical Development Awards','Closed','Calibr','Adult Stem Cell','2306703'),
('PC1-08103','Placental Stem Cells for the In Utero Treatment of Spina Bifida',NULL,'Neurological Disorders, Pediatrics, Spina Bifida','Sep 1, 2015','Aug 31, 2018','Preclinical Development Awards','Closed','University of California, Davis','Adult Stem Cell','2182146'),
('PC1-08118','Scaffold for dermal regeneration containing pre-conditioned mesenchymal stem cells to heal chronic diabetic wounds',NULL,'Diabetes, Diabetic Wounds, Metabolic Disorders, Skin Disease','Sep 1, 2015','Feb 28, 2019','Preclinical Development Awards','Closed','University of California, Davis','Adult Stem Cell','4620144'),
('PC1-08128','Embryonic Stem Cell-Derived Chondroprogenitor Cells to Repair Osteochondral Defects',NULL,'Bone or Cartilage Disease','Aug 1, 2015','Jan 31, 2019','Preclinical Development Awards','Closed','Scripps Health','Embryonic Stem Cell','7660211'),
('PC1-08111','Pre-clinical development of gene correction therapy of hematopoietic stem cells for SCID-X1',NULL,'Blood Disorders, Genetic Disorder, Immune Disease, Pediatrics, Severe Combined Immunodeficiency, X-linked (X-SCID)','Oct 1, 2015','Mar 31, 2018','Preclinical Development Awards','Closed','Stanford University','Adult Stem Cell','874877'),
('CG1-08207','Cellular Therapies in Trauma and Critical Care Medicine: Forging New Frontiers',NULL,'Trauma','Jun 1, 2015','Sep 30, 2015','Conference','Closed','Vitalant Research Institute','','40000'),
('CG1-08209','USC/UCSF/UCLA Tri-Institutional Stem Cell Retreat',NULL,'','May 1, 2015','Jul 31, 2015','Conference','Closed','University of Southern California','','5000'),
('CG1-08216','SIGHT RESTORATION THROUGH STEM CELL THERAPY',NULL,'','Jun 1, 2015','Aug 31, 2015','Conference','Closed','Ocular Research Symposia Foundation, Inc.','','20000'),
('CG1-08225','Cardiovascular Tissue Engineering Symposium',NULL,'','May 1, 2015','Jul 31, 2015','Conference','Closed','Stanford University','','25000'),
('CG1-08274','Pathways of Neurodevelopmental Disorders (C8)',NULL,'','Apr 1, 2015','Jun 30, 2015','Conference','Closed','University of California, Davis','','29939'),
('RT3-07914-B','Skin-derived precursor cells for the treatment of enteric neuromuscular dysfunction',NULL,'Intestinal Disease, Metabolic Disorders, Neurological Disorders, Pediatrics','Apr 1, 2017','Mar 31, 2019','Tools and Technologies III','Closed','Stanford University','Adult Stem Cell','772098'),
('RT3-07838','Development of a scalable, practical, and transferable GMP-compliant suspension culture-based differentiation process for cardiomyocyte production from human embryonic stem cells.',NULL,'Heart Disease','Apr 1, 2015','Mar 31, 2017','Tools and Technologies III','Closed','City of Hope, Beckman Research Institute','Embryonic Stem Cell','891518'),
('RT3-07670','Development of a clinical-grade extracorporeal liver support system using human induced pluripotent stem cell-derived hepatic cells',NULL,'Liver Disease, Metabolic Disorders','Oct 1, 2015','Jul 31, 2019','Tools and Technologies III','Closed','University of Southern California','iPS Cell','1257011'),
('RT3-07763','A suite of engineered human pluripotent stem cell lines to facilitate the generation of hematopoietic stem cells',NULL,'Blood Disorders','Aug 1, 2015','Apr 30, 2019','Tools and Technologies III','Closed','University of California, Los Angeles','Embryonic Stem Cell','1382400'),
('RT3-07796','A Chromatin Context Tool for Predicting iPS Lineage Predisposition and Tissue Graftability',NULL,'Skin Disease','Apr 1, 2015','Mar 31, 2018','Tools and Technologies III','Closed','Stanford University','Embryonic Stem Cell, iPS Cell','1391125'),
('RT3-07899','Development of 3D Bioprinting Techniques using Human Embryonic Stem Cells Derived Cardiomyocytes for Cardiac Tissue Engineering',NULL,'Heart Disease','Jun 1, 2015','May 31, 2018','Tools and Technologies III','Closed','University of California, San Diego','Embryonic Stem Cell, iPS Cell','1368264'),
('RT3-07800','Engineered Biomaterials for Scalable Manufacturing and High Viability Implantation of hPSC-Derived Cells to Treat Neurodegenerative Disease',NULL,'Neurological Disorders, Parkinson\'s Disease, Vision Loss','May 1, 2015','Apr 30, 2018','Tools and Technologies III','Closed','University of California, Berkeley','Embryonic Stem Cell, iPS Cell','1239276'),
('RT3-07948','Injectable Hydrogels for the Delivery, Maturation, and Engraftment of Clinically Relevant Numbers of Human Induced Pluripotent Stem Cell-Derived Neural Progenitors to the Central Nervous System',NULL,'Neurological Disorders, Spinal Cord Injury','Jun 1, 2015','Sep 30, 2018','Tools and Technologies III','Closed','Stanford University','iPS Cell','1347767'),
('RT3-07907','Technologies to improve in vivo function of transplanted stem cells',NULL,'Skeletal/Smooth Muscle disorders','Apr 1, 2015','Feb 28, 2019','Tools and Technologies III','Closed','University of California, San Diego','Embryonic Stem Cell, iPS Cell','1373683'),
('RT3-07893','Optimizing the differentiation and expansion of microglial progenitors from human pluripotent stem cells for the study and treatment of neurological disease.',NULL,'Alzheimer\'s Disease, Neurological Disorders','Aug 1, 2015','Jul 31, 2018','Tools and Technologies III','Closed','University of California, Irvine','Embryonic Stem Cell','1147596'),
('RT3-07655','User-friendly predictive molecular diagnostic assays for quality control of stem cell derivatives for transplantation and drug discovery',NULL,'Neurological Disorders','Oct 1, 2015','Mar 31, 2019','Tools and Technologies III','Closed','Scripps Research Institute','Embryonic Stem Cell, iPS Cell','1728390'),
('RT3-07683','Identification and isolation of transplantable human hematopoietic stem cells from pluripotent cell lines; two steps from primitive hematopoiesis to transplantable definitive cells, and non-toxic conditioning of hosts for hematopoeitic stem cell transp...',NULL,'Blood Disorders','Aug 1, 2015','Jul 31, 2018','Tools and Technologies III','Closed','Stanford University','Embryonic Stem Cell','1271952'),
('RT3-07914-A','Skin-derived precursor cells for the treatment of enteric neuromuscular dysfunction',NULL,'Intestinal Disease, Metabolic Disorders, Neurological Disorders, Pediatrics','Apr 1, 2015','Mar 31, 2017','Tools and Technologies III','Closed','University of California, Los Angeles','Adult Stem Cell','1044423'),
('RT3-07848','Site-specific gene editing in hematopoietic stem cells as an anti-HIV therapy',NULL,'HIV/AIDS, Infectious Disease','Aug 1, 2015','Jul 31, 2018','Tools and Technologies III','Closed','University of Southern California','Adult Stem Cell','1495665'),
('RT3-07981','Multi-modal technology for non-destructive characterization of bioengineered tissues',NULL,'Bone or Cartilage Disease','Jun 1, 2015','Nov 30, 2018','Tools and Technologies III','Closed','University of California, Davis','Adult Stem Cell','1574151'),
('RT3-07949','Embryonic stem cell-based generation of rat models for assessing human cellular therapies',NULL,'Other','May 1, 2015','Apr 30, 2018','Tools and Technologies III','Closed','University of Southern California','Embryonic Stem Cell','1326979'),
('RT3-07879','Multimodal platform combining optical and ultrasonic technologies for in vivo nondestructive evaluation of engineered vascular tissue constructs',NULL,'Vascular Disease','Jun 1, 2015','Jan 31, 2019','Tools and Technologies III','Closed','University of California, Davis','Adult Stem Cell','1834350'),
('RT3-07692','Small molecule tools and scale-up technologies to expand human umbilical cord blood stem and progenitor cells for clinical and research use',NULL,'Blood Disorders','Jul 1, 2015','Jun 30, 2019','Tools and Technologies III','Closed','University of California, San Francisco','Adult Stem Cell','1416600'),
('RT3-07804','Injectable Macroporous Matrices to Enhance Stem Cell Engraftment and Survival',NULL,'Bone or Cartilage Disease','Jul 1, 2015','Jun 30, 2019','Tools and Technologies III','Closed','Stanford University','Adult Stem Cell','1434235'),
('RT3-07798','Macaca mulatta as advanced model for predictive preclinical testing of engineered cardiac autografts and allografts',NULL,'Heart Disease','Jul 1, 2015','Jun 30, 2018','Tools and Technologies III','Closed','Stanford University','iPS Cell','1689744'),
('RT3-07678','A small molecule tool for reducing the malignant potential in reprogramming human iPSCs and ESCs',NULL,'Other','Jun 1, 2015','Nov 30, 2018','Tools and Technologies III','Closed','University of California, Los Angeles','Embryonic Stem Cell, iPS Cell','1283900'),
('RT3-07616','Development of a Relevant Pre-Clinical Animal Model as a Tool to Evaluate Human Stem Cell-Derived Replacement Therapies for Motor Neuron Injuries and Degenerative Diseases',NULL,'Amyotrophic Lateral Sclerosis, Neurological Disorders, Spinal Cord Injury, Spinal Muscular Atrophy','Aug 1, 2015','Apr 30, 2019','Tools and Technologies III','Closed','University of California, Los Angeles','Embryonic Stem Cell','1308711'),
('CG1-08071','2015 Gordon Research Conference: Stem Cells & Cancer',NULL,'','Feb 2, 2015','Apr 30, 2015','Conference','Closed','Gordon Research Conferences','','20000'),
('CG1-08177','15th Annual Rachmiel Levine Diabetes and Obesity Symposium',NULL,'','Mar 1, 2015','May 31, 2015','Conference','Closed','City of Hope, Beckman Research Institute','','20000'),
('CG1-08023','THE 5TH ANNUAL CALIFORNIA ALS PAC10 AND RESEARCH NETWORK MEETING',NULL,'Amyotrophic Lateral Sclerosis, Neurological Disorders','Dec 1, 2014','Feb 28, 2015','Conference','Closed','Gladstone Institutes, J. David','','9529'),
('AC1-07659','The Innovation-Alpha Clinic for Cellular Therapies (I-ACT) – A Program for the Development and Delivery of Innovative Cell-based Treatments and Cures for Life-threatening Diseases.',NULL,'Multiple Indications (Alpha Clinics)','Feb 1, 2015','Jul 31, 2020','Alpha Stem Cell Clinics','Closed','City of Hope, Beckman Research Institute','Adult Stem Cell','8000000'),
('AC1-07764','Alpha Stem Cell Clinic for the Development of Regenerative Therapies',NULL,'Multiple Indications (Alpha Clinics)','Feb 1, 2015','Jul 31, 2021','Alpha Stem Cell Clinics','Active','University of California, San Diego','Adult Stem Cell, Embryonic Stem Cell','7999137'),
('AC1-07675','UCLA-UCI Alpha Stem Cell Clinic (ASCC) Consortium',NULL,'Multiple Indications (Alpha Clinics)','Apr 1, 2015','Mar 31, 2021','Alpha Stem Cell Clinics','Active','University of California, Los Angeles','Adult Stem Cell','8000000'),
('CG1-08171','13th Annual Gene Therapy Symposium for Heart, Lung, and Blood Diseases',NULL,'','Nov 1, 2014','Jan 31, 2015','Conference','Closed','University of California, Davis','','10000'),
('AP1-08039','Clinical Development of a Cell Therapy for Diabetes','000000068','Diabetes, Metabolic Disorders, Type 1 diabetes','Jan 1, 2015','Apr 30, 2018','Accelerated Development Pathway I','Closed','ViaCyte, Inc.','Embryonic Stem Cell','8783852'),
('CG1-07588','The Stem Cell Niche in Development and Disease',NULL,'','Oct 1, 2014','Dec 31, 2014','Conference','Closed','University of California, San Francisco','','5000'),
('CG1-08160','Stem Cell Meeting on the Mesa',NULL,'','Oct 1, 2014','Dec 31, 2014','Conference','Closed','Sanford Consortium for Regenerative Medicine','','40000'),
('CG1-08046','The 2014 Santa Cruz Developmental Biology Meeting',NULL,'','Aug 1, 2014','Oct 31, 2014','Conference','Closed','University of California, San Francisco','','3000'),
('LA1-08013','Single Molecule Biophysics and Biology of Cellular Identity',NULL,'Other','Jun 1, 2015','Dec 31, 2019','Research Leadership','Closed','University of California, Berkeley','Embryonic Stem Cell','4175924'),
('LA1-08015','Engineering microscale tissue constructs from human pluripotent stem cells',NULL,'Heart Disease, Neurological Disorders','Dec 1, 2014','Nov 30, 2019','Research Leadership','Closed','Gladstone Institutes, J. David','Embryonic Stem Cell, iPS Cell','5849100'),
('LA1-08014','Niche-Focused Research: Discovery & Development of Hematopoietic Regenerative Factors',NULL,'Blood Cancer, Blood Disorders, Cancer, Leukemia','Sep 1, 2014','Aug 31, 2019','Research Leadership','Closed','University of California, Los Angeles','Adult Stem Cell','4645297'),
('SP3A-07552','A Phase I/IIa Dose Escalation Safety Study of AST-OPC1 in Patients with Cervical Sensorimotor Complete Spinal Cord Injury','000000064','Neurological Disorders, Spinal Cord Injury','Oct 1, 2014','Nov 11, 2020','Strategic Partnership III Track A','Closed','Lineage Cell Therapeutics Inc.','Embryonic Stem Cell','14323318'),
('SP3A-07536','A Phase I, Open-Label Study To Assess The Safety, Feasibility and Engraftment of Zinc Finger Nucleases (ZFN) CCR5 Modified Autologous CD34+ Hematopoietic Stem/Progenitor Cells (SB-728MR-HSPC) with Escalating Doses of Busulfan In HIV-1 (R5) Infected Sub...','000000027','HIV/AIDS, Infectious Disease','Apr 1, 2015','Dec 31, 2021','Strategic Partnership III Track A','Active','City of Hope, Beckman Research Institute','Adult Stem Cell','5583438'),
('CG1-07874','UC Systemwide Bioengineering Symposium',NULL,'','May 1, 2014','Jul 31, 2014','Conference','Closed','University of California, Irvine','','7525'),
('CG1-07825','The 2014 BIO International Convention',NULL,'','May 1, 2014','Jul 31, 2014','Conference','Closed','Biocom Institute','','50000'),
('CG1-07623','2014 Materials Research Society (MRS) Spring Meeting: Symposium Y: Biomaterials for Biomolecule Delivery and Understanding Cell-Niche Interactions',NULL,'','Mar 1, 2014','Aug 31, 2014','Conference','Closed','Stanford University','','10000'),
('CG1-07636','In Utero Hematopoietic Stem Cell Transplantation and Maternal-Fetal Tolerance',NULL,'','Mar 1, 2014','Nov 30, 2014','Conference','Closed','University of California, San Francisco','','17526'),
('RB5-07414','Directed Differentiation of Specialized Endothelial Cells',NULL,'Vascular Disease','Jun 1, 2014','May 31, 2016','Basic Biology V','Closed','University of California, Merced','Embryonic Stem Cell, iPS Cell','475686'),
('RB5-07384','Metabolically-driven epigenetic changes in iPSC reprogramming',NULL,'','May 1, 2014','Apr 30, 2017','Basic Biology V','Closed','Salk Institute for Biological Studies','Embryonic Stem Cell, iPS Cell','1491900'),
('RB5-07285','A novel druggable mechanism to safeguard stem cell genome',NULL,'','Mar 1, 2014','Feb 28, 2017','Basic Biology V','Closed','Gladstone Institutes, J. David','Adult Stem Cell, Embryonic Stem Cell','1294495'),
('RB5-07480','In vitro modeling of human motor neuron disease',NULL,'Neurological Disorders, Spinal Muscular Atrophy','Apr 1, 2014','Mar 31, 2018','Basic Biology V','Closed','University of California, Los Angeles','iPS Cell','1148758'),
('RB5-07409','Biophysical Determinants of Early Embryonic Stem Cell Fate Specification',NULL,'Other','Jul 1, 2014','Jun 30, 2018','Basic Biology V','Closed','University of California, San Francisco','Embryonic Stem Cell','1186500'),
('RB5-07379','Role of intracytoplasmic pattern recognition receptors in HSC engraftment',NULL,'Blood Disorders','May 1, 2014','Apr 30, 2016','Basic Biology V','Closed','University of California, San Diego','','615639'),
('GC1R-06673-A','Center of Excellence for Stem Cell Genomics - Stanford',NULL,'Multiple Indications (Alpha Clinics)','Jun 1, 2014','Nov 30, 2019','Genomics Centers of Excellence Awards (R)','Closed','Stanford University','Adult Stem Cell, Cancer Stem Cell, iPS Cell','22787914'),
('RB5-06978','CD61-driven stemness program in epithelial cancer',NULL,'Cancer, Solid Tumors','Jul 1, 2014','Jun 30, 2017','Basic Biology V','Closed','University of California, San Diego','Cancer Stem Cell','1161000'),
('RB5-07458','Non-invasive live imaging of stem cell signature metabolic states',NULL,'','Jun 1, 2014','May 31, 2016','Basic Biology V','Closed','University of California, Irvine','Adult Stem Cell, Embryonic Stem Cell','516366'),
('GC1R-06673-B','Center of Excellence for Stem Cell Genomics - Salk',NULL,'Multiple Indications (Alpha Clinics)','Jun 1, 2014','May 31, 2020','Genomics Centers of Excellence Awards (R)','Closed','Salk Institute for Biological Studies','','13201635'),
('RB5-06974','A Requirement for Protein Homeostasis in the Mediation of Stem Cell Health',NULL,'','Mar 1, 2014','Feb 28, 2017','Basic Biology V','Closed','University of California, Berkeley','Embryonic Stem Cell, iPS Cell','1034100'),
('GC1R-06673-C','Center of Excellence for Stem Cell Genomics - UCSC',NULL,'Multiple Indications (Alpha Clinics)','Jun 1, 2014','May 31, 2020','Genomics Centers of Excellence Awards (R)','Closed','University of California, Santa Cruz','','3999083'),
('RB5-07210','New Regulators of Spermatogonial Stem Cells: RHOX Homeobox Transcription Factors',NULL,'','May 1, 2014','Apr 30, 2016','Basic Biology V','Closed','University of California, San Diego','Adult Stem Cell','552811'),
('RB5-07236','Defining links between chromatin state and developmental competence',NULL,'','Apr 1, 2014','Mar 31, 2017','Basic Biology V','Closed','University of California, San Diego','Embryonic Stem Cell','1050300'),
('RB5-07012','Systems-level discovery of the regulatory mechanisms directing differentiation of hESC',NULL,'','Mar 1, 2014','Mar 31, 2017','Basic Biology V','Closed','University of California, San Diego','Embryonic Stem Cell','1161000'),
('RB5-07466','Mechanisms of human induced neuronal cell reprogramming',NULL,'','Jul 1, 2014','Jun 30, 2017','Basic Biology V','Closed','Stanford University','Directly Reprogrammed Cell','1178370'),
('RB5-07363','Paracrine and synaptic mechanisms underlying neural stem cell-mediated stroke recovery',NULL,'Neurological Disorders, Stroke','Aug 1, 2014','Jul 31, 2017','Basic Biology V','Closed','Stanford University','Embryonic Stem Cell','1178370'),
('RB5-06935','Misregulated Mitophagy in Parkinsonian Neurodegeneration',NULL,'Neurological Disorders, Parkinson\'s Disease','Aug 1, 2014','Jul 31, 2018','Basic Biology V','Closed','Stanford University','iPS Cell','1174943'),
('RB5-07398','Engineered matrices for control of lineage commitment in human pancreatic stem cells',NULL,'Diabetes, Metabolic Disorders','Mar 1, 2014','Feb 28, 2016','Basic Biology V','Closed','California Institute of Technology','','526896'),
('RB5-07089','Differentiation of Human Hematopoietic Stem Cells into iNKT Cells',NULL,'Blood Disorders','Mar 1, 2014','Feb 28, 2016','Basic Biology V','Closed','University of California, Los Angeles','','614400'),
('RB5-07254','Molecular basis of plasma membrane characteristics reflecting stem cell fate potential',NULL,'Neurological Disorders','Apr 1, 2014','Mar 31, 2018','Basic Biology V','Closed','University of California, Irvine','Adult Stem Cell','994108'),
('RB5-07230-A','Promoting survival and countering hypertrophy of pluripotent stem cell (PSC)-derived chondrocytes',NULL,'Arthritis','Jul 1, 2014','Aug 31, 2015','Basic Biology V','Closed','University of California, Los Angeles','Embryonic Stem Cell','411330'),
('RB5-07356','Metabolic regulation of cardiac differentiation and maturation',NULL,'Heart Disease','May 1, 2014','Oct 31, 2017','Basic Biology V','Closed','University of California, San Diego','Embryonic Stem Cell, iPS Cell','1124834'),
('RB5-07302','Innate Immune Regulation of Lung Alveolar Stem Cell Renewal in Mouse and Man',NULL,'','Jun 1, 2014','May 31, 2016','Basic Biology V','Closed','Cedars-Sinai Medical Center','','617662'),
('RB5-07320','Assessing the mechanism by which the Bone Morphogenetic Proteins direct stem cell fate',NULL,'Neurological Disorders, Spinal Cord Injury','Mar 1, 2014','Feb 28, 2016','Basic Biology V','Closed','University of California, Los Angeles','Embryonic Stem Cell','515730'),
('RB5-07025','Epigenetic mechanisms that enforce pluripotency in embryonic stem cells',NULL,'','May 1, 2014','Aug 31, 2017','Basic Biology V','Closed','University of California, San Diego','Embryonic Stem Cell, iPS Cell','1160997'),
('RB5-07011','Elucidating pathways from hereditary Alzheimer mutations to pathological tau phenotypes',NULL,'Alzheimer\'s Disease, Neurological Disorders','Apr 1, 2014','Mar 31, 2017','Basic Biology V','Closed','University of California, San Diego','iPS Cell','1050300'),
('RB5-07262','Generation of a functional thymus to induce immune tolerance to stem cell derivatives',NULL,'Diabetes, HIV/AIDS, Immune Disease, Infectious Disease, Metabolic Disorders','Jul 1, 2014','Dec 31, 2017','Basic Biology V','Closed','University of California, San Francisco','Embryonic Stem Cell','1191000'),
('RB5-07422','Molecular regulation of stem cell potency',NULL,'Aging, Skeletal/Smooth Muscle disorders, Trauma','Jul 1, 2014','Aug 31, 2017','Basic Biology V','Closed','Palo Alto Veterans Institute for Research','Adult Stem Cell','966510'),
('RB5-07230-B','Promoting survival and countering hypertrophy of pluripotent stem cell (PSC)-derived chondrocytes',NULL,'Arthritis','Sep 1, 2015','Dec 31, 2017','Basic Biology V','Closed','University of Southern California','Embryonic Stem Cell','735138'),
('RB5-07469','Mass Cytometry to Delineate the Human Muscle Stem Cell Hierarchy and Dysfunction in Aging',NULL,'','Jun 1, 2014','May 31, 2017','Basic Biology V','Closed','Stanford University','Adult Stem Cell','1175357'),
('CG1-07647','Tri-Institutional Stem Cell Retreat',NULL,'','Mar 1, 2014','May 31, 2014','Conference','Closed','University of California, San Francisco','','3500'),
('CG1-07688','Cardiovascular Regenerative Medicine Symposium',NULL,'','Feb 1, 2014','Apr 30, 2014','Conference','Closed','Stanford University','','9000'),
('CG1-07550','Third Annual Symposium on Regenerative Rehabilitation',NULL,'','Mar 1, 2014','May 31, 2014','Conference','Closed','Stanford University','','20000'),
('CG1-07618','Regenerative Medicine Foundation 2014 Conference',NULL,'','Apr 1, 2014','Jun 30, 2014','Conference','Closed','Human Organ Project','','50000'),
('DR3-06924','Therapeutic Eradication of Cancer Stem Cells with UC-961 (Cirmtuzumab)','000000012','Blood Cancer, Cancer','Jun 1, 2014','Nov 30, 2017','Disease Team Therapy Development III','Closed','University of California, San Diego','Cancer Stem Cell','4179598'),
('DR3-06965','Clinical Investigation of a Humanized Anti-CD47 Antibody in Targeting Cancer Stem Cells in Hematologic Malignancies and Solid Tumors','000000011','Blood Cancer, Cancer, Solid Tumors','Jun 1, 2014','May 31, 2016','Disease Team Therapy Development III','Closed','Stanford University','Cancer Stem Cell','6505568'),
('DR3-06945','Clinical Trial of Stem Cell Gene Therapy for Sickle Cell Disease','000000060','Blood Disorders, Pediatrics, Sickle Cell Disease','Jul 1, 2014','Dec 31, 2021','Disease Team Therapy Development III','Active','University of California, Los Angeles','Adult Stem Cell','13145465'),
('DR3-07281','Tissue Engineered Recellularized Laryngotracheal Implants',NULL,'Respiratory Disorders','Apr 1, 2014','Dec 31, 2016','Disease Team Therapy Development III','Closed','University of California, Davis','Adult Stem Cell','3181162'),
('DR3-07438','Phase 1 Safety Assessment of CPCB-RPE1, hESC-derived RPE Cell Coated Parylene Membrane Implants, in Patients with Advanced Dry Age Related Macular Degeneration','000000001','Age-related macular degeneration, Vision Loss','Aug 1, 2014','Jul 31, 2019','Disease Team Therapy Development III','Closed','University of Southern California','Embryonic Stem Cell','16339827'),
('DR3-07067','A Phase I dose escalation and expansion clinical trial of the novel first-in-class Polo-like Kinase 4 (PLK4) inhibitor, CFI-400945 in patients with advanced solid tumors','000000061','Cancer, Solid Tumors','May 1, 2014','Apr 30, 2019','Disease Team Therapy Development III','Closed','University of California, Los Angeles','Cancer Stem Cell','5683693'),
('CG1-07597','Keystone Symposia, \"Stem Cells and Reprogramming\"',NULL,'','Mar 1, 2014','May 31, 2014','Conference','Closed','Gladstone Institutes, J. David','','50000'),
('CG1-07599','Stem Cell Research for Neurological Disorders: A Case Study in Ethical and Policy Issues in ALS Research',NULL,'','Dec 1, 2013','Dec 31, 2014','Conference','Closed','University of California, Davis','','1020'),
('CG1-07614','California ALS Research Summit 2014',NULL,'','Dec 1, 2013','Feb 28, 2014','Conference','Closed','University of California, San Francisco','','8563'),
('CG1-07544','2013 World Alliance Forum in San Francisco',NULL,'','Nov 1, 2013','Jan 31, 2014','Conference','Closed','Alliance Forum Foundation','','3500'),
('CG1-07572','7th CA/HSCI Junior PI Conference:  Stem Cells 2.0',NULL,'','Nov 1, 2013','Jan 31, 2014','Conference','Closed','University of California, Los Angeles','','2500'),
('CG1-07590','The Sanford Consortium for Regenerative Medicine\'s Scientific Symposium and the Regen Med Partnering Forum at Stem Cell Meeting on the Mesa VIII',NULL,'','Oct 1, 2013','Dec 31, 2013','Conference','Closed','Sanford Consortium for Regenerative Medicine','','35000'),
('CG1-07598','The Science of Staying Younger Longer',NULL,'','Oct 1, 2013','Dec 31, 2013','Conference','Closed','University of California, San Francisco','','6500'),
('CG1-07538','12th Annual Gene Therapy Symposium for Heart, Lung, and Blood Diseases',NULL,'','Nov 1, 2013','Jan 31, 2014','Conference','Closed','University of California, Davis','','8000'),
('CG1-07539','World Stem Cell Summit',NULL,'','Nov 1, 2013','Jan 31, 2014','Conference','Closed','Scripps Research Institute','','30000'),
('TR4-06788-A','Programming Human ESC-derived Neural Stem Cells with MEF2C for Transplantation in Stroke',NULL,'Neurological Disorders, Stroke','Mar 1, 2014','Jun 30, 2015','Early Translational IV','Closed','Sanford Burnham Prebys Medical Discovery Institute','Embryonic Stem Cell','1020815'),
('TR4-06711','Engineered iPSC for therapy of limb girdle muscular dystrophy type 2B',NULL,'Muscular Dystrophy, Pediatrics, Skeletal/Smooth Muscle disorders','Jan 1, 2014','Dec 31, 2016','Early Translational IV','Closed','Stanford University','iPS Cell','1876253'),
('TR4-06867','Clinical Development of an N-cadherin Antibody to Target Cancer Stem Cells',NULL,'Cancer, Prostate Cancer, Solid Tumors','Mar 1, 2014','Jan 1, 2019','Early Translational IV','Closed','University of California, Los Angeles','Cancer Stem Cell','4075668'),
('TR4-06845','Stem Cell Programming With Chimeric Antigen Receptors to Eradicate HIV Infection',NULL,'HIV/AIDS, Infectious Disease','Jan 1, 2014','Dec 31, 2017','Early Translational IV','Closed','University of California, Los Angeles','Adult Stem Cell','4925166'),
('TR4-06648','Restoring vision by sheet transplants of retinal progenitors and retinal pigment epithelium (RPE) derived from human embryonic stem cells (hESCs)',NULL,'Vision Loss','Mar 1, 2014','Dec 31, 2017','Early Translational IV','Closed','University of California, Irvine','Embryonic Stem Cell','3998948'),
('TR4-06823','Beta-Globin Gene Correction of Sickle Cell Disease in Hematopoietic Stem Cells',NULL,'Blood Disorders, Pediatrics','Feb 1, 2014','Sep 30, 2017','Early Translational IV','Closed','University of California, Los Angeles','Adult Stem Cell','1651884'),
('TR4-06809','Development of a cell and gene based therapy for hemophilia',NULL,'Blood Disorders, Liver Disease, Metabolic Disorders, Pediatrics','Feb 1, 2014','Jan 31, 2017','Early Translational IV','Closed','Salk Institute for Biological Studies','iPS Cell','2298634'),
('TR4-06857','Improving Existing Drugs for Long QT Syndrome type 3 (LQT3) by hiPSC Disease-in-Dish Model',NULL,'Heart Disease','Dec 1, 2013','Feb 28, 2018','Early Translational IV','Closed','Human BioMolecular Research Institute','iPS Cell','6361369'),
('TR4-06831','Gene therapy-corrected autologous hepatocyte-like cells from induced pluripotent stem cells for the treatment of pediatric single enzyme disorders',NULL,'Genetic Disorder, Liver Disease, Metabolic Disorders, Pediatrics','Feb 1, 2014','Jan 31, 2018','Early Translational IV','Closed','University of California, Los Angeles','iPS Cell','1801629'),
('TR4-06788-B','Programming Human ESC-derived Neural Stem Cells with MEF2C for Transplantation in Stroke',NULL,'Neurological Disorders, Stroke','Jul 1, 2015','Feb 28, 2017','Early Translational IV','Closed','The Scintillon Institute','Embryonic Stem Cell','1103185'),
('TR4-06713','Gene Targeting to Endogenous Stem Cells for Segmental Bone Fracture Healing',NULL,'Arthritis, Bone or Cartilage Disease','Dec 1, 2013','Nov 30, 2017','Early Translational IV','Closed','Cedars-Sinai Medical Center','Adult Stem Cell','5121514'),
('TR4-06747','A drug-screening platform for autism spectrum disorders using human astrocytes',NULL,'Autism, Neurological Disorders, Pediatrics, Rett\'s Syndrome','Feb 1, 2014','Jan 31, 2017','Early Translational IV','Closed','University of California, San Diego','iPS Cell','1656456'),
('TR4-06693','Development of Novel Autophagy Inducers to Block the Progression of and Treat Amyotrophic Lateral Sclerosis (ALS) and Other Neurodegenerative Diseases',NULL,'Amyotrophic Lateral Sclerosis, Neurological Disorders','Mar 1, 2014','May 31, 2017','Early Translational IV','Closed','Gladstone Institutes, J. David','iPS Cell','2049053'),
('TR4-06847','Use of human iPSC-derived neurons from Huntington’s Disease patients to develop novel, disease-modifying small molecule structural corrector drug candidates targeting the unique, neurotoxic conformation of mutant huntingtin',NULL,'Huntington\'s Disease, Neurological Disorders','Dec 1, 2013','Nov 30, 2014','Early Translational IV','Closed','Numerate, Inc.','iPS Cell','520015'),
('CG1-07537','3rd International RB conference',NULL,'','Sep 1, 2013','Nov 30, 2013','Conference','Closed','Stanford University','','10000'),
('CG1-07547','Orange County Summit on Regenerative Medicine (OCSRM)',NULL,'','Sep 1, 2013','Nov 30, 2013','Conference','Closed','OCTANe Foundation for Innovation','','2500'),
('CG1-07581','IPITA 2013 - 14th World Congress of the International Pancreas and Islet transplant Association',NULL,'','Sep 1, 2013','Nov 30, 2013','Conference','Closed','University of California, San Francisco','','10000'),
('CG1-07541','International Society for Heart Research (ISHR) XX1 World Congress',NULL,'','Jun 1, 2013','Aug 31, 2013','Conference','Closed','University of California, San Diego','','10000'),
('LA1-06915','Epithelial progenitors and the stromal niche as therapeutic targets in lung disease',NULL,'Respiratory Disorders','Jul 1, 2013','Jun 30, 2019','Research Leadership','Closed','Cedars-Sinai Medical Center','iPS Cell','4841830'),
('LA1-06917','Generation of functional cells and organs from iPSCs',NULL,'Blood Disorders','Jun 1, 2014','May 31, 2020','Research Leadership','Closed','Stanford University','iPS Cell','5426810'),
('LA1-06919','Molecular Imaging for Stem Cell Science and Clinical Application',NULL,'Amyotrophic Lateral Sclerosis, Neurological Disorders, Spinal Cord Injury','Sep 1, 2013','Aug 31, 2021','Research Leadership','Active','University of California, San Diego','Embryonic Stem Cell, iPS Cell','5920899'),
('SP2-06902','A Treatment For Beta-thalassemia via High-Efficiency Targeted Genome Editing of Hematopoietic Stem Cells',NULL,'Blood Disorders, Pediatrics','Nov 1, 2013','Jun 30, 2015','Strategic Partnership II','Closed','Sangamo BioSciences, Inc.','Adult Stem Cell','2760540'),
('CG1-99052','Cell Therapy for amyotrophic Lateral Sclerosis (ALS) -Testing the Limits: What should we use as preclinical standards of clinical trials?',NULL,'Amyotrophic Lateral Sclerosis, Neurological Disorders','May 1, 2013','Jul 31, 2013','Conference','Closed','University of California, San Diego','','7193'),
('CG1-99048','UCSC Frontiers of Stem Cells and Aging Symposium',NULL,'Aging','May 1, 2013','Jul 31, 2013','Conference','Closed','University of California, Santa Cruz','','24405'),
('CG1-99051','The 14th UC Systemwide Bioengineering Symposium',NULL,'','May 1, 2013','Jul 31, 2013','Conference','Closed','University of California, San Diego','','5000'),
('IT1-06571','Induced pluripotent stem cells from children with autism spectrum disorders',NULL,'Autism, Neurological Disorders, Pediatrics','Oct 1, 2013','Sep 30, 2016','Tissue Collection for Disease Modeling','Closed','Stanford University','','530265'),
('IT1-06570','Using human induced pluripotent stem cells to improve our understanding of Idiopathic Pulmonary Fibrosis',NULL,'Respiratory Disorders','Oct 1, 2013','Sep 30, 2016','Tissue Collection for Disease Modeling','Closed','University of California, Los Angeles','','811231'),
('IT1-06596','Tissue Collection for Accelerating iPSC Research in Cardiovascular Diseases',NULL,'Heart Disease','Oct 1, 2013','Sep 30, 2016','Tissue Collection for Disease Modeling','Closed','Stanford University','','1291832'),
('IT1-06601','Generation of fibroblast cell lines in patients with common blinding eye diseases',NULL,'Vision Loss','Oct 1, 2013','Sep 30, 2016','Tissue Collection for Disease Modeling','Closed','University of California, San Diego','','1034425'),
('IT1-06611','CIRM Tissue Collection for Neurodevelopmental Disabilities',NULL,'Neurological Disorders, Pediatrics','Oct 1, 2013','Sep 30, 2016','Tissue Collection for Disease Modeling','Closed','University of California, San Diego','','830426'),
('IT1-06563','iPSC-derived Hepatocytes as Platforms for Research in Viral Hepatitis and Non-alcoholic Steatohepatitis',NULL,'Infectious Disease, Liver Disease, Metabolic Disorders','Oct 1, 2013','Mar 31, 2016','Tissue Collection for Disease Modeling','Closed','University of California, San Francisco','iPS Cell','791680'),
('IT1-06589','Collection of skin biopsies to prepare fibroblasts from patients with Alzheimer\'s disease and cognitively healthy elderly controls',NULL,'Alzheimer\'s Disease, Neurological Disorders','Oct 1, 2013','Sep 30, 2016','Tissue Collection for Disease Modeling','Closed','University of California, San Diego','','643693'),
('ID1-06557','Generation and characterization of  high-quality, footprint-free human induced pluripotent stem cell lines from 3,000 donors to investigate multigenic diseases',NULL,'Multiple Indications (Alpha Clinics)','Nov 1, 2013','Nov 30, 2017','hiPSC Derivation','Closed','Cellular Dynamics International','','16000000'),
('IR1-06600','The CIRM Human Pluripotent Stem Cell Biorepository – A Resource for Safe Storage and Distribution of High Quality iPSCs',NULL,'Multiple Indications (Alpha Clinics)','Dec 1, 2013','Nov 30, 2018','hPSC Repository','Closed','FUJIFILM Cellular Dynamics','iPS Cell','9942175'),
('CG1-99049','2013 Materials Research Society (MRS) Spring Meeting Symposium \"Design of Cell Instructive Materials\"',NULL,'','Mar 1, 2013','May 31, 2013','Conference','Closed','University of California, Los Angeles','','4000'),
('CG1-99046','2013 Rachmiel Diabetes and Obesity Levine Symposium - Advances in Diabetes Research',NULL,'Diabetes, Metabolic Disorders','Feb 1, 2013','Apr 30, 2013','Conference','Closed','City of Hope, Beckman Research Institute','','27750'),
('RN3-06510','White matter neuroregeneration after chemotherapy: stem cell therapy for “chemobrain”',NULL,'Brain Cancer, Cancer, Neurological Disorders, Solid Tumors','Jul 1, 2013','Jun 30, 2018','New Faculty Physician Scientist','Closed','Stanford University','Adult Stem Cell, iPS Cell','2800526'),
('RN3-06532','In Utero Embryonic Stem Cell Transplantation to Treat Congenital Anomalies',NULL,'Blood Disorders, Pediatrics','Jun 1, 2013','May 31, 2019','New Faculty Physician Scientist','Closed','University of California, San Francisco','Embryonic Stem Cell','2661742'),
('RN3-06530','Human iPSC modeling and therapeutics for degenerative peripheral nerve disease',NULL,'Neurological Disorders, Neuropathy','Apr 1, 2013','Mar 31, 2018','New Faculty Physician Scientist','Closed','Cedars-Sinai Medical Center','iPS Cell','3031737'),
('RN3-06378','Preclinical evaluation of human embryonic stem cell-derived cardiovascular progenitors in a large animal model',NULL,'Heart Disease','Jun 1, 2013','May 31, 2019','New Faculty Physician Scientist','Closed','University of California, Los Angeles','Embryonic Stem Cell','2930388'),
('RN3-06460','Tunable hydrogels for therapeutic delivery of multipotent stem cells.',NULL,'Skin Disease','Apr 1, 2013','Sep 30, 2018','New Faculty Physician Scientist','Closed','University of California, Davis','Adult Stem Cell','2771903'),
('RN3-06455','Human Induced Pluripotent Stem Cell-Derived Cardiovascular Progenitor Cells for Cardiac Cell Therapy.',NULL,'Heart Disease','Mar 1, 2013','May 31, 2017','New Faculty Physician Scientist','Closed','University of California, Los Angeles','iPS Cell','2316894'),
('RN3-06425','The generation and expansion of tissue-engineered small intestine from human stem/ progenitor cells: a preclinical study of functional translation',NULL,'Intestinal Disease, Metabolic Disorders','Jan 1, 2014','Dec 31, 2019','New Faculty Physician Scientist','Closed','Children\'s Hospital of Los Angeles','Adult Stem Cell','3146160'),
('RN3-06529','Enhancing hair cell regeneration in mouse and human inner ear',NULL,'Hearing Loss','Jun 1, 2013','May 31, 2018','New Faculty Physician Scientist','Closed','Stanford University','Adult Stem Cell','3088525'),
('RN3-06396','Human pluripotent stem cell-based therapeutics for preeclampsia',NULL,'Fertility','Jun 1, 2013','Nov 30, 2018','New Faculty Physician Scientist','Closed','University of California, San Diego','iPS Cell','2974750'),
('RN3-06525','Stem cell therapy for inflammatory bowel disease',NULL,'Intestinal Disease, Metabolic Disorders','Apr 1, 2013','Mar 31, 2018','New Faculty Physician Scientist','Closed','University of California, San Francisco','Adult Stem Cell, Embryonic Stem Cell','3019013'),
('RN3-06504','Characterization of Human Skeletal Muscle Stem Cells for Clinical Application',NULL,'Skeletal/Smooth Muscle disorders','Mar 1, 2013','Aug 31, 2018','New Faculty Physician Scientist','Closed','University of California, San Francisco','Adult Stem Cell','2959014'),
('RN3-06479','Human endothelial reprogramming for hematopoietic stem cell therapy.',NULL,'Blood Cancer, Blood Disorders, Cancer','May 1, 2013','Apr 30, 2018','New Faculty Physician Scientist','Closed','University of California, San Francisco','Directly Reprogrammed Cell, iPS Cell','2197683'),
('CG1-99047','The Best Next Steps: Setting a Path for Advancing Pediatric Neurology',NULL,'Neurological Disorders, Pediatrics','Dec 1, 2012','Feb 28, 2013','Conference','Closed','Children\'s Neurobiological Solutions (CNS) Foundation','','10000'),
('SP1-06513','Preclinical and clinical testing of a stem cell-based combination product for insulin-dependent diabetes','000000068','Diabetes, Metabolic Disorders','Sep 1, 2013','Aug 31, 2017','Strategic Partnership I','Closed','ViaCyte, Inc.','Embryonic Stem Cell','9475070'),
('CG1-99043','California ALS Summit 2012',NULL,'Amyotrophic Lateral Sclerosis, Neurological Disorders','Nov 1, 2012','Jan 31, 2013','Conference','Closed','Cedars-Sinai Medical Center','','6825'),
('CG1-99041','Cell Therapies in Trauma and Critical Care: Barriers in Translation from Pre-clinical to Clinical Development',NULL,'Trauma','Nov 1, 2012','Jan 31, 2013','Conference','Closed','Vitalant Research Institute','','18440'),
('CG1-99040','Stem Cells Craniofacial Development and Disease',NULL,'Developmental Disorders','Oct 1, 2012','Dec 31, 2012','Conference','Closed','University of California, San Francisco','','4500'),
('CG1-99045','The Sanford Consortium for Regenerative Medicine Symposium and the investor and Partnering Forum at Stem Cells on the Mesa',NULL,'','Oct 1, 2012','Dec 31, 2012','Conference','Closed','Sanford Consortium for Regenerative Medicine','','44000'),
('CG1-99039','11th Annual Gene Therapy Symposium for Heart, Lung, and Blood Diseases',NULL,'Blood Disorders, Heart Disease','Oct 1, 2012','Jan 31, 2013','Conference','Closed','University of California, Davis','','16850'),
('CG1-99042','ISSCR - Roddenberry International Symposium on Cellular reprogramming',NULL,'','Oct 1, 2012','Dec 31, 2012','Conference','Closed','Gladstone Institutes, J. David','','43000'),
('CG1-99038','Working 2 Walk Science & Advocacy Symposium',NULL,'','Oct 1, 2012','Dec 31, 2012','Conference','Closed','Research for Cure','','22113'),
('RB4-06087','Energy metabolism and aging pathways in human stem cell reprogramming and differentiation',NULL,'','May 1, 2013','Apr 30, 2016','Basic Biology IV','Closed','Stanford University','iPS Cell','1414044'),
('RB4-06036','Prostaglandin pathway regulation of self-renwal in hematopoietic and leukemia stem cells',NULL,'Blood Cancer, Cancer','Nov 1, 2012','Jan 31, 2016','Basic Biology IV','Closed','Stanford University','Adult Stem Cell, Cancer Stem Cell','1244455'),
('RB4-05764','Induction of Pluripotent Stem Cell-Derived Pacemaking Cells',NULL,'Heart Disease','Feb 1, 2013','Jan 31, 2017','Basic Biology IV','Closed','University of California, Davis','iPS Cell','1333689'),
('RB4-06028','Genetic dissection of human cellular reprogramming to pluripotency',NULL,'','Nov 1, 2012','Oct 31, 2015','Basic Biology IV','Closed','University of California, San Francisco','','1184883'),
('RB4-06277','Modeling Alexander disease using patient-specific induced pluripotent stem cells',NULL,'Neurological Disorders, Pediatrics','Jan 1, 2013','Dec 31, 2016','Basic Biology IV','Closed','City of Hope, Beckman Research Institute','','1366656'),
('RB4-05785','3D Modeling of Retina using Polymer Scaffolds for Understanding Disease Pathogenesis',NULL,'Vision Loss','Nov 1, 2012','Jan 31, 2016','Basic Biology IV','Closed','Buck Institute for Age Research','Embryonic Stem Cell, iPS Cell','1212553'),
('RB4-06144','Deciphering transcriptional control of pancreatic beta-cell maturation in vitro',NULL,'Diabetes, Metabolic Disorders','Nov 1, 2012','Oct 31, 2015','Basic Biology IV','Closed','University of California, San Diego','Embryonic Stem Cell','1258560'),
('RB4-05855','Modeling disease in human embryonic stem cells using new genetic tools',NULL,'Neurological Disorders, Neuropathy','Jan 1, 2013','Dec 31, 2015','Basic Biology IV','Closed','University of California, San Francisco','Embryonic Stem Cell','1387800'),
('RB4-06276','Studying Arrhythmogenic Right Ventricular Dysplasia with patient-specific iPS cells',NULL,'Heart Disease, Pediatrics','Jan 1, 2013','Jul 31, 2016','Basic Biology IV','Closed','Sanford Burnham Prebys Medical Discovery Institute','iPS Cell','1579250'),
('RB4-06102','Role of mechanical signaling in stem cell self-renewal and differentiation',NULL,'','Feb 1, 2013','Jan 31, 2017','Basic Biology IV','Closed','Stanford University','Embryonic Stem Cell','1062998'),
('RB4-05763','Long noncoding RNAs for pluripotency and cell fate commitment',NULL,'','Mar 1, 2013','Feb 28, 2016','Basic Biology IV','Closed','Stanford University','Embryonic Stem Cell','1386627'),
('RB4-05779','Regulation of Epidermal Self-Renewal and Differentiation by Histone and DNA Demethylases.',NULL,'Skin Disease','Feb 1, 2013','Jan 31, 2016','Basic Biology IV','Closed','University of California, San Diego','Adult Stem Cell','1080000'),
('RB4-06079','Common molecular mechanisms in neurodegenerative diseases using patient based iPSC neurons',NULL,'Huntington\'s Disease, Neurological Disorders, Parkinson\'s Disease','Nov 1, 2012','Oct 31, 2015','Basic Biology IV','Closed','Gladstone Institutes, J. David','iPS Cell','1395184'),
('RB4-06133','Understanding the status of the X chromosomes in human ESCs and preimplantation embryos',NULL,'','Mar 1, 2013','Feb 29, 2016','Basic Biology IV','Closed','University of California, Los Angeles','Embryonic Stem Cell','1382400'),
('RB4-05901','Epigenetic regulation of human cardiac differentiation',NULL,'Heart Disease','Mar 1, 2013','Feb 29, 2016','Basic Biology IV','Closed','Gladstone Institutes, J. David','Embryonic Stem Cell, iPS Cell','1568148'),
('RB4-06035','A new paradigm of lineage-specific reprogramming',NULL,'Heart Disease','Mar 1, 2013','Feb 29, 2016','Basic Biology IV','Closed','Gladstone Institutes, J. David','Directly Reprogrammed Cell','1568395'),
('RB4-06345','Role of the NMD RNA Decay Pathway in Maintaining the Stem-Like State',NULL,'Neurological Disorders','Nov 1, 2012','Oct 31, 2016','Basic Biology IV','Closed','University of California, San Diego','Embryonic Stem Cell','1360450'),
('RB4-06209','Trop2 dependent and independent mechanisms of self-renewal in human cancer stem cells',NULL,'Cancer, Prostate Cancer, Solid Tumors','Dec 1, 2012','Nov 30, 2015','Basic Biology IV','Closed','University of California, Los Angeles','Cancer Stem Cell','1254960'),
('RB4-05886','Mechanism and Utility of Direct Neuronal Conversion with a MicroRNA-Chromatin Switch',NULL,'Neurological Disorders','Nov 1, 2012','Oct 31, 2015','Basic Biology IV','Closed','Stanford University','Directly Reprogrammed Cell','1392150'),
('RB4-06158','DECIPHERING THE INSTRUCTIONS FOR VERTEBRATE HSC SPECIFICATION AND AMPLIFICATION.',NULL,'','Sep 1, 2013','Aug 31, 2016','Basic Biology IV','Closed','University of California, San Diego','Adult Stem Cell, Embryonic Stem Cell','1363698'),
('RB4-06244','Mechanisms to protect hESC-derived cells from allogenic immune rejection',NULL,'','Dec 1, 2012','Feb 29, 2016','Basic Biology IV','Closed','University of California, San Diego','Embryonic Stem Cell','1160997'),
('RB4-06093','Stem Cell Mechanisms Governing Discrete Waves of Gliogenesis in the Childhood Brain',NULL,'Neurological Disorders, Pediatrics','Feb 1, 2013','Jan 31, 2016','Basic Biology IV','Closed','Stanford University','Adult Stem Cell, Embryonic Stem Cell','1264248'),
('RB4-05825','Asymmetric stem cell division oriented by a local self-renewing signal',NULL,'','Apr 1, 2013','Mar 31, 2017','Basic Biology IV','Closed','Stanford University','Adult Stem Cell, Embryonic Stem Cell','1038600'),
('RB4-06045','Stem cell models to analyze the role of mutated C9ORF72 in neurodegeneration',NULL,'Amyotrophic Lateral Sclerosis, Dementia, Neurological Disorders','Mar 1, 2013','Feb 29, 2016','Basic Biology IV','Closed','University of California, San Diego','iPS Cell','1260360'),
('RB4-06215','Mechanism of heart regeneration by cardiosphere-derived cells',NULL,'Heart Disease','Dec 1, 2012','Nov 30, 2015','Basic Biology IV','Closed','Cedars-Sinai Medical Center','Adult Stem Cell','1367604'),
('RB4-05990','Investigation of the role of O-GlcNAcylation in SOX2 function during reprogramming',NULL,'','Nov 1, 2012','Oct 31, 2015','Basic Biology IV','Closed','University of California, San Francisco','iPS Cell','1260037'),
('RB4-06016','Transcriptional regulation of pluripotency in human embryonic stem cells',NULL,'','Dec 1, 2012','Nov 30, 2015','Basic Biology IV','Closed','University of California, Berkeley','Embryonic Stem Cell, iPS Cell','1220968'),
('DR2A-05394','Human Embryonic Stem Cell-Derived Cardiomyocytes for Patients with End Stage Heart Failure',NULL,'Heart Disease','Apr 1, 2013','Oct 30, 2019','Disease Team Therapy Development - Research','Closed','Stanford University','Embryonic Stem Cell','19060330'),
('DR2A-05365','A monoclonal antibody that depletes blood stem cells and enables chemotherapy free transplants','000000056','Blood Disorders, Immune Disease, Pediatrics, Severe Combined Immunodeficiency, X-linked (X-SCID)','Aug 1, 2013','Apr 30, 2020','Disease Team Therapy Development - Research','Closed','Stanford University','Adult Stem Cell','18990683'),
('DR2A-05309','Genetic Re-programming of Stem Cells to Fight Cancer','000000042','Cancer, Melanoma, Skin cancer, Solid Tumors','Apr 1, 2014','Nov 30, 2020','Disease Team Therapy Development - Research','Closed','University of California, Los Angeles','Adult Stem Cell','14144221'),
('DR2A-05423','Phase I study of IM Injection of VEGF-Producing MSC for the Treatment of Critical Limb Ischemia',NULL,'Vascular Disease','Feb 1, 2013','Sep 30, 2015','Disease Team Therapy Development - Research','Closed','University of California, Davis','Adult Stem Cell','3728384'),
('DR2A-05302','Treatment of non-traumatic osteonecrosis with endogenous Mesenchymal stem cells','000000045','Bone or Cartilage Disease, Osteonecrosis','Jan 1, 2013','Sep 30, 2021','Disease Team Therapy Development - Research','Active','University of California, Davis','Adult Stem Cell','19606481'),
('DR2A-05415','MSC engineered to produce BDNF for the treatment of Huntington\'s disease','000000029','Huntington\'s Disease, Neurological Disorders','Feb 1, 2013','Sep 30, 2016','Disease Team Therapy Development - Research','Closed','University of California, Davis','Adult Stem Cell','8924235'),
('DR2A-05320','Progenitor Cells Secreting GDNF for the Treatment of ALS',NULL,'Amyotrophic Lateral Sclerosis, Neurological Disorders','Feb 1, 2013','Apr 30, 2017','Disease Team Therapy Development - Research','Closed','Cedars-Sinai Medical Center','Adult Stem Cell','16168464'),
('LA1-06536','Repair and regeneration of the nephron',NULL,'Kidney Disease','Aug 1, 2012','Jul 31, 2018','Research Leadership','Closed','University of Southern California','Embryonic Stem Cell','5672206'),
('DR2A-05739','Retinal progenitor cells for treatment of retinitis pigmentosa','000000051','Retinitis Pigmentosa, Vision Loss','Jan 1, 2013','Dec 31, 2017','Disease Team Therapy Development - Research','Closed','University of California, Irvine','Adult Stem Cell','17144825'),
('TRX-05426','Combination therapy to Enhance Antisense Mediated Exon Skipping for Duchenne Muscular Dystrophy',NULL,'Muscular Dystrophy, Pediatrics, Skeletal/Smooth Muscle disorders','Mar 1, 2013','Feb 29, 2016','Early Translational from Disease Team Conversion','Closed','University of California, Los Angeles','Adult Stem Cell','1823545'),
('DR2A-05416','Restoration of memory in Alzheimer’s disease: a new paradigm using neural stem cell therapy',NULL,'Alzheimer\'s Disease, Neurological Disorders','Jul 1, 2013','Dec 11, 2014','Disease Team Therapy Development - Research','Closed','StemCells, Inc.','Adult Stem Cell','8901641'),
('DR2A-05735','Allogeneic Cardiac-Derived Stem Cells for Patients Following a Myocardial Infarction','000000024','Heart Disease, Heart failure','Jan 1, 2013','Dec 31, 2017','Disease Team Therapy Development - Research','Closed','Capricor, Inc','Adult Stem Cell','14405857'),
('TR3-05559','Human ES cell based therapy of heart failure without allogenic immune rejection',NULL,'Heart Disease','Oct 1, 2012','Mar 31, 2016','Early Translational III','Closed','University of California, San Diego','Embryonic Stem Cell','1857600'),
('TR3-05542','Generation of safe and therapeutically effective human induced hepatocyte-like cells',NULL,'Liver Disease, Metabolic Disorders','May 1, 2013','Apr 30, 2017','Early Translational III','Closed','University of California, San Francisco','Directly Reprogrammed Cell','1544170'),
('TR3-05535','Gene Correction of Autologous Hematopoietic Stem Cells in Artemis Deficient SCID',NULL,'Immune Disease, Pediatrics','Nov 1, 2012','Oct 31, 2016','Early Translational III','Closed','University of California, San Francisco','Adult Stem Cell','3862367'),
('TR3-05593','Direct Cardiac Reprogramming for Heart Regeneration',NULL,'Heart Disease','Nov 1, 2012','Oct 31, 2016','Early Translational III','Closed','Gladstone Institutes, J. David','Directly Reprogrammed Cell','5795871'),
('TR3-05709','Tissue engineered cartilage from autologous, dermis-isolated, adult, stem (DIAS) cells',NULL,'Bone or Cartilage Disease','Mar 1, 2013','Nov 30, 2016','Early Translational III','Closed','University of California, Davis','Adult Stem Cell','1735703'),
('TR3-05641','Targeting glioma cancer stem cells with receptor-engineered self-renewing memory T cells',NULL,'Brain Cancer, Cancer, Solid Tumors','Mar 1, 2013','Aug 31, 2016','Early Translational III','Closed','City of Hope, Beckman Research Institute','Adult Stem Cell','5215447'),
('TR3-05617','Targeting Stem Cells to Enhance Remyelination in the Treatment of Multiple Sclerosis',NULL,'Multiple Sclerosis, Neurological Disorders','Dec 1, 2012','May 31, 2016','Early Translational III','Closed','Scripps Research Institute','Adult Stem Cell','2559333'),
('TR3-05556','Heart Repair with Human Tissue Engineered Myocardium',NULL,'Heart Disease','Mar 1, 2013','Feb 29, 2016','Early Translational III','Closed','Stanford University','Embryonic Stem Cell','4396738'),
('TR3-05568','Direct reprogramming towards vascular progenitors for the treatment of ischemia',NULL,'Vascular Disease','Nov 1, 2012','Oct 31, 2015','Early Translational III','Closed','Salk Institute for Biological Studies','Directly Reprogrammed Cell','2340000'),
('TR3-05603','Multiple Sclerosis therapy: Human Pluripotent Stem Cell-Derived Neural Progenitor Cells',NULL,'Multiple Sclerosis, Neurological Disorders','Mar 1, 2013','May 31, 2016','Early Translational III','Closed','University of California, Irvine','Embryonic Stem Cell, iPS Cell','4535005'),
('TR3-05628','Functional Neural Relay Formation by Human Neural Stem Cell Grafting in Spinal Cord Injury',NULL,'Neurological Disorders, Spinal Cord Injury','Nov 1, 2012','Oct 31, 2015','Early Translational III','Closed','University of California, San Diego','Embryonic Stem Cell','4600447'),
('TR3-05676','Molecules to Correct Aberrant RNA Signature in Human Diseased Neurons',NULL,'Amyotrophic Lateral Sclerosis, Neurological Disorders','Dec 1, 2012','Nov 30, 2015','Early Translational III','Closed','University of California, San Diego','iPS Cell','1532323'),
('TR3-05669','Stem cell based small molecule therapy for Alzheimer\'s disease',NULL,'Alzheimer\'s Disease, Neurological Disorders','Sep 1, 2012','Aug 31, 2015','Early Translational III','Closed','Salk Institute for Biological Studies','Embryonic Stem Cell','1673757'),
('TR3-05501','Local Delivery of Rejuvenated Old Muscle Stem Cells to Increase Strength in Aged Patients',NULL,'Aging, Skeletal/Smooth Muscle disorders','Oct 1, 2012','Dec 31, 2015','Early Translational III','Closed','Stanford University','Adult Stem Cell','1825666'),
('TR3-05626','Extracellular Matrix Bioscaffold Augmented with Human Stem Cells for Cardiovascular Repair',NULL,'Heart Disease','Nov 1, 2012','Oct 31, 2015','Early Translational III','Closed','University of California, Davis','Adult Stem Cell','4631754'),
('TR3-05687','Identification of Novel Therapeutics for Danon Disease Using an iPS Model of the Disease',NULL,'Heart Disease, Pediatrics','Oct 1, 2012','Sep 30, 2016','Early Translational III','Closed','University of California, San Diego','iPS Cell','1701575'),
('TR3-05488','Generation of hepatic cell from placental stem cell for congenital metabolic disorders',NULL,'Liver Disease, Metabolic Disorders, Pediatrics','Oct 1, 2012','Sep 30, 2016','Early Translational III','Closed','University of Southern California','Adult Stem Cell','1750375'),
('TR3-05606','Human ES cell-derived MGE inhibitory interneuron transplantation for spinal cord injury',NULL,'Neurological Disorders, Spinal Cord Injury','Oct 1, 2012','Sep 30, 2015','Early Translational III','Closed','University of California, San Francisco','Embryonic Stem Cell','1623251'),
('TR3-05569','Autologous iPSC Therapy for Urinary Incontinence',NULL,'Incontinence','Dec 1, 2012','Nov 30, 2016','Early Translational III','Closed','Stanford University','iPS Cell','4715738'),
('TR3-05577','Identifying Drugs for Alzheimer\'s Disease with Human Neurons Made From Human IPS cells',NULL,'Alzheimer\'s Disease, Neurological Disorders','Oct 1, 2012','Sep 30, 2015','Early Translational III','Closed','University of California, San Diego','iPS Cell','1774420'),
('TR3-05476','Immune-Matched Neural Stem Cell Transplantation for Pediatric Neurodegenerative Disease',NULL,'Neurological Disorders, Pediatrics','Nov 1, 2012','Oct 31, 2016','Early Translational III','Closed','Children\'s Hospital of Orange County','Adult Stem Cell','4266015'),
('CG1-99037','University of California Systemwide Bioengineering Symposium 2012',NULL,'','May 1, 2012','Jul 31, 2012','Conference','Closed','University of California, Berkeley','','25200'),
('CG1-99035','The Stem Cell Niche in Development and Regeneration',NULL,'','May 1, 2012','Jul 31, 2012','Conference','Closed','University of Southern California','','7476'),
('RP1-05741','The HD iPSC Consortium: Repeat Length Dependent Phenotypes for Assay Development',NULL,'Huntington\'s Disease, Neurological Disorders','Jul 1, 2012','Jun 30, 2014','iPSC Consortia Award','Closed','Cedars-Sinai Medical Center','iPS Cell','300000'),
('TC1-05946','CHORI/UC Berkeley Summer Stem Cell Research Internship Program for High School Students',NULL,'','Jun 1, 2012','Dec 1, 2015','Creativity Awards','Closed','Children\'s Hospital of Oakland Research Institute','','151046'),
('TC1-05956','Stem Cell Summer Academy: Creating the Next Generation of Scientists',NULL,'','Jun 1, 2012','Nov 30, 2015','Creativity Awards','Closed','Scripps Research Institute','','205122'),
('TC1-05961','UCSF SEP High School Intern Program',NULL,'','Jun 1, 2012','Dec 1, 2015','Creativity Awards','Closed','University of California, San Francisco','','168947'),
('TC1-06070','Internship at a Cutting Edge CIRM-funded Stem Cell Research Facility',NULL,'','Jun 1, 2012','Dec 1, 2015','Creativity Awards','Closed','University of California, Davis','','250064'),
('TC1-06227','Creativity Award Program in Stem Cell Biology for California High School Students',NULL,'','Jun 1, 2012','Dec 1, 2015','Creativity Awards','Closed','City of Hope, Beckman Research Institute','','260825'),
('TC1-06252','Gladstone Summer Scholars (GSS) internship program',NULL,'','Jun 1, 2012','Dec 1, 2015','Creativity Awards','Closed','Gladstone Institutes, J. David','','35044'),
('TC1-06302','CIRM STAR High School Summer Research and Creativity Program',NULL,'','Jun 1, 2012','Dec 1, 2015','Creativity Awards','Closed','University of Southern California','','271160'),
('TC1-05787','Research Mentorship Program-Immersing High School Students in College Research',NULL,'','Jun 1, 2012','Dec 1, 2015','Creativity Awards','Closed','University of California, Santa Barbara','','280726'),
('TC1-05868','SIMR Program: Stem Cell & Developmental Biology Research Internships',NULL,'','Jun 1, 2012','Dec 1, 2015','Creativity Awards','Closed','Stanford University','','340611'),
('CG1-99036','Keystone Symposia, \'The Life of a Stem Cell: From Birth to Death\'',NULL,'','Mar 1, 2012','Mar 31, 2012','Conference','Closed','Stanford University','','50000'),
('CG1-99034','Stem Cell Research and Aging',NULL,'Aging','Feb 1, 2012','Apr 30, 2012','Conference','Closed','Buck Institute for Age Research','','30000'),
('CG1-99032','2012 Rachmiel Levine Diabetes and Obesity Symposium: Advances in Diabetes Research',NULL,'Diabetes, Metabolic Disorders','Jan 1, 2012','Mar 31, 2012','Conference','Closed','City of Hope, Beckman Research Institute','','15000'),
('CG1-99027','14th International Symposium on Neural Regeneration',NULL,'Neurological Disorders','Dec 1, 2011','Dec 31, 2011','Conference','Closed','International Symposium on Neural Regeneration, Inc.','','20000'),
('CG1-99031','Innovative Partnerships: Bringing Stem Cell Discoveries to the Clinic',NULL,'','Nov 1, 2011','Jan 31, 2012','Conference','Closed','City of Hope, Beckman Research Institute','','14994'),
('CG1-99030','Stem Cell Meeting on the Mesa: 6th Annual Scientific Symposium & 1st Annual Investor and Partnering Forum',NULL,'','Oct 1, 2011','Dec 31, 2011','Conference','Closed','Sanford Consortium for Regenerative Medicine','','40000'),
('CG1-99025','World Stem Cell Summit',NULL,'','Oct 1, 2011','Oct 31, 2012','Conference','Closed','California Institute of Technology','','50000'),
('CG1-99029-1','10th Annual Gene Therapy Symposium for Heart, Lung, and Blood Diseases',NULL,'Blood Disorders, Heart Disease','Nov 1, 2011','Jan 31, 2012','Conference','Closed','University of California, Davis','','18300'),
('DR2-05298','Airways for Children',NULL,'Respiratory Disorders','Sep 1, 2011','Feb 29, 2012','Disease Team Therapy Planning I','Closed','University of California, Davis','','19800'),
('DR2-05352','Anti-Notch1, OMP-52M51: A New Cancer Therapeutic to Reduce CSC Frequency',NULL,'Cancer','Sep 1, 2011','Feb 29, 2012','Disease Team Therapy Planning I','Closed','OncoMed Pharmaceuticals, Inc.','','65120'),
('DR2-05431','Neural Stem Cell-Based Therapy For Parkinson’s Disease',NULL,'Neurological Disorders, Parkinson\'s Disease','Sep 1, 2011','Feb 29, 2012','Disease Team Therapy Planning I','Closed','Sanford Burnham Prebys Medical Discovery Institute','','63952'),
('DR2-05288','Genetically Engineered Mesenchymal Stem Cells for the Treatment of Vertebral Compression Fractures.',NULL,'Bone or Cartilage Disease','Sep 1, 2011','Feb 29, 2012','Disease Team Therapy Planning I','Closed','Cedars-Sinai Medical Center','','107622'),
('DR2-05426','Combination therapy to Enhance Antisense Mediated Exon Skipping for Duchenne Muscular Dystrophy',NULL,'Muscular Dystrophy, Skeletal/Smooth Muscle disorders','Sep 1, 2011','Feb 29, 2012','Disease Team Therapy Planning I','Closed','University of California, Los Angeles','','68947'),
('DR2-05423','Phase I study of IM Injection of VEGF Producing MSC for the Treatment of Critical Limb Ischemia',NULL,'Heart Disease','Sep 1, 2011','Aug 31, 2012','Disease Team Therapy Planning I','Closed','University of California, Davis','','76066'),
('DR2-05415','MSC engineered to produce BDNF for the treatment of Huntington\'s disease',NULL,'Huntington\'s Disease, Neurological Disorders','Sep 1, 2011','Jun 30, 2012','Disease Team Therapy Planning I','Closed','University of California, Davis','','97564'),
('DR2-05365','A monoclonal antibody that depletes blood stem cells and enables chemotherapy free transplants',NULL,'Immune Disease','Sep 1, 2011','Feb 29, 2012','Disease Team Therapy Planning I','Closed','Stanford University','','90147'),
('DR2-05327','Stem Cell Gene Therapy for HIV in AIDS Lymphoma Patients',NULL,'Blood Cancer, Cancer, HIV/AIDS, Infectious Disease','Sep 1, 2011','Aug 31, 2012','Disease Team Therapy Planning I','Closed','University of California, Davis','','66880'),
('DR2-05416','Neuroprotection to treat Alzheimer\'s: a new paradigm using human central nervous system cells',NULL,'Alzheimer\'s Disease, Neurological Disorders','Sep 1, 2011','Feb 29, 2012','Disease Team Therapy Planning I','Closed','StemCells, Inc.','','90101'),
('DR2-05309','Genetic Re-programming of Stem Cells to Fight Cancer',NULL,'Cancer, Melanoma, Solid Tumors','Sep 1, 2011','Feb 29, 2012','Disease Team Therapy Planning I','Closed','University of California, Los Angeles','','97785'),
('DR2-05373','Recombinant Bispecific Antibody Targeting Cancer Stem Cells for the Therapy of Glioblastoma',NULL,'Brain Cancer, Cancer, Solid Tumors','Sep 1, 2011','Feb 29, 2012','Disease Team Therapy Planning I','Closed','Stanford University','','109750'),
('DR2-05368','Clinical Development of an osteoinductive therapy to prevent osteoporosis-related fractures',NULL,'Bone or Cartilage Disease','Sep 1, 2011','Feb 29, 2012','Disease Team Therapy Planning I','Closed','Samumed, LLC','','99110'),
('DR2-05272','hESC-derived NPCs Programmed with MEF2C for Cell Transplantation in Parkinson’s Disease',NULL,'Neurological Disorders, Parkinson\'s Disease','Sep 1, 2011','Feb 29, 2012','Disease Team Therapy Planning I','Closed','Sanford Burnham Prebys Medical Discovery Institute','','96448'),
('DR2-05320','Stem Cells Secreting GDNF for the Treatment of ALS',NULL,'Amyotrophic Lateral Sclerosis, Neurological Disorders','Sep 1, 2011','Feb 29, 2012','Disease Team Therapy Planning I','Closed','Cedars-Sinai Medical Center','','63487'),
('DR2-05410','A CIRM Disease Team to Develop Allopregnanolone for Prevention and Treatment of Alzheimer\'s Disease',NULL,'Alzheimer\'s Disease, Neurological Disorders','Sep 1, 2011','Feb 29, 2012','Disease Team Therapy Planning I','Closed','University of Southern California','','107961'),
('DR2-05394','Human Embryonic Stem Cell-Derived Cardiomyocytes for Patients with End Stage Heart Failure',NULL,'Heart Disease','Sep 1, 2011','Aug 31, 2012','Disease Team Therapy Planning I','Closed','Stanford University','','73030'),
('DR2-05302','Increasing the endogenous mesenchymal stem cells to the bone surface to treat osteoporosis',NULL,'Bone or Cartilage Disease','Sep 1, 2011','Feb 29, 2012','Disease Team Therapy Planning I','Closed','University of California, Davis','','107750'),
('CG1-99028','California ALS Summit 2011',NULL,'Amyotrophic Lateral Sclerosis, Neurological Disorders','Sep 1, 2011','Nov 30, 2011','Conference','Closed','University of California, Los Angeles','','13300'),
('CG1-99022','International RUNX Workshop',NULL,'','Aug 1, 2011','Aug 31, 2011','Conference','Closed','University of California, San Diego','','24000'),
('PA1-07523','CIRM Patent Prosecution Assistance Fund for Stem Cell Technologies - UCD',NULL,'','Jun 1, 2013','May 31, 2017','Patent Assistance Fund Awards','Closed','University of California, Davis','','48595'),
('PA1-07525','Patent Assistance Fund Proposal - UCSF',NULL,'','Sep 1, 2013','Aug 31, 2018','Patent Assistance Fund Awards','Closed','University of California, San Francisco','','87257'),
('PA1-07216','Intellectual Property in Regenerative Bioengineering from CIRM funded research in regenerative medicine at the University of California, Santa Barbara.',NULL,'','Apr 1, 2013','Mar 31, 2018','Patent Assistance Fund Awards','Closed','University of California, Santa Barbara','','23564'),
('PA1-08156','Intellectual Property for Stem Cell-Related Inventions - HBRI',NULL,'','Jul 1, 2014','Jun 30, 2019','Patent Assistance Fund Awards','Closed','Human BioMolecular Research Institute','','50000'),
('PA1-06899','Patent Assistance Fund Application - UCSD',NULL,'','Feb 1, 2013','Jan 31, 2018','Patent Assistance Fund Awards','Closed','University of California, San Diego','','38162'),
('PA1-06901','Funding for Patent Applications for CIRM-funded Inventions out of Stanford University',NULL,'','May 1, 2013','Apr 30, 2017','Patent Assistance Fund Awards','Closed','Stanford University','','3525'),
('PA1-06921','Patent Assistance Fund - UCLA',NULL,'','Mar 1, 2013','Feb 28, 2017','Patent Assistance Fund Awards','Closed','University of California, Los Angeles','','84973'),
('PA1-06938','CIRM Patent Assistance Fund Application - UCI',NULL,'','Mar 1, 2013','Feb 28, 2018','Patent Assistance Fund Awards','Closed','University of California, Irvine','','46155'),
('CG1-99026','8th Annual World Congress for Brain, Spinal Cord Mapping and Image Guided Therapy at Mission Bay Conference Center of UCSF School of Medicine',NULL,'Neurological Disorders','Jun 1, 2011','Jun 30, 2011','Conference','Closed','Brain Mapping Foundation','','17200'),
('RB3-05232','Induced Pluripotent Stem Cells for Tissue Regeneration',NULL,'Neurological Disorders, Neuropathy','Aug 1, 2011','Jul 31, 2014','Basic Biology III','Closed','University of California, Berkeley','iPS Cell','1209148'),
('RB3-05086','Characterization and Engineering of the Cardiac Stem Cell Niche',NULL,'Heart Disease','Jun 1, 2012','May 31, 2015','Basic Biology III','Closed','University of California, Los Angeles','iPS Cell','1127741'),
('RB3-05229','Investigation of synaptic defects in autism using patient-derived induced pluripotent stem cells',NULL,'Autism, Neurological Disorders, Pediatrics','Jul 1, 2011','Jun 30, 2013','Basic Biology III','Closed','University of California, San Diego','iPS Cell','843597'),
('RB3-02209','Correlated time-lapse imaging and single cell molecular analysis of human embryo development',NULL,'Fertility','Sep 1, 2011','Aug 31, 2014','Basic Biology III','Closed','Stanford University','Embryonic Stem Cell, iPS Cell','1259733'),
('RB3-05080','Discovery of mechanisms that control epigenetic states in human reprogramming and pluripotent cells',NULL,'','Dec 1, 2011','Nov 30, 2014','Basic Biology III','Closed','University of California, Los Angeles','iPS Cell','1364598'),
('RB3-05009','Neural and general splicing factors control self-renewal, neural survival and differentiation',NULL,'Amyotrophic Lateral Sclerosis, Dementia, Neurological Disorders','Jul 1, 2011','Jun 30, 2014','Basic Biology III','Closed','University of California, San Diego','Embryonic Stem Cell','1287619'),
('RB3-05100','Enhancer-mediated gene regulation during early human embryonic development',NULL,'','Aug 1, 2011','Jul 31, 2014','Basic Biology III','Closed','Stanford University','Embryonic Stem Cell','1420618'),
('RB3-02098','Molecular basis of human ES cell neurovascular differentiation and co-patterning',NULL,'','Jul 1, 2011','Jun 30, 2014','Basic Biology III','Closed','University of California, San Diego','Embryonic Stem Cell','1359996'),
('RB3-05103','Molecular Mechanisms Underlying Human Cardiac Cell Junction Maturation and Disease Using Human iPSC',NULL,'Heart Disease, Pediatrics','Jul 1, 2011','Jun 30, 2014','Basic Biology III','Closed','University of California, San Diego','iPS Cell','1341955'),
('RB3-02266','Biological relevance of microRNAs in hESC differentiation to endocrine pancreas',NULL,'Diabetes, Metabolic Disorders','Oct 1, 2011','Dec 31, 2014','Basic Biology III','Closed','University of California, San Diego','Embryonic Stem Cell','1313649'),
('RB3-05217','Forming the Hematopoietic Niche from Human Pluripotent Stem Cells',NULL,'Blood Disorders','Dec 1, 2011','Nov 30, 2015','Basic Biology III','Closed','University of California, Los Angeles','Embryonic Stem Cell','1252857'),
('RB3-05129','Elucidating Molecular Basis of Hypertrophic Cardiomyopathy with Human Induced Pluripotent Stem Cells',NULL,'Heart Disease','Sep 1, 2011','Aug 31, 2014','Basic Biology III','Closed','Stanford University','iPS Cell','1260537'),
('RB3-05174','Mechanisms of Direct Cardiac Reprogramming',NULL,'Heart Disease','Sep 1, 2011','Aug 31, 2014','Basic Biology III','Closed','Gladstone Institutes, J. David','','1572380'),
('RB3-05022','Triplet Repeat Instability in Human iPSCs',NULL,'Huntington\'s Disease, Neurological Disorders','Aug 1, 2011','Jul 31, 2014','Basic Biology III','Closed','Scripps Research Institute','iPS Cell','1705494'),
('RB3-05041','Phenotypic Analysis of Human ES Cell-Derived Muscle Stem Cells',NULL,'Muscular Dystrophy, Skeletal/Smooth Muscle disorders','Jul 1, 2011','Jun 30, 2015','Basic Biology III','Closed','University of California, San Francisco','Embryonic Stem Cell','1381296'),
('RB3-05207','Molecular determinants of accurate differentiation from human pluripotent stem cells',NULL,'','Aug 1, 2011','Feb 28, 2015','Basic Biology III','Closed','University of California, Los Angeles','Embryonic Stem Cell, iPS Cell','677115'),
('RB3-02129','Studying neurotransmission of normal and diseased human ES cell-derived neurons in vivo',NULL,'Autism, Neurological Disorders, Pediatrics, Rett\'s Syndrome','Aug 1, 2011','Feb 1, 2015','Basic Biology III','Closed','University of California, Los Angeles','Embryonic Stem Cell','1382400'),
('RB3-02165','Etsrp/ER71 mediated stem cell differentiation into vascular lineage',NULL,'','Sep 1, 2011','Aug 31, 2015','Basic Biology III','Closed','University of California, Los Angeles','Embryonic Stem Cell','1378781'),
('RB3-02143','Generation and characterization of corticospinal neurons from human embryonic stem cells',NULL,'Neurological Disorders','Jul 1, 2011','Sep 30, 2014','Basic Biology III','Closed','University of California, San Diego','Embryonic Stem Cell','1355063'),
('RB3-05066','USP16 controls stem cell number: implications for Down Syndrome',NULL,'Genetic Disorder','Aug 1, 2011','Jul 31, 2014','Basic Biology III','Closed','Stanford University','Adult Stem Cell','1263826'),
('RB3-02186','Identifying sources of mutation in human induced pluripotent stem cells by whole genome sequencing',NULL,'','Oct 1, 2011','Sep 30, 2014','Basic Biology III','Closed','Scripps Research Institute','iPS Cell','1705500'),
('RB3-05219','Viral-host interactions affecting neural differentiation of human progenitors',NULL,'Infectious Disease, Neurological Disorders, Pediatrics','Jul 1, 2011','Jun 30, 2014','Basic Biology III','Closed','University of California, San Diego','Embryonic Stem Cell','1372660'),
('RB3-05020','Genomic instability during culturing of human embryonic stem cells',NULL,'','Aug 1, 2011','Jul 31, 2014','Basic Biology III','Closed','University of California, San Francisco','Embryonic Stem Cell','1070919'),
('RB3-05083','Functional characterization of mutational load in nuclear reprogramming and differentiation',NULL,'','Jul 1, 2011','Jun 30, 2014','Basic Biology III','Closed','University of California, San Diego','iPS Cell','1295318'),
('RB3-02222','Ubiquitin-dependent control of hESC self-renewal and expansion',NULL,'','Oct 1, 2011','Sep 30, 2014','Basic Biology III','Closed','University of California, Berkeley','Embryonic Stem Cell','1224805'),
('RB3-02161','Use of human iPS cells to study spinal muscular atrophy',NULL,'Neurological Disorders, Pediatrics, Spinal Muscular Atrophy','Sep 1, 2011','Sep 30, 2014','Basic Biology III','Closed','City of Hope, Beckman Research Institute','iPS Cell','1268868'),
('RB3-02221','Understanding the role of LRRK2 in iPSC cell models of Parkinson\'s Disease',NULL,'Neurological Disorders, Parkinson\'s Disease','Aug 1, 2011','Jan 31, 2015','Basic Biology III','Closed','Parkinson\'s Institute','iPS Cell','1482822'),
('CG1-99023','12th Annual Systemwide Bioengineering Symposium',NULL,'','May 1, 2011','Jul 31, 2011','Conference','Closed','University of California, Santa Barbara','','15000'),
('CG1-99024','First Annual Stem Cell Therapies for Neurological Disorders: Overcoming the Current Barriers to Clinical Translation, April 30 (special stem cell program for high school students on April 28)',NULL,'Neurological Disorders','Apr 1, 2011','May 31, 2011','Conference','Closed','Cedars-Sinai Medical Center','','18500'),
('CG1-99021','2011 Rachmiel Levine Diabetes and Obesity Symposium: Advances in Diabetes Research',NULL,'Diabetes, Metabolic Disorders','Mar 1, 2011','Mar 31, 2011','Conference','Closed','City of Hope, Beckman Research Institute','','15000'),
('RT2-01880','Site-specific integration of Lmx1a, FoxA2, & Otx2 to optimize dopaminergic differentiation',NULL,'Neurological Disorders, Parkinson\'s Disease','May 1, 2011','Feb 28, 2015','Tools and Technologies II','Closed','Stanford University','iPS Cell','1592897'),
('RT2-02057','Tri-resolution Visualization System for Stem Cells and Tissue Regeneration Monitoring',NULL,'','Oct 1, 2011','Mar 31, 2015','Tools and Technologies II','Closed','TriFoil Imaging, Inc.','Adult Stem Cell','1456989'),
('RT2-01881','Development of a Hydrogel Matrix for Stem Cell Growth and Neural Repair after Stroke',NULL,'Neurological Disorders, Stroke','Jul 1, 2011','Oct 31, 2014','Tools and Technologies II','Closed','University of California, Los Angeles','iPS Cell','1825613'),
('RT2-02060','Antibody tools to deplete or isolate teratogenic, cardiac, and blood stem cells from hESCs',NULL,'Blood Disorders, Heart Disease, Liver Disease, Metabolic Disorders','Aug 1, 2011','Jul 31, 2014','Tools and Technologies II','Closed','Stanford University','Embryonic Stem Cell, iPS Cell','1463814'),
('RT2-01889','Development of Synthetic Microenvironments for Stem Cell Growth and Differentiation',NULL,'','Jun 1, 2011','Dec 1, 2014','Tools and Technologies II','Closed','University of California, San Diego','Embryonic Stem Cell','1706628'),
('RT2-02061','Cellular tools to study brain diseases affecting synaptic transmission',NULL,'Autism, Neurological Disorders, Pediatrics, Rett\'s Syndrome','Aug 1, 2011','Jul 31, 2014','Tools and Technologies II','Closed','Stanford University','Embryonic Stem Cell, iPS Cell','1664382'),
('RT2-01893','Magnetic Particle Imaging: A Novel Ultra-sensitive Imaging Scanner for Tracking Stem Cells In Vivo',NULL,'','May 1, 2011','Oct 31, 2014','Tools and Technologies II','Closed','University of California, Berkeley','Embryonic Stem Cell','1311596'),
('RT2-02064','Homologous recombination in human pluripotent stem cells using adeno-associated virus.',NULL,'','Apr 1, 2011','Sep 30, 2014','Tools and Technologies II','Closed','University of California, San Diego','Embryonic Stem Cell','1659043'),
('RT2-01906','Development of small molecule screens for autism using patient-derived iPS cells',NULL,'Autism, Neurological Disorders, Pediatrics','Apr 1, 2011','Mar 31, 2014','Tools and Technologies II','Closed','Stanford University','iPS Cell','1797606'),
('RT2-01920','Use of hiPSCs to develop lead compounds for the treatment of genetic diseases',NULL,'Neurological Disorders, Pediatrics','Apr 1, 2011','Mar 31, 2014','Tools and Technologies II','Closed','University of California, Los Angeles','iPS Cell','1833054'),
('RT2-01927','Developing a method for rapid identification of high-quality disease specific hIPSC lines',NULL,'Alzheimer\'s Disease, Neurological Disorders','Apr 1, 2011','Mar 31, 2014','Tools and Technologies II','Closed','University of California, San Diego','iPS Cell','1692334'),
('RT2-01938','Preparation and Delivery of Clinically Relevant Numbers of Stem Cells Using 3D Hydrogels',NULL,'','May 1, 2011','Apr 30, 2014','Tools and Technologies II','Closed','Stanford University','Adult Stem Cell','600695'),
('RT2-01942','Robust generation of induced pluripotent stem cells by a potent set of engineered factors',NULL,'','Aug 1, 2011','Jul 31, 2014','Tools and Technologies II','Closed','GMR Epigenetics','iPS Cell','1356052'),
('RT2-01965','Editing of Parkinson’s disease mutation in patient-derived iPSCs by zinc-finger nucleases',NULL,'Neurological Disorders, Parkinson\'s Disease','May 1, 2011','Apr 30, 2015','Tools and Technologies II','Closed','Parkinson\'s Institute','iPS Cell','1327983'),
('RT2-01975','Development and preclinical testing of new devices for cell transplantation to the brain.',NULL,'Neurological Disorders, Parkinson\'s Disease','May 1, 2011','Apr 30, 2015','Tools and Technologies II','Closed','University of California, San Francisco','','1795891'),
('RT2-01985','Pluripotent and Somatic Stem Cell Models to Study Inherited Diarrheal Disorders',NULL,'Genetic Disorder, Intestinal Disease, Metabolic Disorders, Pediatrics','May 1, 2011','Apr 30, 2015','Tools and Technologies II','Closed','University of California, Los Angeles','iPS Cell','1783250'),
('RT2-02018','Development of Single Cell MRI Technology using Genetically-Encoded Iron-Based Reporters',NULL,'Neurological Disorders, Stroke','Apr 1, 2011','Sep 30, 2014','Tools and Technologies II','Closed','Stanford University','Adult Stem Cell','1833348'),
('RT2-02022','Engineering Defined and Scaleable Systems for Dopaminergic Neuron Differentiation of hPSCs',NULL,'Neurological Disorders, Parkinson\'s Disease','Jun 1, 2011','May 31, 2014','Tools and Technologies II','Closed','University of California, Berkeley','Embryonic Stem Cell, iPS Cell','1340816'),
('RT2-02040','Use of iPS cells (iPSCs) to develop novels tools for the treatment of spinal muscular atrophy.',NULL,'Neurological Disorders, Pediatrics, Spinal Muscular Atrophy','May 1, 2011','Oct 31, 2014','Tools and Technologies II','Closed','Cedars-Sinai Medical Center','iPS Cell','1933022'),
('RT2-02052','Development and Application of Versatile, Automated, Microfluidic Cell Culture System',NULL,'','May 1, 2011','Apr 30, 2014','Tools and Technologies II','Closed','Fluidigm Corporation','iPS Cell','1939236'),
('CG1-99020','2011 Gordon Conference on Stem Cells and Cancer',NULL,'Cancer','Feb 1, 2011','Feb 28, 2011','Conference','Closed','Gordon Research Conferences','','40000'),
('CG1-99018','Stem Cell Meeting on Mesa',NULL,'','Dec 1, 2010','Dec 31, 2010','Conference','Closed','Sanford Consortium for Regenerative Medicine','','40000'),
('CG1-99016','Stem Cells: A New Avenue of HIV Research and New Approaches to HIV Treatment',NULL,'HIV/AIDS, Infectious Disease','Nov 1, 2010','Feb 28, 2011','Conference','Closed','University of California, Los Angeles','','24456'),
('CG1-99019','9th Annual Gene Therapy Symposium for Heart, Lung and Blood Diseases',NULL,'Blood Disorders, Heart Disease','Nov 1, 2010','Nov 30, 2010','Conference','Closed','University of California, Davis','','12000'),
('CG1-99017','New Approaches in Cell Based Therapies',NULL,'','Nov 1, 2010','Nov 30, 2010','Conference','Closed','City of Hope, Beckman Research Institute','','20000'),
('TR2-01844','New Drug Discovery for SMA using Patient-derived Induced Pluripotent Stem Cells',NULL,'Neurological Disorders, Pediatrics, Spinal Muscular Atrophy','Apr 1, 2011','Sep 19, 2012','Early Translational II','Closed','iPierian, Inc.','iPS Cell','2410000'),
('TR2-01787','Bone Marrow Mesenchymal Stem Cells to Heal Chronic Diabetic Wounds',NULL,'Skin Disease','Sep 1, 2011','Aug 31, 2015','Early Translational II','Closed','University of California, Davis','Adult Stem Cell','4629747'),
('TR2-01816-B','Dual targeting of tyrosine kinase and BCL6 signaling for leukemia stem cell eradication',NULL,'Blood Cancer, Cancer','Apr 1, 2013','Sep 30, 2015','Early Translational II','Closed','University of California, San Francisco','Cancer Stem Cell','2756536'),
('TR2-01749','Inhibitory Nerve Cell Precursors: Dosing, Safety and Efficacy',NULL,'Epilepsy, Neurological Disorders, Pediatrics','May 1, 2011','Apr 30, 2014','Early Translational II','Closed','University of California, San Francisco','Embryonic Stem Cell','1564016'),
('TR2-01821','Harnessing native fat-residing stem cells for bone regeneration',NULL,'Bone or Cartilage Disease','Feb 1, 2011','Aug 31, 2014','Early Translational II','Closed','University of California, Los Angeles','Adult Stem Cell','5359076'),
('TR2-01767','Neural restricted, FAC-sorted, human neural stem cells to treat traumatic brain injury',NULL,'Neurological Disorders, Trauma','May 1, 2011','Oct 30, 2014','Early Translational II','Closed','University of California, Irvine','Embryonic Stem Cell','1517767'),
('TR2-01780','Systemic Adult Stem Cell Therapy for Osteoporosis-Related Vertebral Compression Fractures',NULL,'Bone or Cartilage Disease','Mar 1, 2011','Feb 28, 2014','Early Translational II','Closed','Cedars-Sinai Medical Center','Adult Stem Cell','1927698'),
('LA1-02086','Development of Cellular Therapies for Retinal Disease',NULL,'Vision Loss','Nov 1, 2011','Oct 31, 2017','Research Leadership','Closed','University of California, Santa Barbara','Embryonic Stem Cell, iPS Cell','4690963'),
('TR2-01832','Developing a therapeutic candidate for Canavan disease using induced pluripotent stem cell',NULL,'Genetic Disorder, Neurological Disorders, Pediatrics','Jun 1, 2011','May 31, 2015','Early Translational II','Closed','City of Hope, Beckman Research Institute','iPS Cell','1835983'),
('TR2-01756','Stem Cell Therapy for Duchenne Muscular Dystrophy',NULL,'Muscular Dystrophy, Pediatrics, Skeletal/Smooth Muscle disorders','Feb 1, 2011','Apr 30, 2014','Early Translational II','Closed','Stanford University','iPS Cell','2267261'),
('TR2-01856','Banking transplant ready dopaminergic neurons using a scalable process',NULL,'Neurological Disorders, Parkinson\'s Disease','Jun 1, 2011','Aug 31, 2014','Early Translational II','Closed','Buck Institute for Age Research','Embryonic Stem Cell','4983013'),
('TR2-01785-A','Repair of Conus Medullaris/Cauda Equina Injury using Human ES Cell-Derived Motor Neurons',NULL,'Neurological Disorders, Spinal Cord Injury','Jun 1, 2011','Jan 31, 2015','Early Translational II','Closed','University of California, Irvine','Embryonic Stem Cell','1527011'),
('TR2-01857','Liver Cell Transplantation',NULL,'Liver Disease, Metabolic Disorders','Apr 1, 2011','Mar 31, 2014','Early Translational II','Closed','University of California, Davis','Embryonic Stem Cell','4212621'),
('TR2-01778','Crosstalk: Inflammation in Parkinson’s disease (PD) in a humanized in vitro model',NULL,'Neurological Disorders, Parkinson\'s Disease','May 1, 2011','Apr 30, 2014','Early Translational II','Closed','Salk Institute for Biological Studies','iPS Cell','2472839'),
('TR2-01791','Stem cell-based carriers for RCR vector delivery to glioblastoma',NULL,'Brain Cancer, Cancer, Solid Tumors','Jul 1, 2011','Dec 31, 2014','Early Translational II','Closed','University of California, Los Angeles','Adult Stem Cell','3340625'),
('TR2-01768-B','Regeneration of Functional Human Corneal Epithelial Progenitor Cells',NULL,'Vision Loss','Aug 1, 2014','Apr 30, 2015','Early Translational II','Closed','University of California, Los Angeles','Adult Stem Cell','697507'),
('TR2-01789','Preclinical development of a pan Bcl2 inhibitor for cancer stem cell directed therapy',NULL,'Blood Cancer, Cancer','May 1, 2011','Apr 30, 2014','Early Translational II','Closed','University of California, San Diego','Cancer Stem Cell','3103041'),
('TR2-01841','A hESc-based Development Candidate for Huntington\'s Disease',NULL,'Huntington\'s Disease, Neurological Disorders','Jun 1, 2011','Aug 31, 2015','Early Translational II','Closed','University of California, Irvine','Embryonic Stem Cell','3955038'),
('TR2-01814','Developing a drug-screening system for Autism Spectrum Disorders using human neurons',NULL,'Autism, Neurological Disorders, Pediatrics','Apr 1, 2011','Oct 31, 2014','Early Translational II','Closed','University of California, San Diego','iPS Cell','1376198'),
('TR2-01771','Development of RNA-based approaches to stem cell gene therapy for HIV',NULL,'HIV/AIDS, Immune Disease, Infectious Disease','Apr 1, 2011','Jul 31, 2014','Early Translational II','Closed','City of Hope, Beckman Research Institute','Adult Stem Cell','3097160'),
('TR2-01768','Regeneration of Functional Human Corneal Epithelial Progenitor Cells',NULL,'Vision Loss','Mar 1, 2011','Feb 28, 2014','Early Translational II','Closed','University of California, Los Angeles','Adult Stem Cell','1524947'),
('TR2-01816-A','Dual targeting of tyrosine kinase and BCL6 signaling for leukemia stem cell eradication',NULL,'Blood Cancer, Cancer','Oct 1, 2011','Mar 31, 2013','Early Translational II','Closed','Children\'s Hospital of Los Angeles','Cancer Stem Cell','850769'),
('TR2-01794','Human retinal progenitor cells as candidate therapy for retinitis pigmentosa',NULL,'Vision Loss','Jul 1, 2011','Sep 30, 2012','Early Translational II','Closed','University of California, Irvine','Adult Stem Cell','1803768'),
('TR2-01785-B','Repair of Conus Medullaris/Cauda Equina Injury using Human ES Cell-Derived Motor Neurons',NULL,'Neurological Disorders, Spinal Cord Injury','Mar 1, 2015','May 31, 2015','Early Translational II','Closed','University of California, Los Angeles','Embryonic Stem Cell','75628'),
('TR2-01829','Cartilage Regeneration by the Chondrogenic Small Molecule PRO1 during Osteoarthritis',NULL,'Arthritis, Bone or Cartilage Disease','Feb 1, 2011','Dec 31, 2014','Early Translational II','Closed','Scripps Research Institute','Adult Stem Cell','6047249'),
('CG1-99013','Translation of Stem Cell Therapies: Strategies and Best Practices for PreClinical Developments',NULL,'','Sep 27, 2010','Nov 28, 2010','Conference','Closed','Vitalant Research Institute','','25000'),
('CG1-99015','CA-HSCI 1st Generation Stem Cell PI Meeting',NULL,'','Sep 1, 2010','Sep 30, 2010','Conference','Closed','University of California, San Francisco','','20000'),
('CG1-99014','ISSCR 8th Annual Meeting - San Francisco',NULL,'','Jun 1, 2010','Jun 30, 2010','Conference','Closed','International Society for Stem Cell Research','','62475'),
('LA1-01747','The role of neural stem cells in cerebellar development, regeneration and tumorigenesis',NULL,'Brain Cancer, Cancer, Solid Tumors','Nov 1, 2010','Oct 31, 2017','Research Leadership','Closed','Sanford Burnham Prebys Medical Discovery Institute','','5226049'),
('RB2-01530','Molecular Characterization and Functional Exploration of Nuclear Receptors in hiPSCs',NULL,'','Aug 1, 2010','Jul 31, 2013','Basic Biology II','Closed','Salk Institute for Biological Studies','Embryonic Stem Cell, iPS Cell','1712880'),
('RM1-01724','Donor natural killer (NK) cells as “veto” cells to promote donor-specific tolerance',NULL,'','Oct 1, 2010','Sep 30, 2013','Transplantation Immunology','Closed','University of California, Davis','Embryonic Stem Cell, iPS Cell','1257601'),
('RB2-01628','Cellular Reprogramming: Dissecting the Molecular Mechanism and Enhancing Efficiency',NULL,'Neurological Disorders','Sep 1, 2010','Aug 31, 2013','Basic Biology II','Closed','iPierian, Inc.','iPS Cell','1458000'),
('RM1-01725','Regulatory T cell induced tolerance to ESC transplantation',NULL,'','Sep 1, 2010','Nov 30, 2013','Transplantation Immunology','Closed','Stanford University','','1382658'),
('RB2-01567','Differentiation of Human Embryonic Stem Cells into Urothelium',NULL,'Pediatrics','Oct 1, 2010','Dec 31, 2012','Basic Biology II','Closed','University of California, Davis','Embryonic Stem Cell','849037'),
('RM1-01729','Generation of regulatory T cells by reprogramming',NULL,'Immune Disease','Nov 1, 2010','Oct 31, 2013','Transplantation Immunology','Closed','La Jolla Institute for Allergy and Immunology','Adult Stem Cell','1464446'),
('RM1-01730','Inactivating  NK cell reactivity to facilitate transplantation of stem cell derived tissue',NULL,'Blood Disorders','Dec 1, 2010','Nov 30, 2013','Transplantation Immunology','Closed','University of California, Berkeley','Adult Stem Cell','952896'),
('RB2-01637','Systemic Protein Factors as Modulators of the Aging Neurogenic Niche',NULL,'Alzheimer\'s Disease, Neurological Disorders','Sep 1, 2010','Feb 28, 2014','Basic Biology II','Closed','Palo Alto Veterans Institute for Research','Embryonic Stem Cell, iPS Cell','1159806'),
('RM1-01732','Human Immune System Mouse models as preclinical platforms for stem cell derived grafts',NULL,'Immune Disease','Sep 1, 2010','Aug 31, 2013','Transplantation Immunology','Closed','University of California, Berkeley','Embryonic Stem Cell','1005605'),
('RB2-01502','Programs of alternative splicing regulation by polypyrimidine tract binding protein',NULL,'','Aug 1, 2010','Jul 31, 2014','Basic Biology II','Closed','University of California, Los Angeles','Embryonic Stem Cell','1344562'),
('RM1-01733','Purified allogeneic hematopoietic stem cells as a platform for tolerance induction',NULL,'Blood Disorders, Immune Disease, Muscular Dystrophy, Skeletal/Smooth Muscle disorders','Oct 1, 2010','Sep 30, 2013','Transplantation Immunology','Closed','Stanford University','Adult Stem Cell','1233275'),
('RB2-01562','Novel Mechanism in Self-Renewal/Differentiation of Human Embryonic Stem Cells',NULL,'','Aug 1, 2010','Nov 30, 2013','Basic Biology II','Closed','University of California, Los Angeles','Embryonic Stem Cell','1259371'),
('RM1-01702','Stem cell differentiation to thymic epithelium for inducing tolerance to stem cells',NULL,'HIV/AIDS, Immune Disease, Infectious Disease, Pediatrics','Oct 1, 2010','Sep 30, 2014','Transplantation Immunology','Closed','University of California, San Francisco','Embryonic Stem Cell, iPS Cell','1314089'),
('RM1-01735-B','Role of HLA in neural stem cell rejection using humanized mice',NULL,'Neurological Disorders','May 1, 2013','Sep 30, 2014','Transplantation Immunology','Closed','University of Southern California','Embryonic Stem Cell','353249'),
('RB2-01497','Self-renewal and senescence in iPS cells derived from patients with a stem cell disease',NULL,'Blood Disorders, Pediatrics','Apr 1, 2011','Mar 31, 2015','Basic Biology II','Closed','Stanford University','Embryonic Stem Cell, iPS Cell','931285'),
('RM1-01703','Stem cell tolerance through the use of engineered antigen-specific regulatory T cells',NULL,'Diabetes, Immune Disease, Metabolic Disorders','Dec 31, 2010','Dec 30, 2013','Transplantation Immunology','Closed','University of California, San Francisco','Embryonic Stem Cell','1152768'),
('RM1-01739','Engineered immune tolerance by Stem Cell-derived thymic regeneration',NULL,'Immune Disease, Pediatrics','Dec 1, 2010','May 30, 2014','Transplantation Immunology','Closed','Stanford University','Adult Stem Cell','1271729'),
('RB2-01512','Endothelial cells and ion channel maturation of human stem cell-derived cardiomyocytes',NULL,'','Oct 1, 2010','Mar 31, 2014','Basic Biology II','Closed','Sanford Burnham Prebys Medical Discovery Institute','Embryonic Stem Cell','1587610'),
('RM1-01706','Engineering Embryonic Stem Cell Allografts for Operational Tolerance',NULL,'','Oct 1, 2010','Dec 31, 2013','Transplantation Immunology','Closed','Stanford University','Adult Stem Cell, iPS Cell','1411338'),
('RM1-01743','Induction of immune tolerance to human embryonic stem cell-derived allografts',NULL,'Immune Disease','Sep 1, 2010','Aug 31, 2013','Transplantation Immunology','Closed','University of California, San Diego','Embryonic Stem Cell','1192680'),
('RB2-01602','MGE Enhancers to Select for Interneuron Precursors Produced from Human ES Cells',NULL,'Epilepsy, Neurological Disorders','Aug 1, 2010','Jul 31, 2013','Basic Biology II','Closed','University of California, San Francisco','Embryonic Stem Cell','1387800'),
('RM1-01707','Engineering Thymic Regeneration to Induce Tolerance',NULL,'Immune Disease','Dec 1, 2010','May 31, 2014','Transplantation Immunology','Closed','University of California, Los Angeles','','1235445'),
('RM1-01735-A','Role of HLA in neural stem cell rejection using humanized mice',NULL,'Neurological Disorders','Oct 1, 2010','May 31, 2013','Transplantation Immunology','Closed','Cedars-Sinai Medical Center','Embryonic Stem Cell','1119385'),
('RB2-01592','Kinase signaling analysis of iPS cell reprogramming and differentiation',NULL,'','Aug 1, 2010','Apr 30, 2013','Basic Biology II','Closed','Stanford University','iPS Cell','1343100'),
('RM1-01709','Role of Innate Immunity in hematopoeitic stem cell-mediated allograft tolerance',NULL,'Blood Disorders, Immune Disease','Sep 1, 2010','Aug 31, 2013','Transplantation Immunology','Closed','Scripps Research Institute','Adult Stem Cell','1705554'),
('RB2-01496','Role of the microenvironment in human iPS and NSC fate and tumorigenesis',NULL,'Neurological Disorders, Spinal Cord Injury','Oct 1, 2010','Sep 30, 2013','Basic Biology II','Closed','University of California, Irvine','Adult Stem Cell, Embryonic Stem Cell','1256194'),
('RM1-01710','Application of Tolerogenic Dendritic Cells for Hematopoietic Stem Cell Transplantation',NULL,'Immune Disease','Oct 1, 2010','Dec 31, 2012','Transplantation Immunology','Closed','Palo Alto Veterans Institute for Research','Adult Stem Cell','733061'),
('RB2-01629','TCF-3:  A Wnt Pathway Effector and Nanog Regulator in Pluripotent Stem Cell Self-Renewal',NULL,'','Aug 1, 2010','Apr 30, 2014','Basic Biology II','Closed','University of California, Irvine','Embryonic Stem Cell, iPS Cell','1259879'),
('RB2-01645','RUNX1 in maintenance, expansion, and differentiation of therapeutic pluripotent stem cells',NULL,'','Aug 1, 2010','Oct 31, 2013','Basic Biology II','Closed','University of California, San Diego','Embryonic Stem Cell, iPS Cell','1371540'),
('RM1-01711','Development of an immune tolerant hESC source for allogeneic cell therapy applications',NULL,'','Sep 1, 2010','Aug 31, 2013','Transplantation Immunology','Closed','Escape Therapeutics, Inc','Embryonic Stem Cell','1453040'),
('RB2-01547','The function of YAP in human embryonic stem cells',NULL,'','Jul 1, 2010','Jun 30, 2013','Basic Biology II','Closed','University of California, San Diego','Embryonic Stem Cell, iPS Cell','1245693'),
('RM1-01717','Thymus based tolerance to stem cell therapies',NULL,'Immune Disease','Feb 1, 2011','Jan 31, 2014','Transplantation Immunology','Closed','Scripps Research Institute','Embryonic Stem Cell, iPS Cell','1108921'),
('RB2-01571','The EphrinB2/EphB4 axis in regulating hESC pluripotency and differentiation',NULL,'','Aug 1, 2010','Jul 31, 2013','Basic Biology II','Closed','University of California, Los Angeles','Embryonic Stem Cell','1371936'),
('RM1-01718','Maternal and Fetal Immune Responses to In Utero Hematopoietic Stem Cell Transplantation',NULL,'Blood Disorders, Immune Disease, Pediatrics','Dec 1, 2010','Oct 31, 2014','Transplantation Immunology','Closed','University of California, San Francisco','Other','1230869'),
('RB2-01553','Maturation of Human Oocytes for SCNT and Embryonic Stem Cell Derivation',NULL,'Fertility','Aug 1, 2010','Jul 31, 2013','Basic Biology II','Closed','Stanford University','SCNT','1309018'),
('RM1-01720','Induction of immune tolerance after spinal grafting of human ES-derived neural precursors',NULL,'Neurological Disorders, Spinal Cord Injury','Sep 1, 2010','Aug 31, 2013','Transplantation Immunology','Closed','University of California, San Diego','Embryonic Stem Cell, iPS Cell','1387800'),
('CG1-99011','Systems Biology of Stem Cells',NULL,'','May 1, 2010','May 31, 2010','Conference','Closed','University of California, Irvine','','25000'),
('DR1-01461','Autologous cardiac-derived cells for advanced ischemic cardiomyopathy',NULL,'Heart Disease','Mar 1, 2010','Sep 30, 2012','Disease Team Research I','Closed','Cedars-Sinai Medical Center','Adult Stem Cell','5560232'),
('DR1-01490','ZINC FINGER NUCLEASE-BASED STEM CELL THERAPY FOR AIDS',NULL,'HIV/AIDS, Immune Disease, Infectious Disease','May 1, 2010','Sep 30, 2014','Disease Team Research I','Closed','City of Hope, Beckman Research Institute','Adult Stem Cell','14536969'),
('DR1-01431','HPSC based therapy for HIV disease using RNAi to CCR5.',NULL,'HIV/AIDS, Immune Disease, Infectious Disease','Jun 1, 2010','Aug 31, 2012','Disease Team Research I','Closed','University of California, Los Angeles','Adult Stem Cell','9905604'),
('DR1-01426','Stem Cell-Mediated Oncocidal Gene Therapy of Glioblastoma (GBM)',NULL,'Brain Cancer, Cancer, Solid Tumors','Apr 1, 2010','Mar 31, 2012','Disease Team Research I','Closed','University of California, San Francisco','Adult Stem Cell','6214914'),
('DR1-01444','Stem cell based treatment strategy for Age-related Macular Degeneration (AMD)',NULL,'Vision Loss','Apr 1, 2010','Dec 31, 2014','Disease Team Research I','Closed','University of Southern California','Embryonic Stem Cell','18904916'),
('DR1-01471','Stem Cell-Derived Astrocyte Precursor Transplants in Amyotrophic Lateral Sclerosis',NULL,'Amyotrophic Lateral Sclerosis, Neurological Disorders','Jun 1, 2010','Sep 30, 2012','Disease Team Research I','Closed','University of California, San Diego','Embryonic Stem Cell','5694308'),
('DR1-01430','Development of Highly Active Anti-Leukemia Stem Cell Therapy (HALT)',NULL,'Blood Cancer, Cancer','Mar 1, 2010','Feb 28, 2014','Disease Team Research I','Closed','University of California, San Diego','Cancer Stem Cell','19999826'),
('DR1-01454','iPS Cell-Based Treatment of Dominant Dystrophic Epidermolysis Bullosa',NULL,'Epidermolysis Bullosa, Pediatrics, Skin Disease','May 1, 2010','Jan 31, 2015','Disease Team Research I','Closed','Stanford University','iPS Cell','11039208'),
('DR1-01421','Stem Cell-mediated Therapy for High-grade Glioma:  Toward Phase I-II Clinical Trials',NULL,'Brain Cancer, Cancer, Solid Tumors','Mar 1, 2010','Feb 28, 2015','Disease Team Research I','Closed','City of Hope, Beckman Research Institute','Adult Stem Cell','17890623'),
('DR1-01480','Embryonic-Derived Neural Stem Cells for Treatment of Motor Sequelae following Sub-cortical Stroke',NULL,'Neurological Disorders, Stroke','Feb 1, 2010','Mar 31, 2015','Disease Team Research I','Closed','Stanford University','Embryonic Stem Cell','17244851'),
('DR1-01477','Therapeutic Opportunities To Target Tumor Initiating Cells in Solid Tumors',NULL,'Cancer, Solid Tumors','May 1, 2010','Apr 30, 2015','Disease Team Research I','Closed','University of California, Los Angeles','Cancer Stem Cell','19979660'),
('DR1-06893','GENE-MODIFIED HEMATOPOIETIC STEM/PROGENITOR CELL BASED THERAPY FOR HIV DISEASE','000000026','HIV/AIDS, Infectious Disease','Feb 1, 2013','Jan 31, 2016','Disease Team Research I','Closed','Calimmune, Inc.','Adult Stem Cell','8278722'),
('DR1-01452','Stem Cell Gene Therapy for Sickle Cell Disease',NULL,'Blood Disorders, Pediatrics, Sickle Cell Disease','Mar 1, 2010','Jun 30, 2014','Disease Team Research I','Closed','University of California, Los Angeles','Adult Stem Cell','8833695'),
('TRX-01431','Development of a humanized mouse model for testing anti-HIV HSPC gene therapy strategies in HIV-1 infected mice.',NULL,'HIV/AIDS, Infectious Disease','Sep 1, 2012','Nov 30, 2014','Early Translational from Disease Team Conversion','Closed','University of California, Los Angeles','Adult Stem Cell','1505000'),
('DR1-01485','Development of Therapeutic Antibodies Targeting Human Acute Myeloid Leukemia Stem Cells',NULL,'Blood Cancer, Cancer','Mar 1, 2010','Feb 28, 2015','Disease Team Research I','Closed','Stanford University','Cancer Stem Cell','18759276'),
('TRX-01471','Stem Cell-Derived Astrocyte Precursor Transplants in Amyotrophic Lateral Sclerosis',NULL,'Amyotrophic Lateral Sclerosis, Neurological Disorders','Oct 1, 2012','Mar 31, 2015','Early Translational from Disease Team Conversion','Closed','University of California, San Diego','Embryonic Stem Cell','4139754'),
('DR1-01423','Cell Therapy for Diabetes',NULL,'Diabetes, Metabolic Disorders','Feb 1, 2010','Jul 31, 2014','Disease Team Research I','Closed','ViaCyte, Inc.','Embryonic Stem Cell','22999933'),
('CG1-99010','Stem Cell Meeting on the Mesa',NULL,'','Nov 1, 2009','Nov 30, 2009','Conference','Closed','Sanford Consortium for Regenerative Medicine','','40000'),
('RB1-01413','RNA Binding Protein-mediated Post-transcriptional Networks Regulating HPSC Pluripotency',NULL,'','Oct 1, 2009','Sep 30, 2012','Basic Biology I','Closed','University of California, San Diego','Embryonic Stem Cell, iPS Cell','1308901'),
('RB1-01385','The retinoblastoma (RB) gene family in cellular reprogramming',NULL,'','Nov 1, 2009','Jun 30, 2013','Basic Biology I','Closed','Stanford University','iPS Cell','1357085'),
('RB1-01292','Molecular Mechanisms of Reprogramming towards Pluripotency',NULL,'','Nov 1, 2009','Dec 31, 2012','Basic Biology I','Closed','Stanford University','iPS Cell','1408332'),
('RB1-01406','WNT signaling and the control of cell fate decisions in human pluripotent stem cells.',NULL,'','Oct 1, 2009','Mar 31, 2013','Basic Biology I','Closed','University of California, San Diego','Embryonic Stem Cell, iPS Cell','1329298'),
('RB1-01354','Human Cardiovascular Progenitors, their Niches and Control of Self-renewal and Cell Fate',NULL,'Heart Disease','Nov 1, 2009','Oct 31, 2011','Basic Biology I','Closed','University of California, Los Angeles','Adult Stem Cell','917667'),
('RB1-01417','Directing migration of human stem cells with electric fields',NULL,'','Nov 1, 2009','Apr 30, 2013','Basic Biology I','Closed','University of California, Davis','Embryonic Stem Cell','816228'),
('RB1-01353','Defining the molecular mechanisms of somatic cell reprogramming',NULL,'','Jan 1, 2010','Mar 31, 2013','Basic Biology I','Closed','University of Southern California','iPS Cell','1365580'),
('RB1-01328','Molecular Characterization and Functional Exploration of Hemogenic Endothelium',NULL,'Blood Disorders','Nov 1, 2009','Oct 31, 2012','Basic Biology I','Closed','University of California, Los Angeles','Directly Reprogrammed Cell, Embryonic Stem Cell','1371477'),
('RB1-01367','Molecular Characterization of hESC and hIPSC-Derived Spinal Motor Neurons',NULL,'Amyotrophic Lateral Sclerosis, Genetic Disorder, Neurological Disorders, Pediatrics, Spinal Cord Injury, Spinal Muscular Atrophy','Nov 1, 2009','May 31, 2013','Basic Biology I','Closed','University of California, Los Angeles','Embryonic Stem Cell, iPS Cell','1229922'),
('RB1-01372','The stem cell microenvironment in the maintenance of pluripotency and reprogramming',NULL,'','Oct 1, 2009','Sep 30, 2012','Basic Biology I','Closed','University of Southern California','Embryonic Stem Cell, iPS Cell','1325723'),
('RB1-01397','Mitochondrial Metabolism in hESC and hiPSC Differentiation, Reprogramming, and Cancer',NULL,'','Nov 1, 2009','Oct 31, 2013','Basic Biology I','Closed','University of California, Los Angeles','Embryonic Stem Cell, iPS Cell','1323029'),
('RB1-01358','Identification and characterization of human ES-derived DA neuronal subtypes',NULL,'Neurological Disorders, Parkinson\'s Disease','Nov 1, 2009','Dec 31, 2012','Basic Biology I','Closed','Stanford University','Embryonic Stem Cell','1404853'),
('CG1-99008','Innovation and Translational Stem Cell Therapy for Diabetes and Neurological Diseases: Paving the way for real life solutions',NULL,'Diabetes, Metabolic Disorders, Neurological Disorders','Aug 1, 2009','Sep 30, 2009','Conference','Closed','City of Hope, Beckman Research Institute','','14878'),
('CG1-99004','UCSF Frontiers of Neural Stem Cells Symposium',NULL,'','Aug 1, 2009','Oct 31, 2009','Conference','Closed','University of California, San Francisco','','35000'),
('CG1-99009','Stem Cell Policy: Understanding the Scientific and Legal Challenges Ahead',NULL,'','Jul 1, 2009','Oct 31, 2009','Conference','Closed','Stanford University','','5838'),
('TR1-01215','Methods for detection and elimination of residual human embryonic stem cells in a differentiated cell product',NULL,'Diabetes, Metabolic Disorders','Sep 1, 2009','Feb 28, 2013','Early Translational I','Closed','ViaCyte, Inc.','Embryonic Stem Cell','5405397'),
('TR1-01216','Stem Cell-Based Therapy for Cartilage Regeneration and Osteoarthritis',NULL,'Arthritis, Bone or Cartilage Disease','Sep 1, 2009','Feb 28, 2013','Early Translational I','Closed','Scripps Health','Embryonic Stem Cell, iPS Cell','3118431'),
('TR1-01219','Autologous Retinal Pigmented Epithelial Cells Derived from Induced Pluripotent Stem Cells for the Treatment of Atrophic Age Related Macular Degeneration',NULL,'Aging, Vision Loss','Oct 1, 2009','Jul 31, 2013','Early Translational I','Closed','Scripps Research Institute','iPS Cell','5806321'),
('TR1-01227','Maximizing the Safety of Induced Pluripotent Stem Cells as an Infusion Therapy: Limiting the Mutagenic Threat of Retroelement Retrotransposition during iPSC Generation, Expansion and Differentiation',NULL,'','Aug 1, 2009','Sep 30, 2012','Early Translational I','Closed','Gladstone Institutes, J. David','Embryonic Stem Cell, iPS Cell','1280001'),
('TR1-01232','Mouse Models for Stem Cell Therapeutic Development',NULL,'','Nov 1, 2009','Oct 31, 2013','Early Translational I','Closed','Jackson Labs','','3759134'),
('TR1-01246','Using patient-specific iPSC derived dopaminergic neurons to overcome a major bottleneck in Parkinson\'s disease research and drug discovery',NULL,'Neurological Disorders, Parkinson\'s Disease','Aug 1, 2009','Jul 31, 2012','Early Translational I','Closed','Parkinson\'s Institute','iPS Cell','3698646'),
('TR1-01249','Enhancing healing via Wnt-protein mediated activation of endogenous stem cells',NULL,'Bone or Cartilage Disease','Sep 1, 2009','Oct 31, 2014','Early Translational I','Closed','Stanford University','Adult Stem Cell','6464126'),
('TR1-01272','Development of a Stem Cell-based Transplantation Strategy for Treating Age-related Macular Degeneration',NULL,'Vision Loss','Nov 1, 2009','Oct 31, 2012','Early Translational I','Closed','University of California, Los Angeles','Adult Stem Cell, iPS Cell','5487136'),
('TR1-01273','Curing Hematological Diseases',NULL,'Blood Disorders, Immune Disease','Sep 1, 2009','Feb 28, 2013','Early Translational I','Closed','Salk Institute for Biological Studies','iPS Cell','5979252'),
('TR1-01267','Developmental Candidates for Cell-Based Therapies for Parkinson\'s Disease (PD)',NULL,'Neurological Disorders, Parkinson\'s Disease','Jun 1, 2010','Feb 28, 2014','Early Translational I','Closed','Sanford Burnham Prebys Medical Discovery Institute','Adult Stem Cell, Embryonic Stem Cell, iPS Cell','5190752'),
('TR1-01269','In Utero Model to Assess the Fate of Transplanted Human Cells for Translational Research and Pediatric Therapies',NULL,'','Sep 1, 2009','Aug 31, 2013','Early Translational I','Closed','University of California, Davis','Embryonic Stem Cell','3143392'),
('TR1-01276','Addressing the Cell Purity and Identity Bottleneck Through Generation and Expansion of Clonal Human Embryonic Progenitor Cell Lines',NULL,'','Sep 1, 2009','Aug 31, 2012','Early Translational I','Closed','BioTime, Inc.','Embryonic Stem Cell','4721706'),
('TR1-01257','Sustained siRNA production from human MSC to treat Huntingtons Disease and other neurodegenerative disorders',NULL,'Huntington\'s Disease, Neurological Disorders','Aug 1, 2009','Oct 31, 2012','Early Translational I','Closed','University of California, Davis','Adult Stem Cell, Embryonic Stem Cell','2615674'),
('TR1-01245','Neural Stem Cells as a Developmental Candidate to Treat Alzheimer Disease',NULL,'Aging, Alzheimer\'s Disease, Neurological Disorders','Dec 1, 2009','Nov 30, 2012','Early Translational I','Closed','University of California, Irvine','Adult Stem Cell, Embryonic Stem Cell','3599997'),
('TR1-01277','Developing induced pluripotent stem cells into human therapeutics and disease models',NULL,'Diabetes, Metabolic Disorders','Aug 1, 2009','Jan 31, 2013','Early Translational I','Closed','University of California, San Diego','iPS Cell','5165028'),
('TR1-01250','Ensuring the safety of cell therapy: a quality control pipeline for cell purification and validation',NULL,'','Sep 1, 2009','Feb 28, 2013','Early Translational I','Closed','Scripps Research Institute','Embryonic Stem Cell, iPS Cell','5830771'),
('CG1-99003','Weinstein Cardiovascular Development Conference',NULL,'Blood Disorders, Heart Disease','May 1, 2009','Jun 30, 2009','Conference','Closed','University of California, San Francisco','','35000'),
('CG1-99006','10th Annual UC Systemwide Bioengineering Symposium',NULL,'','May 4, 2009','Oct 3, 2009','Conference','Closed','University of California, San Diego','','8000'),
('CG1-99005','San Diego Stem Cell Science Education Symposium at UCSD',NULL,'','Apr 17, 2009','Aug 1, 2009','Conference','Closed','University of California, San Diego','','6237'),
('CG1-99001','2009 Rachmiel Levine Diabetes and Obesity Symposium:  Advances in Diabetes Biology, Immunology and Cell Therapy',NULL,'Diabetes, Metabolic Disorders','Jan 9, 2009','Jun 30, 2009','Conference','Closed','City of Hope, Beckman Research Institute','','15000'),
('TB1-01197','Specialty in Stem Cell Biology',NULL,'','Aug 1, 2010','Jul 31, 2017','Bridges','Closed','Berkeley City College','','2227230'),
('TG2-01150','City of Hope Research Training Program in Stem Cell Biology',NULL,'','Jul 1, 2009','Sep 30, 2015','Research Training II','Closed','City of Hope, Beckman Research Institute','','2197782'),
('TG2-01169','UCLA CIRM Research Training Program II',NULL,'','Jul 1, 2009','Jun 30, 2015','Research Training II','Closed','University of California, Los Angeles','','7790488'),
('TG2-01151','Training Program in Stem Cell Biology and Engineering',NULL,'','Sep 1, 2009','Mar 31, 2016','Research Training II','Closed','University of California, Santa Barbara','','2448823'),
('TB1-01175','Masters of Science Specialization in Stem Cell Technology',NULL,'','Jul 1, 2009','Jun 30, 2017','Bridges','Closed','Cal Poly Corporation, an Auxiliary of California Polytechnic State University, San Luis Obispo','','3480357'),
('TG2-01152','UCI-CIRM Research Training Program II',NULL,'','Sep 1, 2009','Apr 30, 2016','Research Training II','Closed','University of California, Irvine','','6067550'),
('TB1-01176','Cal Poly Pomona and Cal State LA Collaborative CIRM Bridges Program to Enhance Stem Cell Research Training and Education',NULL,'','Jun 1, 2009','May 31, 2017','Bridges','Closed','Cal Poly Pomona','','3056191'),
('TG2-01153','Training Program in Stem Cell Research at UCSF',NULL,'','Sep 1, 2009','Feb 29, 2016','Research Training II','Closed','University of California, San Francisco','','7814027'),
('TB1-01177','Curriculum Development and Implementation of Stem Cell Technology and Laboratory Management Emphasis in an Established MS Biotechnology and Bioinformatics Program at California State University Channel Islands and Co-development of a GE Course on Stem Cel',NULL,'','Jun 1, 2009','Oct 31, 2016','Bridges','Closed','Cal State Univ, Channel Island','','4165092'),
('TG2-01154','Interdisciplinary Stem Cell Training Program at UCSD II',NULL,'','Oct 1, 2009','Feb 29, 2016','Research Training II','Closed','University of California, San Diego','','7432600'),
('TB1-01181','Stem Cell Training Program at CSU Fullerton - A Bridge to Stem Cell Research',NULL,'','Aug 1, 2010','Jul 31, 2017','Bridges','Closed','Cal State Univ, Fullerton','','2764079'),
('TG2-01155','CIRM Research Training Program in Stem Cells and Aging',NULL,'','Jul 1, 2010','Feb 28, 2014','Research Training II','Closed','Buck Institute for Age Research','','1472416'),
('TB1-01182','CIRM Stem Cell Research Biotechnology Training Program at CSULB',NULL,'','Jul 1, 2009','Jun 30, 2016','Bridges','Closed','Cal State Univ, Long Beach','','3487091'),
('TG2-01157','UCSC CIRM Training Program in Systems Biology of Stem cells',NULL,'','Oct 1, 2009','Dec 31, 2015','Research Training II','Closed','University of California, Santa Cruz','','4397002'),
('TB1-01183','CSUN-UCLA Bridges to Stem Cell Research',NULL,'','Aug 1, 2010','Jul 31, 2017','Bridges','Closed','Cal State Univ, Northridge','','3814078'),
('RN3-06455-1.2','Medical School Loan Repayment Program',NULL,'','Mar 1, 2013','Feb 28, 2018','New Faculty Physician Scientist','Closed','Ali Nsair','','120312'),
('TG2-01158','Training in the Biology of Human Embryonic Stem Cells and Emerging Technologies II',NULL,'','Jul 1, 2009','Jan 31, 2016','Research Training II','Closed','Salk Institute for Biological Studies','','2886221'),
('TB1-01184','Strengthening the Pipeline of Masters-level Scientific and Laboratory Personnel in Stem Cell Research',NULL,'','Oct 1, 2009','Dec 31, 2016','Bridges','Closed','Cal State Univ, Sacramento','','3057754'),
('RN3-06532-1.2','Medical School Loan Repayment Program',NULL,'','Jun 1, 2013','May 31, 2018','New Faculty Physician Scientist','Closed','Tippi C. Mackenzie','','36436'),
('TG2-01159','Stanford CIRM Training Program',NULL,'','Oct 1, 2009','Feb 29, 2016','Research Training II','Closed','Stanford University','','7017629'),
('TB1-01185','CSUSB Bridges to Stem Cell Research',NULL,'','Sep 1, 2010','Mar 31, 2018','Bridges','Closed','Cal State Univ, San Bernadino','','2762085'),
('TG2-01160','Gladstone CIRM Scholars Program',NULL,'','May 1, 2009','Aug 31, 2015','Research Training II','Closed','Gladstone Institutes, J. David','','4869300'),
('TB1-01186','California State University-San Marcos CIRM Bridges to the Stem Cell Research Training Grant',NULL,'','Jun 1, 2009','Dec 31, 2016','Bridges','Closed','Cal State Univ, San Marcos','','4114712'),
('TB1-01188','City College of San Francisco Stem Cell Training Enhancement Program',NULL,'','Aug 1, 2010','Jul 31, 2017','Bridges','Closed','City College Of San Francisco','','2649780'),
('TG2-01161','CIRM Stem Cell Biology Training Program',NULL,'','Apr 1, 2010','Aug 31, 2016','Research Training II','Closed','University of Southern California','','5827817'),
('TB1-01190','The HSU CIRM Bridges  to Stem Cell Research Certificate Program',NULL,'','Jul 1, 2009','Jun 30, 2016','Bridges','Closed','Humboldt State University','','3195858'),
('TG2-01162','Type III CIRM Stem Cell Research Training Program',NULL,'','Sep 1, 2010','Jun 30, 2017','Research Training II','Closed','Sanford Burnham Prebys Medical Discovery Institute','','2781376'),
('TB1-01192','Bridges to Stem Cell Research at Pasadena City College',NULL,'','Sep 1, 2009','Aug 31, 2016','Bridges','Closed','Pasadena City College','','3596922'),
('TG2-01163','UC Davis Stem Cell Training Program',NULL,'','Aug 1, 2009','Jul 31, 2016','Research Training II','Closed','University of California, Davis','','4838291'),
('TB1-01193','SDSU/CIRM Stem Cell Internship Program',NULL,'','Aug 1, 2009','Jul 31, 2016','Bridges','Closed','San Diego State University Foundation','','4156315'),
('TG2-01164','Interdisciplinary Training in Stem Cell Biology, Engineering and Medicine',NULL,'','Jan 1, 2010','Jun 30, 2016','Research Training II','Closed','University of California, Berkeley','','6888557'),
('TB1-01194','SFSU Bridges to Stem Cell Research',NULL,'','Jun 1, 2009','Jul 31, 2016','Bridges','Closed','San Francisco State University','','4168243'),
('RN3-06378-1.2','Medical School Loan Repayment Program',NULL,'','Jun 1, 2013','May 31, 2018','New Faculty Physician Scientist','Closed','Reza Ardehali','','35511'),
('TG2-01165','Training Stem Cell Researchers at the Chemistry-Biology Interface',NULL,'','Jul 1, 2009','Jun 30, 2016','Research Training II','Closed','Scripps Research Institute','','3697326'),
('TB1-01195','San Jose State University Stem Cell Internships for Laboratory-based Learning (SJSU SCILL)',NULL,'','Jun 1, 2009','May 31, 2017','Bridges','Closed','San Jose State University','','4154051'),
('TG2-01168','CHLA Stem Cell Training Grant',NULL,'','Jul 1, 2009','Jun 30, 2016','Research Training II','Closed','Children\'s Hospital of Los Angeles','','5020920'),
('RT1-01012','Development of an hES Cell-Based Assay System for Hepatocyte Differentiation Studies and Predictive Toxicology Drug Screening',NULL,'Liver Disease, Metabolic Disorders, Toxicity','Apr 1, 2009','Sep 30, 2011','Tools and Technologies I','Closed','VistaGen Therapeutics, Inc.','Embryonic Stem Cell','971558'),
('RT1-01103','Development of a novel technology for precise, efficient, and safe genetic modification of stem cells',NULL,'','Apr 1, 2009','Mar 31, 2011','Tools and Technologies I','Closed','Scripps Research Institute','Embryonic Stem Cell','1138548'),
('RT1-01019','In Vivo Imaging for the Detection and Quantitation of Transplanted Stem/Progenitor Cells in Nonhuman Primates',NULL,'','Apr 1, 2009','Mar 31, 2012','Tools and Technologies I','Closed','University of California, Davis','Adult Stem Cell','799350'),
('RT1-01107','Generation of disease models for neurodegenerative disorders in hESCs by gene targeting',NULL,'Amyotrophic Lateral Sclerosis, Neurological Disorders','Dec 1, 2009','Nov 30, 2011','Tools and Technologies I','Closed','University of California, San Diego','Embryonic Stem Cell','709829'),
('RT1-01021','Directed Evolution of Novel AAV Variants for Enhanced Gene Targeting in Pluripotent Human Stem Cells and Investigation of Dopaminergic Neuron Differentiation',NULL,'Neurological Disorders, Parkinson\'s Disease','Apr 1, 2009','Mar 31, 2012','Tools and Technologies I','Closed','University of California, Berkeley','Embryonic Stem Cell','918000'),
('RT1-01108','The Stem Cell Matrix: a map of the molecular pathways that define pluripotent cells',NULL,'','Apr 1, 2009','May 31, 2011','Tools and Technologies I','Closed','Scripps Research Institute','Embryonic Stem Cell, iPS Cell','1133552'),
('RT1-01022','Microfluidic Platform for Screening Chemically Defined Conditions that Facilitate Clonal Expansion of Human Pluripotent Stem Cells',NULL,'','Apr 1, 2009','Mar 31, 2011','Tools and Technologies I','Closed','University of California, Los Angeles','Embryonic Stem Cell','914096'),
('RT1-01120','A MULTI-MODALITY  MOLECULAR IMAGING SYSTEM (MRSPECT) FOR IN VIVO STEM CELL TRACKING',NULL,'','Mar 1, 2009','Feb 28, 2011','Tools and Technologies I','Closed','University of California, Irvine','','719798'),
('RT1-01024','Scaleup of Versatile, Fully Automated, Microfluidic Cell Culture System',NULL,'','Apr 1, 2009','Mar 31, 2011','Tools and Technologies I','Closed','Fluidigm Corporation','Embryonic Stem Cell','749518'),
('RT1-01126','Novel Tools and Technologies for Translational PET Imaging of Cell-based Therapies',NULL,'','May 1, 2009','Apr 30, 2011','Tools and Technologies I','Closed','University of California, Los Angeles','','914039'),
('RT1-01027','A Novel SPECT Microscopy System for 3D Imaging of Single Stem Cells In Vivo',NULL,'','Apr 1, 2009','Mar 31, 2011','Tools and Technologies I','Closed','Gamma Medica-Ideas, Inc.','','800065'),
('RT1-01143','Optimization in the Identification, Selection and Induction of Maturation of Subtypes of Cardiomyocytes derived from Human Embryonic Stem Cells',NULL,'Heart Disease','Apr 1, 2009','Mar 31, 2011','Tools and Technologies I','Closed','Vala Sciences, Inc.','Embryonic Stem Cell','870717'),
('RT1-01028','Development of Baculoviral Vectors for Gene Editing of Human Stem Cells',NULL,'','Apr 1, 2009','Dec 31, 2011','Tools and Technologies I','Closed','University of Southern California','Embryonic Stem Cell','945604'),
('RT1-01052','RNA Analysis by Biosynthetic Tagging (RABT): a tool for the identification of cell type-specific RNAs',NULL,'','Apr 1, 2009','Sep 30, 2011','Tools and Technologies I','Closed','University of California, Merced','Cancer Stem Cell','481096'),
('RT1-01053','Synthetic Matrices for Stem Cell Growth and Differentiation',NULL,'','Apr 1, 2009','Mar 31, 2012','Tools and Technologies I','Closed','University of California, Santa Barbara','Embryonic Stem Cell','599404'),
('RT1-01055','Magnetic Particle Imaging: A Novel Ultra-sensitive Imaging Scanner for Tracking Stem Cells In Vivo',NULL,'','Apr 1, 2009','Mar 31, 2012','Tools and Technologies I','Closed','University of California, Berkeley','Embryonic Stem Cell','858345'),
('RT1-01057','Development of Suspension Adaptation, Scale-up cGMP Banking and Cell Characterization Technologies for hESC Lines',NULL,'','Apr 1, 2009','Mar 31, 2011','Tools and Technologies I','Closed','City of Hope, Beckman Research Institute','Embryonic Stem Cell','882929'),
('RT1-01063','TAT Cell-Permeable Protein Delivery of siRNAs for Epigenetic Programming of Human Pluripotent and Adult Stem Cells',NULL,'','Apr 1, 2009','Mar 31, 2011','Tools and Technologies I','Closed','University of California, San Diego','Embryonic Stem Cell','720000'),
('RT1-01074','Novel Separation of Stem Cell Subpopulations',NULL,'','Mar 1, 2009','Feb 28, 2012','Tools and Technologies I','Closed','University of California, Irvine','Adult Stem Cell, Embryonic Stem Cell','861122'),
('RT1-01093','Development of the Theracyte Cellular Encapsulation System for Delivery of human ES Cell-derived Pancreatic Islets and Progenitors.',NULL,'Diabetes, Metabolic Disorders','Apr 1, 2009','Mar 31, 2011','Tools and Technologies I','Closed','ViaCyte, Inc.','Adult Stem Cell, Embryonic Stem Cell','827072'),
('RT1-01095','AO Wide-Field Microscope',NULL,'','Jun 1, 2009','Sep 30, 2011','Tools and Technologies I','Closed','University of California, Santa Cruz','','549551'),
('RT1-01001','Regulation of Stem Cell Fate in Bioengineered Arrays of Hydrogel Microwells',NULL,'Aging, Skeletal/Smooth Muscle disorders, Trauma','Apr 1, 2009','Mar 31, 2011','Tools and Technologies I','Closed','Stanford University','Adult Stem Cell','949608'),
('RT1-01097','Discovery of adhesion ligands for pluripotent human stem cells',NULL,'','Mar 1, 2009','Feb 28, 2011','Tools and Technologies I','Closed','University of California, Davis','Embryonic Stem Cell, iPS Cell','834003'),
('CG1-99000','Stem Cell Therapies for Pediatric Diseases and Injuries:  A Critial Evaluation',NULL,'Pediatrics','Dec 15, 2008','Jun 14, 2009','Conference','Closed','Children\'s Hospital of Orange County','','786'),
('CG1-99002','Translation of Stem Cell Therapies: Best Practices and Regulatory Considerations',NULL,'','Feb 1, 2009','Jul 31, 2009','Conference','Closed','Vitalant Research Institute','','30000'),
('RN2-00905','Mechanisms of chromatin dynamics at enhancers during ES cell differentiation',NULL,'','Jan 1, 2009','Dec 31, 2013','New Faculty II','Closed','Ludwig Institute for Cancer Research','Embryonic Stem Cell','1726564'),
('RN2-00945','A Novel Microenvironment-Mediated Functional Skeletal Muscle from Human Embryonic Stem Cells and their In Vivo Engraftment',NULL,'Muscular Dystrophy, Skeletal/Smooth Muscle disorders','Jan 1, 2009','Dec 31, 2014','New Faculty II','Closed','University of California, San Diego','Embryonic Stem Cell','2300569'),
('RN2-00906','Mechanisms of small RNA regulation in early embryonic development',NULL,'','Jan 1, 2009','Dec 31, 2014','New Faculty II','Closed','University of California, San Francisco','Embryonic Stem Cell','2790695'),
('RN2-00946','Mechanism of Tissue Engineered Small Intestine Formation',NULL,'Intestinal Disease, Metabolic Disorders, Pediatrics','Jan 1, 2009','Dec 31, 2013','New Faculty II','Closed','Children\'s Hospital of Los Angeles','Adult Stem Cell','3211122'),
('RN2-00950','Molecular dissection of adult liver regeneration to guide the generation of hepatocytes from pluripotent stem cells',NULL,'Liver Disease, Metabolic Disorders','Jan 1, 2009','Dec 31, 2014','New Faculty II','Closed','University of California, San Francisco','Adult Stem Cell, Embryonic Stem Cell','2832008'),
('RN2-00915','Mechanisms in Choroid Plexus Epithelial Development',NULL,'Neurological Disorders','Jan 1, 2009','Dec 31, 2013','New Faculty II','Closed','University of California, Irvine','Embryonic Stem Cell','2793395'),
('RN2-00952','Defining the Isoform-Specific Effects of Apolipoprotein E on the Development of iPS Cells into Functional Neurons in Vitro and in Vivo',NULL,'Alzheimer\'s Disease, Neurological Disorders, Stroke','Feb 1, 2009','Jan 31, 2014','New Faculty II','Closed','Gladstone Institutes, J. David','iPS Cell','2757303'),
('RN2-00916','Skeletogenic Neural Crest Cells in Embryonic Development and Adult Regeneration of the Jaw',NULL,'Bone or Cartilage Disease, Trauma','Feb 1, 2009','Jun 30, 2014','New Faculty II','Closed','University of Southern California','Embryonic Stem Cell','2247403'),
('RN2-00908','Regulation of Adult Stem Cell Proliferation by RAS and Cell-Permeable Proteins',NULL,'','Jan 1, 2009','Jun 30, 2014','New Faculty II','Closed','University of California, San Diego','Embryonic Stem Cell','3017978'),
('RN2-00919','High throughput modeling of human neurodegenerative diseases in embryonic stem cells',NULL,'Amyotrophic Lateral Sclerosis, Neurological Disorders, Neuropathy','Jan 1, 2009','Dec 31, 2013','New Faculty II','Closed','University of California, San Francisco','Embryonic Stem Cell','2259092'),
('RN2-00909','VEGF signaling in adventitial stem cells in vascular physiology and disease',NULL,'Heart Disease','Jan 1, 2009','Jun 15, 2013','New Faculty II','Closed','Stanford University','Adult Stem Cell','3005695'),
('RN2-00921','Building Cardiac Tissue from Stem Cells and Natural Matrices',NULL,'Heart Disease','Jan 1, 2009','Dec 31, 2013','New Faculty II','Closed','University of California, Merced','Embryonic Stem Cell','1656083'),
('RN2-00910','Derivation and Characterization of Myeloproliferative Disorder Stem Cells from Human ES Cells',NULL,'Blood Cancer, Cancer','Jan 1, 2009','Dec 31, 2013','New Faculty II','Closed','University of California, San Diego','Cancer Stem Cell, Embryonic Stem Cell','3065572'),
('RN2-00922','Molecular mechanisms governing hESC and iPS cell self-renewal and pluripotency',NULL,'','Jan 1, 2009','Dec 31, 2014','New Faculty II','Closed','University of California, Davis','Embryonic Stem Cell, iPS Cell','2157255'),
('RN2-00923','The roles of non-coding RNAs in the self-renewal and differentiation of pluripotent stem cells',NULL,'','Jan 1, 2009','Dec 31, 2014','New Faculty II','Closed','University of California, Berkeley','Embryonic Stem Cell','1406823'),
('RN2-00931','Molecular Mechanisms of Trophoblast Stem Cell Specification and Self-Renewal',NULL,'Fertility','Jan 1, 2009','May 31, 2014','New Faculty II','Closed','University of California, San Diego','Adult Stem Cell, Embryonic Stem Cell','3077918'),
('RN2-00933','Laying the groundwork for building a tooth: analysis of dental epithelial stem cells',NULL,'','Jan 1, 2009','Dec 31, 2013','New Faculty II','Closed','University of California, San Francisco','Adult Stem Cell, Embryonic Stem Cell','3075251'),
('RN2-00902','Stem Cells for Immune System Regeneration to Fight Cancer',NULL,'Cancer, Melanoma, Solid Tumors','Jan 1, 2009','Dec 31, 2013','New Faculty II','Closed','University of California, Los Angeles','Adult Stem Cell','3072000'),
('RN2-00934','Mechanisms Underlying the Responses of Normal and Cancer Stem Cells to Environmental and Therapeutic Insults',NULL,'Blood Cancer, Cancer, Trauma','Jan 1, 2009','Dec 31, 2013','New Faculty II','Closed','University of California, San Francisco','','2124488'),
('RN2-00903','Induction of cardiogenesis in pluripotent cells via chromatin remodeling factors',NULL,'Heart Disease','Dec 1, 2008','Aug 15, 2013','New Faculty II','Closed','Gladstone Institutes, J. David','Embryonic Stem Cell, iPS Cell','2723653'),
('RN2-00938','Mechanisms Underlying the Diverse Functions of STAT3 in Embryonic Stem Cell Fate Regulation',NULL,'','Jan 1, 2009','Dec 31, 2014','New Faculty II','Closed','University of Southern California','Embryonic Stem Cell','2261174'),
('RN2-00904','Stem Cells in Lung Cancer',NULL,'Cancer, Lung Cancer, Respiratory Disorders, Solid Tumors','Jan 1, 2009','Dec 31, 2014','New Faculty II','Closed','University of California, Los Angeles','Adult Stem Cell, Cancer Stem Cell','2381572'),
('RN2-00940','The molecular basis underlying adult neurogenesis during regeneration and tissue renewal',NULL,'','Jan 1, 2009','Dec 31, 2014','New Faculty II','Closed','San Diego State University Foundation','','1712225'),
('DT1-00652','A CIRM Disease Team for the Treatment and Cure of Diabetes',NULL,'Diabetes, Metabolic Disorders','Aug 1, 2008','Jan 31, 2009','Disease Team Planning','Closed','University of California, San Francisco','','55000'),
('DT1-00704','\"Stem Cell Therapies for Heart Failure\"',NULL,'Heart Disease, Heart failure','Aug 1, 2008','Jan 31, 2009','Disease Team Planning','Closed','Sanford Burnham Prebys Medical Discovery Institute','','44450'),
('RL1-00649','Development of Induced Pluripotent Stem Cells for Modeling Human Disease',NULL,'Amyotrophic Lateral Sclerosis, Autism, Blood Disorders, Neurological Disorders, Pediatrics, Rett\'s Syndrome','Dec 1, 2008','Nov 30, 2011','New Cell Lines','Closed','Salk Institute for Biological Studies','iPS Cell','1737720'),
('DT1-00653','Clinical Regenerative Wound Healing With Stem Cells',NULL,'','Aug 1, 2008','Jan 31, 2009','Disease Team Planning','Closed','University of Southern California','','33626'),
('DT1-00708','Genetically-modified neural stem cells for treatment of high-grade glioma',NULL,'Brain Cancer, Cancer, Solid Tumors','Aug 1, 2008','Jan 31, 2009','Disease Team Planning','Closed','City of Hope, Beckman Research Institute','','55000'),
('RL1-00660','Induction of pluripotent stem cells by small RNA-guided transcriptional activation',NULL,'','Dec 1, 2008','Nov 30, 2012','New Cell Lines','Closed','University of California, San Francisco','iPS Cell','1368461'),
('DT1-00656','A CIRM Disease Team for the Repair of Traumatically Injured and Arthritic Cartilage',NULL,'','Aug 1, 2008','Jan 31, 2009','Disease Team Planning','Closed','University of California, San Francisco','','33172'),
('DT1-00709','CIRM Planning Grant in Leukemia',NULL,'','Aug 1, 2008','Jan 31, 2009','Disease Team Planning','Closed','University of California, San Diego','','52174'),
('RL1-00662','Derivation and analysis of pluripotent stem cell lines with inherited TGF-b mediated disorders from donated IVF embryos and reprogrammed adult skin fibroblasts',NULL,'Heart Disease','Nov 1, 2008','Oct 31, 2011','New Cell Lines','Closed','Stanford University','Embryonic Stem Cell, iPS Cell','1406636'),
('DT1-00657','Stem cell based treatment strategy for Age-related Macular Degeneration (AMD)',NULL,'Age-related macular degeneration, Vision Loss','Aug 1, 2008','Jan 31, 2009','Disease Team Planning','Closed','University of Southern California','','3088'),
('DT1-00710','{REDACTED} Cardiovascular Regenerative Team',NULL,'','Aug 1, 2008','Mar 31, 2009','Disease Team Planning','Closed','Stanford University','','25119'),
('RL1-00669','Somatic cell age and memory in the generation of iPS cells',NULL,'','Nov 1, 2008','Oct 31, 2012','New Cell Lines','Closed','University of California, San Francisco','iPS Cell','1307201'),
('DT1-00659','Motor neuron diseases: Finding cures through basic, translational, and clinical collaboration',NULL,'','Aug 1, 2008','Mar 31, 2009','Disease Team Planning','Closed','Salk Institute for Biological Studies','','51266'),
('DT1-00669','Development of a Stem Cell Therapy to Promote Functional Recovery in Stroke',NULL,'','Aug 1, 2008','Jan 31, 2009','Disease Team Planning','Closed','University of California, Los Angeles','','42748'),
('RL1-00670','Derivation and comparative analysis of human pluripotent ESCs, iPSCs and SSCs: Convergence to an embryonic phenotype',NULL,'Fertility','Nov 1, 2008','Oct 31, 2012','New Cell Lines','Closed','Stanford University','Adult Stem Cell, Embryonic Stem Cell, iPS Cell','1409243'),
('DT1-00671','Pluripotent Stem Cell–Based Therapy for Heart Disease',NULL,'','Aug 1, 2008','Jan 31, 2009','Disease Team Planning','Closed','Gladstone Institutes, J. David','','13505'),
('RL1-00642-B','Derivation of New ICM-stage hESCs',NULL,'','Apr 1, 2011','Apr 30, 2012','New Cell Lines','Closed','Gladstone Institutes, J. David','Embryonic Stem Cell, iPS Cell, Other','778859'),
('DT1-00672','Development of a Cell Replacement Therapy Product for Insulin Dependent Diabetes',NULL,'','Aug 1, 2008','Jan 31, 2009','Disease Team Planning','Closed','ViaCyte, Inc.','','48950'),
('RL1-00678','New Cell Lines for Huntington\'s Disease',NULL,'Huntington\'s Disease, Neurological Disorders','Jan 1, 2009','Dec 31, 2011','New Cell Lines','Closed','University of California, Irvine','Embryonic Stem Cell, iPS Cell','1302526'),
('DT1-00675','Human Stem Cell Approaches to Alzheimers Disease Therapies',NULL,'','Aug 1, 2008','Jan 31, 2009','Disease Team Planning','Closed','University of California, San Diego','','55000'),
('RL1-00681','Generation of clinical grade human iPS cells',NULL,'Amyotrophic Lateral Sclerosis, Cancer, Melanoma, Muscular Dystrophy, Neurological Disorders, Skeletal/Smooth Muscle disorders, Solid Tumors','Nov 1, 2008','Oct 31, 2011','New Cell Lines','Closed','University of California, Los Angeles','iPS Cell','1341000'),
('RL1-00642-A','Derivation of New ICM-stage hESCs',NULL,'','May 1, 2009','Mar 31, 2011','New Cell Lines','Closed','Scripps Research Institute','Embryonic Stem Cell, iPS Cell, Other','936973'),
('DT1-00683','Stem Cell Therapy for AIDS- Disease Team Planning',NULL,'','Aug 1, 2008','Jan 31, 2009','Disease Team Planning','Closed','University of California, Los Angeles','','51490'),
('RL1-00682','Derivation of Parkinson\'s Disease Coded-Stem Cells (PD-SCs)',NULL,'Neurological Disorders, Parkinson\'s Disease','Mar 1, 2009','Feb 28, 2013','New Cell Lines','Closed','Sanford Burnham Prebys Medical Discovery Institute','Embryonic Stem Cell, iPS Cell','1556448'),
('DT1-00688','Develop a cell replacement therapy for Parkinson\'s disease using human embryonic stem cells',NULL,'','Aug 1, 2008','Jan 31, 2009','Disease Team Planning','Closed','Buck Institute for Age Research','','37161'),
('RL1-00630','Derivation of hESC Lines with Disease Lesions',NULL,'Genetic Disorder','Nov 1, 2008','Jun 30, 2012','New Cell Lines','Closed','Stanford University','Embryonic Stem Cell','1404725'),
('DT1-00690','Stem cells for neuroprotection of photoreceptors in retinitis pigmentosa',NULL,'','Aug 1, 2008','Jan 31, 2009','Disease Team Planning','Closed','University of California, Irvine','','23537'),
('RL1-00634','Safe, efficient creation of human induced pluripotent stem cells without the use of retroviruses',NULL,'Immune Disease','Nov 1, 2008','Oct 31, 2011','New Cell Lines','Closed','Stanford University','iPS Cell','1406875'),
('DT1-00696','Stem Cell-Mediated Oncocidal Therapy of Primary & Metastatic Brain Tumors',NULL,'','Aug 1, 2008','Jan 31, 2009','Disease Team Planning','Closed','Ludwig Institute for Cancer Research','','3867'),
('RL1-00636','Generation of Pluripotent Cell Lines from Human Embryos',NULL,'Genetic Disorder, Pediatrics','Nov 1, 2008','Oct 31, 2012','New Cell Lines','Closed','University of California, Los Angeles','Embryonic Stem Cell','1168501'),
('RL1-00667','New Technology for the Derivation of Human Pluripotent Stem Cell Lines for Clinical Use',NULL,'','Mar 1, 2009','Feb 29, 2012','New Cell Lines','Closed','University of Southern California','Embryonic Stem Cell, iPS Cell, Other','1266134'),
('DT1-00697','CIRM Disease Team Planning Award',NULL,'','Aug 1, 2008','Jan 31, 2009','Disease Team Planning','Closed','Children\'s Hospital of Oakland Research Institute','','16939'),
('RL1-00639','Induced Pluripotent Stem Cells for Cardiovascular Diagnostics',NULL,'Heart Disease, Toxicity','Feb 1, 2009','Apr 30, 2012','New Cell Lines','Closed','Gladstone Institutes, J. David','iPS Cell','1708560'),
('DT1-00698','{REDACTED} Heart Disease Regenerative Medicine Team Planning Award',NULL,'Heart Disease','Aug 1, 2008','Jan 31, 2009','Disease Team Planning','Closed','Cedars-Sinai Medical Center','','38980'),
('RL1-00644','Protein transduction of transcription factors: a non-genetic approach to generate new pluripotent cell lines from human skin.',NULL,'','Nov 1, 2008','Oct 31, 2011','New Cell Lines','Closed','University of California, San Diego','iPS Cell','1073585'),
('DT1-00700','Huntington\'s Disease Team',NULL,'Huntington\'s Disease, Neurological Disorders','Aug 1, 2008','Jan 31, 2009','Disease Team Planning','Closed','University of California, Irvine','','41953'),
('RL1-00648','Optimization of Human Embryonic Stem Cell Derivation Techniques and Production/Distribution of GMP-Grade Lines',NULL,'','Nov 1, 2008','Oct 31, 2012','New Cell Lines','Closed','University of California, San Francisco','Embryonic Stem Cell','1383419'),
('DT1-00701','STEM CELL GENE THERAPY FOR SICKLE CELL DISEASE',NULL,'Blood Disorders, Sickle Cell Disease','Aug 1, 2008','Jan 31, 2009','Disease Team Planning','Closed','Children\'s Hospital of Los Angeles','','12131'),
('RL1-00650','Establishment of Frontotemporal Dementia Patient-Specific Induced Pluripotent Stem (iPS) Cell Lines with Defined Genetic Mutations',NULL,'Dementia, Neurological Disorders','Feb 1, 2009','Jan 31, 2012','New Cell Lines','Closed','Gladstone Institutes, J. David','iPS Cell','1696424'),
('FA1-00600','CIRM Center of Excellence at Buck Institute for Age Research',NULL,'','Apr 1, 2010','Mar 31, 2012','Major Facilities','Closed','Buck Institute for Age Research','','20500000'),
('FA1-00607','Sanford Consortium for Regenerative Medicine',NULL,'','Sep 12, 2008','Jun 11, 2011','Major Facilities','Closed','Sanford Consortium for Regenerative Medicine','','42827439'),
('FA1-00609','Stanford SIM1 Building',NULL,'','Jun 20, 2008','Dec 31, 2010','Major Facilities','Closed','Stanford University','','43578000'),
('FA1-00610','UC Berkeley CIRM Center of Excellence',NULL,'','Jun 20, 2008','Feb 29, 2012','Major Facilities','Closed','University of California, Berkeley','','20183500'),
('FA1-00611','UC Davis CIRM Institute',NULL,'','Jun 20, 2008','Dec 31, 2010','Major Facilities','Closed','University of California, Davis','','20082400'),
('FA1-00612','UC Irvine CIRM Institute',NULL,'','Jun 20, 2008','Jun 30, 2010','Major Facilities','Closed','University of California, Irvine','','27156000'),
('FA1-00613','UCLA CIRM Institute',NULL,'','Jun 20, 2008','Dec 31, 2010','Major Facilities','Closed','University of California, Los Angeles','','19854900'),
('FA1-00614','Stem Cell Instrumentation Foundry',NULL,'','Jul 1, 2009','Dec 31, 2010','Major Facilities','Closed','University of California, Merced','','4341321'),
('FA1-00616','UC Santa Barbara Bio Sciences II',NULL,'','Jun 20, 2008','Jun 30, 2012','Major Facilities','Closed','University of California, Santa Barbara','','3205800'),
('FA1-00617','UC Santa Cruz IBSC Facility',NULL,'','Sep 12, 2008','Dec 31, 2012','Major Facilities','Closed','University of California, Santa Cruz','','7191950'),
('FA1-00618','UCSF CIRM Building',NULL,'','Jun 20, 2008','Jun 30, 2010','Major Facilities','Closed','University of California, San Francisco','','34862400'),
('FA1-00619','Broad CIRM Facility at USC',NULL,'','Jun 20, 2008','Jun 30, 2011','Major Facilities','Closed','University of Southern California','','26972500'),
('RN2-00908-1.2','Medical School Loan Repayment Program',NULL,'','Jan 1, 2009','Jun 30, 2014','New Faculty II','Closed','Benjamin D. Yu','','28388'),
('RN1-00562-1.2','Medical School Loan Repayment Program',NULL,'','Jul 1, 2008','Jun 30, 2014','New Faculty I','Closed','Mohammad Pashmforoush','','27949'),
('RN1-00538-B','ES-Derived Cells for the Treatment of Alzheimer\'s Disease',NULL,'Aging, Alzheimer\'s Disease, Neurological Disorders','Mar 1, 2010','Aug 31, 2013','New Faculty I','Closed','Western University of Health Sciences','Embryonic Stem Cell','1401642'),
('RN1-00540','Mechanisms of Stem Cell Fate Decisions',NULL,'','Mar 1, 2008','Aug 31, 2013','New Faculty I','Closed','University of California, Santa Cruz','','2201759'),
('RN1-00544-B','Characterization of mechanisms regulating de-differentiation and the re-acquisition of stem cell identity',NULL,'','Jan 1, 2013','Mar 31, 2014','New Faculty I','Closed','University of California, Los Angeles','Embryonic Stem Cell','382773'),
('RN1-00550','Epigenetics in cancer stem cell initiation and clinical outcome prediction',NULL,'Cancer, Solid Tumors','Jul 1, 2008','Jun 30, 2013','New Faculty I','Closed','University of California, Los Angeles','Embryonic Stem Cell','3063450'),
('RN1-00554','Enhancing Survival of Embryonic Stem Cell-Derived Grafts by Induction of Immunological Tolerance',NULL,'','Jun 1, 2008','May 31, 2013','New Faculty I','Closed','University of California, Merced','Embryonic Stem Cell','1576389'),
('RN1-00557','Mechanisms of Hematopoietic stem cell Specification and Self-Renewal',NULL,'Anemia, Blood Cancer, Blood Disorders, Cancer','Apr 1, 2008','Mar 31, 2013','New Faculty I','Closed','University of California, Los Angeles','Adult Stem Cell, Embryonic Stem Cell','2286900'),
('RN1-00561','Combinatorial Chemistry Approaches to Develop LIgands against Leukemia Stem Cells',NULL,'Blood Cancer, Cancer','Mar 1, 2008','Aug 31, 2013','New Faculty I','Closed','University of California, Davis','Adult Stem Cell, Cancer Stem Cell','2386409'),
('RN1-00562','Transcriptional Regulation of Cardiac Pacemaker Cell Progenitors',NULL,'Heart Disease','Jul 1, 2008','Jun 30, 2014','New Faculty I','Closed','University of Southern California','Embryonic Stem Cell','2816578'),
('RN1-00564','In vitro reprogramming of mouse and human somatic cells to an embryonic state',NULL,'Neurological Disorders, Rett\'s Syndrome','Jun 1, 2008','May 31, 2013','New Faculty I','Closed','University of California, Los Angeles','iPS Cell','2229427'),
('RN1-00566','A Novel Engineered Niche to Explore the Vasculogenic Potential of Embryonic Stem Cells',NULL,'Heart Disease','Jun 1, 2008','Jun 30, 2009','New Faculty I','Closed','University of California, Irvine','Adult Stem Cell, Embryonic Stem Cell','395764'),
('RN1-00525','Skeletal muscle development from hESC and its in vivo applications in animal models of muscular dystrophy',NULL,'Muscular Dystrophy, Skeletal/Smooth Muscle disorders','May 1, 2008','Jul 31, 2009','New Faculty I','Closed','City of Hope, Beckman Research Institute','Embryonic Stem Cell','131840'),
('RN1-00572','Oral and Craniofacial Reconstruction Using Mesenchymal Stem Cells',NULL,'Bone or Cartilage Disease','Mar 1, 2008','Aug 31, 2013','New Faculty I','Closed','University of Southern California','Adult Stem Cell','3242651'),
('RN1-00536-A','Reprogramming of human somatic cells back to pluripotent embryonic stem cells',NULL,'','May 1, 2008','Mar 31, 2011','New Faculty I','Closed','Scripps Research Institute','Embryonic Stem Cell, iPS Cell','1393876'),
('RN1-00527','Molecular mechanisms involved in adult neural stem cell maintenance',NULL,'Aging, Neurological Disorders','Mar 1, 2008','Feb 28, 2013','New Faculty I','Closed','Stanford University','Adult Stem Cell, Embryonic Stem Cell','2348435'),
('RN1-00575','Genetic dissection of mesodermal commitment to the hematopoietic fates.',NULL,'','Apr 1, 2008','Mar 31, 2013','New Faculty I','Closed','University of California, San Diego','','2150620'),
('RN1-00538-A','ES-Derived Cells for the Treatment of Alzheimer\'s Disease',NULL,'Aging, Alzheimer\'s Disease, Neurological Disorders','Mar 1, 2008','Feb 28, 2013','New Faculty I','Closed','University of California, Riverside','Embryonic Stem Cell','621639'),
('RN1-00529','Noncoding RNAs in Cell Fate Determination',NULL,'','Jun 1, 2008','May 31, 2013','New Faculty I','Closed','Stanford University','Embryonic Stem Cell','2985894'),
('RN1-00577','Genetic Encoding Novel Amino Acids in Embryonic Stem Cells for Molecular Understanding of Differentiation to Dopamine Neurons',NULL,'Neurological Disorders, Parkinson\'s Disease','Apr 1, 2008','Aug 31, 2013','New Faculty I','Closed','Salk Institute for Biological Studies','','2587742'),
('RN1-00544-A','Characterization of mechanisms regulating de-differentiation and the re-acquisition of stem cell identity',NULL,'','Apr 1, 2008','Dec 31, 2012','New Faculty I','Closed','Salk Institute for Biological Studies','Embryonic Stem Cell','2134100'),
('RN1-00530','Molecular mechanisms of neural stem cell differentiation in the developing brain',NULL,'Amyotrophic Lateral Sclerosis, Neurological Disorders','Mar 1, 2008','Feb 28, 2014','New Faculty I','Closed','University of California, Santa Cruz','Adult Stem Cell','2147592'),
('RN1-00579','Trithorax and Polycomb methyltransferase complexes in cell fate determination.',NULL,'','Apr 1, 2008','Mar 31, 2013','New Faculty I','Closed','Stanford University','Embryonic Stem Cell','2373903'),
('RN1-00584','Generating pluripotent cell lines from neurons.',NULL,'','May 1, 2008','Apr 30, 2013','New Faculty I','Closed','Scripps Research Institute','','2786560'),
('RN1-00532','Identification of hESC-mediated molecular mechanism that positively regulates the regenerative capacity of post-natal tissues',NULL,'Aging, Muscular Dystrophy, Pediatrics, Skeletal/Smooth Muscle disorders, Trauma','Mar 1, 2008','Jul 31, 2013','New Faculty I','Closed','University of California, Berkeley','Embryonic Stem Cell','2246020'),
('RN1-00535','Bioengineering technology for fast optical control of differentiation and function in stem cells and stem cell progeny',NULL,'','Aug 1, 2008','Aug 31, 2012','New Faculty I','Closed','Stanford University','Embryonic Stem Cell','2424209'),
('RN1-00536-B','Reprogramming of human somatic cells back to pluripotent embryonic stem cells',NULL,'','Apr 1, 2011','Mar 31, 2013','New Faculty I','Closed','Gladstone Institutes, J. David','Embryonic Stem Cell, iPS Cell','1320101'),
('CL1-00502-1.2','TSRI Center for hESC Research',NULL,'','Jan 1, 2009','Dec 31, 2014','Shared Labs','Closed','Scripps Research Institute','Embryonic Stem Cell, iPS Cell','3725070'),
('CL1-00511-1.1','Collaborative Laboratory for Human Embryonic Stem Cell Research at Sanford-Burnham Medical Research Institute',NULL,'','Sep 4, 2007','Sep 3, 2009','Shared Labs','Closed','Sanford Burnham Prebys Medical Discovery Institute','','1361825'),
('CL1-00504-1.2','UC Davis Translational Human Embryonic Stem Cell Shared Research Facility',NULL,'','Nov 1, 2009','Oct 31, 2016','Shared Labs','Closed','University of California, Davis','Embryonic Stem Cell, iPS Cell','1728111'),
('CL1-00514-1.1','The Gladstone CIRM Shared Human Embryonic Stem Cell Core Laboratory',NULL,'','Aug 3, 2007','Aug 2, 2009','Shared Labs','Closed','Gladstone Institutes, J. David','','842672'),
('CL1-00505-1.2','CIRM Shared Research Laboratories',NULL,'','Feb 1, 2010','Jan 31, 2016','Shared Labs','Closed','University of California, Los Angeles','Embryonic Stem Cell, iPS Cell','1751297'),
('CL1-00518-1.1','The Stanford University Center for Human Embryonic Stem Cell Research and Education',NULL,'','Sep 1, 2007','Aug 31, 2009','Shared Labs','Closed','Stanford University','','2439590'),
('CL1-00506-1.2','UCSC Shared Stem Cell Facility',NULL,'','Mar 1, 2009','Feb 29, 2016','Shared Labs','Closed','University of California, Santa Cruz','Embryonic Stem Cell, iPS Cell','1719722'),
('CL1-00519-1.1','The Berkeley Human Embryonic Stem Cell Shared Research Laboratory',NULL,'','Aug 21, 2007','Aug 20, 2009','Shared Labs','Closed','University of California, Berkeley','','1227659'),
('CL1-00507-1.2','The Childrens Hospital of Los Angeles hESC Facility',NULL,'','Sep 1, 2009','Aug 31, 2016','Shared Labs','Closed','Children\'s Hospital of Los Angeles','Embryonic Stem Cell, iPS Cell','1750259'),
('CL1-00520-1.1','The University of California: Irvine Regional Human Embryonic Stem Cell Shared Research Laboratory and Stem Cell Techniques Course',NULL,'','Aug 21, 2007','Aug 19, 2009','Shared Labs','Closed','University of California, Irvine','','2107376'),
('CL1-00508-1.2','A Stem Cell Core Facility for Studying Human Embryonic Stem Cell Differentiation',NULL,'','Aug 1, 2009','Jul 31, 2016','Shared Labs','Closed','University of California, Riverside','Embryonic Stem Cell, iPS Cell','1663284'),
('CL1-00521-1.1','The UCSB Laboratory for Stem Cell Biology and Engineering',NULL,'','Sep 14, 2007','Sep 13, 2010','Shared Labs','Closed','University of California, Santa Barbara','','1407192'),
('CL1-00511-1.2','Collaborative Laboratory for Human Embryonic Stem Cell Research at Sanford-Burnham Medical Research Institute',NULL,'','Feb 1, 2009','Jan 31, 2015','Shared Labs','Closed','Sanford Burnham Prebys Medical Discovery Institute','Embryonic Stem Cell, iPS Cell','1805884'),
('CL1-00522-1.1','Enhancing Facilities for Genetic Manipulation and Engineering of Human Embryonic Stem Cells at UCSD',NULL,'','Sep 14, 2007','Sep 13, 2009','Shared Labs','Closed','University of California, San Diego','','1728080'),
('CL1-00514-1.2','The Gladstone CIRM Shared Human Embryonic Stem Cell Core Laboratory',NULL,'','Jan 1, 2008','Dec 31, 2014','Shared Labs','Closed','Gladstone Institutes, J. David','','1698515'),
('CL1-00523-1.1','The University of California San Francisco Shared Research and Teaching Laboratory: a Non-Federal Human Embryonic Stem Cell Resource for the Bay Area Community',NULL,'','Oct 25, 2007','Oct 24, 2010','Shared Labs','Closed','University of California, San Francisco','','2144758'),
('CL1-00518-1.2','The Stanford University Center for Human Embryonic Stem Cell Research and Education',NULL,'','Sep 1, 2007','Feb 28, 2015','Shared Labs','Closed','Stanford University','Adult Stem Cell, Embryonic Stem Cell, iPS Cell','3434600'),
('CL1-00500-1.1','Shared viral vector facility for genetic manipulation of huamn ES cell',NULL,'','Aug 3, 2007','Aug 2, 2009','Shared Labs','Closed','Salk Institute for Biological Studies','','1478923'),
('CL1-00524-1.1','USC Center for Stem Cell and Regenerative Medicine: Shared Research Laboratory and Course in Current Protocols in Human Embryonic Stem Cell Research',NULL,'','Aug 21, 2007','Aug 20, 2009','Shared Labs','Closed','University of Southern California','','1724015'),
('CL1-00519-1.2','The Berkeley Human Embryonic Stem Cell Shared Research Laboratory',NULL,'','Jan 1, 2010','Jun 30, 2016','Shared Labs','Closed','University of California, Berkeley','','1673221'),
('CL1-00501-1.1','North Bay CIRM Shared Research Laboratory for Stem Cells and Aging',NULL,'','Oct 30, 2007','Oct 29, 2009','Shared Labs','Closed','Buck Institute for Age Research','','2414749'),
('CL1-00520-1.2','The University of California: Irvine Regional Human Embryonic Stem Cell Shared Research Laboratory and Stem Cell Techniques Course',NULL,'','May 1, 2009','Oct 31, 2015','Shared Labs','Closed','University of California, Irvine','Embryonic Stem Cell, iPS Cell','3072500'),
('CL1-00502-1.1','TSRI Center for hESC Research',NULL,'','Aug 3, 2007','Aug 2, 2009','Shared Labs','Closed','Scripps Research Institute','','1440164'),
('CL1-00521-1.2','The UCSB Laboratory for Stem Cell Biology and Engineering',NULL,'','Oct 1, 2009','Sep 30, 2016','Shared Labs','Closed','University of California, Santa Barbara','Adult Stem Cell, Embryonic Stem Cell, iPS Cell','1638357'),
('CL1-00504-1.1','UC Davis Translational Human Embryonic Stem Cell Shared Research Facility',NULL,'','Sep 14, 2007','Sep 13, 2009','Shared Labs','Closed','University of California, Davis','','2000000'),
('CL1-00522-1.2','Enhancing Facilities for Genetic Manipulation and Engineering of Human Embryonic Stem Cells at UCSD',NULL,'','Nov 1, 2008','Oct 31, 2014','Shared Labs','Closed','University of California, San Diego','Embryonic Stem Cell, iPS Cell','1737133'),
('CL1-00505-1.1','CIRM Shared Research Laboratories',NULL,'','Sep 4, 2007','Aug 31, 2010','Shared Labs','Closed','University of California, Los Angeles','','2000000'),
('CL1-00523-1.2','The University of California San Francisco Shared Research and Teaching Laboratory: a Non-Federal Human Embryonic Stem Cell Resource for the Bay Area Community',NULL,'','Jun 1, 2009','May 31, 2015','Shared Labs','Closed','University of California, San Francisco','Embryonic Stem Cell, iPS Cell','3289649'),
('CL1-00506-1.1','UCSC Shared Stem Cell Facility',NULL,'','Aug 16, 2007','Aug 15, 2010','Shared Labs','Closed','University of California, Santa Cruz','','1849452'),
('CL1-00500-1.2','Shared viral vector facility for genetic manipulation of huamn ES cell',NULL,'','Nov 15, 2007','Mar 31, 2015','Shared Labs','Closed','Salk Institute for Biological Studies','Embryonic Stem Cell, iPS Cell','1844315'),
('CL1-00524-1.2','USC Center for Stem Cell and Regenerative Medicine: Shared Research Laboratory and Course in Current Protocols in Human Embryonic Stem Cell Research',NULL,'','Jul 1, 2009','Jun 30, 2016','Shared Labs','Closed','University of Southern California','Embryonic Stem Cell, iPS Cell','3411861'),
('CL1-00507-1.1','The Childrens Hospital of Los Angeles hESC Facility',NULL,'','Sep 4, 2007','Sep 3, 2010','Shared Labs','Closed','Children\'s Hospital of Los Angeles','','1684648'),
('CL1-00501-1.2','North Bay CIRM Shared Research Laboratory for Stem Cells and Aging',NULL,'Neurological Disorders','Jul 1, 2008','Nov 30, 2014','Shared Labs','Closed','Buck Institute for Age Research','Embryonic Stem Cell, iPS Cell','3478933'),
('CL1-00508-1.1','A Stem Cell Core Facility for Studying Human Embryonic Stem Cell Differentiation',NULL,'','Sep 14, 2007','Sep 13, 2009','Shared Labs','Closed','University of California, Riverside','','1976931'),
('RC1-00125','MEF2C-Directed Neurogenesis From Human Embryonic Stem Cells',NULL,'Neurological Disorders, Parkinson\'s Disease, Stroke','Oct 1, 2007','Apr 30, 2012','Comprehensive Grant','Closed','Sanford Burnham Prebys Medical Discovery Institute','Embryonic Stem Cell','2832000'),
('RC1-00149','Human Embryonic Stem Cell Therapeutic Strategies to Target HIV Disease',NULL,'HIV/AIDS, Immune Disease, Infectious Disease','Aug 1, 2007','Jan 31, 2012','Comprehensive Grant','Closed','University of California, Los Angeles','Embryonic Stem Cell','2401903'),
('RC1-00354','Prospective isolation of hESC-derived hematopoietic and cardiomyocyte stem cells',NULL,'Blood Disorders, Heart Disease, Immune Disease','Jul 1, 2007','Jun 30, 2011','Comprehensive Grant','Closed','Stanford University','Embryonic Stem Cell','2471386'),
('RC1-00151','Engineering a Cardiovascular Tissue Graft from Human Embryonic Stem Cells',NULL,'Heart Disease','Jul 1, 2007','Jun 30, 2011','Comprehensive Grant','Closed','Stanford University','Embryonic Stem Cell','2454490'),
('RC1-00110','Improved hES Cell Growth and Differentiation',NULL,'','Aug 1, 2007','Jan 31, 2012','Comprehensive Grant','Closed','University of California, Irvine','Embryonic Stem Cell','2381713'),
('RC1-00345','hESC-Derived Motor Neurons For the Treatment of Cervical Spinal Cord Injury',NULL,'Amyotrophic Lateral Sclerosis, Neurological Disorders, Spinal Cord Injury, Spinal Muscular Atrophy','Aug 1, 2007','Jul 31, 2011','Comprehensive Grant','Closed','University of California, Irvine','Embryonic Stem Cell','2158445'),
('RC1-00347','Understanding hESC-based Hematopoiesis for Therapeutic Benefit',NULL,'','Aug 1, 2007','Jul 31, 2011','Comprehensive Grant','Closed','University of California, San Francisco','Embryonic Stem Cell','2460822'),
('RC1-00346','Derivation of Inhibitory Nerve Cells from Human Embryonic Stem Cells',NULL,'Epilepsy, Neurological Disorders','Aug 1, 2007','Jul 31, 2011','Comprehensive Grant','Closed','University of California, San Francisco','Embryonic Stem Cell','2410874'),
('RC1-00353','The Dangers of Mitochondrial DNA Heteroplasmy in Stem Cells Created by Therapeutic Cloning',NULL,'','Aug 1, 2007','Jun 30, 2010','Comprehensive Grant','Closed','University of California, Irvine','Embryonic Stem Cell, Other','1790133'),
('RC1-00137','Human oocyte development for genetic, pharmacological and reprogramming applications',NULL,'Fertility','Aug 1, 2007','Jul 31, 2012','Comprehensive Grant','Closed','Stanford University','Embryonic Stem Cell','2298411'),
('RC1-00108-B','Regulated Expansion of Lympho-hematopoietic Stem and Progenitor Cells from Human Embryonic Stem Cells (hESC)',NULL,'','Feb 1, 2009','Nov 30, 2011','Comprehensive Grant','Closed','University of California, Los Angeles','Embryonic Stem Cell','1653416'),
('RC1-00142','microRNA Regulation of Cardiomyocyte Differentiation from Human Embryonic Stem Cells',NULL,'Heart Disease','Aug 1, 2007','Jul 31, 2011','Comprehensive Grant','Closed','Gladstone Institutes, J. David','Embryonic Stem Cell','2994719'),
('RC1-00108-A','Regulated Expansion of Lympho-hematopoietic Stem and Progenitor Cells from Human Embryonic Stem Cells (hESC)',NULL,'','Aug 1, 2007','Jan 31, 2009','Comprehensive Grant','Closed','Children\'s Hospital of Los Angeles','Embryonic Stem Cell','575994'),
('RC1-00359','An in vitro and in vivo comparison among three different human hepatic stem cell populations.',NULL,'Liver Disease, Metabolic Disorders','Oct 1, 2007','Sep 30, 2011','Comprehensive Grant','Closed','University of California, Davis','Adult Stem Cell, Embryonic Stem Cell','2251223'),
('RC1-00111','Epigenetic gene regulation during the differentiation of human embryonic stem cells: Impact on neural repair',NULL,'Neurological Disorders, Stroke','Aug 1, 2007','Jul 31, 2011','Comprehensive Grant','Closed','University of California, Los Angeles','Embryonic Stem Cell, iPS Cell','2412995'),
('RC1-00119','Generation of inner ear sensory cells from human ES cells toward a cure for deafness',NULL,'Hearing Loss','Jul 1, 2007','Jun 30, 2011','Comprehensive Grant','Closed','Stanford University','Embryonic Stem Cell','2330371'),
('RC1-00113','Constructing a fate map of the human embryo',NULL,'','Aug 1, 2007','Jul 31, 2012','Comprehensive Grant','Closed','University of California, San Francisco','Embryonic Stem Cell','2430487'),
('RC1-00124','Embryonic Stem Cell-Derived Therapies Targeting Cardiac Ischemic Disease',NULL,'Heart Disease','Aug 1, 2007','Nov 30, 2011','Comprehensive Grant','Closed','University of California, San Francisco','Embryonic Stem Cell','2424353'),
('RC1-00115','Molecular and Cellular Transitions from ES Cells to Mature Functioning Human Neurons',NULL,'Amyotrophic Lateral Sclerosis, Genetic Disorder, Neurological Disorders, Parkinson\'s Disease','Oct 1, 2007','Sep 30, 2011','Comprehensive Grant','Closed','Salk Institute for Biological Studies','Embryonic Stem Cell','2749293'),
('RC1-00133','Guiding the developmental program of human embryonic stem cells by isolated Wnt factors',NULL,'','Jul 1, 2007','Jun 30, 2011','Comprehensive Grant','Closed','Stanford University','Embryonic Stem Cell','1710462'),
('RC1-00116','Using Human Embryonic Stem Cells  to Understand and to Develop New Therapies for Alzheimer\'s Disease',NULL,'Aging, Alzheimer\'s Disease, Genetic Disorder, Neurological Disorders','Aug 1, 2007','Jul 31, 2011','Comprehensive Grant','Closed','University of California, San Diego','Embryonic Stem Cell, iPS Cell','1859414'),
('RC1-00144','Preclinical Model for Labeling, Transplant, and In Vivo Imaging of Differentiated Human Embryonic Stem Cells',NULL,'Kidney Disease','Aug 1, 2007','Jul 31, 2012','Comprehensive Grant','Closed','University of California, Davis','Embryonic Stem Cell','2166757'),
('RC1-00131','Spinal ischemic paraplegia: modulation by human embryonic stem cell implant.',NULL,'Neurological Disorders, Spinal Cord Injury','Aug 1, 2007','Jul 31, 2011','Comprehensive Grant','Closed','University of California, San Diego','Embryonic Stem Cell','2356090'),
('RC1-00148','Mechanisms to maintain the self-renewal and genetic stability of human embryonic stem cells',NULL,'Cancer, Genetic Disorder','Aug 1, 2007','Jul 31, 2011','Comprehensive Grant','Closed','University of California, San Diego','Embryonic Stem Cell','2467200'),
('RC1-00132','Chemical Genetic Approach to Production of hESC-derived Cardiomyocytes',NULL,'Heart Disease','Oct 1, 2007','Sep 30, 2011','Comprehensive Grant','Closed','Sanford Burnham Prebys Medical Discovery Institute','Embryonic Stem Cell','2832000'),
('RC1-00100','Functional Genomic Analysis of Chemically Defined Human Embryonic Stem Cells',NULL,'Genetic Disorder, Muscular Dystrophy, Pediatrics, Skeletal/Smooth Muscle disorders','Jul 1, 2007','Jun 30, 2011','Comprehensive Grant','Closed','Stanford University','Embryonic Stem Cell','2518303'),
('RC1-00104','Modeling Myocardial Therapy with Human Embryonic Stem Cells',NULL,'Heart Disease','Aug 1, 2007','Jul 31, 2011','Comprehensive Grant','Closed','University of California, San Francisco','Embryonic Stem Cell','2134694'),
('RC1-00134','Immunology of neural stem cell fate and function',NULL,'Trauma','Jul 1, 2007','Dec 31, 2011','Comprehensive Grant','Closed','Stanford University','Adult Stem Cell, Embryonic Stem Cell','2396000'),
('RC1-00135','Human stem cell derived oligodendrocytes for treatment of stroke and MS',NULL,'Immune Disease, Multiple Sclerosis, Neurological Disorders, Stroke','Aug 1, 2007','Jan 31, 2012','Comprehensive Grant','Closed','University of California, San Francisco','Adult Stem Cell, Embryonic Stem Cell','2459235'),
('RS1-00402','Down-Regulation of Alloreactive Immune Responses to hES Cell-Derived Graft Tissues',NULL,'','Oct 1, 2007','Sep 30, 2009','SEED Grant','Closed','University of California, Los Angeles','Embryonic Stem Cell','399239'),
('RS1-00313','Role of Mitochondria in Self-Renewal Versus Differentiation of Human Embryonic Stem Cells',NULL,'','Aug 1, 2007','Jul 31, 2009','SEED Grant','Closed','University of California, Los Angeles','Embryonic Stem Cell','543274'),
('RS1-00174','A method to maintain and propagate pluripotent human ES cells',NULL,'','Oct 1, 2007','Sep 30, 2009','SEED Grant','Closed','Salk Institute for Biological Studies','Embryonic Stem Cell','760042'),
('RS1-00289','Stem Cell Survival and Differentiation Through Chemical Genetics',NULL,'','Aug 1, 2007','Jul 31, 2010','SEED Grant','Closed','University of California, Riverside','Embryonic Stem Cell','522933'),
('RS1-00381','Labeling of human embryonic stem cells with iron oxide nanoparticles and fluorescent dyes for a non-invasive cell depiction with MR imaging and optical imaging',NULL,'','Aug 1, 2007','Jul 31, 2009','SEED Grant','Closed','University of California, San Francisco','Embryonic Stem Cell','240214'),
('RS1-00319','Reprogramming Differentiated Human Cells to a Pluripotent State',NULL,'','Aug 1, 2007','Jul 31, 2009','SEED Grant','Closed','Stanford University','Embryonic Stem Cell, iPS Cell','380005'),
('RS1-00193','Retinoic Acid-FGF Antagonism during Motor Neuron Differentiation of Human ES Cells',NULL,'','Oct 1, 2007','Sep 30, 2009','SEED Grant','Closed','Sanford Burnham Prebys Medical Discovery Institute','Embryonic Stem Cell','695229'),
('RS1-00171','Development of Neuro-Coupled  Human Embryonic Stem Cell-Derived Cardiac Pacemaker Cells.',NULL,'Heart Disease','Oct 1, 2007','Sep 30, 2010','SEED Grant','Closed','Sanford Burnham Prebys Medical Discovery Institute','Embryonic Stem Cell','695680'),
('RS1-00203','Genetic Enhancement of the Immune Response to Melanoma via hESC-derived T cells',NULL,'Cancer, Melanoma, Solid Tumors','Aug 1, 2007','Nov 30, 2009','SEED Grant','Closed','University of California, Los Angeles','Embryonic Stem Cell','616800'),
('RS1-00321','Embryonic stem cell-derived thymic epithelial cells',NULL,'Immune Disease','Jul 1, 2007','Jun 30, 2009','SEED Grant','Closed','Stanford University','Embryonic Stem Cell','628793'),
('RS1-00331','Modeling Parkinson\'s Disease Using Human Embryonic Stem Cells',NULL,'Neurological Disorders, Parkinson\'s Disease','Oct 1, 2007','Sep 30, 2009','SEED Grant','Closed','Sanford Burnham Prebys Medical Discovery Institute','Embryonic Stem Cell','701060'),
('RS1-00292','Mapping the transcriptional regulatory elements in the genome of hESC',NULL,'','Feb 1, 2008','Jul 31, 2010','SEED Grant','Closed','Ludwig Institute for Cancer Research','Embryonic Stem Cell','653823'),
('RS1-00428','Sources of Genetic Instability in Human Embryonic Stem Cells.',NULL,'Cancer','Jan 1, 2008','Dec 31, 2009','SEED Grant','Closed','City of Hope, Beckman Research Institute','Embryonic Stem Cell','327311'),
('RS1-00322','In Vivo Imaging of Human Embryonic Stem Cell Derivatives and Tumorigenicity',NULL,'','Jan 1, 2008','Dec 31, 2009','SEED Grant','Closed','Stanford University','Embryonic Stem Cell','623634'),
('RS1-00262','Regulation of human neural progenitor cell proliferation by Ryk-mediated Wnt signaling',NULL,'','Jan 1, 2008','Jun 30, 2010','SEED Grant','Closed','University of Southern California','Embryonic Stem Cell','624000'),
('RS1-00295','In Vitro Differentiation of T cells from Human Embryonic Stem Cells.',NULL,'','Jul 1, 2007','Jun 30, 2010','SEED Grant','Closed','University of California, Berkeley','Embryonic Stem Cell','477894'),
('RS1-00434','Transcriptional Regulation of Human Embryonic Stem Cells',NULL,'','Oct 1, 2007','Sep 30, 2010','SEED Grant','Closed','University of California, San Francisco','Embryonic Stem Cell','595755'),
('RS1-00323','Role of Chromatin Modifiers in Regulating Human Embryonic Stem Cell Pluripotency',NULL,'','Jul 1, 2007','Jun 30, 2009','SEED Grant','Closed','Stanford University','Embryonic Stem Cell','629952'),
('RS1-00249','hESC as tools to investigate the neural crest origin of Ewing\'s sarcoma',NULL,'Cancer, Pediatrics, Solid Tumors','Aug 1, 2007','Jul 31, 2009','SEED Grant','Closed','Children\'s Hospital of Los Angeles','Embryonic Stem Cell','595576'),
('RS1-00183','EC regeneration in cerebrovascular ischemia: role of NO',NULL,'Vascular Disease','Jul 1, 2007','Jun 30, 2008','SEED Grant','Closed','Stanford University','Embryonic Stem Cell','476995'),
('RS1-00170','In vitro differentiation of hESCs into corticospinal motor neurons',NULL,'Amyotrophic Lateral Sclerosis, Neurological Disorders','Aug 1, 2007','Jul 31, 2010','SEED Grant','Closed','University of California, Santa Cruz','Embryonic Stem Cell','465624'),
('RS1-00210','The APOBEC3 Gene Family as Guardians of Genome Stability in Human Embryonic Stem Cells',NULL,'Cancer','Aug 1, 2007','Jul 31, 2009','SEED Grant','Closed','Gladstone Institutes, J. David','Embryonic Stem Cell','717363'),
('RS1-00199','Assessing the role of Eph/ephrin signaling in hESC growth and differentiation',NULL,'','Aug 1, 2007','Jul 31, 2010','SEED Grant','Closed','University of California, Santa Cruz','Embryonic Stem Cell','474161'),
('RS1-00239-A','Micro Platform for Controlled Cardiac Myocyte Differentiation',NULL,'Heart Disease','Aug 1, 2007','Jun 30, 2009','SEED Grant','Closed','University of California, Merced','Embryonic Stem Cell','193700'),
('RS1-00317','Role of HDAC in human stem cells pluripotentiality and differentiation',NULL,'','Aug 1, 2007','Apr 30, 2009','SEED Grant','Closed','Gladstone Institutes, J. David','Embryonic Stem Cell','590997'),
('RS1-00444','Role of the tumor suppressor gene, p16INK4a, in regulating stem cell phenotypes in embryonic stem cells and human epithelial cells.',NULL,'Cancer','Aug 1, 2007','Jul 31, 2010','SEED Grant','Closed','University of California, San Francisco','Embryonic Stem Cell','614784'),
('RS1-00326','In Vivo Molecular Magnetic Resonance Imaging of Human Embryonic Stem Cells in Murine Model of Myocardial Infarction',NULL,'Heart Disease','Jul 1, 2007','Jun 30, 2010','SEED Grant','Closed','Stanford University','Embryonic Stem Cell','629952'),
('RS1-00259','Modeling Human Embryonic Development with Human Embryonic Stem Cells',NULL,'','Aug 1, 2007','Jul 31, 2009','SEED Grant','Closed','University of California, Los Angeles','Embryonic Stem Cell, iPS Cell','528096'),
('RS1-00198','Specification of Ventricular Myocyte and Pacemaker Lineages Utilizing Human Embryonic Stem Cells',NULL,'Heart Disease','Jul 1, 2007','Jun 30, 2009','SEED Grant','Closed','University of California, San Diego','Embryonic Stem Cell','585600'),
('RS1-00215','Identifying small molecules that stimulate the differentiation of hESCs into dopamine-producing neurons',NULL,'Neurological Disorders, Parkinson\'s Disease','Jul 1, 2007','Jun 30, 2009','SEED Grant','Closed','University of California, San Francisco','Embryonic Stem Cell','542619'),
('RS1-00449','Force, Dimensionality and Stem Cell Fate',NULL,'','Aug 1, 2007','Jul 31, 2009','SEED Grant','Closed','University of California, San Francisco','Embryonic Stem Cell','529762'),
('RS1-00205','Generation of forebrain neurons from human embryonic stem cells',NULL,'Aging, Alzheimer\'s Disease, Neurological Disorders','Jul 1, 2007','Jun 30, 2009','SEED Grant','Closed','University of California, San Diego','Embryonic Stem Cell','587591'),
('RS1-00225','New Chemokine-Derived Therapeutics Targeting Stem Cell Migration',NULL,'Neurological Disorders, Spinal Cord Injury, Stroke, Trauma','Oct 1, 2007','Sep 30, 2009','SEED Grant','Closed','Sanford Burnham Prebys Medical Discovery Institute','Adult Stem Cell, Embryonic Stem Cell','708000'),
('RS1-00333','Genetic manipulation of human embryonic stem cells and its application in studying CNS development and repair',NULL,'Amyotrophic Lateral Sclerosis, Neurological Disorders, Spinal Cord Injury','Jul 1, 2007','Jun 30, 2010','SEED Grant','Closed','University of California, San Diego','Embryonic Stem Cell','600441'),
('RS1-00222','Therapeutic potential of Retinal Pigment Epithelial cell lines derived from hES cells for retinal degeneration.',NULL,'Aging, Vision Loss','Jul 1, 2007','Jun 30, 2009','SEED Grant','Closed','University of Southern California','Embryonic Stem Cell','651607'),
('RS1-00466','Analysis of Candidate Neural Crest Cells Derived from Human ES Cells',NULL,'','Oct 1, 2007','Sep 30, 2009','SEED Grant','Closed','Sanford Burnham Prebys Medical Discovery Institute','Embryonic Stem Cell','703684'),
('RS1-00377','The Immunological Niche: Effect of immunosuppressant drugs on stem cell proliferation, gene expression, and differentiation in a model of spinal cord injury.',NULL,'Neurological Disorders, Spinal Cord Injury','Dec 1, 2007','Nov 30, 2009','SEED Grant','Closed','University of California, Irvine','Adult Stem Cell, Embryonic Stem Cell','595345'),
('RS1-00236','Novel vectors for gene transfer into human ES cells',NULL,'','Jul 1, 2007','Jun 30, 2009','SEED Grant','Closed','Stanford University','Embryonic Stem Cell','574737'),
('RS1-00365','Profiling surface glycans and glycoprotein expression of human embryonic stem cells',NULL,'','Aug 1, 2007','Jul 31, 2010','SEED Grant','Closed','University of California, Berkeley','Embryonic Stem Cell','444847'),
('RS1-00239-B','Micro Platform for Controlled Cardiac Myocyte Differentiation',NULL,'Heart Disease','Jul 1, 2009','Jun 30, 2010','SEED Grant','Closed','University of California, Irvine','Embryonic Stem Cell','156426'),
('RS1-00195','Regulation of Specific Chromosomal Boundary Elements by CTCF Protein Complexes in Human Embryonic Stem Cells',NULL,'','Dec 1, 2007','Nov 30, 2009','SEED Grant','Closed','Salk Institute for Biological Studies','Embryonic Stem Cell','647343'),
('RS1-00200','Role of Glycans in Human Embryonic Stem Cell Conversion to Neural Precursor Cells',NULL,'','Oct 1, 2007','Sep 30, 2010','SEED Grant','Closed','Sanford Burnham Prebys Medical Discovery Institute','Embryonic Stem Cell','708000'),
('RS1-00298','Functions of RB family proteins in human embryonic stem cells',NULL,'Cancer','Jul 1, 2007','Sep 30, 2009','SEED Grant','Closed','Stanford University','Embryonic Stem Cell','498609'),
('RS1-00242','Technology for hESC-Derived Cardiomyocyte Differentiation and Optimization of Graft-Host Integration in Adult Myocardium',NULL,'Heart Disease','Jul 1, 2007','Jan 31, 2010','SEED Grant','Closed','Stanford University','Embryonic Stem Cell','572891'),
('RS1-00477','Non-coding RNA as tool for the active control of stem cell differentiation',NULL,'','Aug 1, 2007','Jul 31, 2010','SEED Grant','Closed','University of California, Riverside','Embryonic Stem Cell','571650'),
('RS1-00228','Derivation and Characterization of Cancer Stem Cells from Human ES Cells',NULL,'Blood Cancer, Cancer','Aug 1, 2007','Jul 31, 2009','SEED Grant','Closed','University of California, San Diego','Cancer Stem Cell, Embryonic Stem Cell','616305'),
('RS1-00404','Patient-specific cells with nuclear transfer',NULL,'','Feb 1, 2008','May 31, 2010','SEED Grant','Closed','Stanford University','Embryonic Stem Cell, SCNT','629653'),
('RS1-00327','Self-renewal of human embryonic stem cells',NULL,'','Jul 1, 2007','Jun 30, 2009','SEED Grant','Closed','University of Southern California','Embryonic Stem Cell','621421'),
('RS1-00302','A Chemical Approach to Stem Cell Biology',NULL,'','Jan 1, 2008','Dec 31, 2009','SEED Grant','Closed','Scripps Research Institute','Embryonic Stem Cell','748944'),
('RS1-00243','Differentiation of Human Embryonic Stem Cells to Intestinal Fates',NULL,'Intestinal Disease, Metabolic Disorders, Pediatrics, Trauma','Jul 1, 2007','Jun 30, 2009','SEED Grant','Closed','Stanford University','Embryonic Stem Cell','554176'),
('RS1-00452','Induction of pluripotency in fibroblasts by fusion with enucleated human embryonic stem cell syncytia',NULL,'','Jul 1, 2007','Jun 30, 2009','SEED Grant','Closed','University of California, San Francisco','Other','329245'),
('RS1-00420','Improving microenvironments to promote hematopoietic stem cell development from human embryonic stem cells',NULL,'Blood Disorders','Oct 1, 2007','Mar 31, 2010','SEED Grant','Closed','University of California, Los Angeles','Embryonic Stem Cell','550241'),
('RS1-00408','Screening for Oncogenic Epigenetic Alterations in Human ES Cells',NULL,'Cancer','Jul 1, 2007','Jun 30, 2010','SEED Grant','Closed','University of Southern California','Embryonic Stem Cell','647431'),
('RS1-00271','Optimization of guidance response in human embryonic stem cell derived midbrain dopaminergic neurons in development and disease',NULL,'Neurological Disorders, Parkinson\'s Disease','Jul 1, 2007','Dec 31, 2009','SEED Grant','Closed','Stanford University','Embryonic Stem Cell','607363'),
('RS1-00432','Mitochondrial Dysfunction in Embryonic Stem Cells',NULL,'','Jul 1, 2007','Jun 30, 2008','SEED Grant','Closed','University of California, Irvine','Embryonic Stem Cell','245582'),
('RS1-00172','Genetic modification of the human genome to resist HIV-1 infection and/or disease progression',NULL,'HIV/AIDS, Immune Disease, Infectious Disease','Aug 1, 2007','Jul 31, 2009','SEED Grant','Closed','University of California, Los Angeles','Embryonic Stem Cell','616800'),
('RS1-00308','Endodermal differentiation of human ES cells',NULL,'Diabetes, Metabolic Disorders','Aug 1, 2007','Jul 31, 2010','SEED Grant','Closed','University of California, San Francisco','Embryonic Stem Cell','611027'),
('RS1-00409','Human Embryonic Stem Cells and Remyelination in a Viral Model of Demyelination',NULL,'Immune Disease, Multiple Sclerosis, Neurological Disorders','Aug 1, 2007','Jul 31, 2010','SEED Grant','Closed','University of California, Irvine','Embryonic Stem Cell','368081'),
('RS1-00413','Using human embryonic stem cells to treat radiation-induced stem cell loss: Benefits vs cancer risk',NULL,'Cancer, Neurological Disorders, Skeletal/Smooth Muscle disorders','Dec 1, 2007','May 31, 2010','SEED Grant','Closed','University of California, Irvine','Embryonic Stem Cell','593242'),
('RS1-00464','hESCs for Articular Cartilage Regeneration',NULL,'Bone or Cartilage Disease','Jul 1, 2007','Apr 6, 2009','SEED Grant','Closed','University of California, Davis','Embryonic Stem Cell','301703'),
('RS1-00161','MicroRNA Regulation of Human Embryonic Stem Cell Self-Renewal and Differentiation',NULL,'','Mar 1, 2008','Aug 31, 2010','SEED Grant','Closed','University of California, San Francisco','Embryonic Stem Cell','605886'),
('RS1-00453','Hair Cells and Spiral Ganglion Neuron Differentiation from Human Embryonic Stem Cells',NULL,'Hearing Loss','Aug 1, 2007','Jul 31, 2009','SEED Grant','Closed','University of California, Davis','Embryonic Stem Cell','458071'),
('RS1-00280','Generation of long-term cultures of human hematopoietic multipotent progenitors from embryonic stem cells',NULL,'Blood Disorders','Jul 1, 2007','Jun 30, 2009','SEED Grant','Closed','University of California, San Diego','Embryonic Stem Cell','473952'),
('RS1-00247','Development of human ES cell lines as a model system for Alzheimer disease drug discovery',NULL,'Alzheimer\'s Disease, Neurological Disorders','Jul 1, 2007','Dec 31, 2009','SEED Grant','Closed','University of California, Irvine','Embryonic Stem Cell','473963'),
('RS1-00163','Programmed Cell Death Pathways Activated in Embryonic Stem Cells',NULL,'','Aug 1, 2007','Oct 31, 2009','SEED Grant','Closed','Buck Institute for Age Research','Embryonic Stem Cell','728950'),
('RS1-00455','Derivation and characterization of human ES cells from FSHD embryos',NULL,'Genetic Disorder, Muscular Dystrophy, Skeletal/Smooth Muscle disorders','Oct 1, 2007','Sep 30, 2009','SEED Grant','Closed','University of California, Irvine','Embryonic Stem Cell','607200'),
('RS1-00283','Trophoblast differentiation of human ES cells.',NULL,'Fertility','Oct 1, 2007','Sep 30, 2009','SEED Grant','Closed','Sanford Burnham Prebys Medical Discovery Institute','Embryonic Stem Cell','696354'),
('RS1-00207','Human Embryonic Stem Cell Differentiation to Trophoblast: Basic Biology and Clinical Translation to Improve Human Fertility',NULL,'Fertility','Jul 1, 2007','Dec 31, 2009','SEED Grant','Closed','University of California, San Francisco','Embryonic Stem Cell','614784'),
('RS1-00169','Discovering Potent Molecules with Human ESCs to Treat Heart Disease',NULL,'Heart Disease','Jan 1, 2008','Jun 30, 2010','SEED Grant','Closed','Human BioMolecular Research Institute','Embryonic Stem Cell','688274'),
('RS1-00245','Cellular epigenetic diversity as a blueprint for defining the identity and functional potential of human embryonic stem cells',NULL,'','Aug 1, 2007','Jul 31, 2009','SEED Grant','Closed','University of California, Los Angeles','Embryonic Stem Cell','549698'),
('RS1-00288','Gene regulatory mechanisms that control spinal neuron differentiation from hES cells.',NULL,'Amyotrophic Lateral Sclerosis, Neurological Disorders, Spinal Muscular Atrophy','Oct 1, 2007','Sep 30, 2009','SEED Grant','Closed','Salk Institute for Biological Studies','Embryonic Stem Cell','704543'),
('RS1-00173','Combinatorial Platform for Optimizing Microenvironments to Control hESC Fate',NULL,'','Jul 1, 2007','Dec 31, 2009','SEED Grant','Closed','University of California, San Diego','Embryonic Stem Cell','577148'),
('RS1-00416','Production of Oocytes from Human ES Cells',NULL,'','Jul 1, 2007','Jun 30, 2010','SEED Grant','Closed','University of California, Irvine','Embryonic Stem Cell','385466'),
('RS1-00462','MicroRNAs in Human Stem Cell Differentiation and Mental Disorders',NULL,'Autism, Developmental Disorders, Neurological Disorders','Aug 1, 2007','Jan 31, 2010','SEED Grant','Closed','Gladstone Institutes, J. David','Embryonic Stem Cell','748800'),
('T3-00006','Training Program in Systems Biology of Stem Cells',NULL,'','Apr 1, 2006','Dec 30, 2009','Training Grant I-3','Closed','University of California, Santa Cruz','','1133701'),
('T3-00007','Training in the Biology of Human Enbryonic Stem Cells and Emerging Technologies',NULL,'','Apr 1, 2006','May 31, 2009','Training Grant I-3','Closed','Salk Institute for Biological Studies','','1261333'),
('T3-00009','UCSB Stem Cell Biology Training Program',NULL,'','Apr 1, 2006','Mar 31, 2010','Training Grant I-3','Closed','University of California, Santa Barbara','','975334'),
('T1-00001','Stanford CIRM Training Program',NULL,'','Apr 1, 2006','Mar 31, 2010','Training Grant I-1','Closed','Stanford University','','3035282'),
('T1-00002','Training Grant I',NULL,'','Apr 1, 2006','Mar 31, 2010','Training Grant I-1','Closed','University of California, San Francisco','','2868145'),
('T1-00003','Interdisciplinary Stem Cell Training Program at UCSD',NULL,'','Apr 1, 2006','Mar 31, 2010','Training Grant I-1','Closed','University of California, San Diego','','3459396'),
('T1-00004','CIRM Stem Cell Biology Training Grant',NULL,'','Apr 1, 2006','Mar 31, 2010','Training Grant I-1','Closed','University of Southern California','','2332431'),
('T1-00005','CIRM Type I Comprehensive Training Program',NULL,'','Apr 1, 2006','Nov 30, 2009','Training Grant I-1','Closed','University of California, Los Angeles','','3660398'),
('T1-00006','Stem Cell Research Training Grant',NULL,'','Apr 1, 2006','Mar 31, 2010','Training Grant I-1','Closed','University of California, Davis','','1780859'),
('T1-00007','Human Stem Cell Training at UC Berkeley and Childrens Hospital of Oakland',NULL,'','Apr 1, 2006','May 31, 2009','Training Grant I-1','Closed','University of California, Berkeley','','2360457'),
('T1-00008','Stem Cell Research Training Grant',NULL,'','Apr 1, 2006','Nov 30, 2009','Training Grant I-1','Closed','University of California, Irvine','','1935487'),
('T2-00001','Training Grant I',NULL,'','Apr 1, 2006','Mar 31, 2010','Training Grant I-2','Closed','Scripps Research Institute','','1021395'),
('T2-00003','Gladstone CIRM Scholar Program',NULL,'','Apr 1, 2006','Mar 31, 2010','Training Grant I-2','Closed','Gladstone Institutes, J. David','','2192073'),
('T2-00004','Burnham Institute CIRM Stem Cell Training Grant (Type II)',NULL,'','Apr 1, 2006','Aug 31, 2009','Training Grant I-2','Closed','Sanford Burnham Prebys Medical Discovery Institute','','1061865'),
('T2-00005','Training Grant 1',NULL,'','Apr 1, 2006','Mar 31, 2010','Training Grant I-2','Closed','Children\'s Hospital of Los Angeles','','2173872'),
('T2-00006','Training in Stem Cell Biology at CIT',NULL,'','Apr 1, 2006','Mar 31, 2010','Training Grant I-2','Closed','California Institute of Technology','','1817214');
